<http://bio2rdf.org/drugbank:DB00112>	<http://bio2rdf.org/drugbank_vocabulary:clearance>	<http://bio2rdf.org/drugbank_resource:893efa195cf56cf85e98a5c5f0867045> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:7fc0069b68f72ba58fdad65bec3cc1df> .
<http://bio2rdf.org/drugbank:DB00095>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/DB00095> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:8f7450a053d86ee89751c06a230561d0> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00091-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Melting-Point> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-8>	<http://purl.org/dc/terms/title>	"IUPAC Name: [(4-formyl-5-hydroxy-6-methylpyridin-3-yl)methoxy]phosphonic acid from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Hydrophobicity> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Formula> .
<http://bio2rdf.org/drugbank_resource:e39dd3e5ddfc2038fa77efd8d6d5305d>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:e39dd3e5ddfc2038fa77efd8d6d5305d"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/DB00091> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-3>	<http://bio2rdf.org/drugbank_vocabulary:value>	"51801.1"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/DB00093> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00090>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/DB00090> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Weight> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-18>	<http://purl.org/dc/terms/title>	"H Bond Acceptor Count: 12 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:451abb4a53a3d4bc5e17cc485a3899b3>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"480 ug/.8mL"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0000456>	<http://bio2rdf.org/drugbank_vocabulary:amino-acid-sequence>	">Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial precursor\nMAVCGLGSRLGLGSRLGLRGCFGAARLLYPRFQSRGPQGVEDGDRPQPSSKTPRIPKIYT\nKTGDKGFSSTFTGERRPKDDQVFEAVGTTDELSSAIGFALELVTEKGHTFAEELQKIQCT\nLQDVGSALATPCSSAREAHLKYTTFKAGPILELEQWIDKYTSQLPPLTAFILPSGGKISS\nALHFCRAVCRRAERRVVPLVQMGETDANVAKFLNRLSDYLFTLARYAAMKEGNQEKIYMK\nNDPSAESEGL"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00092>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/DB00092> .
<http://bio2rdf.org/drugbank:DB00090>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:8abd75317f3f7b8f7d56e3fe7d6204bd> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-13>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00116-13"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:bbf3cb3443969f24e50666e131185bd8>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:bbf3cb3443969f24e50666e131185bd8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-4>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00090-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-5>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00097-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00111>	<http://bio2rdf.org/drugbank_vocabulary:mechanism-of-action>	<http://bio2rdf.org/drugbank_resource:986ea485795ab092b3199f449ca4056e> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:773530fb248596d00289b12dba48a0cc> .
<http://bio2rdf.org/drugbank_resource:78c0a8b73fca87dcc5402f26970c94a4>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:78c0a8b73fca87dcc5402f26970c94a4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:mechanism-of-action>	<http://bio2rdf.org/drugbank_resource:98458df79187b81a7709036be48a75a4> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-1>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00099-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:5c103a2b0c3fce1acc1c2e135c6684bf>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"5c103a2b0c3fce1acc1c2e135c6684bf"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00103>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/DB00103> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-20>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00116-20"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:7a67baa1bb7b49a978b39d77e07946e0> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:77b52954fa911921450d2b426c1a7a3a> .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:locus>	"7q21-q22.1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:d46b970056d0a083cca1f813197ccf0c>	<http://purl.org/dc/terms/title>	"19.2 ug/.5mL Injection, solution form with intralesional; intramuscular; subcutaneous route"@en .
<http://bio2rdf.org/drugbank:DB00105>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/DB00105> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-3>	<http://purl.org/dc/terms/title>	"logS: -2.6 from ALOGPS"@en .
<http://bio2rdf.org/drugbank_resource:39094d4a5017cb7945c3ca22e421306d>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"39094d4a5017cb7945c3ca22e421306d"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00106>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/DB00106> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-3>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00096-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00102>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/DB00102> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"macromolecule metabolism"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00109>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/DB00109> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:807b0e58e0eead4b875202221ebe0f53> .
<http://bio2rdf.org/drugbank:DB00099>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:7975713dad73e24fab2cbb6c89586ea4> .
<http://bio2rdf.org/drugbank:DB00100>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/DB00100> .
<http://bio2rdf.org/drugbank:DB00107>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/DB00107> .
<http://bio2rdf.org/drugbank:DB00099>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/DB00099> .
<http://bio2rdf.org/drugbank_resource:3f54718d1deb0dbafe47e6e45eda5914>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:eb670a907e9a4e83aa692353515a741c> .
<http://bio2rdf.org/drugbank:DB00111>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/DB00111> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:7b6b9c68c4dd8e5a8f74e987f9a92ce7> .
<http://bio2rdf.org/drugbank:DB00099>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:787ef58546dc52c80027a1e3a2b925b9> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-5>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Formula: C2041H3136N558O641S25 [drugbank_resource:experimental-properties-DB00100-5]"@en .
<http://bio2rdf.org/drugbank:DB00113>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/DB00113> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:904bc2c9127fa8f18e0965559eecc60c> .
<http://bio2rdf.org/drugbank:DB00110>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/DB00110> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-15>	<http://bio2rdf.org/drugbank_vocabulary:value>	"292.76"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:7abeba6bed290a4b16075521bc0113ca> .
<http://bio2rdf.org/drugbank_resource:DB00115_DB00446>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-3>	<http://purl.org/dc/terms/title>	"Molecular Weight: 51801.1000"@en .
<http://bio2rdf.org/drugbank_resource:3f34afd99cc9695ee26d778d111874cf>	<http://purl.org/dc/terms/description>	"The elimination half-life following both intramuscular and subcutaneous injections was approximately 2 to 3 hours. The elimination half-life was approximately 2 hours following intravenous injection."@en .
<http://bio2rdf.org/drugbank_resource:3f34afd99cc9695ee26d778d111874cf>	<http://www.w3.org/2000/01/rdf-schema#label>	"half-life for drugbank:DB00105 [drugbank_resource:3f34afd99cc9695ee26d778d111874cf]"@en .
<http://bio2rdf.org/drugbank:DB00099>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:75aa077303c09d80af404a7a6c6ac735> .
<http://bio2rdf.org/drugbank_resource:81987a5783579e8eae4261b8d95226da>	<http://purl.org/dc/terms/title>	"indication for drugbank:DB00109"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-11>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-11"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00115_DB01394>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction> .
<http://bio2rdf.org/drugbank:DB00112>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/DB00112> .
<http://bio2rdf.org/drugbank_resource:592de4a57c1d28519d666f4b36fa6b2b>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:592de4a57c1d28519d666f4b36fa6b2b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/DB00117> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:80e4560d8a88ff69231ec21ee09506be> .
<http://bio2rdf.org/drugbank:DB00103>	<http://bio2rdf.org/drugbank_vocabulary:half-life>	<http://bio2rdf.org/drugbank_resource:99633b36b8289d3e0a8562067bd42c03> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/DB00116> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:theoretical-pi>	"9.09"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:81ce8d1a0627bc88956132de1e1a93c2> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-13>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00091-13"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:81ce8d1a0627bc88956132de1e1a93c2> .
<http://bio2rdf.org/drugbank:DB00102>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:76cc7a41e93863bcbab0bba32bc52311> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-6>	<http://www.w3.org/2000/01/rdf-schema#label>	"IUPAC Name: (2S)-6-amino-2-{[(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-13,16-dibenzyl-10-(2-carbamoylethyl)-7-(carbamoylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl]pyrrolidin-2-yl]formamido}-N-(carbamoylmethyl)hexanamide from ChemAxon [drugbank_resource:calculated-properties-DB00093-6]"@en .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/DB00114> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-26>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-26"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:mechanism-of-action>	<http://bio2rdf.org/drugbank_resource:85e4414ae6d2bc12695a4539100e286f> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB08879>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:DB00112_DB08879"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2619a21616645ee9827c33c6e2f65268>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"2619a21616645ee9827c33c6e2f65268"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/DB00115> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-3>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00116-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a02555c5c58332bf7ac5fef198a34814>	<http://purl.org/dc/terms/description>	"For the treatment of hairy cell leukemia, malignant melanoma, and AIDS-related Kaposi's sarcoma."@en .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:81ce8d1a0627bc88956132de1e1a93c2> .
<http://bio2rdf.org/drugbank_resource:e9f580ccd34b70a11720b2f316225025>	<http://purl.org/dc/terms/description>	"0.5 - 0.7 mL/minute/kg (SC administration of 3.45 mcg/kg and 11.5 mcg/kg in both normal subjects and cancer patients, Neupogen)"@en .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"monooxygenase activity"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:762a7c535540c35c3ec0a9932635da58>	<http://www.w3.org/2000/01/rdf-schema#label>	"absorption for drugbank:DB00106 [drugbank_resource:762a7c535540c35c3ec0a9932635da58]"@en .
<http://bio2rdf.org/drugbank_resource:574e7d1136f355daec35f6fd17ef29e5>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:574e7d1136f355daec35f6fd17ef29e5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:408e99a507da89ecb16b006481be4f7d>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:408e99a507da89ecb16b006481be4f7d"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-18>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-18"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:d025612c433b867a6ebb00b2532e2626>	<http://purl.org/dc/terms/description>	"Elimination half-life, healthy subjects and cancer patients, Neopogen = 3.5 hours;\r\nElimination half-life, cancer patients, tbo-filgrastim = 3.2-3.8 hours"@en .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/DB00118> .
<http://bio2rdf.org/drugbank_resource:e52e95d4f4c438c7fbf93397e39c26e3>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:e52e95d4f4c438c7fbf93397e39c26e3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2af3e19f02b1eb81db93222ed2b38a44>	<http://www.w3.org/2000/01/rdf-schema#label>	"mechanism-of-action for drugbank:DB00107 [drugbank_resource:2af3e19f02b1eb81db93222ed2b38a44]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-16>	<http://bio2rdf.org/drugbank_vocabulary:value>	"InChI=1S/C6H9N3O2/c7-5(6(10)11)1-4-2-8-3-9-4/h2-3,5H,1,7H2,(H,8,9)(H,10,11)/t5-/m0/s1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003533>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"monooxygenase activity"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3669e274097fc69149d3dbad3ba6b01c>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:3669e274097fc69149d3dbad3ba6b01c"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c0c3695e2cc0b1f8b2708aa4329a566e>	<http://www.w3.org/2000/01/rdf-schema#label>	"indication for drugbank:DB00099 [drugbank_resource:c0c3695e2cc0b1f8b2708aa4329a566e]"@en .
<http://bio2rdf.org/drugbank_vocabulary:e328a6cf619c4105669d93dc30d36096>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"P450 PB-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-3>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Vitamin-B-Complex>	<http://www.w3.org/2000/01/rdf-schema#label>	"Vitamin B Complex [drugbank_vocabulary:Vitamin-B-Complex]"@en .
<http://bio2rdf.org/drugbank:DB00114>	<http://www.w3.org/2000/01/rdf-schema#label>	"Pyridoxal Phosphate [drugbank:DB00114]"@en .
<http://bio2rdf.org/drugbank:DB00110>	<http://bio2rdf.org/drugbank_vocabulary:half-life>	<http://bio2rdf.org/drugbank_resource:8eb135a8f519839c5f289226017b68a3> .
<http://bio2rdf.org/drugbank_resource:24189bc5fb16bfce4551ecdfb0196def>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:24189bc5fb16bfce4551ecdfb0196def"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-16>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-16"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:7a67baa1bb7b49a978b39d77e07946e0> .
<http://bio2rdf.org/drugbank_resource:1c9905a95fe27572eaf4822554262551>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Absorption> .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"monooxygenase activity"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:0f3c814d30566a7614f1fab32f4e0302>	<http://www.w3.org/2000/01/rdf-schema#label>	"Fertinex [drugbank_vocabulary:0f3c814d30566a7614f1fab32f4e0302]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-11>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00091-11"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:e6be3ee899ac0f450592b2c5985631de>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:8ad571235d010ca525f3733fd9b517fb>	<http://bio2rdf.org/drugbank_vocabulary:company>	"Biogen Inc."^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-3>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Weight: 1007.1870 [drugbank_resource:experimental-properties-DB00107-3]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-2>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00093-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:97f751c9423321c8864c0243afcff111>	<http://www.w3.org/2000/01/rdf-schema#label>	"Imidolactams [drugbank_resource:97f751c9423321c8864c0243afcff111]"@en .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:773530fb248596d00289b12dba48a0cc> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-13>	<http://bio2rdf.org/drugbank_vocabulary:value>	"InChIKey=SFKQVVDKFKYTNA-YVGXZPIDNA-N"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:76cc7a41e93863bcbab0bba32bc52311>	<http://purl.org/dc/terms/title>	"100 ug/g Gel form with topical route"@en .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:locus>	"10q23.33"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-5>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00117-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-4>	<http://purl.org/dc/terms/title>	"Molecular Formula: C3160H4848N898O881S12"@en .
<http://bio2rdf.org/drugbank_resource:d56193a54171cd8858918adbb1b34e8c>	<http://www.w3.org/2000/01/rdf-schema#label>	"6-aminopurines [drugbank_resource:d56193a54171cd8858918adbb1b34e8c]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00116-1>	<http://www.w3.org/2000/01/rdf-schema#label>	"logP: -2.7 [drugbank_resource:experimental-properties-DB00116-1]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-2>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00094-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:6f3fc4bb7965f22f3fc655ec5e1faab0>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"6f3fc4bb7965f22f3fc655ec5e1faab0"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00109>	<http://bio2rdf.org/drugbank_vocabulary:indication>	<http://bio2rdf.org/drugbank_resource:81987a5783579e8eae4261b8d95226da> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:96b90ed2d49ca40e5c82fd787db32b84> .
<http://bio2rdf.org/drugbank_resource:e52e95d4f4c438c7fbf93397e39c26e3>	<http://purl.org/dc/terms/title>	"mechanism-of-action for drugbank:DB00093"@en .
<http://bio2rdf.org/drugbank_vocabulary:Supplements>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB03880>	<http://purl.org/dc/terms/title>	"DDI between Enfuvirtide and Batimastat - Enfuvirtide may increase the serum concentration of Protease Inhibitors. Protease Inhibitors may increase the serum concentration of Enfuvirtide."@en .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:96faa670b368b06113b9e58e3db1d86c> .
<http://bio2rdf.org/drugbank:DB00107>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:9ea94506ab138833cc18501d48712af4> .
<http://bio2rdf.org/drugbank_resource:1c9905a95fe27572eaf4822554262551>	<http://purl.org/dc/terms/description>	"74%"@en .
<http://bio2rdf.org/drugbank_resource:3eff294ae1a633c8845359753061fac9>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:3eff294ae1a633c8845359753061fac9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:half-life>	<http://bio2rdf.org/drugbank_resource:78c0a8b73fca87dcc5402f26970c94a4> .
<http://bio2rdf.org/drugbank_vocabulary:0f3c814d30566a7614f1fab32f4e0302>	<http://bio2rdf.org/drugbank_vocabulary:name>	"Fertinex"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:75aa077303c09d80af404a7a6c6ac735>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:75aa077303c09d80af404a7a6c6ac735"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-23>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00093-23"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00111>	<http://bio2rdf.org/drugbank_vocabulary:indication>	<http://bio2rdf.org/drugbank_resource:78fce134a0e754813388f2850f268625> .
<http://bio2rdf.org/drugbank_vocabulary:Vitamin-B-Complex>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:97f751c9423321c8864c0243afcff111> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-12>	<http://www.w3.org/2000/01/rdf-schema#label>	"InChI: InChI=1S/C15H22N6O5S/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/p+1/t7-,8+,10+,11+,14+,27?/m0/s1 from ChemAxon [drugbank_resource:calculated-properties-DB00118-12]"@en .
<http://bio2rdf.org/drugbank_vocabulary:Vasoconstrictor-Agents>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:9a71495dd3f52eed3f338a39501d4bfa> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-9>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00118-9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-2>	<http://bio2rdf.org/drugbank_vocabulary:value>	"9.09"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_vocabulary:Vitamins>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:70d5905dbbb671a2bf66275527b38e09>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:70d5905dbbb671a2bf66275527b38e09"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:773530fb248596d00289b12dba48a0cc>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"773530fb248596d00289b12dba48a0cc"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:8ae8b01597df174d257016596812aeab> .
<http://bio2rdf.org/drugbank:DB00110>	<http://bio2rdf.org/drugbank_vocabulary:indication>	<http://bio2rdf.org/drugbank_resource:80aadabf31c519e42d80748f499c7689> .
<http://bio2rdf.org/drugbank:BE0000456>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-22>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00118-22"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-1>	<http://purl.org/dc/terms/title>	"Hydrophobicity: -0.307"@en .
<http://bio2rdf.org/drugbank_vocabulary:908621b9e3153f791dd6dbd4ef6d62a5>	<http://www.w3.org/2000/01/rdf-schema#label>	"CEA-Scan [drugbank_vocabulary:908621b9e3153f791dd6dbd4ef6d62a5]"@en .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:gene-name>	"CYP3A5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-2>	<http://www.w3.org/2000/01/rdf-schema#label>	"Hydrophobicity: -0.431 [drugbank_resource:experimental-properties-DB00100-2]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-25>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00114-25"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Labor-Induction-Agents>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:3549163466db2fa5b979545848c2ef00>	<http://www.w3.org/2000/01/rdf-schema#label>	"Monoalkyl phosphate [drugbank_resource:3549163466db2fa5b979545848c2ef00]"@en .
<http://bio2rdf.org/drugbank:DB00100>	<http://bio2rdf.org/drugbank_vocabulary:half-life>	<http://bio2rdf.org/drugbank_resource:7aa53fec8bf96c3555379e2680167034> .
<http://bio2rdf.org/drugbank_vocabulary:Micronutrients>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:36cf3fe3b4f939b051085b627e517597>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:36cf3fe3b4f939b051085b627e517597"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:eda68d4a7955df0290c1f8b709e905ec>	<http://www.w3.org/2000/01/rdf-schema#label>	"mechanism-of-action for drugbank:DB00090 [drugbank_resource:eda68d4a7955df0290c1f8b709e905ec]"@en .
<http://bio2rdf.org/drugbank_resource:a7531086765fedefe82e0282f7a1d559>	<http://www.w3.org/2000/01/rdf-schema#label>	"Dicarboxylic acids and derivatives [drugbank_resource:a7531086765fedefe82e0282f7a1d559]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-6>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00114-6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Nutraceutical>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/chemspider:4575342>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/chemspider:4575342"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-25>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-25"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:8399ac082eecc289dcd0ff6ce9ff3420> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-4>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00102-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f84c0f373fd98f4297607f206aadd302>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"f84c0f373fd98f4297607f206aadd302"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Oxytocics>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_vocabulary:Conditionally-Essential-Amino-Acids>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:e6fc137e236497aea65dd3bb99d52e53>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:4880c0f12c06dd6d142e7a40b041bf1a> .
<http://bio2rdf.org/drugbank_vocabulary:Enzyme-Inhibitors>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:7a67baa1bb7b49a978b39d77e07946e0>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:7a67baa1bb7b49a978b39d77e07946e0"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Dietary-Supplements>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:1c9905a95fe27572eaf4822554262551>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0003533>	<http://www.w3.org/2000/01/rdf-schema#label>	"Cytochrome P450 2E1 [drugbank:BE0003533]"@en .
<http://bio2rdf.org/drugbank_resource:328c87b1ad60e7356c52d11e15011e6f>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#value>	"Ge healthcare"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:HIV-Fusion-Inhibitors>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00932>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:DB00109_DB00932"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:de11407327a5468776fbcbec28a97ca0>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:de11407327a5468776fbcbec28a97ca0"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:129ef94b8ca8b89a244a3cd1c5b2c72b>	<http://www.w3.org/2000/01/rdf-schema#label>	"1,2-diol [drugbank_resource:129ef94b8ca8b89a244a3cd1c5b2c72b]"@en .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:specific-function>	"Responsible for the metabolism of many drugs and environmental chemicals that it oxidizes. It is involved in the metabolism of drugs such as antiarrhythmics, adrenoceptor antagonists, and tricyclic antidepressants"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Gonadotropins>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:328c87b1ad60e7356c52d11e15011e6f>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"328c87b1ad60e7356c52d11e15011e6f"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Indicators-and-Reagents>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_vocabulary:Hematopoietic-Agents>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_vocabulary:Antifungal-Agents>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-27>	<http://www.w3.org/2000/01/rdf-schema#label>	"Rule of Five: 1 from ChemAxon [drugbank_resource:calculated-properties-DB00114-27]"@en .
<http://bio2rdf.org/drugbank_resource:e52e95d4f4c438c7fbf93397e39c26e3>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:e52e95d4f4c438c7fbf93397e39c26e3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Anti-tocolytic-Agents>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:DB00115_DB00446>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-22>	<http://purl.org/dc/terms/title>	"Physiological Charge: 1 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:585c665fefee46ff4931f369bfe6004a>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"585c665fefee46ff4931f369bfe6004a"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00115_DB01394>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00105>	<http://purl.org/dc/terms/title>	"Interferon Alfa-2b, Recombinant"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-31>	<http://www.w3.org/2000/01/rdf-schema#label>	"MDDR-Like Rule: 0 from ChemAxon [drugbank_resource:calculated-properties-DB00117-31]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-3>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00111-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:328c87b1ad60e7356c52d11e15011e6f>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:328c87b1ad60e7356c52d11e15011e6f"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-18>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00117-18"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-25>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-25"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00112>	<http://www.w3.org/2000/01/rdf-schema#label>	"Bevacizumab [drugbank:DB00112]"@en .
<http://bio2rdf.org/drugbank_resource:3afc1cd15f9de2a07db0081098265ac4>	<http://purl.org/dc/terms/title>	"50 mg/mL Injection form with intravenous route"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-2>	<http://www.w3.org/2000/01/rdf-schema#label>	"Melting Point: 287 dec \u00B0C from PhysProp [drugbank_resource:experimental-properties-DB00117-2]"@en .
<http://bio2rdf.org/drugbank_vocabulary:9e044243b5eb2f95578c80df6000ecdd>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/pdb:THL>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/pdb/THL> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:molecular-weight>	"55629.0"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:97f751c9423321c8864c0243afcff111>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:97f751c9423321c8864c0243afcff111"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-14>	<http://purl.org/dc/terms/title>	"Polar Surface Area (PSA): 405.32 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:7a67baa1bb7b49a978b39d77e07946e0>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"7a67baa1bb7b49a978b39d77e07946e0"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://purl.org/dc/terms/identifier>	"drugbank:DB00115"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-4>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00109-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:Angiogenesis-Inducing-Agents>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_vocabulary:Oxytocics>	<http://www.w3.org/2000/01/rdf-schema#label>	"Oxytocics [drugbank_vocabulary:Oxytocics]"@en .
<http://bio2rdf.org/drugbank_vocabulary:9e044243b5eb2f95578c80df6000ecdd>	<http://www.w3.org/2000/01/rdf-schema#label>	"Optison [drugbank_vocabulary:9e044243b5eb2f95578c80df6000ecdd]"@en .
<http://bio2rdf.org/drugbank:BE0002887>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-14>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00116-14"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Angiogenesis-Inhibitors>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:Angiogenesis-Inhibitors"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Anti-Testosterone-Agents>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:ff5b4bb2ae4fdc7811f87fd38c8b8eda>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"ff5b4bb2ae4fdc7811f87fd38c8b8eda"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8bb9fceb6f80460936af862e9f7d1d94>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:8bb9fceb6f80460936af862e9f7d1d94"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00097>	<http://purl.org/dc/terms/title>	"Choriogonadotropin alfa"@en .
<http://bio2rdf.org/drugbank_vocabulary:Angiogenesis-Inhibitors>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:Citanest-Dental>	<http://www.w3.org/2000/01/rdf-schema#label>	"Citanest Dental [drugbank_resource:Citanest-Dental]"@en .
<http://bio2rdf.org/drugbank_resource:cb386ea42baf8766a3e98e9d24d46516>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:cb386ea42baf8766a3e98e9d24d46516"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00118>	<http://purl.org/dc/terms/title>	"S-Adenosylmethionine"@en .
<http://bio2rdf.org/drugbank_resource:228bf0dff0e17c650e98e541c5291e94>	<http://purl.org/dc/terms/title>	"absorption for drugbank:DB00099"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-2>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00118-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:328c87b1ad60e7356c52d11e15011e6f>	<http://www.w3.org/2000/01/rdf-schema#label>	"manufacturer for drugbank:DB00096 [drugbank_resource:328c87b1ad60e7356c52d11e15011e6f]"@en .
<http://bio2rdf.org/drugbank_resource:2d76fb5dd0f39b41fe92dc87dd6a96d9>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:2d76fb5dd0f39b41fe92dc87dd6a96d9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00099_DB00290>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:DB00099_DB00290"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e8fbddfaa9a4fe87d9328de7cf8cd326>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:93c392ef94d70fc29c467d485b49f786> .
<http://bio2rdf.org/drugbank_resource:13bf7e351282b3c815c4b958aedb585f>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:13bf7e351282b3c815c4b958aedb585f"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:d46b970056d0a083cca1f813197ccf0c>	<http://www.w3.org/2000/01/rdf-schema#label>	"19.2 ug/.5mL Injection, solution form with intralesional; intramuscular; subcutaneous route [drugbank_resource:d46b970056d0a083cca1f813197ccf0c]"@en .
<http://bio2rdf.org/drugbank_vocabulary:705836a5549e0548d20a0ef04e009f28>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:amino-acid-sequence>	">Cytochrome P450 2C9\nMDSLVVLVLCLSCLLLLSLWRQSSGRGKLPPGPTPLPVIGNILQIGIKDISKSLTNLSKV\nYGPVFTLYFGLKPIVVLHGYEAVKEALIDLGEEFSGRGIFPLAERANRGFGIVFSNGKKW\nKEIRRFSLMTLRNFGMGKRSIEDRVQEEARCLVEELRKTKASPCDPTFILGCAPCNVICS\nIIFHKRFDYKDQQFLNLMEKLNENIKILSSPWIQICNNFSPIIDYFPGTHNKLLKNVAFM\nKSYILEKVKEHQESMDMNNPQDFIDCFLMKMEKEKHNQPSEFTIESLENTAVDLFGAGTE\nTTSTTLRYALLLLLKHPEVTAKVQEEIERVIGRNRSPCMQDRSHMPYTDAVVHEVQRYID\nLLPTSLPHAVTCDIKFRNYLIPKGTTILISLTSVLHDNKEFPNPEMFDPHHFLDEGGNFK\nKSKYFMPFSAGKRICVGEALAGMELFLFLTSILQNFNLKSLVDPKNLDTTPVVNGFASVP\nPFYQLCFIPV"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"BE0002638"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-4>	<http://bio2rdf.org/drugbank_vocabulary:value>	"C2029H3080N544O587S27"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:f6203f7c9646b21edf1fa81c5cdf94d1>	<http://www.w3.org/2000/01/rdf-schema#label>	"Sam-Sulfate [drugbank_vocabulary:f6203f7c9646b21edf1fa81c5cdf94d1]"@en .
<http://bio2rdf.org/drugbank_resource:f7f0a15346b2f02764550cb8d9f8ef30>	<http://www.w3.org/2000/01/rdf-schema#label>	"D-alpha-amino acids [drugbank_resource:f7f0a15346b2f02764550cb8d9f8ef30]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-8>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00107>	<http://bio2rdf.org/drugbank_vocabulary:absorption>	<http://bio2rdf.org/drugbank_resource:8683be48baa0e7d62758aed2d9ccf431> .
<http://bio2rdf.org/drugbank_resource:f7f0a15346b2f02764550cb8d9f8ef30>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:f7f0a15346b2f02764550cb8d9f8ef30"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:73192b1a02a81c1e485fb06abc6fdc61>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00089>	<http://purl.org/dc/terms/description>	"Capromab is a Murine IgG1 monoclonal 7E11-C5.3 antibody that recognizes prostate specific membrane antigen (PSMA \u2013 also known as glutamate carboxypeptidase 2) from prostate cancer cells and normal prostate tissue. It is linked to pendetide, a derivative of DTPA. Pendetide acts as a chelating agent for the radionuclide indium-111. Capromab is used to image the extent of prostate cancer."@en .
<http://bio2rdf.org/drugbank_resource:2970662836bc4a17c64d219c534d3f7e>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"2970662836bc4a17c64d219c534d3f7e"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-2>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00116-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:b508d1a45927588b684b5a6fd80aff2b>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:195ccf935d3c9947bcc17b096fdca329>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:195ccf935d3c9947bcc17b096fdca329"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:de11407327a5468776fbcbec28a97ca0>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:de11407327a5468776fbcbec28a97ca0"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00445>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:DB00112_DB00445"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-4>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Formula: C2029H3080N544O587S27 [drugbank_resource:experimental-properties-DB00103-4]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-4>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00113-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:80e4560d8a88ff69231ec21ee09506be>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"80e4560d8a88ff69231ec21ee09506be"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:36cf3fe3b4f939b051085b627e517597>	<http://www.w3.org/2000/01/rdf-schema#label>	"mechanism-of-action for drugbank:DB00097 [drugbank_resource:36cf3fe3b4f939b051085b627e517597]"@en .
<http://bio2rdf.org/drugbank_resource:285048a510ce36e96744886cc83cc631>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"400 mg/16mL"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00091-2>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00091-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-28>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00117-28"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB03880>	<http://www.w3.org/2000/01/rdf-schema#label>	"DDI between Enfuvirtide and Batimastat - Enfuvirtide may increase the serum concentration of Protease Inhibitors. Protease Inhibitors may increase the serum concentration of Enfuvirtide. [drugbank_resource:DB00109_DB03880]"@en .
<http://bio2rdf.org/drugbank_vocabulary:e328a6cf619c4105669d93dc30d36096>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:e328a6cf619c4105669d93dc30d36096"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-13>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00093-13"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"Post-proline cleaving enzyme"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-6>	<http://purl.org/dc/terms/title>	"Water Solubility: 5.70e+00 g/l from ALOGPS"@en .
<http://bio2rdf.org/drugbank_resource:b508d1a45927588b684b5a6fd80aff2b>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:b508d1a45927588b684b5a6fd80aff2b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-24>	<http://www.w3.org/2000/01/rdf-schema#label>	"Bioavailability: 1 from ChemAxon [drugbank_resource:calculated-properties-DB00118-24]"@en .
<http://bio2rdf.org/drugbank_resource:e4e539077bcedbc155e950cadab01679>	<http://purl.org/dc/terms/description>	"Enfuvirtide binds to the first heptad-repeat (HR1) in the gp41 subunit of the viral envelope glycoprotein and prevents the conformational changes required for the fusion of viral and cellular membranes. It works by disrupting the HIV-1 molecular machinery at the final stage of fusion with the target cell, preventing uninfected cells from becoming infected. Enfuvirtide is a biomimetic peptide that was rationally designed to mimic components of the HIV-1 fusion machinery and displace them, preventing normal fusion."@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-2>	<http://bio2rdf.org/drugbank_vocabulary:value>	"149 kDa"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:908621b9e3153f791dd6dbd4ef6d62a5>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_vocabulary:Biotech>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-14>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00091-14"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/BE0002148> .
<http://bio2rdf.org/drugbank_resource:38b20638a91b63e0378b18fb8d8f4c38>	<http://purl.org/dc/terms/title>	"Aminopyrimidine"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-3>	<http://bio2rdf.org/drugbank_vocabulary:value>	"12294.4"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:b15aa7d1fbce9f1563623833e416d8f7>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e9ee4548d6d10b87a4a259470fe32c97>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"e9ee4548d6d10b87a4a259470fe32c97"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00113>	<http://purl.org/dc/terms/identifier>	"drugbank:DB00113"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003612>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:8683be48baa0e7d62758aed2d9ccf431>	<http://www.w3.org/2000/01/rdf-schema#label>	"absorption for drugbank:DB00107 [drugbank_resource:8683be48baa0e7d62758aed2d9ccf431]"@en .
<http://bio2rdf.org/drugbank_resource:bf1a15ece689c3f449c06ebc0a90dae3>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"bf1a15ece689c3f449c06ebc0a90dae3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-3>	<http://bio2rdf.org/drugbank_vocabulary:value>	"8.46"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:fdb8e90f512977b9fb2141486454a079>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"fdb8e90f512977b9fb2141486454a079"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:4fcc6e9455872b18c21b74aa6b82db13>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"4fcc6e9455872b18c21b74aa6b82db13"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00106>	<http://bio2rdf.org/drugbank_vocabulary:absorption>	<http://bio2rdf.org/drugbank_resource:762a7c535540c35c3ec0a9932635da58> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:general-function>	"Involved in monooxygenase activity"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a9a65e43cdc103a1f769c3625b080c1d>	<http://www.w3.org/2000/01/rdf-schema#label>	"Secondary alcohol [drugbank_resource:a9a65e43cdc103a1f769c3625b080c1d]"@en .
<http://bio2rdf.org/drugbank_resource:ae52c40c7c1761e3027e159477756625>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:0e7611deb0124f99ac54f3684b112d25>	<http://www.w3.org/2000/01/rdf-schema#label>	"Monosaccharide [drugbank_resource:0e7611deb0124f99ac54f3684b112d25]"@en .
<http://bio2rdf.org/drugbank_resource:e8fbddfaa9a4fe87d9328de7cf8cd326>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:e8fbddfaa9a4fe87d9328de7cf8cd326"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:8ad571235d010ca525f3733fd9b517fb>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00110>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:DB00110"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ae0431719c906d80aa97a27025adc99f>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-20>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-20"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8f7450a053d86ee89751c06a230561d0>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-17>	<http://bio2rdf.org/drugbank_vocabulary:value>	"131.92"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:4d9d641daef8c178a249f1266f1150e5>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:4d9d641daef8c178a249f1266f1150e5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00117>	<http://www.w3.org/2002/07/owl#sameAs>	<http://identifiers.org/drugbank/DB00117> .
<http://bio2rdf.org/drugbank_vocabulary:8550beb9aaabcff323bdfeef04608bb8>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00116>	<http://www.w3.org/2002/07/owl#sameAs>	<http://identifiers.org/drugbank/DB00116> .
<http://bio2rdf.org/drugbank_resource:ad715d0a2b2bcdcad22b975675537588>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:904bc2c9127fa8f18e0965559eecc60c>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00114>	<http://www.w3.org/2002/07/owl#sameAs>	<http://identifiers.org/drugbank/DB00114> .
<http://bio2rdf.org/drugbank_resource:e04ee332a67fe1dea4752f0a68c0a6ee>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:93c392ef94d70fc29c467d485b49f786> .
<http://bio2rdf.org/drugbank_resource:1cb959cb5d30e328a863a3d9f64c120a>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:1cb959cb5d30e328a863a3d9f64c120a"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:47d86c7cb8687c843b27225a6715c3c1>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:47d86c7cb8687c843b27225a6715c3c1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ade41ed0b3f8ac2b059fa8aeb0cdbbb4>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-25>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00114-25"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003612>	<http://purl.org/dc/terms/identifier>	"drugbank:BE0003612"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-10>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-10"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Drug>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ad9e59297973dcc097c2400d81b7888b>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://www.w3.org/2002/07/owl#sameAs>	<http://identifiers.org/drugbank/DB00115> .
<http://bio2rdf.org/pdb:PLP>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/pdb/PLP> .
<http://bio2rdf.org/drugbank:DB00111>	<http://www.w3.org/2002/07/owl#sameAs>	<http://identifiers.org/drugbank/DB00111> .
<http://bio2rdf.org/drugbank:DB00113>	<http://www.w3.org/2002/07/owl#sameAs>	<http://identifiers.org/drugbank/DB00113> .
<http://bio2rdf.org/drugbank:DB00110>	<http://www.w3.org/2002/07/owl#sameAs>	<http://identifiers.org/drugbank/DB00110> .
<http://bio2rdf.org/drugbank_resource:c28ad3ee91a708824325b58f26c403a5>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"c28ad3ee91a708824325b58f26c403a5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-3>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-16>	<http://www.w3.org/2000/01/rdf-schema#label>	"Polarizability: 40.37 from ChemAxon [drugbank_resource:calculated-properties-DB00118-16]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-4>	<http://purl.org/dc/terms/title>	"logP: -0.55 from ALOGPS"@en .
<http://bio2rdf.org/drugbank_vocabulary:8550beb9aaabcff323bdfeef04608bb8>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-6>	<http://purl.org/dc/terms/title>	"logP: -3.1 from ALOGPS"@en .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"BE0002363"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Anti-tocolytic-Agents>	<http://www.w3.org/2000/01/rdf-schema#label>	"Anti-tocolytic Agents [drugbank_vocabulary:Anti-tocolytic-Agents]"@en .
<http://bio2rdf.org/drugbank:DB00112>	<http://www.w3.org/2002/07/owl#sameAs>	<http://identifiers.org/drugbank/DB00112> .
<http://bio2rdf.org/drugbank:BE0003612>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Enzyme> .
<http://bio2rdf.org/drugbank:DB00105>	<http://www.w3.org/2002/07/owl#sameAs>	<http://identifiers.org/drugbank/DB00105> .
<http://bio2rdf.org/drugbank_resource:9ea94506ab138833cc18501d48712af4>	<http://www.w3.org/2000/01/rdf-schema#label>	"10 [iU]/mL Injection form with intravenous route [drugbank_resource:9ea94506ab138833cc18501d48712af4]"@en .
<http://bio2rdf.org/drugbank_resource:3afc1cd15f9de2a07db0081098265ac4>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:3afc1cd15f9de2a07db0081098265ac4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pdb:SAM>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/pdb/SAM> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00106-1>	<http://bio2rdf.org/drugbank_vocabulary:value>	"1416.06"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:f31c373ea0d5f6b6f514f58cf30652a6>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:f31c373ea0d5f6b6f514f58cf30652a6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8e7e8f5ff3cf3466586b956d7330151b>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:29ad2163821ce9d547ef52b7bddcf404>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:29ad2163821ce9d547ef52b7bddcf404"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-28>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00114-28"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00106>	<http://www.w3.org/2002/07/owl#sameAs>	<http://identifiers.org/drugbank/DB00106> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-4>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00118-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00102>	<http://www.w3.org/2002/07/owl#sameAs>	<http://identifiers.org/drugbank/DB00102> .
<http://bio2rdf.org/drugbank_resource:55694a43ccf43a29349054f94c2ce2e7>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"55694a43ccf43a29349054f94c2ce2e7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00109>	<http://www.w3.org/2002/07/owl#sameAs>	<http://identifiers.org/drugbank/DB00109> .
<http://bio2rdf.org/drugbank:DB00100>	<http://www.w3.org/2002/07/owl#sameAs>	<http://identifiers.org/drugbank/DB00100> .
<http://bio2rdf.org/drugbank_vocabulary:Indicators-and-Reagents>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"Indicators-and-Reagents"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00107>	<http://www.w3.org/2002/07/owl#sameAs>	<http://identifiers.org/drugbank/DB00107> .
<http://bio2rdf.org/pdb:CNC>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/pdb/CNC> .
<http://bio2rdf.org/drugbank_resource:8eb135a8f519839c5f289226017b68a3>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00099>	<http://www.w3.org/2002/07/owl#sameAs>	<http://identifiers.org/drugbank/DB00099> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Enzyme> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"electron transport"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in>	<http://bio2rdf.org/drugbank_resource:DB00115_DB00446> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Enzyme> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in>	<http://bio2rdf.org/drugbank_resource:DB00115_DB01394> .
<http://bio2rdf.org/pdb:HIS>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/pdb/HIS> .
<http://bio2rdf.org/drugbank_vocabulary:73192b1a02a81c1e485fb06abc6fdc61>	<http://purl.org/dc/terms/title>	"Sangcya"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-4>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"electron transport"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Enzyme> .
<http://bio2rdf.org/drugbank:DB00103>	<http://www.w3.org/2002/07/owl#sameAs>	<http://identifiers.org/drugbank/DB00103> .
<http://bio2rdf.org/drugbank_resource:abc4b12d5153eba9af71c2c651bd4ff1>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"electron transport"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:85e4414ae6d2bc12695a4539100e286f>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:85e4414ae6d2bc12695a4539100e286f"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8c59273d79bb6ce81fe2a4c0596fa577>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_vocabulary:Conditionally-Essential-Amino-Acids>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:Conditionally-Essential-Amino-Acids"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00091>	<http://www.w3.org/2002/07/owl#sameAs>	<http://identifiers.org/drugbank/DB00091> .
<http://bio2rdf.org/drugbank:DB00093>	<http://www.w3.org/2002/07/owl#sameAs>	<http://identifiers.org/drugbank/DB00093> .
<http://bio2rdf.org/drugbank_resource:8bb9fceb6f80460936af862e9f7d1d94>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_vocabulary:908621b9e3153f791dd6dbd4ef6d62a5>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00090>	<http://www.w3.org/2002/07/owl#sameAs>	<http://identifiers.org/drugbank/DB00090> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-13>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-13"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00103>	<http://www.w3.org/2000/01/rdf-schema#label>	"Agalsidase beta [drugbank:DB00103]"@en .
<http://bio2rdf.org/drugbank_resource:a9a65e43cdc103a1f769c3625b080c1d>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:aa57c62e2e58943f3ce466339bbf00eb>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c007cc919bf71767e61e0b111723c84f>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:c007cc919bf71767e61e0b111723c84f"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"CYPIID6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a9ee55eb5c1344c6ecd656006a4e92f2>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"electron transport"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00092>	<http://www.w3.org/2002/07/owl#sameAs>	<http://identifiers.org/drugbank/DB00092> .
<http://bio2rdf.org/drugbank:DB00097>	<http://www.w3.org/2002/07/owl#sameAs>	<http://identifiers.org/drugbank/DB00097> .
<http://bio2rdf.org/drugbank_resource:d8c37e1ee64fc7f014205837681e99df>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:d8c37e1ee64fc7f014205837681e99df"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-7>	<http://www.w3.org/2000/01/rdf-schema#label>	"Traditional IUPAC Name: SAMe from ChemAxon [drugbank_resource:calculated-properties-DB00118-7]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-28>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00091-28"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-5>	<http://purl.org/dc/terms/title>	"Molecular Formula: C6398H9900N1714O1995S54"@en .
<http://bio2rdf.org/drugbank_resource:3d51d314e6796004243d124d2c5f0793>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:00f0949724208fef8aa81b619295e0b2> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-17>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-17"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00096>	<http://www.w3.org/2002/07/owl#sameAs>	<http://identifiers.org/drugbank/DB00096> .
<http://bio2rdf.org/drugbank_resource:e650b92d5679a4bc966570691fe2d7e4>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:e650b92d5679a4bc966570691fe2d7e4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:8ad571235d010ca525f3733fd9b517fb>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00094>	<http://www.w3.org/2002/07/owl#sameAs>	<http://identifiers.org/drugbank/DB00094> .
<http://bio2rdf.org/drugbank_resource:a9a58af69a8539d913c65b788eb5b178>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-1>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00088-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00095>	<http://www.w3.org/2002/07/owl#sameAs>	<http://identifiers.org/drugbank/DB00095> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00762>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00112_DB00762"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:0d54035b86f9a43f56ecd493c3a6fd59>	<http://purl.org/dc/terms/title>	"Benzenoids"@en .
<http://bio2rdf.org/drugbank_resource:e04ee332a67fe1dea4752f0a68c0a6ee>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:e04ee332a67fe1dea4752f0a68c0a6ee"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:893efa195cf56cf85e98a5c5f0867045>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:8abd75317f3f7b8f7d56e3fe7d6204bd>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:a9516c15b2a67882efd5c7a4c1fa6de4>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-1>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00097-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:225393798d1f4d7a00af1d777e454e22>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"225393798d1f4d7a00af1d777e454e22"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8bb9fceb6f80460936af862e9f7d1d94>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"8bb9fceb6f80460936af862e9f7d1d94"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00105>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Biotech> .
<http://bio2rdf.org/drugbank:DB00110>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug> .
<http://bio2rdf.org/drugbank_resource:ffc8ae70d9900ffb750da168c0f58cc5>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:ffc8ae70d9900ffb750da168c0f58cc5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00109>	<http://www.w3.org/2000/01/rdf-schema#label>	"Enfuvirtide [drugbank:DB00109]"@en .
<http://bio2rdf.org/drugbank:DB00106>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Biotech> .
<http://bio2rdf.org/drugbank:DB00111>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug> .
<http://bio2rdf.org/drugbank_resource:8ae8b01597df174d257016596812aeab>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-21>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00117-21"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/drugbank_vocabulary:locus>	"10q24.1-q24.3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ba0f878619b43a5be9083f01d8ba77fd>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:ba0f878619b43a5be9083f01d8ba77fd"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00112>	<http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in>	<http://bio2rdf.org/drugbank_resource:DB00112_DB08879> .
<http://bio2rdf.org/drugbank_resource:81987a5783579e8eae4261b8d95226da>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:81987a5783579e8eae4261b8d95226da"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00107>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Biotech> .
<http://bio2rdf.org/drugbank:DB00089>	<http://www.w3.org/2002/07/owl#sameAs>	<http://identifiers.org/drugbank/DB00089> .
<http://bio2rdf.org/drugbank:DB00112>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug> .
<http://bio2rdf.org/drugbank_vocabulary:Small-molecule>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"Small-molecule"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:592de4a57c1d28519d666f4b36fa6b2b>	<http://purl.org/dc/terms/title>	"indication for drugbank:DB00100"@en .
<http://bio2rdf.org/drugbank_resource:1c9905a95fe27572eaf4822554262551>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:1c9905a95fe27572eaf4822554262551"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00088>	<http://www.w3.org/2002/07/owl#sameAs>	<http://identifiers.org/drugbank/DB00088> .
<http://bio2rdf.org/drugbank:DB00109>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Biotech> .
<http://bio2rdf.org/drugbank:DB00113>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug> .
<http://bio2rdf.org/drugbank_resource:6d460a13d1af93268984ab262cef479d>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"6d460a13d1af93268984ab262cef479d"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8750c04d33b8546006e83e736eb80647>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:a8454a4c3a73e4a65b3965d9947cc4bd>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00099>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Biotech> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-21>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00117-21"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00114>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug> .
<http://bio2rdf.org/drugbank:DB00090>	<http://purl.org/dc/terms/title>	"Laronidase"@en .
<http://bio2rdf.org/drugbank_resource:a7531086765fedefe82e0282f7a1d559>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00100>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Biotech> .
<http://bio2rdf.org/drugbank:DB00115>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug> .
<http://bio2rdf.org/drugbank_resource:87f0fe251ba4940236c1e30de121922a>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-5>	<http://www.w3.org/2000/01/rdf-schema#label>	"logS: -1.6 from ALOGPS [drugbank_resource:calculated-properties-DB00114-5]"@en .
<http://bio2rdf.org/drugbank:DB00102>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Biotech> .
<http://bio2rdf.org/drugbank_resource:fe2051219bbed1c3f26d756ec49dea95>	<http://purl.org/dc/terms/title>	"Methionine or derivatives"@en .
<http://bio2rdf.org/drugbank:DB00116>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00503>	<http://purl.org/dc/terms/title>	"DDI between Enfuvirtide and Ritonavir - May increase the serum concentration of Protease Inhibitors. Protease Inhibitors may increase the serum concentration of Enfuvirtide."@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-2>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00088-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00103>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Biotech> .
<http://bio2rdf.org/drugbank:DB00117>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug> .
<http://bio2rdf.org/drugbank_resource:88491d7d06bc30fa9586740372808b10>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:a78396bd0ab3d3f25852a0d4008cbdf4>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-16>	<http://bio2rdf.org/drugbank_vocabulary:value>	"329.23"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:molecular-weight>	"80764.0"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:fba31fe582cac619f85335c144278e17>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:fba31fe582cac619f85335c144278e17"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00099>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug> .
<http://bio2rdf.org/drugbank:DB00118>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00100>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug> .
<http://bio2rdf.org/drugbank:DB00118>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Small-molecule> .
<http://bio2rdf.org/drugbank_resource:c7f12f71253c5095c8df9050b7b42f2c>	<http://www.w3.org/2000/01/rdf-schema#label>	"Primary amine [drugbank_resource:c7f12f71253c5095c8df9050b7b42f2c]"@en .
<http://bio2rdf.org/drugbank:DB00102>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug> .
<http://bio2rdf.org/drugbank:DB00103>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug> .
<http://bio2rdf.org/drugbank_resource:85745be17d6c5d398a5d3540508f1a44>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:9a71495dd3f52eed3f338a39501d4bfa>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:9a71495dd3f52eed3f338a39501d4bfa"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00110>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Biotech> .
<http://bio2rdf.org/drugbank:DB00105>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug> .
<http://bio2rdf.org/drugbank:DB00111>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Biotech> .
<http://bio2rdf.org/drugbank:DB00106>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug> .
<http://bio2rdf.org/drugbank_resource:85e4414ae6d2bc12695a4539100e286f>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:a61e3adec088927f97197e2f1513790d>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00112>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Biotech> .
<http://bio2rdf.org/drugbank:DB00107>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug> .
<http://bio2rdf.org/drugbank:DB00116>	<http://purl.org/dc/terms/description>	"Tetrahydrofolic acid is a folic acid derivative. It is produced from dihydrofolic acid by dihydrofolate reductase.\r\nIt is converted into 5,10-methylenetetrahydrofolate by serine hydroxymethyltransferase. It is a coenzyme in many reactions, especially in the metabolism of amino acids and nucleic acids. It acts as a donor of a group with one carbon atom. It gets this carbon atom by sequestering formaldehyde produced in other processes."@en .
<http://bio2rdf.org/drugbank_resource:8683be48baa0e7d62758aed2d9ccf431>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:a6317c6254a0737c350d2f0860ea1ec3>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00113>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Biotech> .
<http://bio2rdf.org/drugbank_vocabulary:705836a5549e0548d20a0ef04e009f28>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00109>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug> .
<http://bio2rdf.org/drugbank_resource:a6302cf127669e87e24a75b24552a9e8>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2ddeeca2fe9449969ab1519d768237c6>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:2ddeeca2fe9449969ab1519d768237c6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00090>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug> .
<http://bio2rdf.org/drugbank_vocabulary:Anti-tocolytic-Agents>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00091>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug> .
<http://bio2rdf.org/drugbank_vocabulary:Antifungal-Agents>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-17>	<http://purl.org/dc/terms/title>	"Rotatable Bond Count: 9 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:a5a6248bbc8b4dd7520b62e64aa85462>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00088>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Biotech> .
<http://bio2rdf.org/drugbank:DB00092>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug> .
<http://bio2rdf.org/drugbank_vocabulary:705836a5549e0548d20a0ef04e009f28>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"705836a5549e0548d20a0ef04e009f28"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00089>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Biotech> .
<http://bio2rdf.org/drugbank_vocabulary:73192b1a02a81c1e485fb06abc6fdc61>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00093>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug> .
<http://bio2rdf.org/drugbank_resource:8399ac082eecc289dcd0ff6ce9ff3420>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00094>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug> .
<http://bio2rdf.org/drugbank_resource:a57533055c136af9a471684ba442d058>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-4>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00095>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug> .
<http://bio2rdf.org/drugbank_resource:a6317c6254a0737c350d2f0860ea1ec3>	<http://www.w3.org/2000/01/rdf-schema#label>	"indication for drugbank:DB00113 [drugbank_resource:a6317c6254a0737c350d2f0860ea1ec3]"@en .
<http://bio2rdf.org/drugbank:DB00089>	<http://purl.org/dc/terms/title>	"Capromab"@en .
<http://bio2rdf.org/drugbank:DB00096>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug> .
<http://bio2rdf.org/drugbank_resource:a595cc1c66cf7314ca9d50542e429c85>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2696048bf20ed0e2d578eb2938c6d8d3>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:2696048bf20ed0e2d578eb2938c6d8d3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:1f87ebefeca8e494680a6a81334c6078>	<http://purl.org/dc/terms/description>	"11-38 days"@en .
<http://bio2rdf.org/drugbank:DB00097>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug> .
<http://bio2rdf.org/drugbank_resource:84c4d4608be206e204e18bc4fee8d4a9>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00116-1>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00116-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00094>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Biotech> .
<http://bio2rdf.org/drugbank_vocabulary:9e044243b5eb2f95578c80df6000ecdd>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00095>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Biotech> .
<http://bio2rdf.org/drugbank_resource:84e1544b4af68672a960baf683724f87>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-14>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00093-14"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00096>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Biotech> .
<http://bio2rdf.org/drugbank_resource:81ce8d1a0627bc88956132de1e1a93c2>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:376c6e6cad258f51a802ccce8c53ca4c>	<http://purl.org/dc/terms/title>	"manufacturer for drugbank:DB00106"@en .
<http://bio2rdf.org/drugbank:DB00097>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Biotech> .
<http://bio2rdf.org/drugbank:DB00090>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Biotech> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-11>	<http://bio2rdf.org/drugbank_vocabulary:value>	"C15H23N6O5S"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01072>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:DB00109_DB01072"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:e78186eb12eeaebda8a530a67513beea>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:e78186eb12eeaebda8a530a67513beea"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Angiogenesis-Inducing-Agents>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a2d4a403a964b1f3a6d6fa73cb73921a>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00099_DB00290>	<http://www.w3.org/2000/01/rdf-schema#label>	"DDI between Filgrastim and Bleomycin - Filgrastim may enhance the adverse/toxic effect of Bleomycin. Specifically, the risk for pulmonary toxicity may be increased. [drugbank_resource:DB00099_DB00290]"@en .
<http://bio2rdf.org/drugbank:DB00092>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Biotech> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00088>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug> .
<http://bio2rdf.org/drugbank_vocabulary:Angiogenesis-Inhibitors>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a39e93df12255155561f3d4acd297da8>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-5>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:ffb414ea32db58bec7ec3339a42c9dee>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:Anti-Testosterone-Agents>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00089>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug> .
<http://bio2rdf.org/drugbank_vocabulary:fa342aed686575ef39a8ec9dc16cbab4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Name> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00114-3>	<http://www.w3.org/2000/01/rdf-schema#label>	"logP: -1.2 [drugbank_resource:experimental-properties-DB00114-3]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00116-1>	<http://purl.org/dc/terms/title>	"logP: -2.7"@en .
<http://bio2rdf.org/drugbank_vocabulary:Labor-Induction-Agents>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00090>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00445>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:DB00112_DB00445"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00093>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Small-molecule> .
<http://bio2rdf.org/drugbank_resource:8c59273d79bb6ce81fe2a4c0596fa577>	<http://purl.org/dc/terms/title>	"Vinylogous amide"@en .
<http://bio2rdf.org/drugbank:DB00091>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:f6203f7c9646b21edf1fa81c5cdf94d1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Name> .
<http://bio2rdf.org/drugbank_vocabulary:Micronutrients>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00092>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:e04ee332a67fe1dea4752f0a68c0a6ee>	<http://purl.org/dc/terms/title>	"300 ug/.5mL Injection, solution form with intravenous route"@en .
<http://bio2rdf.org/drugbank_resource:1cb2d5b9df573a57849083d75e49a5fe>	<http://purl.org/dc/terms/title>	"Hydroxypyridines"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-15>	<http://purl.org/dc/terms/title>	"pKa (strongest basic): 8.77 from ChemAxon"@en .
<http://bio2rdf.org/drugbank:DB00091>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Small-molecule> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-2>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00109-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00118>	<http://www.w3.org/2002/07/owl#sameAs>	<http://identifiers.org/drugbank/DB00118> .
<http://bio2rdf.org/drugbank:DB00093>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:a2615bbb5710b9b992785e63c058b3db>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-2>	<http://www.w3.org/2000/01/rdf-schema#label>	"logP: -1.1 from ALOGPS [drugbank_resource:calculated-properties-DB00093-2]"@en .
<http://bio2rdf.org/drugbank_resource:1f87ebefeca8e494680a6a81334c6078>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:1f87ebefeca8e494680a6a81334c6078"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:d46b970056d0a083cca1f813197ccf0c>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"d46b970056d0a083cca1f813197ccf0c"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00094>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-7>	<http://purl.org/dc/terms/title>	"Traditional IUPAC Name: SAMe from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:80e4560d8a88ff69231ec21ee09506be>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_vocabulary:Nutraceutical>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-1>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00092-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00095>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:fa342aed686575ef39a8ec9dc16cbab4>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:fa342aed686575ef39a8ec9dc16cbab4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:f6203f7c9646b21edf1fa81c5cdf94d1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:Oxytocics>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00096>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:1fc54dd8ec20644e59a52e0b31197dd9>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:1fc54dd8ec20644e59a52e0b31197dd9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00097>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:81987a5783579e8eae4261b8d95226da>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-9>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00114-9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:84c4d4608be206e204e18bc4fee8d4a9>	<http://purl.org/dc/terms/title>	"Cobalamin derivatives"@en .
<http://bio2rdf.org/drugbank_vocabulary:Conditionally-Essential-Amino-Acids>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-5>	<http://purl.org/dc/terms/title>	"logP: -5.8 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_vocabulary:Dietary-Supplements>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a02555c5c58332bf7ac5fef198a34814>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:fa342aed686575ef39a8ec9dc16cbab4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:Enzyme-Inhibitors>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:ffb414ea32db58bec7ec3339a42c9dee>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Name> .
<http://bio2rdf.org/drugbank_resource:Xylonest-Octapressin>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e9ee4548d6d10b87a4a259470fe32c97>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:e9ee4548d6d10b87a4a259470fe32c97"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c2dbd6b14df7875575496a70dff7a209>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"c2dbd6b14df7875575496a70dff7a209"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-21>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-21"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:57db98e1612a44845256ccbbbc457ff8>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:57db98e1612a44845256ccbbbc457ff8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2970662836bc4a17c64d219c534d3f7e>	<http://purl.org/dc/terms/title>	"Methionine and derivatives"@en .
<http://bio2rdf.org/drugbank_vocabulary:Gonadotropins>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-26>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00114-26"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e04ee332a67fe1dea4752f0a68c0a6ee>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:fa632501828d57a2c1fda712393a3927> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-15>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-15"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:HIV-Fusion-Inhibitors>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:7fc0069b68f72ba58fdad65bec3cc1df>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:64b9dc4a304f0bbee322be682a49f08b>	<http://purl.org/dc/terms/title>	"Organic phosphoric acid derivative"@en .
<http://bio2rdf.org/drugbank_vocabulary:Hematopoietic-Agents>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00088>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-9>	<http://purl.org/dc/terms/title>	"Monoisotopic Weight: 445.170981503 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_vocabulary:Indicators-and-Reagents>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00089>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:55694a43ccf43a29349054f94c2ce2e7>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:55694a43ccf43a29349054f94c2ce2e7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:80aadabf31c519e42d80748f499c7689>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00110>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-14>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00118-14"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:807b0e58e0eead4b875202221ebe0f53>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00111>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:451abb4a53a3d4bc5e17cc485a3899b3>	<http://www.w3.org/2000/01/rdf-schema#label>	"480 ug/.8mL Injection, solution form with subcutaneous route [drugbank_resource:451abb4a53a3d4bc5e17cc485a3899b3]"@en .
<http://bio2rdf.org/drugbank:DB00112>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00116>	<http://www.w3.org/2000/01/rdf-schema#label>	"Tetrahydrofolic acid [drugbank:DB00116]"@en .
<http://bio2rdf.org/drugbank_resource:7abeba6bed290a4b16075521bc0113ca>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00113>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00116>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Small-molecule> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-17>	<http://www.w3.org/2000/01/rdf-schema#label>	"Rotatable Bond Count: 9 from ChemAxon [drugbank_resource:calculated-properties-DB00116-17]"@en .
<http://bio2rdf.org/drugbank_resource:7b6b9c68c4dd8e5a8f74e987f9a92ce7>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00114>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00117>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Small-molecule> .
<http://bio2rdf.org/drugbank_resource:ad9e59297973dcc097c2400d81b7888b>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:ad9e59297973dcc097c2400d81b7888b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3f54718d1deb0dbafe47e6e45eda5914>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:3f54718d1deb0dbafe47e6e45eda5914"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:9e044243b5eb2f95578c80df6000ecdd>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:9e044243b5eb2f95578c80df6000ecdd"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-9>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00091-9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00114>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Small-molecule> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-3>	<http://bio2rdf.org/drugbank_vocabulary:value>	"55597.4"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank:DB00116>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00115>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Small-molecule> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-15>	<http://purl.org/dc/terms/title>	"Refractivity: 96.23 from ChemAxon"@en .
<http://bio2rdf.org/drugbank:DB00117>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-11>	<http://www.w3.org/2000/01/rdf-schema#label>	"Traditional IUPAC Name: L-histidine from ChemAxon [drugbank_resource:calculated-properties-DB00117-11]"@en .
<http://bio2rdf.org/drugbank_resource:55842b12e140e13ee25b3a59430d097e>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"55842b12e140e13ee25b3a59430d097e"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-22>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00116-22"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:904bc2c9127fa8f18e0965559eecc60c>	<http://purl.org/dc/terms/title>	"25 mg Capsule, liquid filled form with oral route"@en .
<http://bio2rdf.org/drugbank:DB00118>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug> .
<http://bio2rdf.org/drugbank_resource:31af673f5d82841086059243563cd4c6>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"31af673f5d82841086059243563cd4c6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00099>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:e328a6cf619c4105669d93dc30d36096>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_vocabulary:Supplements>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00100>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:Vasoconstrictor-Agents>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00102>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:78fce134a0e754813388f2850f268625>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_vocabulary:Vitamin-B-Complex>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00103>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00105>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-3>	<http://purl.org/dc/terms/title>	"Isoelectric Point: 5.99"@en .
<http://bio2rdf.org/drugbank_vocabulary:e6be3ee899ac0f450592b2c5985631de>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:7975713dad73e24fab2cbb6c89586ea4>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_vocabulary:Vitamins>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00106>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:f7f0a15346b2f02764550cb8d9f8ef30>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:f7f0a15346b2f02764550cb8d9f8ef30"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00102>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:DB00102"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:7aa53fec8bf96c3555379e2680167034>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00107>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:8399ac082eecc289dcd0ff6ce9ff3420>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:8399ac082eecc289dcd0ff6ce9ff3420"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:7a67baa1bb7b49a978b39d77e07946e0>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-28>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00117-28"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB01177>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00112_DB01177"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00109>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0000456>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial precursor"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-4>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-20>	<http://bio2rdf.org/drugbank_vocabulary:value>	"11.39"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:131ed90e7634d72c92f27daf9a85454a>	<http://www.w3.org/2000/01/rdf-schema#label>	"indication for drugbank:DB00091 [drugbank_resource:131ed90e7634d72c92f27daf9a85454a]"@en .
<http://bio2rdf.org/drugbank_resource:e02568426e5e3817cd6fcddc8dee4bee>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"e02568426e5e3817cd6fcddc8dee4bee"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-19>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00115-19"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ffe7ffbc4b8e341c6b137f185bb434e0>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:ffe7ffbc4b8e341c6b137f185bb434e0"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:77b52954fa911921450d2b426c1a7a3a>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:f2540530a3858d9fa40e7bfd96e4c77d>	<http://www.w3.org/2000/01/rdf-schema#label>	"Organometallic compound [drugbank_resource:f2540530a3858d9fa40e7bfd96e4c77d]"@en .
<http://bio2rdf.org/drugbank_resource:7767fecbc1fcbba1764734e284afdd13>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:7a67baa1bb7b49a978b39d77e07946e0>	<http://www.w3.org/2000/01/rdf-schema#label>	"N-glycosyl compound [drugbank_resource:7a67baa1bb7b49a978b39d77e07946e0]"@en .
<http://bio2rdf.org/drugbank_resource:787ef58546dc52c80027a1e3a2b925b9>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-8>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00117-8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00107_DB00917>	<http://www.w3.org/2000/01/rdf-schema#label>	"DDI between Oxytocin and Dinoprostone - May enhance the adverse/toxic effect of Oxytocin. Specifically,oxytocic effects may be enhanced. [drugbank_resource:DB00107_DB00917]"@en .
<http://bio2rdf.org/drugbank_resource:78c0a8b73fca87dcc5402f26970c94a4>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:6ac630c499c16fd6e1f2a125e397688a>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:6ac630c499c16fd6e1f2a125e397688a"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-9>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:70d5905dbbb671a2bf66275527b38e09>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"70d5905dbbb671a2bf66275527b38e09"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a8454a4c3a73e4a65b3965d9947cc4bd>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"a8454a4c3a73e4a65b3965d9947cc4bd"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:98458df79187b81a7709036be48a75a4>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:98458df79187b81a7709036be48a75a4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-8>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00093-8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:theoretical-pi>	"8.62"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:75aa077303c09d80af404a7a6c6ac735>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-23>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:762a7c535540c35c3ec0a9932635da58>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-6>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-22>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/drugbank_vocabulary:general-function>	"Involved in monooxygenase activity"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:76cc7a41e93863bcbab0bba32bc52311>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:1cb2d5b9df573a57849083d75e49a5fe>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"1cb2d5b9df573a57849083d75e49a5fe"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00107_DB00929>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:DB00107_DB00929"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-25>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/chemspider:4575342>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"4575342"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:6826daa495527ec54b81079e04e89d24>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:6826daa495527ec54b81079e04e89d24"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:b86c00de25382c6ce4d94dae5e4502db>	<http://www.w3.org/2000/01/rdf-schema#label>	"Benzoyl [drugbank_resource:b86c00de25382c6ce4d94dae5e4502db]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-24>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:773530fb248596d00289b12dba48a0cc>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-2>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-17>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-17"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:6d460a13d1af93268984ab262cef479d>	<http://purl.org/dc/terms/title>	"mechanism-of-action for drugbank:DB00110"@en .
<http://bio2rdf.org/drugbank_resource:efdc5ed439af008904afce03f4dd2ec8>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:efdc5ed439af008904afce03f4dd2ec8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-14>	<http://purl.org/dc/terms/title>	"pKa (strongest acidic): 1.84 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-19>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-22>	<http://www.w3.org/2000/01/rdf-schema#label>	"pKa (strongest acidic): 1.68 from ChemAxon [drugbank_resource:calculated-properties-DB00114-22]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-21>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-28>	<http://www.w3.org/2000/01/rdf-schema#label>	"Bioavailability: 1 from ChemAxon [drugbank_resource:calculated-properties-DB00117-28]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-20>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-25>	<http://bio2rdf.org/drugbank_vocabulary:value>	"9.44"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-16>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:d8c37e1ee64fc7f014205837681e99df>	<http://www.w3.org/2000/01/rdf-schema#label>	"mechanism-of-action for drugbank:DB00089 [drugbank_resource:d8c37e1ee64fc7f014205837681e99df]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-15>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00093-1>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00093-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-4>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Formula: C43H66N12O12S2 [drugbank_resource:experimental-properties-DB00107-4]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-29>	<http://www.w3.org/2000/01/rdf-schema#label>	"Rule of Five: 1 from ChemAxon [drugbank_resource:calculated-properties-DB00117-29]"@en .
<http://bio2rdf.org/drugbank_resource:c3ea863492592dff31fb000b21cd1a19>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:c3ea863492592dff31fb000b21cd1a19"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-18>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2c808757b9d5f22f13a70bae1f9e7737>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:2c808757b9d5f22f13a70bae1f9e7737"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:80aadabf31c519e42d80748f499c7689>	<http://purl.org/dc/terms/description>	"For prophylaxis of respiratory diseases casued by respiratory syncytial virus."@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-17>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f84c0f373fd98f4297607f206aadd302>	<http://www.w3.org/2000/01/rdf-schema#label>	"Pyrimidone [drugbank_resource:f84c0f373fd98f4297607f206aadd302]"@en .
<http://bio2rdf.org/drugbank_resource:74985c763ecb65fc6e794b1a003e061f>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-12>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-11>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-5>	<http://purl.org/dc/terms/title>	"Molecular Formula: C860H1353N229O255S9"@en .
<http://bio2rdf.org/drugbank_resource:a61e3adec088927f97197e2f1513790d>	<http://purl.org/dc/terms/title>	"50 mg Capsule, liquid filled form with oral route"@en .
<http://bio2rdf.org/chemspider:1022>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/chemspider:1022"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-14>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-23>	<http://www.w3.org/2000/01/rdf-schema#label>	"Physiological Charge: 0 from ChemAxon [drugbank_resource:calculated-properties-DB00091-23]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-13>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:x-pdb>	<http://bio2rdf.org/pdb:SAM> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-8>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f2977936270a493873be5432bb760ef7>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:f2977936270a493873be5432bb760ef7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-7>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-10>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-7>	<http://purl.org/dc/terms/title>	"logS: -0.4 from ALOGPS"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-9>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-4>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-3>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:9be1f0fbe27fc41feab5fa848add809b>	<http://purl.org/dc/terms/title>	"indication for drugbank:DB00089"@en .
<http://bio2rdf.org/drugbank_resource:6ac630c499c16fd6e1f2a125e397688a>	<http://purl.org/dc/terms/title>	"Aminobenzamide"@en .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00224>	<http://purl.org/dc/terms/title>	"DDI between Enfuvirtide and Indinavir - May increase the serum concentration of Protease Inhibitors. Protease Inhibitors may increase the serum concentration of Enfuvirtide."@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-6>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:gene-name>	"CYP2D6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-5>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003533>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-26>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-25>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-3>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Weight: 45351.6000 [drugbank_resource:experimental-properties-DB00103-3]"@en .
<http://bio2rdf.org/drugbank_resource:0e708564ecff800b67a0d210bc03042c>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:0e708564ecff800b67a0d210bc03042c"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:75aa077303c09d80af404a7a6c6ac735>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:75aa077303c09d80af404a7a6c6ac735"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/chemspider:1022>	<http://purl.org/dc/terms/identifier>	"chemspider:1022"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-28>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-2>	<http://bio2rdf.org/drugbank_vocabulary:value>	"5.51"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-27>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:1fc54dd8ec20644e59a52e0b31197dd9>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"1fc54dd8ec20644e59a52e0b31197dd9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-22>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-21>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:7975713dad73e24fab2cbb6c89586ea4>	<http://www.w3.org/2000/01/rdf-schema#label>	"480 ug/.8mL Injection, solution form with intravenous; subcutaneous route [drugbank_resource:7975713dad73e24fab2cbb6c89586ea4]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-5>	<http://bio2rdf.org/drugbank_vocabulary:value>	"C860H1353N229O255S9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c0c3695e2cc0b1f8b2708aa4329a566e>	<http://purl.org/dc/terms/description>	"Filgrastim is used in patients with acute myeloid leukemia receiving induction or consolidation chemotherapy. It is also used in cancer patients receiving bone marrow transplant. In general, filgrastim increases neutrophil counts in order to decrease the risk of infection or duration of neutropenia in the aforementioned patient populations. Infection and neutropenia are adverse events associated with chemotherapy. Furthermore, filgrastim is also indicated for patients with severe chronic neutropenia. It mobilizes hematopoietic progenitor cells into the peripheral blood for collection by leukapheresis to allow for a more rapid engraftment. Tbo-filgrastim has a narrower indication profile than Neupogen - it is a leukocyte growth factor indicated for the reduction in the duration of severe neutropenia in patients with non-myeloid malignancies."@en .
<http://bio2rdf.org/drugbank_resource:98458df79187b81a7709036be48a75a4>	<http://purl.org/dc/terms/title>	"mechanism-of-action for drugbank:DB00116"@en .
<http://bio2rdf.org/drugbank_resource:787ef58546dc52c80027a1e3a2b925b9>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"787ef58546dc52c80027a1e3a2b925b9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-4>	<http://www.w3.org/2000/01/rdf-schema#label>	"logP: -0.55 from ALOGPS [drugbank_resource:calculated-properties-DB00114-4]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-24>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-2>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e340b19fed6c2eaebccc1a4c652c8eb5>	<http://www.w3.org/2000/01/rdf-schema#label>	"half-life for drugbank:DB00095 [drugbank_resource:e340b19fed6c2eaebccc1a4c652c8eb5]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-23>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-18>	<http://www.w3.org/2000/01/rdf-schema#label>	"H Bond Acceptor Count: 13 from ChemAxon [drugbank_resource:calculated-properties-DB00093-18]"@en .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:a7531086765fedefe82e0282f7a1d559> .
<http://bio2rdf.org/drugbank_resource:01c6a15f6a299a85cd866fc4092d0dce>	<http://purl.org/dc/terms/title>	"100 mg/mL Solution form with oral route"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-18>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:a9516c15b2a67882efd5c7a4c1fa6de4> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:x-pdb>	<http://bio2rdf.org/pdb:THL> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB01177>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:DB00112_DB01177"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-17>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Gonadotropins>	<http://www.w3.org/2000/01/rdf-schema#label>	"Gonadotropins [drugbank_vocabulary:Gonadotropins]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-12>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-12"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-20>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:a9ee55eb5c1344c6ecd656006a4e92f2> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-19>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:ffb414ea32db58bec7ec3339a42c9dee>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"ffb414ea32db58bec7ec3339a42c9dee"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00110>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:a8454a4c3a73e4a65b3965d9947cc4bd> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:aa57c62e2e58943f3ce466339bbf00eb> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:bf1a15ece689c3f449c06ebc0a90dae3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-14>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:17b27330dfdb2b245beadb493e911ddb>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:17b27330dfdb2b245beadb493e911ddb"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-13>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ae52c40c7c1761e3027e159477756625>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:ae52c40c7c1761e3027e159477756625"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-16>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:a9a65e43cdc103a1f769c3625b080c1d> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-15>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-6>	<http://www.w3.org/2000/01/rdf-schema#label>	"IUPAC Name: [(3S)-3-amino-3-carboxypropyl]({[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl})methylsulfanium from ChemAxon [drugbank_resource:calculated-properties-DB00118-6]"@en .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:ae0431719c906d80aa97a27025adc99f> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:a61e3adec088927f97197e2f1513790d> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:ad715d0a2b2bcdcad22b975675537588> .
<http://bio2rdf.org/drugbank_resource:585c665fefee46ff4931f369bfe6004a>	<http://purl.org/dc/terms/description>	"As an immunosuppressive drug, Alefacept can be used for treatment of moderate to severe chronic plaque psoriasis"@en .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:ae52c40c7c1761e3027e159477756625> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-10>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:38b20638a91b63e0378b18fb8d8f4c38>	<http://www.w3.org/2000/01/rdf-schema#label>	"Aminopyrimidine [drugbank_resource:38b20638a91b63e0378b18fb8d8f4c38]"@en .
<http://bio2rdf.org/drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"e1e572616d493b2affcc653e19cbcd21"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:ba0f878619b43a5be9083f01d8ba77fd> .
<http://bio2rdf.org/drugbank_resource:3181b99b434a8db59d197070956de3d9>	<http://purl.org/dc/terms/title>	"mechanism-of-action for drugbank:DB00088"@en .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:affected-organism>	<http://bio2rdf.org/drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-12>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:55842b12e140e13ee25b3a59430d097e>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:55842b12e140e13ee25b3a59430d097e"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:DB00093"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-11>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:b508d1a45927588b684b5a6fd80aff2b> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:x-uniprot>	<http://bio2rdf.org/uniprot:P10635> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:x-pdb>	<http://bio2rdf.org/pdb:PLP> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:b15aa7d1fbce9f1563623833e416d8f7> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:theoretical-pi>	"7.99"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:x-pdb>	<http://bio2rdf.org/pdb:HIS> .
<http://bio2rdf.org/drugbank_resource:c987b0d07b89f29a364501bc29cfebc8>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:b508d1a45927588b684b5a6fd80aff2b> .
<http://bio2rdf.org/drugbank_vocabulary:e328a6cf619c4105669d93dc30d36096>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"e328a6cf619c4105669d93dc30d36096"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-24>	<http://www.w3.org/2000/01/rdf-schema#label>	"Bioavailability: 0 from ChemAxon [drugbank_resource:calculated-properties-DB00116-24]"@en .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"cation binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:cad41663894b5be906782be10b396e06>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:x-pdb>	<http://bio2rdf.org/pdb:CNC> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00106-2>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00106-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00097>	<http://bio2rdf.org/drugbank_vocabulary:half-life>	<http://bio2rdf.org/drugbank_resource:c007cc919bf71767e61e0b111723c84f> .
<http://bio2rdf.org/drugbank_resource:e6fc137e236497aea65dd3bb99d52e53>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:e6fc137e236497aea65dd3bb99d52e53"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e04ee332a67fe1dea4752f0a68c0a6ee>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"e04ee332a67fe1dea4752f0a68c0a6ee"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:55f06b8fc86fce71f0db4c1832cfa819>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:55f06b8fc86fce71f0db4c1832cfa819"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-7>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00117-7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c7d119b1e6d46c382382c2c17e2801ac>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-11>	<http://www.w3.org/2000/01/rdf-schema#label>	"SMILES: CCC1NC(=O)C(C(O)C(C)CC=CC)N(C)C(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C from ChemAxon [drugbank_resource:calculated-properties-DB00091-11]"@en .
<http://bio2rdf.org/drugbank:DB00106>	<http://purl.org/dc/terms/identifier>	"drugbank:DB00106"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:BE0002793"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00094>	<http://bio2rdf.org/drugbank_vocabulary:manufacturer>	<http://bio2rdf.org/drugbank_resource:c51b5b3f72bf15f717f23f1fdda6fe44> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:a9a65e43cdc103a1f769c3625b080c1d> .
<http://bio2rdf.org/drugbank_resource:2af3e19f02b1eb81db93222ed2b38a44>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:2af3e19f02b1eb81db93222ed2b38a44"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00099>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:a2615bbb5710b9b992785e63c058b3db> .
<http://bio2rdf.org/drugbank_resource:c7f12f71253c5095c8df9050b7b42f2c>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"prolyl oligopeptidase activity"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:7fc0069b68f72ba58fdad65bec3cc1df>	<http://bio2rdf.org/drugbank_vocabulary:strength>	".5 mg/mL"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-7>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00116-7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-20>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00115-20"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"generation of precursor metabolites and energy"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00103>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:a39e93df12255155561f3d4acd297da8> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB08879>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:DB00112_DB08879"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"hydrolase activity"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e8fbddfaa9a4fe87d9328de7cf8cd326>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"e8fbddfaa9a4fe87d9328de7cf8cd326"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0000300>	<http://bio2rdf.org/drugbank_vocabulary:locus>	"1p36-p22"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-4>	<http://bio2rdf.org/drugbank_vocabulary:value>	"4.53e-02 g/l"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:a78396bd0ab3d3f25852a0d4008cbdf4> .
<http://bio2rdf.org/drugbank_resource:f38592452c305d31bbbb2909013724ac>	<http://purl.org/dc/terms/title>	"Organosulfur compounds"@en .
<http://bio2rdf.org/drugbank:BE0003533>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"CYPIIE1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00099>	<http://bio2rdf.org/drugbank_vocabulary:indication>	<http://bio2rdf.org/drugbank_resource:c0c3695e2cc0b1f8b2708aa4329a566e> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-11>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00118-11"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:brand>	<http://bio2rdf.org/drugbank_vocabulary:e78186eb12eeaebda8a530a67513beea> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-1>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00090-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-24>	<http://bio2rdf.org/drugbank_vocabulary:value>	"1.85"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:gene-sequence>	">1473 bp\nATGGAACCTTTTGTGGTCCTGGTGCTGTGTCTCTCTTTTATGCTTCTCTTTTCACTCTGG\nAGACAGAGCTGTAGGAGAAGGAAGCTCCCTCCTGGCCCCACTCCTCTTCCTATTATTGGA\nAATATGCTACAGATAGATGTTAAGGACATCTGCAAATCTTTCACCAATTTCTCAAAAGTC\nTATGGTCCTGTGTTCACCGTGTATTTTGGCATGAATCCCATAGTGGTGTTTCATGGATAT\nGAGGCAGTGAAGGAAGCCCTGATTGATAATGGAGAGGAGTTTTCTGGAAGAGGCAATTCC\nCCAATATCTCAAAGAATTACTAAAGGACTTGGAATCATTTCCAGCAATGGAAAGAGATGG\nAAGGAGATCCGGCGTTTCTCCCTCACAAACTTGCGGAATTTTGGGATGGGGAAGAGGAGC\nATTGAGGACCGTGTTCAAGAGGAAGCTCACTGCCTTGTGGAGGAGTTGAGAAAAACCAAG\nGCTTCACCCTGTGATCCCACTTTCATCCTGGGCTGTGCTCCCTGCAATGTGATCTGCTCC\nGTTGTTTTCCAGAAACGATTTGATTATAAAGATCAGAATTTTCTCACCCTGATGAAAAGA\nTTCAATGAAAACTTCAGGATTCTGAACTCCCCATGGATCCAGGTCTGCAATAATTTCCCT\nCTACTCATTGATTGTTTCCCAGGAACTCACAACAAAGTGCTTAAAAATGTTGCTCTTACA\nCGAAGTTACATTAGGGAGAAAGTAAAAGAACACCAAGCATCACTGGATGTTAACAATCCT\nCGGGACTTTATGGATTGCTTCCTGATCAAAATGGAGCAGGAAAAGGACAACCAAAAGTCA\nGAATTCAATATTGAAAACTTGGTTGGCACTGTAGCTGATCTATTTGTTGCTGGAACAGAG\nACAACAAGCACCACTCTGAGATATGGACTCCTGCTCCTGCTGAAGCACCCAGAGGTCACA\nGCTAAAGTCCAGGAAGAGATTGATCATGTAATTGGCAGACACAGGAGCCCCTGCATGCAG\nGATAGGAGCCACATGCCTTACACTGATGCTGTAGTGCACGAGATCCAGAGATACAGTGAC\nCTTGTCCCCACCGGTGTGCCCCATGCAGTGACCACTGATACTAAGTTCAGAAACTACCTC\nATCCCCAAGGGCACAACCATAATGGCATTACTGACTTCCGTGCTACATGATGACAAAGAA\nTTTCCTAATCCAAATATCTTTGACCCTGGCCACTTTCTAGATAAGAATGGCAACTTTAAG\nAAAAGTGACTACTTCATGCCTTTCTCAGCAGGAAAACGAATTTGTGCAGGAGAAGGACTT\nGCCCGCATGGAGCTATTTTTATTTCTAACCACAATTTTACAGAACTTTAACCTGAAATCT\nGTTGATGATTTAAAGAACCTCAATACTACTGCAGTTACCAAAGGGATTGTTTCTCTGCCA\nCCCTCATACCAGATCTGCTTCATCCCTGTCTGA"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"generation of precursor metabolites and energy"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:4d6d8a0bb0437361e22c5fbaf04819ea>	<http://purl.org/dc/terms/title>	"N-substituted imidazoles"@en .
<http://bio2rdf.org/drugbank_resource:c51b5b3f72bf15f717f23f1fdda6fe44>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:abd3e42d8c67111954c278994aa4591d>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"cation binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:brand>	<http://bio2rdf.org/drugbank_vocabulary:e78186eb12eeaebda8a530a67513beea> .
<http://bio2rdf.org/drugbank_vocabulary:ab9182be757cbb637b820f0951931ae2>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:c987b0d07b89f29a364501bc29cfebc8> .
<http://bio2rdf.org/drugbank:DB00097>	<http://bio2rdf.org/drugbank_vocabulary:affected-organism>	<http://bio2rdf.org/drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:c7f12f71253c5095c8df9050b7b42f2c> .
<http://bio2rdf.org/drugbank:BE0003533>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"generation of precursor metabolites and energy"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"cation binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:a6302cf127669e87e24a75b24552a9e8> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:brand>	<http://bio2rdf.org/drugbank_vocabulary:e78186eb12eeaebda8a530a67513beea> .
<http://bio2rdf.org/drugbank:DB00096>	<http://bio2rdf.org/drugbank_vocabulary:affected-organism>	<http://bio2rdf.org/drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21> .
<http://bio2rdf.org/drugbank_resource:372918cb5733e55c6d5baa7bc6f4a30c>	<http://www.w3.org/2000/01/rdf-schema#label>	"100 mg/mL Injection, solution form with intramuscular route [drugbank_resource:372918cb5733e55c6d5baa7bc6f4a30c]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-24>	<http://www.w3.org/2000/01/rdf-schema#label>	"Number of Rings: 1 from ChemAxon [drugbank_resource:calculated-properties-DB00091-24]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-20>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00114-20"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00095>	<http://bio2rdf.org/drugbank_vocabulary:affected-organism>	<http://bio2rdf.org/drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"cation binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c3ea863492592dff31fb000b21cd1a19>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00093>	<http://purl.org/dc/terms/description>	"A synthetic nonapeptide comprising cysteinyl, phenylalanyl, phenylalanyl, glutaminyl, asparaginyl, cysteinyl, prolyl, lysyl, and glycinamide residues in sequence, with a disulfide bridge joining the two cysteine residues. Its antidiuretic effects are less than those of vasopressin. It is used as a vasoconstrictor in local anaesthetic injections for dental use, and is an ingredient of preparations that have been used for treatment of pain and inflammation of the mouth. [ChEBI]"@en .
<http://bio2rdf.org/drugbank:DB00094>	<http://bio2rdf.org/drugbank_vocabulary:affected-organism>	<http://bio2rdf.org/drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21> .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"generation of precursor metabolites and energy"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00111>	<http://bio2rdf.org/drugbank_vocabulary:brand>	<http://bio2rdf.org/drugbank_vocabulary:e78186eb12eeaebda8a530a67513beea> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:a5a6248bbc8b4dd7520b62e64aa85462> .
<http://bio2rdf.org/drugbank_resource:4fcc6e9455872b18c21b74aa6b82db13>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:4fcc6e9455872b18c21b74aa6b82db13"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:affected-organism>	<http://bio2rdf.org/drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-13>	<http://purl.org/dc/terms/title>	"InChIKey: InChIKey=MEFKEPWMEQBLKI-AIRLBKTGSA-O from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:e147a45842193f4b54cd46908fed6204>	<http://www.w3.org/2000/01/rdf-schema#label>	"D-alpha-amino acid [drugbank_resource:e147a45842193f4b54cd46908fed6204]"@en .
<http://bio2rdf.org/drugbank:DB00092>	<http://bio2rdf.org/drugbank_vocabulary:affected-organism>	<http://bio2rdf.org/drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21> .
<http://bio2rdf.org/drugbank_vocabulary:Enzyme-Inhibitors>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:Enzyme-Inhibitors"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c2dbd6b14df7875575496a70dff7a209>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00113>	<http://bio2rdf.org/drugbank_vocabulary:brand>	<http://bio2rdf.org/drugbank_vocabulary:e78186eb12eeaebda8a530a67513beea> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:a5a6248bbc8b4dd7520b62e64aa85462> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:affected-organism>	<http://bio2rdf.org/drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21> .
<http://bio2rdf.org/drugbank_resource:22f72a952683d19d554d47d3919c10f3>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:22f72a952683d19d554d47d3919c10f3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:c7f12f71253c5095c8df9050b7b42f2c> .
<http://bio2rdf.org/drugbank_resource:c28ad3ee91a708824325b58f26c403a5>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00090>	<http://bio2rdf.org/drugbank_vocabulary:affected-organism>	<http://bio2rdf.org/drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:c7f12f71253c5095c8df9050b7b42f2c> .
<http://bio2rdf.org/drugbank:DB00106>	<http://bio2rdf.org/drugbank_vocabulary:brand>	<http://bio2rdf.org/drugbank_vocabulary:e78186eb12eeaebda8a530a67513beea> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-12>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00093-12"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-13>	<http://bio2rdf.org/drugbank_vocabulary:value>	"155.069"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:bbf3cb3443969f24e50666e131185bd8> .
<http://bio2rdf.org/drugbank:DB00089>	<http://bio2rdf.org/drugbank_vocabulary:affected-organism>	<http://bio2rdf.org/drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21> .
<http://bio2rdf.org/drugbank_resource:003185d1d24af95f95de2d64dd76ed33>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:003185d1d24af95f95de2d64dd76ed33"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Enzyme> .
<http://bio2rdf.org/drugbank_resource:c0c3695e2cc0b1f8b2708aa4329a566e>	<http://purl.org/dc/terms/title>	"indication for drugbank:DB00099"@en .
<http://bio2rdf.org/drugbank:DB00088>	<http://bio2rdf.org/drugbank_vocabulary:affected-organism>	<http://bio2rdf.org/drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:cad41663894b5be906782be10b396e06> .
<http://bio2rdf.org/drugbank:DB00109>	<http://bio2rdf.org/drugbank_vocabulary:half-life>	<http://bio2rdf.org/drugbank_resource:ad9e59297973dcc097c2400d81b7888b> .
<http://bio2rdf.org/drugbank:DB00107>	<http://bio2rdf.org/drugbank_vocabulary:brand>	<http://bio2rdf.org/drugbank_vocabulary:e78186eb12eeaebda8a530a67513beea> .
<http://bio2rdf.org/drugbank_vocabulary:aa64bf1510edae009ba1d31553912173>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-1>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00100-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e6fc137e236497aea65dd3bb99d52e53>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:251aa2c7f843f73a59fa2779ab4a885a> .
<http://bio2rdf.org/drugbank_vocabulary:Biotech>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"Biotech"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c254aba7ca3db4f83cda45b27adb5b2b>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00099>	<http://bio2rdf.org/drugbank_vocabulary:brand>	<http://bio2rdf.org/drugbank_vocabulary:e78186eb12eeaebda8a530a67513beea> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-1>	<http://bio2rdf.org/drugbank_vocabulary:value>	"60 \u00B0C"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:manufacturer>	<http://bio2rdf.org/drugbank_resource:a57533055c136af9a471684ba442d058> .
<http://bio2rdf.org/drugbank:DB00107>	<http://bio2rdf.org/drugbank_vocabulary:indication>	<http://bio2rdf.org/drugbank_resource:a9a58af69a8539d913c65b788eb5b178> .
<http://bio2rdf.org/drugbank:DB00103>	<http://bio2rdf.org/drugbank_vocabulary:brand>	<http://bio2rdf.org/drugbank_vocabulary:e78186eb12eeaebda8a530a67513beea> .
<http://bio2rdf.org/drugbank:DB00105>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:c7d119b1e6d46c382382c2c17e2801ac> .
<http://bio2rdf.org/drugbank_resource:fba31fe582cac619f85335c144278e17>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:fba31fe582cac619f85335c144278e17"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:mechanism-of-action>	<http://bio2rdf.org/drugbank_resource:ade41ed0b3f8ac2b059fa8aeb0cdbbb4> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-8>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00091-8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00095>	<http://bio2rdf.org/drugbank_vocabulary:brand>	<http://bio2rdf.org/drugbank_vocabulary:e78186eb12eeaebda8a530a67513beea> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-4>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00103-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:affected-organism>	<http://bio2rdf.org/drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:mixture>	<http://bio2rdf.org/drugbank_resource:Xylonest-Octapressin> .
<http://bio2rdf.org/drugbank:DB00094>	<http://bio2rdf.org/drugbank_vocabulary:brand>	<http://bio2rdf.org/drugbank_vocabulary:e78186eb12eeaebda8a530a67513beea> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:affected-organism>	<http://bio2rdf.org/drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21> .
<http://bio2rdf.org/drugbank_resource:DB00099_DB01030>	<http://www.w3.org/2000/01/rdf-schema#label>	"DDI between Filgrastim and Topotecan - Filgrastim may enhance the adverse/toxic effect of Topotecan. [drugbank_resource:DB00099_DB01030]"@en .
<http://bio2rdf.org/drugbank_resource:c0c3695e2cc0b1f8b2708aa4329a566e>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00097>	<http://bio2rdf.org/drugbank_vocabulary:brand>	<http://bio2rdf.org/drugbank_vocabulary:e78186eb12eeaebda8a530a67513beea> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-24>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-24"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:affected-organism>	<http://bio2rdf.org/drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21> .
<http://bio2rdf.org/drugbank_resource:5ac86da3649163846e9e9d65b58c49fc>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:5ac86da3649163846e9e9d65b58c49fc"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00096>	<http://bio2rdf.org/drugbank_vocabulary:brand>	<http://bio2rdf.org/drugbank_vocabulary:e78186eb12eeaebda8a530a67513beea> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-3>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:d8c37e1ee64fc7f014205837681e99df>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:d8c37e1ee64fc7f014205837681e99df"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:Citanest-Dental>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"Citanest-Dental"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:affected-organism>	<http://bio2rdf.org/drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:brand>	<http://bio2rdf.org/drugbank_vocabulary:e78186eb12eeaebda8a530a67513beea> .
<http://bio2rdf.org/drugbank:DB00113>	<http://bio2rdf.org/drugbank_vocabulary:affected-organism>	<http://bio2rdf.org/drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-1>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:f23a096638ef4dab2583e9257743e71d> .
<http://bio2rdf.org/drugbank_resource:Citanest-Octapressin>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:d8c37e1ee64fc7f014205837681e99df>	<http://purl.org/dc/terms/title>	"mechanism-of-action for drugbank:DB00089"@en .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:b77ba88d4df43eb6dd239cb83101c022> .
<http://bio2rdf.org/drugbank:DB00112>	<http://bio2rdf.org/drugbank_vocabulary:affected-organism>	<http://bio2rdf.org/drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21> .
<http://bio2rdf.org/drugbank_resource:d2b048fbf48d0ab62b1014e2b38c72e9>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:d2b048fbf48d0ab62b1014e2b38c72e9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-13>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-13"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:03746a740bf18cbf4beaae7cc5b7504f>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"03746a740bf18cbf4beaae7cc5b7504f"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:ab9182be757cbb637b820f0951931ae2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:brand>	<http://bio2rdf.org/drugbank_vocabulary:e78186eb12eeaebda8a530a67513beea> .
<http://bio2rdf.org/drugbank_resource:a7531086765fedefe82e0282f7a1d559>	<http://purl.org/dc/terms/title>	"Dicarboxylic acids and derivatives"@en .
<http://bio2rdf.org/drugbank_vocabulary:abd3e42d8c67111954c278994aa4591d>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:aa64bf1510edae009ba1d31553912173>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Name> .
<http://bio2rdf.org/drugbank:DB00111>	<http://bio2rdf.org/drugbank_vocabulary:affected-organism>	<http://bio2rdf.org/drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21> .
<http://bio2rdf.org/drugbank:DB00092>	<http://bio2rdf.org/drugbank_vocabulary:brand>	<http://bio2rdf.org/drugbank_vocabulary:e78186eb12eeaebda8a530a67513beea> .
<http://bio2rdf.org/drugbank_resource:30d0083606d3fa4b4b602b5d3ed0feda>	<http://www.w3.org/2000/01/rdf-schema#label>	"50 mg/mL Injection, solution form with intravenous route [drugbank_resource:30d0083606d3fa4b4b602b5d3ed0feda]"@en .
<http://bio2rdf.org/drugbank_vocabulary:64789d808f73ebe8eac3dbded4a95da0>	<http://www.w3.org/2000/01/rdf-schema#label>	"Raptiva [drugbank_vocabulary:64789d808f73ebe8eac3dbded4a95da0]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-6>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00116-6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c007cc919bf71767e61e0b111723c84f>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:b86c00de25382c6ce4d94dae5e4502db> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00115-1>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:cc3a60452bf8973535a777c3a33bdeb7> .
<http://bio2rdf.org/drugbank:DB00107>	<http://bio2rdf.org/drugbank_vocabulary:affected-organism>	<http://bio2rdf.org/drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00089>	<http://bio2rdf.org/drugbank_vocabulary:brand>	<http://bio2rdf.org/drugbank_vocabulary:e78186eb12eeaebda8a530a67513beea> .
<http://bio2rdf.org/drugbank_resource:aa57c62e2e58943f3ce466339bbf00eb>	<http://www.w3.org/2000/01/rdf-schema#label>	"Tetrahydrofolic acids [drugbank_resource:aa57c62e2e58943f3ce466339bbf00eb]"@en .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:b8f9ca946fec2fca3eb84c3b8cf1ff12> .
<http://bio2rdf.org/drugbank:DB00106>	<http://bio2rdf.org/drugbank_vocabulary:affected-organism>	<http://bio2rdf.org/drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21> .
<http://bio2rdf.org/drugbank_resource:195ccf935d3c9947bcc17b096fdca329>	<http://purl.org/dc/terms/title>	"Alpha-amino acid"@en .
<http://bio2rdf.org/drugbank:DB00102>	<http://bio2rdf.org/drugbank_vocabulary:mechanism-of-action>	<http://bio2rdf.org/drugbank_resource:a2d4a403a964b1f3a6d6fa73cb73921a> .
<http://bio2rdf.org/drugbank:DB00088>	<http://bio2rdf.org/drugbank_vocabulary:brand>	<http://bio2rdf.org/drugbank_vocabulary:e78186eb12eeaebda8a530a67513beea> .
<http://bio2rdf.org/drugbank:DB00090>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:c3ea863492592dff31fb000b21cd1a19> .
<http://bio2rdf.org/drugbank:DB00105>	<http://bio2rdf.org/drugbank_vocabulary:affected-organism>	<http://bio2rdf.org/drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21> .
<http://bio2rdf.org/drugbank_resource:ffa1ac4af9ac617e01349d78fdc482f1>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:ffa1ac4af9ac617e01349d78fdc482f1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:c7f12f71253c5095c8df9050b7b42f2c> .
<http://bio2rdf.org/drugbank_vocabulary:e78186eb12eeaebda8a530a67513beea>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00105>	<http://bio2rdf.org/drugbank_vocabulary:indication>	<http://bio2rdf.org/drugbank_resource:a02555c5c58332bf7ac5fef198a34814> .
<http://bio2rdf.org/drugbank_resource:a6302cf127669e87e24a75b24552a9e8>	<http://purl.org/dc/terms/title>	"1000 ug/mL Injection, solution form with intramuscular route"@en .
<http://bio2rdf.org/drugbank:DB00103>	<http://bio2rdf.org/drugbank_vocabulary:affected-organism>	<http://bio2rdf.org/drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21> .
<http://bio2rdf.org/drugbank:DB00106>	<http://bio2rdf.org/drugbank_vocabulary:mechanism-of-action>	<http://bio2rdf.org/drugbank_resource:a595cc1c66cf7314ca9d50542e429c85> .
<http://bio2rdf.org/drugbank_resource:bf1a15ece689c3f449c06ebc0a90dae3>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003536>	<http://www.w3.org/2000/01/rdf-schema#label>	"Cytochrome P450 2C19 [drugbank:BE0003536]"@en .
<http://bio2rdf.org/drugbank:DB00102>	<http://bio2rdf.org/drugbank_vocabulary:affected-organism>	<http://bio2rdf.org/drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21> .
<http://bio2rdf.org/drugbank_resource:366d45e2564940d9162a27ad0e9e3571>	<http://www.w3.org/2000/01/rdf-schema#label>	"Pyrroline [drugbank_resource:366d45e2564940d9162a27ad0e9e3571]"@en .
<http://bio2rdf.org/drugbank_resource:be8afc258733f250df3262d94e93265b>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00099>	<http://purl.org/dc/terms/identifier>	"drugbank:DB00099"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00100>	<http://bio2rdf.org/drugbank_vocabulary:affected-organism>	<http://bio2rdf.org/drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-3>	<http://purl.org/dc/terms/title>	"Isoelectric Point: 8.61"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-1>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00107-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:a9a65e43cdc103a1f769c3625b080c1d> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:be8afc258733f250df3262d94e93265b> .
<http://bio2rdf.org/drugbank:DB00099>	<http://bio2rdf.org/drugbank_vocabulary:affected-organism>	<http://bio2rdf.org/drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21> .
<http://bio2rdf.org/drugbank_resource:2df9c46833999f4cf9a8383d1003158e>	<http://www.w3.org/2000/01/rdf-schema#label>	"Pyridine carboxaldehydes [drugbank_resource:2df9c46833999f4cf9a8383d1003158e]"@en .
<http://bio2rdf.org/drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21>	<http://www.w3.org/2000/01/rdf-schema#label>	"Humans and other mammals [drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-1>	<http://bio2rdf.org/drugbank_vocabulary:value>	"55 \u00B0C"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:c254aba7ca3db4f83cda45b27adb5b2b> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-3>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00105-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Drug>	<http://www.w3.org/2000/01/rdf-schema#label>	"Drug [drugbank_vocabulary:Drug]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-13>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00114-13"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00106-2>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00106-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:30d0083606d3fa4b4b602b5d3ed0feda>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"30d0083606d3fa4b4b602b5d3ed0feda"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:ab9182be757cbb637b820f0951931ae2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Name> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-1>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:f23a096638ef4dab2583e9257743e71d> .
<http://bio2rdf.org/drugbank_resource:Citanest-Dental-Octapressin>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:c2dbd6b14df7875575496a70dff7a209> .
<http://bio2rdf.org/drugbank_resource:Citanest-Dental>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_vocabulary:aa64bf1510edae009ba1d31553912173>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:abd3e42d8c67111954c278994aa4591d>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Name> .
<http://bio2rdf.org/drugbank_resource:78fce134a0e754813388f2850f268625>	<http://purl.org/dc/terms/description>	"Zenapax is a humanized monoclonal antibody used for prevention of renal transplant rejection"@en .
<http://bio2rdf.org/drugbank_resource:e8fbddfaa9a4fe87d9328de7cf8cd326>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:66a4f22d1577f66fd9737b00a8525f55> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:c28ad3ee91a708824325b58f26c403a5> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-2>	<http://bio2rdf.org/drugbank_vocabulary:value>	"-0.258"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:9ea94506ab138833cc18501d48712af4>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00113>	<http://bio2rdf.org/drugbank_vocabulary:indication>	<http://bio2rdf.org/drugbank_resource:a6317c6254a0737c350d2f0860ea1ec3> .
<http://bio2rdf.org/drugbank_resource:9e10be5c3dafcd8441cdeb69f72cc3f4>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_vocabulary:3465ee54a79f5fd937ce86304a05d4e3>	<http://www.w3.org/2000/01/rdf-schema#label>	"Colupressine [drugbank_vocabulary:3465ee54a79f5fd937ce86304a05d4e3]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-14>	<http://www.w3.org/2000/01/rdf-schema#label>	"Polar Surface Area (PSA): 405.32 from ChemAxon [drugbank_resource:calculated-properties-DB00093-14]"@en .
<http://bio2rdf.org/drugbank_resource:bbf3cb3443969f24e50666e131185bd8>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-27>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-27"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-10> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-11> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-12> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-13> .
<http://bio2rdf.org/drugbank_resource:ade41ed0b3f8ac2b059fa8aeb0cdbbb4>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"ade41ed0b3f8ac2b059fa8aeb0cdbbb4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-14> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-2>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00094-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-15> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-16> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-3>	<http://www.w3.org/2000/01/rdf-schema#label>	"Isoelectric Point: 5.67 [drugbank_resource:experimental-properties-DB00096-3]"@en .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-17> .
<http://bio2rdf.org/drugbank_resource:eb2ea139d16c3216009f5eb2eceb62c8>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"eb2ea139d16c3216009f5eb2eceb62c8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-18> .
<http://bio2rdf.org/drugbank:DB00099>	<http://bio2rdf.org/drugbank_vocabulary:half-life>	<http://bio2rdf.org/drugbank_resource:d025612c433b867a6ebb00b2532e2626> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-10>	<http://www.w3.org/2000/01/rdf-schema#label>	"SMILES: C[S+](CC[C@H](N)C(O)=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12 from ChemAxon [drugbank_resource:calculated-properties-DB00118-10]"@en .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-19> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-20> .
<http://bio2rdf.org/drugbank_resource:a02555c5c58332bf7ac5fef198a34814>	<http://purl.org/dc/terms/title>	"indication for drugbank:DB00105"@en .
<http://bio2rdf.org/drugbank_vocabulary:908621b9e3153f791dd6dbd4ef6d62a5>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"908621b9e3153f791dd6dbd4ef6d62a5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-15>	<http://www.w3.org/2000/01/rdf-schema#label>	"Refractivity: 96.23 from ChemAxon [drugbank_resource:calculated-properties-DB00118-15]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-18>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00116-18"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:0f798f4d70ca79c6d20f50856c6d9d11>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:0f798f4d70ca79c6d20f50856c6d9d11"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:7767fecbc1fcbba1764734e284afdd13>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:7767fecbc1fcbba1764734e284afdd13"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-1>	<http://bio2rdf.org/drugbank_vocabulary:value>	"55 \u00B0C"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ad9e59297973dcc097c2400d81b7888b>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:ad9e59297973dcc097c2400d81b7888b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-3>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Weight: 51801.1000 [drugbank_resource:experimental-properties-DB00092-3]"@en .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-19> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-2> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-20> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-21> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-22> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-23> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-24> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-25> .
<http://bio2rdf.org/drugbank_resource:9be1f0fbe27fc41feab5fa848add809b>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-11> .
<http://bio2rdf.org/drugbank_resource:ba0f878619b43a5be9083f01d8ba77fd>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-12> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-13> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-14> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-15> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-16> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-17> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-18> .
<http://bio2rdf.org/drugbank_resource:a2615bbb5710b9b992785e63c058b3db>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"a2615bbb5710b9b992785e63c058b3db"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-21> .
<http://bio2rdf.org/drugbank_vocabulary:Anti-Testosterone-Agents>	<http://www.w3.org/2000/01/rdf-schema#label>	"Anti-Testosterone Agents [drugbank_vocabulary:Anti-Testosterone-Agents]"@en .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-22> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-23> .
<http://bio2rdf.org/drugbank_resource:c2dbd6b14df7875575496a70dff7a209>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:c2dbd6b14df7875575496a70dff7a209"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-24> .
<http://bio2rdf.org/drugbank_resource:9d6d13e90c7dfeb0d8d2cac125c20125>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-25> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-26> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-27> .
<http://bio2rdf.org/drugbank_resource:a7531086765fedefe82e0282f7a1d559>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"a7531086765fedefe82e0282f7a1d559"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-10> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-28> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-3> .
<http://bio2rdf.org/drugbank_resource:b8f9ca946fec2fca3eb84c3b8cf1ff12>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-4> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:absorption>	<http://bio2rdf.org/drugbank_resource:b8238b8599e6fdc40599cf773d5fb991> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-5> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-6> .
<http://bio2rdf.org/drugbank_resource:99633b36b8289d3e0a8562067bd42c03>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-7> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:indication>	<http://bio2rdf.org/drugbank_resource:d2b048fbf48d0ab62b1014e2b38c72e9> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-8> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-9> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-20>	<http://purl.org/dc/terms/title>	"Polarizability: 14.67 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-3>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00111-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00762>	<http://www.w3.org/2000/01/rdf-schema#label>	"DDI between Bevacizumab and Irinotecan - Bevacizumab may enhance the adverse/toxic effect of Irinotecan. [drugbank_resource:DB00112_DB00762]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-2>	<http://www.w3.org/2000/01/rdf-schema#label>	"logP: -0.96 from ALOGPS [drugbank_resource:calculated-properties-DB00116-2]"@en .
<http://bio2rdf.org/drugbank_resource:9a71495dd3f52eed3f338a39501d4bfa>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:bf1a15ece689c3f449c06ebc0a90dae3>	<http://purl.org/dc/terms/title>	"Monosaccharides"@en .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:d56193a54171cd8858918adbb1b34e8c> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-8>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00117-8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pdb:THL>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank:DB00094>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:DB00094"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-4>	<http://purl.org/dc/terms/title>	"logS: -5.3 from ALOGPS"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-14>	<http://www.w3.org/2000/01/rdf-schema#label>	"pKa (strongest acidic): 1.84 from ChemAxon [drugbank_resource:calculated-properties-DB00115-14]"@en .
<http://bio2rdf.org/drugbank_resource:e6fa8c632405b98301de119a72894c49>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"e6fa8c632405b98301de119a72894c49"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-25>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00116-25"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00107_DB00429>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00107_DB00429"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:7abeba6bed290a4b16075521bc0113ca>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:7abeba6bed290a4b16075521bc0113ca"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:17055fe13e90f0599fe8f9fd1c90c871>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:17055fe13e90f0599fe8f9fd1c90c871"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Antifungal-Agents>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"Antifungal-Agents"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Micronutrients>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:Micronutrients"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00089>	<http://bio2rdf.org/drugbank_vocabulary:mechanism-of-action>	<http://bio2rdf.org/drugbank_resource:d8c37e1ee64fc7f014205837681e99df> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-5>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00117-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c987b0d07b89f29a364501bc29cfebc8>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"c987b0d07b89f29a364501bc29cfebc8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:b86c00de25382c6ce4d94dae5e4502db>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:7abeba6bed290a4b16075521bc0113ca>	<http://purl.org/dc/terms/title>	"Methylpyridines"@en .
<http://bio2rdf.org/drugbank_vocabulary:ffb414ea32db58bec7ec3339a42c9dee>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:b8238b8599e6fdc40599cf773d5fb991>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pdb:SAM>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:97f751c9423321c8864c0243afcff111>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:2619a21616645ee9827c33c6e2f65268>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:2619a21616645ee9827c33c6e2f65268"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-3>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:7b7fb2f56628eae3f95e27a98b2457ae> .
<http://bio2rdf.org/drugbank_resource:84e1544b4af68672a960baf683724f87>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"84e1544b4af68672a960baf683724f87"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-4>	<http://purl.org/dc/terms/title>	"Molecular Formula: C532H892N162O153S9"@en .
<http://bio2rdf.org/drugbank_resource:5b47883807d5fa7a5b0b5ce2dc6e7939>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:5b47883807d5fa7a5b0b5ce2dc6e7939"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Dietary-Supplements>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"Dietary-Supplements"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-6>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:986ea485795ab092b3199f449ca4056e>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/pdb:PLP>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:b77ba88d4df43eb6dd239cb83101c022>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2df9c46833999f4cf9a8383d1003158e>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:2df9c46833999f4cf9a8383d1003158e"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-5>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:885f18deb6f24609bfbc9b8c57b5d653> .
<http://bio2rdf.org/drugbank_resource:051943c0db4f9d17f7dfc49f7bb4329a>	<http://purl.org/dc/terms/title>	"Cyclic peptoid/peptide"@en .
<http://bio2rdf.org/drugbank_resource:98458df79187b81a7709036be48a75a4>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:3c77091e1ee2397a2767e73267a25af5>	<http://purl.org/dc/terms/title>	"Primary aromatic amines"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-3>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00088-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-19>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00093-19"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-13>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00114-13"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-6>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00093-6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00114-3>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00114-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:f6203f7c9646b21edf1fa81c5cdf94d1>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a39e93df12255155561f3d4acd297da8>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:a39e93df12255155561f3d4acd297da8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-11>	<http://bio2rdf.org/drugbank_vocabulary:value>	"L-histidine"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:220e1c2f3029a37a26fd263b95f90c89>	<http://purl.org/dc/terms/title>	"Organic cation"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00114-3>	<http://purl.org/dc/terms/title>	"logP: -1.2"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-12>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00115-12"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-29>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00105>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:d46b970056d0a083cca1f813197ccf0c> .
<http://bio2rdf.org/drugbank_resource:55842b12e140e13ee25b3a59430d097e>	<http://www.w3.org/2000/01/rdf-schema#label>	"absorption for drugbank:DB00092 [drugbank_resource:55842b12e140e13ee25b3a59430d097e]"@en .
<http://bio2rdf.org/pdb:HIS>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-28>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-8>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00115-8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:96faa670b368b06113b9e58e3db1d86c>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-31>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:6be4db795caa5a4f0e9b208f115d277b>	<http://www.w3.org/2000/01/rdf-schema#label>	"mechanism-of-action for drugbank:DB00112 [drugbank_resource:6be4db795caa5a4f0e9b208f115d277b]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-18>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00118-18"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"transition metal ion binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:fa342aed686575ef39a8ec9dc16cbab4>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:96b90ed2d49ca40e5c82fd787db32b84>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/pdb:CNC>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-30>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-25>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-19>	<http://purl.org/dc/terms/title>	"Refractivity: 38.06 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-24>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-11>	<http://bio2rdf.org/drugbank_vocabulary:value>	"247.025"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-27>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:fa342aed686575ef39a8ec9dc16cbab4>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:fa342aed686575ef39a8ec9dc16cbab4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fdb0a3b06aac9bbd85eeda7b1daf8545>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:fa632501828d57a2c1fda712393a3927> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:cb386ea42baf8766a3e98e9d24d46516> .
<http://bio2rdf.org/drugbank_resource:97f751c9423321c8864c0243afcff111>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"97f751c9423321c8864c0243afcff111"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-26>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:Citanest-Dental>	<http://purl.org/dc/terms/title>	"Citanest Dental"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-21>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3314d6a38b90d6a9ef0419bc7224913d>	<http://purl.org/dc/terms/title>	"Organic metal salt"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-6>	<http://www.w3.org/2000/01/rdf-schema#label>	"IUPAC Name: (2S)-2-[(4-{[(2-amino-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl)methyl]amino}phenyl)formamido]pentanedioic acid from ChemAxon [drugbank_resource:calculated-properties-DB00116-6]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-27>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00091-27"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-20>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:1c9905a95fe27572eaf4822554262551>	<http://purl.org/dc/terms/title>	"absorption for drugbank:DB00066"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-23>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01601>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00109_DB01601"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:67b3d3945732c5188334e7f955ca6288>	<http://www.w3.org/2000/01/rdf-schema#label>	"indication for drugbank:DB00093 [drugbank_resource:67b3d3945732c5188334e7f955ca6288]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-22>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:7a67baa1bb7b49a978b39d77e07946e0>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:7a67baa1bb7b49a978b39d77e07946e0"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e04ee332a67fe1dea4752f0a68c0a6ee>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:e04ee332a67fe1dea4752f0a68c0a6ee"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:amino-acid-sequence>	">Cytochrome P450 3A5\nMDLIPNLAVETWLLLAVSLVLLYLYGTRTHGLFKRLGIPGPTPLPLLGNVLSYRQGLWKF\nDTECYKKYGKMWGTYEGQLPVLAITDPDVIRTVLVKECYSVFTNRRSLGPVGFMKSAISL\nAEDEEWKRIRSLLSPTFTSGKLKEMFPIIAQYGDVLVRNLRREAEKGKPVTLKDIFGAYS\nMDVITGTSFGVNIDSLNNPQDPFVESTKKFLKFGFLDPLFLSIILFPFLTPVFEALNVSL\nFPKDTINFLSKSVNRMKKSRLNDKQKHRLDFLQLMIDSQNSKETESHKALSDLELAAQSI\nIFIFAGYETTSSVLSFTLYELATHPDVQQKLQKEIDAVLPNKAPPTYDAVVQMEYLDMVV\nNETLRLFPVAIRLERTCKKDVEINGVFIPKGSMVVIPTYALHHDPKYWTEPEEFRPERFS\nKKKDSIDPYIYTPFGTGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLDTQG\nLLQPEKPIVLKVDSRDGTLSGE"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-17>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a78396bd0ab3d3f25852a0d4008cbdf4>	<http://purl.org/dc/terms/title>	"Cyclosporins"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-16>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/chemspider:6038>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"6038"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:684d8812e411c70454900dc745e593c8>	<http://www.w3.org/2000/01/rdf-schema#label>	"480 ug/.8mL Injection, solution form with intravenous route [drugbank_resource:684d8812e411c70454900dc745e593c8]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-19>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:9be1f0fbe27fc41feab5fa848add809b>	<http://www.w3.org/2000/01/rdf-schema#label>	"indication for drugbank:DB00089 [drugbank_resource:9be1f0fbe27fc41feab5fa848add809b]"@en .
<http://bio2rdf.org/drugbank_resource:67b3d3945732c5188334e7f955ca6288>	<http://purl.org/dc/terms/title>	"indication for drugbank:DB00093"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-13>	<http://purl.org/dc/terms/title>	"Monoisotopic Weight: 155.069476547 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-18>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-9>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00116-9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:x-pubchemsubstance>	<http://bio2rdf.org/pubchem.substance:46507001> .
<http://bio2rdf.org/drugbank_resource:2d6f2db0443dc24ac01149b8df7afb05>	<http://www.w3.org/2000/01/rdf-schema#label>	"10 [USP'U]/mL Injection form with intramuscular; intravenous route [drugbank_resource:2d6f2db0443dc24ac01149b8df7afb05]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-13>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-12>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-10>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-10"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:x-pubchemsubstance>	<http://bio2rdf.org/pubchem.substance:46506428> .
<http://bio2rdf.org/drugbank_resource:1cb959cb5d30e328a863a3d9f64c120a>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"1cb959cb5d30e328a863a3d9f64c120a"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:x-pubchemcompound>	<http://bio2rdf.org/pubchem.compound:91443> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-15>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:x-pubchemcompound>	<http://bio2rdf.org/pubchem.compound:6274> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:x-pubchemsubstance>	<http://bio2rdf.org/pubchem.substance:46504756> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-14>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0000300>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-23>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-23"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:x-pubchemcompound>	<http://bio2rdf.org/pubchem.compound:1051> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-9>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:627446b31de3941cb82db7d08189b597>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:627446b31de3941cb82db7d08189b597"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:592de4a57c1d28519d666f4b36fa6b2b>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"592de4a57c1d28519d666f4b36fa6b2b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:53ca67aedcd10f1c9afc4de0f2138502>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:53ca67aedcd10f1c9afc4de0f2138502"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-8>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-11>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-9>	<http://www.w3.org/2000/01/rdf-schema#label>	"Monoisotopic Weight: 1355.575230332 from ChemAxon [drugbank_resource:calculated-properties-DB00115-9]"@en .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:x-pubchemcompound>	<http://bio2rdf.org/pubchem.compound:44176380> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-10>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://purl.org/dc/terms/identifier>	"drugbank:BE0002362"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f38592452c305d31bbbb2909013724ac>	<http://www.w3.org/2000/01/rdf-schema#label>	"Organosulfur compounds [drugbank_resource:f38592452c305d31bbbb2909013724ac]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-5>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-16>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00114-16"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-4>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-7>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-2>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00096-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:4f9f96147f2386295de420eed7aa9274>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:4f9f96147f2386295de420eed7aa9274"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-6>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00097>	<http://bio2rdf.org/drugbank_vocabulary:absorption>	<http://bio2rdf.org/drugbank_resource:abc4b12d5153eba9af71c2c651bd4ff1> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:x-pubchemsubstance>	<http://bio2rdf.org/pubchem.substance:46509031> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-26>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00102>	<http://purl.org/dc/terms/identifier>	"drugbank:DB00102"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00677>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:DB00109_DB00677"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-25>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-3>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-27>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f2977936270a493873be5432bb760ef7>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:93c392ef94d70fc29c467d485b49f786> .
<http://bio2rdf.org/drugbank:DB00102>	<http://purl.org/dc/terms/title>	"Becaplermin"@en .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"cellular metabolism"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-24>	<http://purl.org/dc/terms/title>	"Number of Rings: 1 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-22>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f2a30f76a373192265e4b663c8339602>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:f2a30f76a373192265e4b663c8339602"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-6> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-21>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3181b99b434a8db59d197070956de3d9>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:3181b99b434a8db59d197070956de3d9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-7> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-8> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-9> .
<http://bio2rdf.org/drugbank_vocabulary:e328a6cf619c4105669d93dc30d36096>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:787ef58546dc52c80027a1e3a2b925b9>	<http://purl.org/dc/terms/title>	"300 \u00B5g Solution form with intravenous route"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-24>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00398>	<http://www.w3.org/2000/01/rdf-schema#label>	"DDI between Bevacizumab and Sorafenib - Bevacizumab may enhance the adverse/toxic effect of SORAfenib. Specifically, the risk for hand-foot skin reaction may be increased. [drugbank_resource:DB00112_DB00398]"@en .
<http://bio2rdf.org/drugbank:BE0000300>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Enzyme> .
<http://bio2rdf.org/drugbank_resource:3f54718d1deb0dbafe47e6e45eda5914>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"0.05 %"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3afc1cd15f9de2a07db0081098265ac4>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"3afc1cd15f9de2a07db0081098265ac4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-23>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-19>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:1059233feb371b14b03a21571fa19968>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:1059233feb371b14b03a21571fa19968"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pdb:CNC>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/pdb:CNC"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:88491d7d06bc30fa9586740372808b10>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"50 mg/.5mL"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-22>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-22"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-18>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e340b19fed6c2eaebccc1a4c652c8eb5>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:e340b19fed6c2eaebccc1a4c652c8eb5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:372918cb5733e55c6d5baa7bc6f4a30c>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:372918cb5733e55c6d5baa7bc6f4a30c"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Dietary-Supplements>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:Dietary-Supplements"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:e6be3ee899ac0f450592b2c5985631de>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-20>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-23>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-23"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-2>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00090-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-2>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-13>	<http://bio2rdf.org/drugbank_vocabulary:value>	"InChIKey=SEKGMJVHSBBHRD-WZHZPDAFSA-M"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-6>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-15>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:787ef58546dc52c80027a1e3a2b925b9>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:787ef58546dc52c80027a1e3a2b925b9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2ec24002f6e3cb0430a51468ee1d26da>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"2ec24002f6e3cb0430a51468ee1d26da"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:6621165671a52f286c0f04fbfcf81106>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"6621165671a52f286c0f04fbfcf81106"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://purl.org/dc/terms/title>	"Cytochrome P450 3A5"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-14>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:d025612c433b867a6ebb00b2532e2626>	<http://purl.org/dc/terms/title>	"half-life for drugbank:DB00099"@en .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:x-pubchemcompound>	<http://bio2rdf.org/pubchem.compound:34756> .
<http://bio2rdf.org/drugbank_resource:7aa53fec8bf96c3555379e2680167034>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:7aa53fec8bf96c3555379e2680167034"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fc61d172cba7ae19145ff846ca1f0aef>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:fc61d172cba7ae19145ff846ca1f0aef"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:e6be3ee899ac0f450592b2c5985631de>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Name> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-17>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-11>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00116-11"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:1c7495e7ba342d224b5028d72d73010d>	<http://www.w3.org/2000/01/rdf-schema#label>	"35 mg Powder for solution form with intravenous route [drugbank_resource:1c7495e7ba342d224b5028d72d73010d]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-16>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-18>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-18"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-4>	<http://purl.org/dc/terms/title>	"Molecular Formula: C2306H3594N610O694S26"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-26>	<http://www.w3.org/2000/01/rdf-schema#label>	"Ghose Filter: 0 from ChemAxon [drugbank_resource:calculated-properties-DB00116-26]"@en .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:x-pubchemsubstance>	<http://bio2rdf.org/pubchem.substance:46505280> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-11>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-25>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00093-25"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-10>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:e328a6cf619c4105669d93dc30d36096>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Name> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-13>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-12>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-7>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-4>	<http://purl.org/dc/terms/title>	"Molecular Weight: 144482.5000"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-11>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00116-11"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-13>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-13"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-25>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00117-25"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:da8dbfa1d167bdbfac5e83608be911ea>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:da8dbfa1d167bdbfac5e83608be911ea"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-6>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-9>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-4>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:180176f4e85931ffb36c855eab8691da>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:180176f4e85931ffb36c855eab8691da"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-8>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-6>	<http://bio2rdf.org/drugbank_vocabulary:value>	"[(1R,2R,3S,4S,8S,9S,14S,18R,19R)-4,9,14-tris(2-carbamoylethyl)-3,8,19-tris(carbamoylmethyl)-18-(2-{[(2R)-2-[({[(2R,3S,4R,5S)-5-(5,6-dimethyl-1H-1,3-benzodiazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy}(hydroxy)phosphoryl)oxy]propyl]carbamoyl}ethyl)-2,3,6,8,13,13,16,18-octamethyl-20,21,22,23-tetraazapentacyclo[15.2.1.1\u00B2,\u2075.1\u2077,\u00B9\u2070.1\u00B9\u00B2,\u00B9\u2075]tricosa-5(23),6,10(22),11,15(21),16-hexaen-20-yl]cobaltcarbonitrile"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:8550beb9aaabcff323bdfeef04608bb8>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:43ebb1f4d3ddbd9ec70fcbba40c42a45>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"43ebb1f4d3ddbd9ec70fcbba40c42a45"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-3>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Vitamins>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:Vitamins"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-21>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00114-1>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00114-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-20>	<http://purl.org/dc/terms/title>	"pKa (strongest acidic): 3.51 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-5>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00100>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugbank.ca/drugs/DB00100> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-4>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8ae8b01597df174d257016596812aeab>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:8ae8b01597df174d257016596812aeab"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugbank.ca/drugs/DB00115> .
<http://bio2rdf.org/drugbank:DB00099>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugbank.ca/drugs/DB00099> .
<http://bio2rdf.org/drugbank_vocabulary:8550beb9aaabcff323bdfeef04608bb8>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Name> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-18>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00114>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugbank.ca/drugs/DB00114> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-18>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00093-18"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"cellular metabolism"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00117>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugbank.ca/drugs/DB00117> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-17>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00102>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugbank.ca/drugs/DB00102> .
<http://bio2rdf.org/drugbank:DB00109>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.rxlist.com/cgi/generic3/fuzeon.htm> .
<http://bio2rdf.org/drugbank_resource:DB00107_DB00834>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00116>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugbank.ca/drugs/DB00116> .
<http://bio2rdf.org/drugbank:DB00107>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.rxlist.com/cgi/generic3/oxytocin.htm> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-20>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:282d8423d2c45b369fa817ef1edbccd5>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"282d8423d2c45b369fa817ef1edbccd5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00103>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugbank.ca/drugs/DB00103> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"cellular metabolism"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0000456>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Enzyme> .
<http://bio2rdf.org/drugbank_resource:DB00107_DB00429>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00112>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugbank.ca/drugs/DB00112> .
<http://bio2rdf.org/drugbank:DB00105>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugbank.ca/drugs/DB00105> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-19>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:195ccf935d3c9947bcc17b096fdca329>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"195ccf935d3c9947bcc17b096fdca329"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00093>	<http://www.w3.org/2000/01/rdf-schema#label>	"Felypressin [drugbank:DB00093]"@en .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"cellular metabolism"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:ffb414ea32db58bec7ec3339a42c9dee>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:DB00107_DB00929>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:5b282e6fa4562e2752afccabea3c29c1>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:5b282e6fa4562e2752afccabea3c29c1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00113>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugbank.ca/drugs/DB00113> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-14>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00102>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.rxlist.com/cgi/generic2/becapler.htm> .
<http://bio2rdf.org/drugbank_vocabulary:Nutraceutical>	<http://www.w3.org/2000/01/rdf-schema#label>	"nutraceutical [drugbank_vocabulary:Nutraceutical]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-19>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00091-19"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00107_DB00917>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-15>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-15"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00100>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.rxlist.com/cgi/generic2/factorix.htm> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-13>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00110>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugbank.ca/drugs/DB00110> .
<http://bio2rdf.org/drugbank:DB00103>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.rxlist.com/cgi/generic3/fabrazyme.htm> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-1>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00096-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00109>	<http://purl.org/dc/terms/identifier>	"drugbank:DB00109"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-5>	<http://purl.org/dc/terms/title>	"logS: -1.6 from ALOGPS"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-16>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"endopeptidase activity"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00111>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugbank.ca/drugs/DB00111> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-29>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-29"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00109>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugbank.ca/drugs/DB00109> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-15>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00089>	<http://purl.org/dc/terms/identifier>	"drugbank:DB00089"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-10>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00107>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugbank.ca/drugs/DB00107> .
<http://bio2rdf.org/drugbank_resource:78fce134a0e754813388f2850f268625>	<http://www.w3.org/2000/01/rdf-schema#label>	"indication for drugbank:DB00111 [drugbank_resource:78fce134a0e754813388f2850f268625]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-9>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00106>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugbank.ca/drugs/DB00106> .
<http://bio2rdf.org/drugbank:DB00118>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugs.com/cdi/s-adenosylmethionine.html> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-12>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:eda68d4a7955df0290c1f8b709e905ec>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:eda68d4a7955df0290c1f8b709e905ec"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00093-1>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00093-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00112>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.rxlist.com/cgi/generic3/avastin.htm> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-3>	<http://www.w3.org/2000/01/rdf-schema#label>	"Isoelectric Point: 5.20 [drugbank_resource:experimental-properties-DB00100-3]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-11>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-4>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:aa64bf1510edae009ba1d31553912173>	<http://bio2rdf.org/drugbank_vocabulary:name>	"ProstaScint"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f2977936270a493873be5432bb760ef7>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:dfe1ce914314329264e9646b2686f5ff> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-2>	<http://www.w3.org/2000/01/rdf-schema#label>	"Hydrophobicity: -0.258 [drugbank_resource:experimental-properties-DB00097-2]"@en .
<http://bio2rdf.org/drugbank:DB00111>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.rxlist.com/cgi/generic3/zenapax.htm> .
<http://bio2rdf.org/drugbank_resource:6621165671a52f286c0f04fbfcf81106>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"108 mg"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-6>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:f6203f7c9646b21edf1fa81c5cdf94d1>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_vocabulary:908621b9e3153f791dd6dbd4ef6d62a5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-5>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"transition metal ion binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:8ad571235d010ca525f3733fd9b517fb>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Name> .
<http://bio2rdf.org/drugbank:DB00110>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.rxlist.com/cgi/generic2/palivizumab.htm> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB03880>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:DB00109_DB03880"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-8>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00088>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.rxlist.com/cgi/generic3/ceredase.htm> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-7>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00118-7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-7>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-11> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-12> .
<http://bio2rdf.org/drugbank_vocabulary:fa342aed686575ef39a8ec9dc16cbab4>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-13> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-14> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-28>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-3>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003533>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"transition metal ion binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-10> .
<http://bio2rdf.org/drugbank_vocabulary:908621b9e3153f791dd6dbd4ef6d62a5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Name> .
<http://bio2rdf.org/drugbank:DB00088>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugbank.ca/drugs/DB00088> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-27>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-19> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-20> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-21> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-22> .
<http://bio2rdf.org/drugbank_vocabulary:8ad571235d010ca525f3733fd9b517fb>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-15> .
<http://bio2rdf.org/drugbank_resource:fe02b6034f5c4d73f73a58815355abf5>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:93c392ef94d70fc29c467d485b49f786> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-4>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-16> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-17> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-18> .
<http://bio2rdf.org/drugbank_resource:fba31fe582cac619f85335c144278e17>	<http://www.w3.org/2000/01/rdf-schema#label>	"100 mg Capsule form with oral route [drugbank_resource:fba31fe582cac619f85335c144278e17]"@en .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-27> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-29>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00089>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugbank.ca/drugs/DB00089> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-4>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00114-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-28> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-29> .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"transition metal ion binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-4> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-23> .
<http://bio2rdf.org/drugbank_resource:f2977936270a493873be5432bb760ef7>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:f2977936270a493873be5432bb760ef7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-24>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-24> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-22>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-22"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-25> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-26> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-9> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/drugbank_vocabulary:transmembrane-regions>	"2-22"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-23>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-5> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-26>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0000456>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"Methylmalonic aciduria type B protein"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-2>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00096-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:7767fecbc1fcbba1764734e284afdd13>	<http://purl.org/dc/terms/title>	"clearance for drugbank:DB00097"@en .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-6> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-10> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-7> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-11> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-8> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-12> .
<http://bio2rdf.org/drugbank:DB00095>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.rxlist.com/cgi/generic3/raptiva.htm> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-25>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-13> .
<http://bio2rdf.org/drugbank:DB00094>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.rxlist.com/cgi/generic3/urofollitropin.htm> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-14> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-15> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-16> .
<http://bio2rdf.org/drugbank_vocabulary:73192b1a02a81c1e485fb06abc6fdc61>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Name> .
<http://bio2rdf.org/drugbank:DB00092>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugbank.ca/drugs/DB00092> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-20>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-17> .
<http://bio2rdf.org/drugbank:DB00093>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugbank.ca/drugs/DB00093> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-18> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-19> .
<http://bio2rdf.org/drugbank:DB00091>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugbank.ca/drugs/DB00091> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-20> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-21> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-19>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-16>	<http://purl.org/dc/terms/title>	"Polarizability: 42.95 from ChemAxon"@en .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-3> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-4> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-1>	<http://bio2rdf.org/drugbank_vocabulary:value>	"-0.300"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:b86c00de25382c6ce4d94dae5e4502db>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:b86c00de25382c6ce4d94dae5e4502db"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-23>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00114-23"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-5> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-6> .
<http://bio2rdf.org/drugbank_vocabulary:Vasoconstrictor-Agents>	<http://purl.org/dc/terms/title>	"Vasoconstrictor Agents"@en .
<http://bio2rdf.org/drugbank_resource:0e708564ecff800b67a0d210bc03042c>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"0e708564ecff800b67a0d210bc03042c"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-22>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-7> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-2>	<http://purl.org/dc/terms/title>	"logP: -1.1 from ALOGPS"@en .
<http://bio2rdf.org/drugbank_resource:70d5905dbbb671a2bf66275527b38e09>	<http://www.w3.org/2000/01/rdf-schema#label>	"Monosaccharide phosphate [drugbank_resource:70d5905dbbb671a2bf66275527b38e09]"@en .
<http://bio2rdf.org/drugbank:DB00090>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugbank.ca/drugs/DB00090> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-8> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-9> .
<http://bio2rdf.org/drugbank:DB00096>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugbank.ca/drugs/DB00096> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-21>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-21> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-9> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-22> .
<http://bio2rdf.org/drugbank:DB00092>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.rxlist.com/cgi/generic3/amevive.htm> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-23> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-24> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-1>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00113-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-3>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00118-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:705836a5549e0548d20a0ef04e009f28>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Name> .
<http://bio2rdf.org/drugbank_resource:3f54718d1deb0dbafe47e6e45eda5914>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:3f54718d1deb0dbafe47e6e45eda5914"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-16>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-18> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-19> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-2> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-20> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-2>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00102-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:b15aa7d1fbce9f1563623833e416d8f7>	<http://www.w3.org/2000/01/rdf-schema#label>	"Substituted anilines [drugbank_resource:b15aa7d1fbce9f1563623833e416d8f7]"@en .
<http://bio2rdf.org/drugbank:DB00100>	<http://www.w3.org/2000/01/rdf-schema#label>	"Coagulation Factor IX [drugbank:DB00100]"@en .
<http://bio2rdf.org/drugbank_resource:13bf7e351282b3c815c4b958aedb585f>	<http://www.w3.org/2000/01/rdf-schema#label>	"Oxolane [drugbank_resource:13bf7e351282b3c815c4b958aedb585f]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-15>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-14> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-26> .
<http://bio2rdf.org/drugbank:DB00097>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugbank.ca/drugs/DB00097> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-15> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-27> .
<http://bio2rdf.org/drugbank:DB00090>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.rxlist.com/cgi/generic3/aldurazyme.htm> .
<http://bio2rdf.org/drugbank:DB00094>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugbank.ca/drugs/DB00094> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:name>	"Cytochrome P450 2C9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-16> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-3> .
<http://bio2rdf.org/drugbank:DB00095>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugbank.ca/drugs/DB00095> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"EC 1.14.13.97"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-17> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-4> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-5> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-18>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-10> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-11> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-1>	<http://bio2rdf.org/drugbank_vocabulary:value>	"54 \u00B0C"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-22>	<http://purl.org/dc/terms/title>	"H Bond Acceptor Count: 4 from ChemAxon"@en .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-6> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-7> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-12> .
<http://bio2rdf.org/drugbank:DB00095>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugs.com/cdi/efalizumab.html> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://www.w3.org/2000/01/rdf-schema#label>	"Cytochrome P450 3A4 [drugbank:BE0002638]"@en .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-13> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-8> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-17>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-25> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-12>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-12"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-26> .
<http://bio2rdf.org/drugbank:DB00091>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.rxlist.com/cgi/generic/cyclosporine.htm> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-27> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-21>	<http://purl.org/dc/terms/title>	"Rotatable Bond Count: 3 from ChemAxon"@en .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-10> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-11> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-3> .
<http://bio2rdf.org/drugbank_vocabulary:705836a5549e0548d20a0ef04e009f28>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-12> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-12>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-8> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-21> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-13> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-22> .
<http://bio2rdf.org/drugbank_vocabulary:6826daa495527ec54b81079e04e89d24>	<http://purl.org/dc/terms/title>	"Biosechs"@en .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-9> .
<http://bio2rdf.org/drugbank:DB00097>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugs.com/cdi/choriogonadotropin-alfa.html> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-23> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-14> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-15> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-3>	<http://bio2rdf.org/drugbank_vocabulary:value>	"69899.4"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-3>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Weight: 55597.4000 [drugbank_resource:experimental-properties-DB00088-3]"@en .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-24> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-4> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-8> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-11>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-5> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-9> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-6> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-7> .
<http://bio2rdf.org/drugbank_resource:00199edd2aba5de431eaa55bda5406d7>	<http://purl.org/dc/terms/title>	"mechanism-of-action for drugbank:DB00105"@en .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-25> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-4> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-14>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-26> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-4>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Formula: C3160H4848N898O881S12 [drugbank_resource:experimental-properties-DB00090-4]"@en .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-5> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-27> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-6> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-3> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-7> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-10> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-4>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Weight: 144482.5000 [drugbank_resource:experimental-properties-DB00113-4]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-9>	<http://purl.org/dc/terms/title>	"Molecular Weight: 1202.6112 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-13>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-24> .
<http://bio2rdf.org/drugbank:DB00091>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugs.com/cdi/cyclosporine-drops.html> .
<http://bio2rdf.org/drugbank_resource:e8fbddfaa9a4fe87d9328de7cf8cd326>	<http://www.w3.org/2000/01/rdf-schema#label>	"300 ug/mL Injection, solution form with intravenous; subcutaneous route [drugbank_resource:e8fbddfaa9a4fe87d9328de7cf8cd326]"@en .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-11> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-25> .
<http://bio2rdf.org/drugbank:DB00090>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugs.com/cdi/laronidase.html> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-26> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-12> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-13> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-1>	<http://purl.org/dc/terms/title>	"Hydrophobicity: -2.7"@en .
<http://bio2rdf.org/drugbank_vocabulary:73192b1a02a81c1e485fb06abc6fdc61>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-27> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-28> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-29> .
<http://bio2rdf.org/drugbank:DB00113>	<http://www.w3.org/2000/01/rdf-schema#label>	"Arcitumomab [drugbank:DB00113]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-5>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-30> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-31> .
<http://bio2rdf.org/drugbank_resource:f30bb36d9cf1cde63e806eb49b64d341>	<http://www.w3.org/2000/01/rdf-schema#label>	"Organic cations [drugbank_resource:f30bb36d9cf1cde63e806eb49b64d341]"@en .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-16> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-18> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-17> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-19> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-2> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-18> .
<http://bio2rdf.org/drugbank_resource:4a0d48b5f8e157c4bbcb34092d4edaf3>	<http://purl.org/dc/terms/title>	"Phosphoethanolamine"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-13>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-13"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-20> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-19> .
<http://bio2rdf.org/drugbank:DB00094>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugs.com/cdi/urofollitropin-purified.html> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-10>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-14> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-20> .
<http://bio2rdf.org/drugbank_resource:5b47883807d5fa7a5b0b5ce2dc6e7939>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"10; .22 mg/mL; mg/mL"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-15> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-21> .
<http://bio2rdf.org/drugbank:DB00097>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.rxlist.com/cgi/generic/ovidrel.htm> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-22> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-16> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-23> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:calculated-properties>	<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-17> .
<http://bio2rdf.org/drugbank_resource:Citanest-Octapressin>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:Citanest-Octapressin"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00088>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugs.com/cdi/alglucerase.html> .
<http://bio2rdf.org/drugbank:DB00092>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugs.com/cdi/alefacept.html> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"P450-PCN1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e52e95d4f4c438c7fbf93397e39c26e3>	<http://www.w3.org/2000/01/rdf-schema#label>	"mechanism-of-action for drugbank:DB00093 [drugbank_resource:e52e95d4f4c438c7fbf93397e39c26e3]"@en .
<http://bio2rdf.org/drugbank_resource:bf1a15ece689c3f449c06ebc0a90dae3>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:bf1a15ece689c3f449c06ebc0a90dae3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e02568426e5e3817cd6fcddc8dee4bee>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:e02568426e5e3817cd6fcddc8dee4bee"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-23>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00091-23"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e650b92d5679a4bc966570691fe2d7e4>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:e650b92d5679a4bc966570691fe2d7e4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-26>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-26"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e39dd3e5ddfc2038fa77efd8d6d5305d>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:e39dd3e5ddfc2038fa77efd8d6d5305d"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-27>	<http://www.w3.org/2000/01/rdf-schema#label>	"Ghose Filter: 0 from ChemAxon [drugbank_resource:calculated-properties-DB00091-27]"@en .
<http://bio2rdf.org/drugbank_resource:80e4560d8a88ff69231ec21ee09506be>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:80e4560d8a88ff69231ec21ee09506be"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-4>	<http://bio2rdf.org/drugbank_vocabulary:value>	"C204H301N51O64"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/bindingdb:7953>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/bindingdb/7953> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-10>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-10"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-22>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-22"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-28>	<http://purl.org/dc/terms/title>	"Ghose Filter: 0 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:ffa1ac4af9ac617e01349d78fdc482f1>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:ffa1ac4af9ac617e01349d78fdc482f1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Supplements>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:Supplements"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:376c6e6cad258f51a802ccce8c53ca4c>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:376c6e6cad258f51a802ccce8c53ca4c"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fffcf97ccb1aeb21dae91caa501b8255>	<http://purl.org/dc/terms/title>	"Aniline"@en .
<http://bio2rdf.org/drugbank_resource:DB00103_DB01118>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/bindingdb:50271301>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/bindingdb/50271301> .
<http://bio2rdf.org/drugbank_resource:9d6d13e90c7dfeb0d8d2cac125c20125>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:9d6d13e90c7dfeb0d8d2cac125c20125"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Enzyme-Inhibitors>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:Enzyme-Inhibitors"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-16>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00117-16"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fe02b6034f5c4d73f73a58815355abf5>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:66a4f22d1577f66fd9737b00a8525f55> .
<http://bio2rdf.org/drugbank_resource:DB00103_DB00608>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:DB00110_DB08879>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:DB00110_DB08879"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:904bc2c9127fa8f18e0965559eecc60c>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"904bc2c9127fa8f18e0965559eecc60c"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugs.com/cdi/cyanocobalamin-b12.html> .
<http://bio2rdf.org/bindingdb:50102442>	<http://purl.org/dc/terms/identifier>	"bindingdb:50102442"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3eff294ae1a633c8845359753061fac9>	<http://purl.org/dc/terms/description>	"* 4.1 +/- 1.2 mL/min/kg [adult patients with Fabry disease,0.3 mg/kg, 1 infusion]\r\n* 4.6 +/- 2.2 mL/min/kg [adult patients with Fabry disease, 0.3 mg/kg, 5 infusions]\r\n* 2.1 +/- 0.7 mL/min/kg [adult patients with Fabry disease, 1 mg/kg, 1 infusion]\r\n* 3.2 +/- 2.6 mL/min/kg [adult patients with Fabry disease, 1 mg/kg, 5 infusions]\r\n* 0.8 +/- 0.3 mL/min/kg [adult patients with Fabry disease, 3 mg/kg, 1 infusion]\r\n* 0.8 +/- 0.4 mL/min/kg [adult patients with Fabry disease, 3 mg/kg, 5 infusions]\r\n* 1.8 +/- 0.8 mL/min/kg [Pediatric Patients with Fabry Disease, 1 mg/kg, 1-3 infusions]\r\n* 4.9 +/- 5.6 mL/min/kg [Pediatric Patients with Fabry Disease, 1 mg/kg, 7 infusions]\r\n* 2.3 +/- 2.2 mL/min/kg [Pediatric Patients with Fabry Disease, 1 mg/kg, 11 infusions]"@en .
<http://bio2rdf.org/drugbank:DB00103>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugs.com/cdi/agalsidase-beta.html> .
<http://bio2rdf.org/drugbank:DB00110>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugs.com/cdi/palivizumab.html> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-7>	<http://bio2rdf.org/drugbank_vocabulary:value>	"30-ethyl-14,17,23,32-tetrahydroxy-33-[(4E)-1-hydroxy-2-methylhex-4-en-1-yl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-13,16,22,31-tetraene-2,5,8,11,20,26,29-heptone"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0000456>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/bindingdb:50102442>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/bindingdb/50102442> .
<http://bio2rdf.org/drugbank:DB00111>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugs.com/cdi/daclizumab.html> .
<http://bio2rdf.org/drugbank_resource:3eff294ae1a633c8845359753061fac9>	<http://purl.org/dc/terms/title>	"clearance for drugbank:DB00103"@en .
<http://bio2rdf.org/drugbank:DB00112>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugs.com/cdi/bevacizumab-solution.html> .
<http://bio2rdf.org/drugbank:DB00106>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugs.com/cdi/abarelix.html> .
<http://bio2rdf.org/drugbank_resource:f31c373ea0d5f6b6f514f58cf30652a6>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:f31c373ea0d5f6b6f514f58cf30652a6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.rxlist.com/cgi/generic/b12inj.htm> .
<http://bio2rdf.org/drugbank_vocabulary:fa342aed686575ef39a8ec9dc16cbab4>	<http://bio2rdf.org/drugbank_vocabulary:name>	"Biocilin"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:99633b36b8289d3e0a8562067bd42c03>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:99633b36b8289d3e0a8562067bd42c03"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Angiogenesis-Inhibitors>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Category> .
<http://bio2rdf.org/drugbank:DB00099>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.rxlist.com/cgi/generic/filgrastim.htm> .
<http://bio2rdf.org/drugbank_vocabulary:Labor-Induction-Agents>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:Anti-Testosterone-Agents>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Category> .
<http://bio2rdf.org/drugbank_resource:DB00099_DB01030>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:DB00099_DB01030"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00109>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugs.com/cdi/enfuvirtide.html> .
<http://bio2rdf.org/drugbank_resource:c2dbd6b14df7875575496a70dff7a209>	<http://purl.org/dc/terms/title>	"Glycosyl compound"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-2>	<http://www.w3.org/2000/01/rdf-schema#label>	"Isoelectric Point: 5.17 [drugbank_resource:experimental-properties-DB00103-2]"@en .
<http://bio2rdf.org/drugbank_vocabulary:Micronutrients>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00103>	<http://purl.org/dc/terms/title>	"Agalsidase beta"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-12>	<http://bio2rdf.org/drugbank_vocabulary:value>	"InChI=1S/C15H22N6O5S/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/p+1/t7-,8+,10+,11+,14+,27?/m0/s1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a595cc1c66cf7314ca9d50542e429c85>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:a595cc1c66cf7314ca9d50542e429c85"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Angiogenesis-Inducing-Agents>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Category> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-12>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00116-12"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00118>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugbank.ca/drugs/DB00118> .
<http://bio2rdf.org/drugbank:DB00099>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugs.com/cdi/filgrastim.html> .
<http://bio2rdf.org/drugbank_resource:7975713dad73e24fab2cbb6c89586ea4>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:7975713dad73e24fab2cbb6c89586ea4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fdb0a3b06aac9bbd85eeda7b1daf8545>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:49b21ad0d38942f635877e7bbc5d7a1e> .
<http://bio2rdf.org/drugbank:DB00102>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugs.com/cdi/becaplermin.html> .
<http://bio2rdf.org/drugbank:DB00106>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.rxlist.com/cgi/generic/plenaxis.htm> .
<http://bio2rdf.org/drugbank:DB00105>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.rxlist.com/cgi/generic/introna.htm> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-18>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00116-18"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00107>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugs.com/cdi/oxytocin.html> .
<http://bio2rdf.org/pubchem.compound:6274>	<http://purl.org/dc/terms/identifier>	"pubchem.compound:6274"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:22f72a952683d19d554d47d3919c10f3>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"22f72a952683d19d554d47d3919c10f3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-8>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Weight: 445.4292 from ChemAxon [drugbank_resource:calculated-properties-DB00116-8]"@en .
<http://bio2rdf.org/drugbank_vocabulary:Nutraceutical>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-9>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00100>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.drugs.com/cdi/coagulation-factor-ix-injection-human.html> .
<http://bio2rdf.org/drugbank_vocabulary:Oxytocics>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:6826daa495527ec54b81079e04e89d24>	<http://bio2rdf.org/drugbank_vocabulary:name>	"Biosechs"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f84c0f373fd98f4297607f206aadd302>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:f84c0f373fd98f4297607f206aadd302"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:433dda4a1117986cabe237dcf80bd242>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"433dda4a1117986cabe237dcf80bd242"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-26>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00117-26"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-6>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-2>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00113-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Conditionally-Essential-Amino-Acids>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-8>	<http://www.w3.org/2000/01/rdf-schema#label>	"IUPAC Name: [(4-formyl-5-hydroxy-6-methylpyridin-3-yl)methoxy]phosphonic acid from ChemAxon [drugbank_resource:calculated-properties-DB00114-8]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-1>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-5>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00099_DB00531>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_vocabulary:Dietary-Supplements>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-8>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00099_DB00290>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_vocabulary:Enzyme-Inhibitors>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB01268>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:DB00112_DB01268"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pdb:HIS>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"HIS"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-7>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Gonadotropins>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-27>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00099_DB01030>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_vocabulary:HIV-Fusion-Inhibitors>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-26>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Anti-tocolytic-Agents>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Category> .
<http://bio2rdf.org/drugbank_vocabulary:Hematopoietic-Agents>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-4>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-5>	<http://bio2rdf.org/drugbank_vocabulary:value>	"C1105H1770N318O336S26"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Antifungal-Agents>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Category> .
<http://bio2rdf.org/drugbank_vocabulary:Indicators-and-Reagents>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-3>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-4>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00090-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-28>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-28"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-11>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00093-11"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-5>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-9>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-1>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8750c04d33b8546006e83e736eb80647>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:8750c04d33b8546006e83e736eb80647"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:585c665fefee46ff4931f369bfe6004a>	<http://www.w3.org/2000/01/rdf-schema#label>	"indication for drugbank:DB00092 [drugbank_resource:585c665fefee46ff4931f369bfe6004a]"@en .
<http://bio2rdf.org/drugbank_vocabulary:HIV-Fusion-Inhibitors>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"HIV-Fusion-Inhibitors"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00762>	<http://purl.org/dc/terms/title>	"DDI between Bevacizumab and Irinotecan - Bevacizumab may enhance the adverse/toxic effect of Irinotecan."@en .
<http://bio2rdf.org/drugbank_resource:99633b36b8289d3e0a8562067bd42c03>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:99633b36b8289d3e0a8562067bd42c03"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-4>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Formula: C204H301N51O64 [drugbank_resource:experimental-properties-DB00109-4]"@en .
<http://bio2rdf.org/drugbank_resource:DB00107_DB00917>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:DB00107_DB00917"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:DB00116"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:376c6e6cad258f51a802ccce8c53ca4c>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#value>	"Speciality european pharma ltd"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-1>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00100-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a9a65e43cdc103a1f769c3625b080c1d>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:a9a65e43cdc103a1f769c3625b080c1d"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Supplements>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-25>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00118-25"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Vasoconstrictor-Agents>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:73192b1a02a81c1e485fb06abc6fdc61>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:73192b1a02a81c1e485fb06abc6fdc61"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f2a30f76a373192265e4b663c8339602>	<http://purl.org/dc/terms/title>	"indication for drugbank:DB00102"@en .
<http://bio2rdf.org/drugbank_vocabulary:Vitamin-B-Complex>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:585c665fefee46ff4931f369bfe6004a>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:585c665fefee46ff4931f369bfe6004a"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a2615bbb5710b9b992785e63c058b3db>	<http://purl.org/dc/terms/title>	"480 ug/1.6mL Injection, solution form with intravenous; subcutaneous route"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-8>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00114-8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Vitamins>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-4>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00100-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0000456>	<http://bio2rdf.org/drugbank_vocabulary:locus>	"12q24"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8abd75317f3f7b8f7d56e3fe7d6204bd>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"2.9 mg/5mL"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00363>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:64b9dc4a304f0bbee322be682a49f08b>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:64b9dc4a304f0bbee322be682a49f08b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Gonadotropins>	<http://purl.org/dc/terms/title>	"Gonadotropins"@en .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00694>	<http://purl.org/dc/terms/title>	"DDI between Bevacizumab and Daunorubicin - May enhance the cardiotoxic effect of Antineoplastic Agents (Anthracycline, Systemic)."@en .
<http://bio2rdf.org/drugbank_resource:DB00099_DB00531>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00099_DB00531"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00445>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-15>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-15"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c28ad3ee91a708824325b58f26c403a5>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:c28ad3ee91a708824325b58f26c403a5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a6317c6254a0737c350d2f0860ea1ec3>	<http://purl.org/dc/terms/description>	"For imaging colorectal tumors"@en .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00398>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-26>	<http://purl.org/dc/terms/title>	"Ghose Filter: 0 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:0e7611deb0124f99ac54f3684b112d25>	<http://purl.org/dc/terms/title>	"Monosaccharide"@en .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00762>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_vocabulary:Vitamins>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Category> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00694>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-3>	<http://bio2rdf.org/drugbank_vocabulary:value>	"7.5"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:30d0083606d3fa4b4b602b5d3ed0feda>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:30d0083606d3fa4b4b602b5d3ed0feda"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Vasoconstrictor-Agents>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Category> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB01268>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_vocabulary:ffb414ea32db58bec7ec3339a42c9dee>	<http://purl.org/dc/terms/title>	"Profasi"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-23>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00114-23"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Vitamin-B-Complex>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Category> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB01177>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:4a0d48b5f8e157c4bbcb34092d4edaf3>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:4a0d48b5f8e157c4bbcb34092d4edaf3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-4>	<http://purl.org/dc/terms/title>	"Water Solubility: 1.19e+00 g/l from ALOGPS"@en .
<http://bio2rdf.org/drugbank_resource:0e7611deb0124f99ac54f3684b112d25>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"0e7611deb0124f99ac54f3684b112d25"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Supplements>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Category> .
<http://bio2rdf.org/drugbank_resource:282d8423d2c45b369fa817ef1edbccd5>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:282d8423d2c45b369fa817ef1edbccd5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:98458df79187b81a7709036be48a75a4>	<http://www.w3.org/2000/01/rdf-schema#label>	"mechanism-of-action for drugbank:DB00116 [drugbank_resource:98458df79187b81a7709036be48a75a4]"@en .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:gene-sequence>	">1512 bp\nATGGATCTCATCCCAAACTTGGCCGTGGAAACCTGGCTTCTCCTGGCTGTCAGCCTGATA\nCTCCTCTATCTATATGGAACCCGTACACATGGACTTTTTAAGAAGCTTGGAATTCCAGGG\nCCCACACCTCTGCCTTTTTTGGGAAATGCTTTGTCCTTCCGTAAGGGCTATTGGACGTTT\nGACATGGAATGTTATAAAAAGTATAGAAAAGTCTGGGGTATTTATGACTGTCAACAGCCT\nATGCTGGCTATCACAGATCCCGACATGATCAAAACAGTGCTAGTGAAAGAATGTTATTCT\nGTCTTCACAAACCGGAGGCCTTTCGGGCCAGTGGGATTTATGAAAAATGCCATCTCTATA\nGCTGAGGATGAAGAATGGAAGAGAATACGATCATTGCTGTCTCCAACATTCACCAGCGGA\nAAACTCAAGGAGATGGTCCCTATCATTGCCCAGTATGGAGATGTGTTGGTGAGAAATCTG\nAGGCGGGAAGCAGAGACAGGCAAGCCTGTCACCTTGAAACACGTCTTTGGGGCCTACAGC\nATGGATGTGATCACTAGCACATCATTTGGAGTGAGCATCGACTCTCTCAACAATCCACAA\nGACCCCTTTGTGGAAAACACCAAGAAGCTTTTAAGATTTAATCCATTAGATCCATTCGTT\nCTCTCAATAAAAGTCTTTCCATTCCTTACCCCAATTCTTGAAGCATTAAATATCACTGTG\nTTTCCAAGAAAAGTTATAAGTTTTCTAACAAAATCTGTAAAACAGATAAAAGAAGGTCGC\nCTCAAAGAGACACAAAAGCACCGAGTGGATTTCCTTCAGCTGATGATTGACTCTCAGAAT\nTCAAAAGACTCTGAGACCCACAAAGCTCTGTCTGATCTGGAGCTCATGGCCCAATCAATT\nATCTTTATTTTTGCTGGCTATGAAACCACGAGCAGTGTTCTCTCCTTCATTATATATGAA\nCTGGCCACTCACCCTGATGTCCAGCAGAAAGTGCAGAAGGAAATTGATACAGTTTTACCC\nAATAAGGCACCACCCACCTATGATACTGTGCTACAGTTGGAGTATCTTGACATGGTGGTG\nAATGAAACACTCAGATTATTCCCAGTTGCTATGAGACTTGAGAGGGTCTGCAAAAAAGAT\nGTTGAAATCAATGGGATGTTTATTCCCAAAGGGGTGGTGGTGATGATTCCAAGCTATGTT\nCTTCATCATGACCCAAAGTACTGGACAGAGCCTGAGAAGTTCCTCCCTGAAAGGTTCAGT\nAAAAAGAACAAGGACAACATAGATCCTTACATATACACACCCTTTGGAAGTGGACCCAGA\nAACTGCATTGGCATGAGGTTTGCTCTCGTGAACATGAAACTTGCTCTAGTCAGAGTCCTT\nCAGAACTTCTCCTTCAAACCTTGTAAAGAAACACAGATCCCCCTGAAATTACGCTTTGGA\nGGACTTCTTCTAACAGAAAAACCCATTGTTCTAAAGGCTGAGTCAAGGGATGAGACCGTA\nAGTGGAGCCTGA"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:73192b1a02a81c1e485fb06abc6fdc61>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:73192b1a02a81c1e485fb06abc6fdc61"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:408e99a507da89ecb16b006481be4f7d>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:408e99a507da89ecb16b006481be4f7d"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-15>	<http://www.w3.org/2000/01/rdf-schema#label>	"Polar Surface Area (PSA): 292.76 from ChemAxon [drugbank_resource:calculated-properties-DB00091-15]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-30>	<http://purl.org/dc/terms/title>	"Ghose Filter: 0 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:a2d4a403a964b1f3a6d6fa73cb73921a>	<http://purl.org/dc/terms/title>	"mechanism-of-action for drugbank:DB00102"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-19>	<http://www.w3.org/2000/01/rdf-schema#label>	"Rule of Five: 0 from ChemAxon [drugbank_resource:calculated-properties-DB00115-19]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-6>	<http://www.w3.org/2000/01/rdf-schema#label>	"IUPAC Name: [(1R,2R,3S,4S,8S,9S,14S,18R,19R)-4,9,14-tris(2-carbamoylethyl)-3,8,19-tris(carbamoylmethyl)-18-(2-{[(2R)-2-[({[(2R,3S,4R,5S)-5-(5,6-dimethyl-1H-1,3-benzodiazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy}(hydroxy)phosphoryl)oxy]propyl]carbamoyl}ethyl)-2,3,6,8,13,13,16,18-octamethyl-20,21,22,23-tetraazapentacyclo[15.2.1.1\u00B2,\u2075.1\u2077,\u00B9\u2070.1\u00B9\u00B2,\u00B9\u2075]tricosa-5(23),6,10(22),11,15(21),16-hexaen-20-yl]cobaltcarbonitrile from ChemAxon [drugbank_resource:calculated-properties-DB00115-6]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-1>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00094-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-4>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Weight: 19271.0000 [drugbank_resource:experimental-properties-DB00105-4]"@en .
<http://bio2rdf.org/drugbank_resource:a39e93df12255155561f3d4acd297da8>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:a39e93df12255155561f3d4acd297da8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e147a45842193f4b54cd46908fed6204>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"e147a45842193f4b54cd46908fed6204"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Hematopoietic-Agents>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Category> .
<http://bio2rdf.org/drugbank_vocabulary:Anti-tocolytic-Agents>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:Nutraceutical>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Group> .
<http://bio2rdf.org/drugbank_vocabulary:Indicators-and-Reagents>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Category> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-25>	<http://purl.org/dc/terms/title>	"pKa (strongest basic): 9.44 from ChemAxon"@en .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"BE0003536"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Antifungal-Agents>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-26>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00091-26"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Gonadotropins>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Category> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-4>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00094-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3181b99b434a8db59d197070956de3d9>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"3181b99b434a8db59d197070956de3d9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:HIV-Fusion-Inhibitors>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Category> .
<http://bio2rdf.org/drugbank_resource:DB00115_DB01394>	<http://purl.org/dc/terms/title>	"DDI between Cyanocobalamin and Colchicine - May decrease the serum concentration of Cyanocobalamin."@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-27>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00117-27"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Dietary-Supplements>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Category> .
<http://bio2rdf.org/chemspider:1022>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/chemspider/1022> .
<http://bio2rdf.org/drugbank_vocabulary:9e044243b5eb2f95578c80df6000ecdd>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Name> .
<http://bio2rdf.org/drugbank_vocabulary:64789d808f73ebe8eac3dbded4a95da0>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:64789d808f73ebe8eac3dbded4a95da0"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Enzyme-Inhibitors>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Category> .
<http://bio2rdf.org/drugbank_resource:75aa077303c09d80af404a7a6c6ac735>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:bee4f78f9cba3b09abdc595ab87f170e> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-4>	<http://www.w3.org/2000/01/rdf-schema#label>	"logS: -0.53 from ADME Research, USCD [drugbank_resource:experimental-properties-DB00117-4]"@en .
<http://bio2rdf.org/drugbank_resource:091b1b5a04486711c0e6615b4e552e7e>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"091b1b5a04486711c0e6615b4e552e7e"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-4>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Weight: 142612.1000 [drugbank_resource:experimental-properties-DB00111-4]"@en .
<http://bio2rdf.org/drugbank_resource:DB00110_DB08879>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:de11407327a5468776fbcbec28a97ca0>	<http://www.w3.org/2000/01/rdf-schema#label>	"Hydroxypyridine [drugbank_resource:de11407327a5468776fbcbec28a97ca0]"@en .
<http://bio2rdf.org/drugbank_vocabulary:Conditionally-Essential-Amino-Acids>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Category> .
<http://bio2rdf.org/drugbank_vocabulary:Oxytocics>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Category> .
<http://bio2rdf.org/drugbank_vocabulary:9e044243b5eb2f95578c80df6000ecdd>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00445>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00112_DB00445"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:58cc96ec8bd0d25f62dde9d4e4a829dd>	<http://purl.org/dc/terms/title>	"Secondary alkylarylamines"@en .
<http://bio2rdf.org/drugbank_resource:e9f580ccd34b70a11720b2f316225025>	<http://purl.org/dc/terms/title>	"clearance for drugbank:DB00099"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-4>	<http://www.w3.org/2000/01/rdf-schema#label>	"Water Solubility: 1.19e+00 g/l from ALOGPS [drugbank_resource:calculated-properties-DB00118-4]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-3>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00092-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a6302cf127669e87e24a75b24552a9e8>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"a6302cf127669e87e24a75b24552a9e8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:b8238b8599e6fdc40599cf773d5fb991>	<http://purl.org/dc/terms/title>	"absorption for drugbank:DB00091"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-10>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Weight: 247.1419 from ChemAxon [drugbank_resource:calculated-properties-DB00114-10]"@en .
<http://bio2rdf.org/pdb:CNC>	<http://purl.org/dc/terms/identifier>	"pdb:CNC"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Micronutrients>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Category> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-1>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3669e274097fc69149d3dbad3ba6b01c>	<http://purl.org/dc/terms/description>	"very little systemic absorption. 15% of patients experienced complete healing within 8 weeks, while for 25% of patients, it was at 10 weeks."@en .
<http://bio2rdf.org/drugbank_vocabulary:Angiogenesis-Inducing-Agents>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:Labor-Induction-Agents>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Category> .
<http://bio2rdf.org/drugbank_vocabulary:Angiogenesis-Inhibitors>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-6>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Anti-Testosterone-Agents>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:Drug>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00107>	<http://purl.org/dc/terms/description>	"Synthetic 9 residue cyclic peptide. The hormone is prepared synthetically to avoid possible contamination with vasopressin (ADH) and other small polypeptides with biologic activity."@en .
<http://bio2rdf.org/drugbank_resource:6621165671a52f286c0f04fbfcf81106>	<http://www.w3.org/2000/01/rdf-schema#label>	"108 mg Powder for solution form with subcutaneous route [drugbank_resource:6621165671a52f286c0f04fbfcf81106]"@en .
<http://bio2rdf.org/pubchem.substance:46504756>	<http://purl.org/dc/terms/identifier>	"pubchem.substance:46504756"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:1c7495e7ba342d224b5028d72d73010d>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:1c7495e7ba342d224b5028d72d73010d"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-26>	<http://purl.org/dc/terms/title>	"Ghose Filter: 0 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-19>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00117-19"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-3>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00093-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-6>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:IUPAC-Name> .
<http://bio2rdf.org/drugbank_resource:807b0e58e0eead4b875202221ebe0f53>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:9f8bf5d0591cad82e962ae77fe1a04c2> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01264>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"monooxygenase activity"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-24>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Bioavailability> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-24>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-24"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-3>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00103-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01232>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01601>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:131ed90e7634d72c92f27daf9a85454a>	<http://purl.org/dc/terms/title>	"indication for drugbank:DB00091"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-26>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Ghose-Filter> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01319>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB06290>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB03880>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:theoretical-pi>	"5.58"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:069ab916580192548ff172f164a424bf>	<http://purl.org/dc/terms/title>	"absorption for drugbank:DB00117"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-26>	<http://www.w3.org/2000/01/rdf-schema#label>	"Rule of Five: 0 from ChemAxon [drugbank_resource:calculated-properties-DB00091-26]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-20>	<http://www.w3.org/2000/01/rdf-schema#label>	"pKa (strongest acidic): 11.39 from ChemAxon [drugbank_resource:calculated-properties-DB00093-20]"@en .
<http://bio2rdf.org/drugbank_resource:DB00107_DB00834>	<http://purl.org/dc/terms/title>	"DDI between Oxytocin and Mifepristone - May enhance the QTc-prolonging effect of QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying)."@en .
<http://bio2rdf.org/drugbank_resource:30d0083606d3fa4b4b602b5d3ed0feda>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"50 mg/mL"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-12>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-12"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00097>	<http://purl.org/dc/terms/identifier>	"drugbank:DB00097"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2c7d5048f3ab623475c1e9c503997a85>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:2c7d5048f3ab623475c1e9c503997a85"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-18>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:H-Bond-Acceptor-Count> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-19>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:H-Bond-Donor-Count> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00224>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-3>	<http://purl.org/dc/terms/title>	"logP: -3.32 from CHMELIK,J ET AL. (1991)"@en .
<http://bio2rdf.org/drugbank_vocabulary:Biotech>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:a7531086765fedefe82e0282f7a1d559>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:a7531086765fedefe82e0282f7a1d559"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00220>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:8abd75317f3f7b8f7d56e3fe7d6204bd>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"8abd75317f3f7b8f7d56e3fe7d6204bd"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Small-molecule>	<http://purl.org/dc/terms/title>	"Small molecule"@en .
<http://bio2rdf.org/drugbank_resource:fc61d172cba7ae19145ff846ca1f0aef>	<http://www.w3.org/2000/01/rdf-schema#label>	"This compound belongs to the class of organic compounds known as tetrahydrofolic acids. These are heterocyclic compounds based on the 5,6,7,8-tetrahydropteroic acid skeleton conjugated with at least one L-glutamic acid unit. [drugbank_resource:fc61d172cba7ae19145ff846ca1f0aef]"@en .
<http://bio2rdf.org/drugbank_resource:8eb135a8f519839c5f289226017b68a3>	<http://purl.org/dc/terms/title>	"half-life for drugbank:DB00110"@en .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00677>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-15>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-15"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00093-1>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:7daa15d453ae86a3a8584a10240731af> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00503>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB01177>	<http://purl.org/dc/terms/title>	"DDI between Bevacizumab and Idarubicin - May enhance the cardiotoxic effect of Antineoplastic Agents (Anthracycline, Systemic)."@en .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01072>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:c51b5b3f72bf15f717f23f1fdda6fe44>	<http://purl.org/dc/terms/title>	"manufacturer for drugbank:DB00094"@en .
<http://bio2rdf.org/drugbank_resource:c7f12f71253c5095c8df9050b7b42f2c>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:c7f12f71253c5095c8df9050b7b42f2c"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00932>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:75aa077303c09d80af404a7a6c6ac735>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:93c392ef94d70fc29c467d485b49f786> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"EC 3.4.21.26"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-20>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-20"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-16>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-16"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:81ce8d1a0627bc88956132de1e1a93c2>	<http://www.w3.org/2000/01/rdf-schema#label>	"Carboxylic acid [drugbank_resource:81ce8d1a0627bc88956132de1e1a93c2]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-14>	<http://purl.org/dc/terms/title>	"Polar Surface Area (PSA): 207.27 from ChemAxon"@en .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"monooxygenase activity"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-4>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"monooxygenase activity"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-3>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"monooxygenase activity"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:285048a510ce36e96744886cc83cc631>	<http://purl.org/dc/terms/title>	"400 mg/16mL Injection, solution form with intravenous route"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-7>	<http://www.w3.org/2000/01/rdf-schema#label>	"Traditional IUPAC Name: [(1R,2R,3S,4S,8S,9S,14S,18R,19R)-4,9,14-tris(2-carbamoylethyl)-3,8,19-tris(carbamoylmethyl)-18-(2-{[(2R)-2-({[(2R,3S,4R,5S)-5-(5,6-dimethyl-1,3-benzodiazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy(hydroxy)phosphoryl}oxy)propyl]carbamoyl}ethyl)-2,3,6,8,13,13,16,18-octamethyl-20,21,22,23-tetraazapentacyclo[15.2.1.1\u00B2,\u2075.1\u2077,\u00B9\u2070.1\u00B9\u00B2,\u00B9\u2075]tricosa-5(23),6,10(22),11,15(21),16-hexaen-20-yl]cobaltcarbonitrile from ChemAxon [drugbank_resource:calculated-properties-DB00115-7]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-1>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-5>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-15>	<http://www.w3.org/2000/01/rdf-schema#label>	"Refractivity: 121.39 from ChemAxon [drugbank_resource:calculated-properties-DB00116-15]"@en .
<http://bio2rdf.org/drugbank_resource:fba31fe582cac619f85335c144278e17>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:251aa2c7f843f73a59fa2779ab4a885a> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-3>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:ec0915fa5d5da881fd812adc490bcd65>	<http://purl.org/dc/terms/description>	"Average efalizumab bioavailability following subcutaneous administration was estimated at 30 to 50%."@en .
<http://bio2rdf.org/drugbank_resource:986ea485795ab092b3199f449ca4056e>	<http://purl.org/dc/terms/title>	"mechanism-of-action for drugbank:DB00111"@en .
<http://bio2rdf.org/drugbank_resource:eb2ea139d16c3216009f5eb2eceb62c8>	<http://www.w3.org/2000/01/rdf-schema#label>	"Vinylogous amides [drugbank_resource:eb2ea139d16c3216009f5eb2eceb62c8]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-2>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:3afc1cd15f9de2a07db0081098265ac4>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"50 mg/mL"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-5>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-14>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:328c87b1ad60e7356c52d11e15011e6f>	<http://purl.org/dc/terms/title>	"manufacturer for drugbank:DB00096"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-6>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:LogP> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-4>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-15>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-9>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:LogP> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-2>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:ba0f878619b43a5be9083f01d8ba77fd>	<http://purl.org/dc/terms/title>	"6-aminopurine"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-16>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-17>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Rotatable-Bond-Count> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-5>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-7>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:LogS> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-1>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-17>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-4>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:7975713dad73e24fab2cbb6c89586ea4>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:93c392ef94d70fc29c467d485b49f786> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-18>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:8750c04d33b8546006e83e736eb80647>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:fa632501828d57a2c1fda712393a3927> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-20>	<http://purl.org/dc/terms/title>	"Ghose Filter: 0 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_vocabulary:8ad571235d010ca525f3733fd9b517fb>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"8ad571235d010ca525f3733fd9b517fb"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"iron ion binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-3>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-19>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-11>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Formula> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-3>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00094-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-12>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:InChI> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:1588f62bddb8c0b1cca8f11ce8e653b9>	<http://www.w3.org/2000/01/rdf-schema#label>	"10 [USP'U]/mL Injection, solution form with intramuscular; intravenous route [drugbank_resource:1588f62bddb8c0b1cca8f11ce8e653b9]"@en .
<http://bio2rdf.org/drugbank_vocabulary:aa64bf1510edae009ba1d31553912173>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:aa64bf1510edae009ba1d31553912173"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-5>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:BE0002362"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-20>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-13>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:InChIKey> .
<http://bio2rdf.org/drugbank_resource:8abd75317f3f7b8f7d56e3fe7d6204bd>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:fa632501828d57a2c1fda712393a3927> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-3>	<http://purl.org/dc/terms/title>	"Molecular Weight: 45351.6000"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-2>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-6>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-1>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-7>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:47d86c7cb8687c843b27225a6715c3c1>	<http://purl.org/dc/terms/title>	"Carboxylic acids"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-4>	<http://bio2rdf.org/drugbank_vocabulary:value>	"18.8 kDa"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-20>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:PKa-(strongest-acidic)> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"iron ion binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-5>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-8>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:a7531086765fedefe82e0282f7a1d559>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:a7531086765fedefe82e0282f7a1d559"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:b86c00de25382c6ce4d94dae5e4502db>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:b86c00de25382c6ce4d94dae5e4502db"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-4>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:19d3289105c9a843a041cb4f7a0883a1>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"19d3289105c9a843a041cb4f7a0883a1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-9>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:Antifungal-Agents>	<http://www.w3.org/2000/01/rdf-schema#label>	"Antifungal Agents [drugbank_vocabulary:Antifungal-Agents]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-1>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"iron ion binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003533>	<http://bio2rdf.org/drugbank_vocabulary:amino-acid-sequence>	">Cytochrome P450 2E1\nMSALGVTVALLVWAAFLLLVSMWRQVHSSWNLPPGPFPLPIIGNLFQLELKNIPKSFTRL\nAQRFGPVFTLYVGSQRMVVMHGYKAVKEALLDYKDEFSGRGDLPAFHAHRDRGIIFNNGP\nTWKDIRRFSLTTLRNYGMGKQGNESRIQREAHFLLEALRKTQGQPFDPTFLIGCAPCNVI\nADILFRKHFDYNDEKFLRLMYLFNENFHLLSTPWLQLYNNFPSFLHYLPGSHRKVIKNVA\nEVKEYVSERVKEHHQSLDPNCPRDLTDCLLVEMEKEKHSAERLYTMDGITVTVADLFFAG\nTETTSTTLRYGLLILMKYPEIEEKLHEEIDRVIGPSRIPAIKDRQEMPYMDAVVHEIQRF\nITLVPSNLPHEATRDTIFRGYLIPKGTVVVPTLDSVLYDNQEFPDPEKFKPEHFLNENGK\nFKYSDYFKPFSTGKRVCAGEGLARMELFLLLCAILQHFNLKPLVDPKDIDLSPIHIGFGC\nIPPRYKLCVIPRS"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-10>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-8>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Water-Solubility> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-10>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:SMILES> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00095-1>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:5295f08395d80bb2a78d48e62dbf8c19>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:5295f08395d80bb2a78d48e62dbf8c19"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-7>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00091-7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-16>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Polarizability> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-11>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-15>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Refractivity> .
<http://bio2rdf.org/drugbank_resource:f5f75e6bf165e0a25b8c2fab60ccf2e0>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:f5f75e6bf165e0a25b8c2fab60ccf2e0"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-3>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-12>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00106-2>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00106-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:LogP> .
<http://bio2rdf.org/drugbank_resource:3181b99b434a8db59d197070956de3d9>	<http://www.w3.org/2000/01/rdf-schema#label>	"mechanism-of-action for drugbank:DB00088 [drugbank_resource:3181b99b434a8db59d197070956de3d9]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-14>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Polar-Surface-Area-(PSA)> .
<http://bio2rdf.org/drugbank:BE0003533>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"iron ion binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-2>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-13>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-10>	<http://www.w3.org/2000/01/rdf-schema#label>	"SMILES: NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O from ChemAxon [drugbank_resource:calculated-properties-DB00093-10]"@en .
<http://bio2rdf.org/drugbank:DB00111>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00111"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-5>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:ad715d0a2b2bcdcad22b975675537588>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:ad715d0a2b2bcdcad22b975675537588"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-9>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-22>	<http://www.w3.org/2000/01/rdf-schema#label>	"Physiological Charge: 1 from ChemAxon [drugbank_resource:calculated-properties-DB00118-22]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-4>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:a02555c5c58332bf7ac5fef198a34814>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"a02555c5c58332bf7ac5fef198a34814"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-8>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pubchem.substance:46509031>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-6>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00115-6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-2>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-6>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-1>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-7>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-1>	<http://bio2rdf.org/drugbank_vocabulary:value>	"-0.160"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-23>	<http://www.w3.org/2000/01/rdf-schema#label>	"Number of Rings: 4 from ChemAxon [drugbank_resource:calculated-properties-DB00093-23]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-4>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_vocabulary:73192b1a02a81c1e485fb06abc6fdc61>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"73192b1a02a81c1e485fb06abc6fdc61"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-8>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-27>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:MDDR-Like-Rule> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-5>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:LogS> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-3>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00088-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-3>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-21>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:PKa-(strongest-basic)> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-9>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-10>	<http://bio2rdf.org/drugbank_vocabulary:value>	"C[S+](CC[C@H](N)C(O)=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-4>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-23>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Number-of-Rings> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-1>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Water-Solubility> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-22>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Physiological-Charge> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-7>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-7>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Traditional-IUPAC-Name> .
<http://bio2rdf.org/drugbank_resource:a6317c6254a0737c350d2f0860ea1ec3>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:a6317c6254a0737c350d2f0860ea1ec3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00093-1>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-23>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-23"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-6>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00099>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:DB00099"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pubchem.substance:46506428>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:LogP> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-3>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-21>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:x-genbank>	<http://bio2rdf.org/genbank:M17397> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-26>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:6621165671a52f286c0f04fbfcf81106>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:6621165671a52f286c0f04fbfcf81106"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ad9e59297973dcc097c2400d81b7888b>	<http://purl.org/dc/terms/title>	"half-life for drugbank:DB00109"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-12>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00118-12"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-2>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-9>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Monoisotopic-Weight> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-22>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-25>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00089-1>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:53e4e7c3f9db35ed7e24a59c1546788c>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"53e4e7c3f9db35ed7e24a59c1546788c"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003533>	<http://bio2rdf.org/drugbank_vocabulary:name>	"Cytochrome P450 2E1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-23>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-3>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pubchem.substance:46507001>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-4>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-15>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00115-15"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-24>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-14>	<http://www.w3.org/2000/01/rdf-schema#label>	"InChIKey: InChIKey=PMATZTZNYRCHOR-IMVLJIQENA-N from ChemAxon [drugbank_resource:calculated-properties-DB00091-14]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-27>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:b77ba88d4df43eb6dd239cb83101c022>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"b77ba88d4df43eb6dd239cb83101c022"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-2>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-25>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-22>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-1>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-25>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Rule-of-Five> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-26>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-21>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-9>	<http://bio2rdf.org/drugbank_vocabulary:value>	"-3.6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-4>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-27>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-24>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-8>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Weight> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-3>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-23>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pubchem.compound:91443>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00091-2>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-6>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00117-6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-19>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c7d119b1e6d46c382382c2c17e2801ac>	<http://www.w3.org/2000/01/rdf-schema#label>	"11.6 ug/.5mL Injection, solution form with intramuscular; subcutaneous route [drugbank_resource:c7d119b1e6d46c382382c2c17e2801ac]"@en .
<http://bio2rdf.org/drugbank_resource:9a71495dd3f52eed3f338a39501d4bfa>	<http://www.w3.org/2000/01/rdf-schema#label>	"Aralkylamine [drugbank_resource:9a71495dd3f52eed3f338a39501d4bfa]"@en .
<http://bio2rdf.org/pubchem.compound:6274>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00091-1>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-17>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00114-17"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-18>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pubchem.substance:46504756>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-13>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-13"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:efdc5ed439af008904afce03f4dd2ec8>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-20>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:8550beb9aaabcff323bdfeef04608bb8>	<http://purl.org/dc/terms/title>	"Plenaxis"@en .
<http://bio2rdf.org/drugbank_resource:efd9b57513efb0eb6e90f59807e0e8d9>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-2>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-6>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00093-6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-15>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pubchem.substance:46505280>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-18>	<http://www.w3.org/2000/01/rdf-schema#label>	"Bioavailability: 0 from ChemAxon [drugbank_resource:calculated-properties-DB00115-18]"@en .
<http://bio2rdf.org/drugbank_resource:5888181b550399d2a84e1e4db3715340>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:5888181b550399d2a84e1e4db3715340"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c0c3695e2cc0b1f8b2708aa4329a566e>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"c0c3695e2cc0b1f8b2708aa4329a566e"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-14>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:574e7d1136f355daec35f6fd17ef29e5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:57db98e1612a44845256ccbbbc457ff8>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Half-life> .
<http://bio2rdf.org/pubchem.compound:44176380>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-2>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Weight: 149 kDa [drugbank_resource:experimental-properties-DB00112-2]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-1>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-17>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pubchem.compound:34756>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:376c6e6cad258f51a802ccce8c53ca4c>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:376c6e6cad258f51a802ccce8c53ca4c"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:986ea485795ab092b3199f449ca4056e>	<http://www.w3.org/2000/01/rdf-schema#label>	"mechanism-of-action for drugbank:DB00111 [drugbank_resource:986ea485795ab092b3199f449ca4056e]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-16>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:57ad8968da7ad0cb58cba7e058039db9>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/kegg_resource:bio2rdf.dataset.kegg.R3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://purl.org/dc/terms/Dataset> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-24>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-24"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-3>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-21>	<http://www.w3.org/2000/01/rdf-schema#label>	"pKa (strongest basic): 10.18 from ChemAxon [drugbank_resource:calculated-properties-DB00093-21]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-11>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:Citanest-Octapressin>	<http://www.w3.org/2000/01/rdf-schema#label>	"Citanest Octapressin [drugbank_resource:Citanest-Octapressin]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-2>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-10>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:5ac86da3649163846e9e9d65b58c49fc>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:091b1b5a04486711c0e6615b4e552e7e>	<http://purl.org/dc/terms/title>	"Hippuric acids"@en .
<http://bio2rdf.org/drugbank_resource:592de4a57c1d28519d666f4b36fa6b2b>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Indication> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-15>	<http://purl.org/dc/terms/title>	"Molecular Formula: C6H9N3O2 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-3>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-13>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:5b282e6fa4562e2752afccabea3c29c1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-11>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-11"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-3>	<http://bio2rdf.org/drugbank_vocabulary:value>	"45351.6"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-12>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:5b47883807d5fa7a5b0b5ce2dc6e7939>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-2>	<http://www.w3.org/2000/01/rdf-schema#label>	"Isoelectric Point: 9.09 [drugbank_resource:experimental-properties-DB00090-2]"@en .
<http://bio2rdf.org/drugbank_resource:eda68d4a7955df0290c1f8b709e905ec>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:88491d7d06bc30fa9586740372808b10>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:c5eeb0cb7807d3f1cec573ef5532f521> .
<http://bio2rdf.org/drugbank_resource:Xylonest-Octapressin>	<http://bio2rdf.org/drugbank_vocabulary:ingredient>	<http://bio2rdf.org/drugbank_resource:Prilocaine-and-Felypressin> .
<http://bio2rdf.org/drugbank_resource:55694a43ccf43a29349054f94c2ce2e7>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-7>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2ec24002f6e3cb0430a51468ee1d26da>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:2ec24002f6e3cb0430a51468ee1d26da"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-6>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:228bf0dff0e17c650e98e541c5291e94>	<http://www.w3.org/2000/01/rdf-schema#label>	"absorption for drugbank:DB00099 [drugbank_resource:228bf0dff0e17c650e98e541c5291e94]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-2>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-9>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:da8dbfa1d167bdbfac5e83608be911ea>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:da8dbfa1d167bdbfac5e83608be911ea"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-5>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00091-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-4>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00103-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-8>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:5888181b550399d2a84e1e4db3715340>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/pubchem.compound:1051>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-3>	<http://bio2rdf.org/drugbank_vocabulary:value>	"C6538H10034N1716O2033S44"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ef0da8f521b780a50b08c455970978ac>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:58cc96ec8bd0d25f62dde9d4e4a829dd>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:eb23978cb768321237553e12616e3b84>	<http://purl.org/dc/terms/title>	"Glycosylamines"@en .
<http://bio2rdf.org/drugbank_resource:c254aba7ca3db4f83cda45b27adb5b2b>	<http://purl.org/dc/terms/title>	"Monosaccharide phosphates"@en .
<http://bio2rdf.org/drugbank_resource:f5f75e6bf165e0a25b8c2fab60ccf2e0>	<http://purl.org/dc/terms/title>	"Cyanide salts"@en .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00220>	<http://www.w3.org/2000/01/rdf-schema#label>	"DDI between Enfuvirtide and Nelfinavir - May increase the serum concentration of Protease Inhibitors. Protease Inhibitors may increase the serum concentration of Enfuvirtide. [drugbank_resource:DB00109_DB00220]"@en .
<http://bio2rdf.org/drugbank_resource:eb2ea139d16c3216009f5eb2eceb62c8>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:592de4a57c1d28519d666f4b36fa6b2b>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00089>	<http://www.w3.org/2000/01/rdf-schema#label>	"Capromab [drugbank:DB00089]"@en .
<http://bio2rdf.org/drugbank_resource:eb23978cb768321237553e12616e3b84>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/pubchem.substance:46507001>	<http://purl.org/dc/terms/identifier>	"pubchem.substance:46507001"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:5ba52774f54e88019dd4d17f32a34f7b>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Indication> .
<http://bio2rdf.org/drugbank_resource:5295f08395d80bb2a78d48e62dbf8c19>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:220e1c2f3029a37a26fd263b95f90c89>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:220e1c2f3029a37a26fd263b95f90c89"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2d6f2db0443dc24ac01149b8df7afb05>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"10 [USP'U]/mL"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00105>	<http://bio2rdf.org/drugbank_vocabulary:absorption>	<http://bio2rdf.org/drugbank_resource:913e4e077c76fcc7c941f5fbedf4db30> .
<http://bio2rdf.org/drugbank_resource:7fc0069b68f72ba58fdad65bec3cc1df>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"7fc0069b68f72ba58fdad65bec3cc1df"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:5eace972d6db7e2d3395f1ce1f56c40a>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-26>	<http://purl.org/dc/terms/title>	"Ghose Filter: 0 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:df42fd14b400446e8cc7e69facd62cba>	<http://www.w3.org/2000/01/rdf-schema#label>	"Dicarboxylic acid or derivatives [drugbank_resource:df42fd14b400446e8cc7e69facd62cba]"@en .
<http://bio2rdf.org/drugbank_resource:53ca67aedcd10f1c9afc4de0f2138502>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:f2540530a3858d9fa40e7bfd96e4c77d>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:f2540530a3858d9fa40e7bfd96e4c77d"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8683be48baa0e7d62758aed2d9ccf431>	<http://purl.org/dc/terms/title>	"absorption for drugbank:DB00107"@en .
<http://bio2rdf.org/drugbank_resource:8683be48baa0e7d62758aed2d9ccf431>	<http://purl.org/dc/terms/description>	"Uterine response after IV administration is immediate and subsides after 1 hour. Uterine contractions occur 3-5mins after IM administration and decreases within 2-3 hours. When 100-200milliunits is administered IV, contractions of the myoepithelial tissue surrounding the alveoli of the breasts occur within minutes and last for about 20 mins."@en .
<http://bio2rdf.org/drugbank_resource:74985c763ecb65fc6e794b1a003e061f>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:74985c763ecb65fc6e794b1a003e061f"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:53e4e7c3f9db35ed7e24a59c1546788c>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:ec0915fa5d5da881fd812adc490bcd65>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-5>	<http://www.w3.org/2000/01/rdf-schema#label>	"Water Solubility: 5.81e-03 g/l from ALOGPS [drugbank_resource:calculated-properties-DB00091-5]"@en .
<http://bio2rdf.org/drugbank_vocabulary:Resource>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/2000/01/rdf-schema#Resource> .
<http://bio2rdf.org/drugbank_vocabulary:Vitamin-B-Complex>	<http://purl.org/dc/terms/title>	"Vitamin B Complex"@en .
<http://bio2rdf.org/drugbank_resource:bbf3cb3443969f24e50666e131185bd8>	<http://purl.org/dc/terms/title>	"Benzene and substituted derivatives"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-4>	<http://purl.org/dc/terms/title>	"logS: -0.53 from ADME Research, USCD"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-3>	<http://www.w3.org/2000/01/rdf-schema#label>	"logS: -2.6 from ALOGPS [drugbank_resource:calculated-properties-DB00118-3]"@en .
<http://bio2rdf.org/drugbank_resource:2ec24002f6e3cb0430a51468ee1d26da>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:2ec24002f6e3cb0430a51468ee1d26da"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:d025612c433b867a6ebb00b2532e2626>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:d025612c433b867a6ebb00b2532e2626"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-26>	<http://www.w3.org/2000/01/rdf-schema#label>	"Ghose Filter: 0 from ChemAxon [drugbank_resource:calculated-properties-DB00093-26]"@en .
<http://bio2rdf.org/drugbank_resource:e91ecbd8702c2bd53755e648fa5c9435>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_vocabulary:abd3e42d8c67111954c278994aa4591d>	<http://purl.org/dc/terms/title>	"Replagal"@en .
<http://bio2rdf.org/drugbank_resource:e9ee4548d6d10b87a4a259470fe32c97>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:5ba52774f54e88019dd4d17f32a34f7b>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:5c103a2b0c3fce1acc1c2e135c6684bf>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:e9f580ccd34b70a11720b2f316225025>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:c987b0d07b89f29a364501bc29cfebc8>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:c987b0d07b89f29a364501bc29cfebc8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8c59273d79bb6ce81fe2a4c0596fa577>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:8c59273d79bb6ce81fe2a4c0596fa577"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00113>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00113"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ea9490984599c557a86db10a8e93e890>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00117>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/lhi_0137.shtml> .
<http://bio2rdf.org/drugbank_resource:5d2074ef1500127ada3cef721a746c89>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:55842b12e140e13ee25b3a59430d097e>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Absorption> .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/drugbank_vocabulary:general-function>	"Secondary metabolites biosynthesis, transport and catabolism"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e6fa8c632405b98301de119a72894c49>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:893efa195cf56cf85e98a5c5f0867045>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:893efa195cf56cf85e98a5c5f0867045"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Angiogenesis-Inducing-Agents>	<http://www.w3.org/2000/01/rdf-schema#label>	"Angiogenesis Inducing Agents [drugbank_vocabulary:Angiogenesis-Inducing-Agents]"@en .
<http://bio2rdf.org/drugbank_resource:0d47651b62c008d202fcec19e0c3b7c7>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-16>	<http://www.w3.org/2000/01/rdf-schema#label>	"Refractivity: 329.23 from ChemAxon [drugbank_resource:calculated-properties-DB00091-16]"@en .
<http://bio2rdf.org/drugbank:BE0003533>	<http://bio2rdf.org/drugbank_vocabulary:general-function>	"Secondary metabolites biosynthesis, transport and catabolism"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:55f06b8fc86fce71f0db4c1832cfa819>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Absorption> .
<http://bio2rdf.org/drugbank_resource:88491d7d06bc30fa9586740372808b10>	<http://www.w3.org/2000/01/rdf-schema#label>	"50 mg/.5mL Injection, solution form with intramuscular route [drugbank_resource:88491d7d06bc30fa9586740372808b10]"@en .
<http://bio2rdf.org/drugbank_resource:0d1969d27d89c3b774c942d81666c5d3>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-10>	<http://purl.org/dc/terms/title>	"IUPAC Name: (2S)-2-amino-3-(1H-imidazol-5-yl)propanoic acid from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:0e708564ecff800b67a0d210bc03042c>	<http://purl.org/dc/terms/description>	"Biphasic and variable, approximately 7 hours (range 7 to 19 hours) in children and approximately 19 hours (range 10 to 27 hours) in adults."@en .
<http://bio2rdf.org/drugbank_resource:5b47883807d5fa7a5b0b5ce2dc6e7939>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:5b47883807d5fa7a5b0b5ce2dc6e7939"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:5295f08395d80bb2a78d48e62dbf8c19>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:a595cc1c66cf7314ca9d50542e429c85>	<http://www.w3.org/2000/01/rdf-schema#label>	"mechanism-of-action for drugbank:DB00106 [drugbank_resource:a595cc1c66cf7314ca9d50542e429c85]"@en .
<http://bio2rdf.org/drugbank_resource:e6fc137e236497aea65dd3bb99d52e53>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:0d54035b86f9a43f56ecd493c3a6fd59>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:787ef58546dc52c80027a1e3a2b925b9>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:fa632501828d57a2c1fda712393a3927> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-2>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00117-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:094779e1e90e423f19e46305ba872c9c>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:5eace972d6db7e2d3395f1ce1f56c40a>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:53ca67aedcd10f1c9afc4de0f2138502>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:091b1b5a04486711c0e6615b4e552e7e>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:e8fbddfaa9a4fe87d9328de7cf8cd326>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-12>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Formula: C62H111N11O12 from ChemAxon [drugbank_resource:calculated-properties-DB00091-12]"@en .
<http://bio2rdf.org/drugbank_resource:a5a6248bbc8b4dd7520b62e64aa85462>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"a5a6248bbc8b4dd7520b62e64aa85462"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:53e4e7c3f9db35ed7e24a59c1546788c>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:ad715d0a2b2bcdcad22b975675537588>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"ad715d0a2b2bcdcad22b975675537588"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-3>	<http://purl.org/dc/terms/title>	"Isoelectric Point: 5.20"@en .
<http://bio2rdf.org/drugbank_resource:e52e95d4f4c438c7fbf93397e39c26e3>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:88491d7d06bc30fa9586740372808b10>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:93c392ef94d70fc29c467d485b49f786> .
<http://bio2rdf.org/drugbank_resource:dc4a561c55d386ce9aa0ac35fa50583b>	<http://purl.org/dc/terms/title>	"manufacturer for drugbank:DB00091"@en .
<http://bio2rdf.org/drugbank_resource:e4e539077bcedbc155e950cadab01679>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:9ea94506ab138833cc18501d48712af4>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:548bb431406ebb2d5ba9dd380ede692a> .
<http://bio2rdf.org/drugbank_resource:3eff294ae1a633c8845359753061fac9>	<http://www.w3.org/2000/01/rdf-schema#label>	"clearance for drugbank:DB00103 [drugbank_resource:3eff294ae1a633c8845359753061fac9]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-1>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00112-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:1588f62bddb8c0b1cca8f11ce8e653b9>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"1588f62bddb8c0b1cca8f11ce8e653b9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-11>	<http://purl.org/dc/terms/title>	"Traditional IUPAC Name: L-histidine from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:5c103a2b0c3fce1acc1c2e135c6684bf>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:8750c04d33b8546006e83e736eb80647>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:93c392ef94d70fc29c467d485b49f786> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00093-1>	<http://purl.org/dc/terms/title>	"Melting Point: 222 from Boissonnas, R.and Guttmann, S.; U.S. Patent 3,232,923; February 1, 1966: assigned to Sandoz AG, Switzerland."@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-6>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:22f72a952683d19d554d47d3919c10f3>	<http://www.w3.org/2000/01/rdf-schema#label>	"Organonitrogen compounds [drugbank_resource:22f72a952683d19d554d47d3919c10f3]"@en .
<http://bio2rdf.org/drugbank_resource:e650b92d5679a4bc966570691fe2d7e4>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-4>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:07c2684a57210d1f5bc920d112d11ecd>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:5d2074ef1500127ada3cef721a746c89>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:0d1969d27d89c3b774c942d81666c5d3>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:0d1969d27d89c3b774c942d81666c5d3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:name>	"Prolyl endopeptidase"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:07769f07381a36b9cbc482dc6db9e40d>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:locus>	"7q21.1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-10>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-4>	<http://bio2rdf.org/drugbank_vocabulary:value>	"142612.0"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank:DB00118>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/sad_0231.shtml> .
<http://bio2rdf.org/drugbank_resource:5b282e6fa4562e2752afccabea3c29c1>	<http://www.w3.org/2000/01/rdf-schema#label>	"half-life for drugbank:DB00106 [drugbank_resource:5b282e6fa4562e2752afccabea3c29c1]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-9>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-2>	<http://www.w3.org/2000/01/rdf-schema#label>	"Hydrophobicity: -0.437 [drugbank_resource:experimental-properties-DB00111-2]"@en .
<http://bio2rdf.org/drugbank_resource:08f1295028a77909e61816add07f6343>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:DB00091"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-8>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:c7f12f71253c5095c8df9050b7b42f2c>	<http://purl.org/dc/terms/title>	"Primary amine"@en .
<http://bio2rdf.org/drugbank_resource:574e7d1136f355daec35f6fd17ef29e5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:051943c0db4f9d17f7dfc49f7bb4329a>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-7>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:e340b19fed6c2eaebccc1a4c652c8eb5>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-24>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:55f06b8fc86fce71f0db4c1832cfa819>	<http://purl.org/dc/terms/title>	"absorption for drugbank:DB00109"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-3>	<http://purl.org/dc/terms/title>	"Isoelectric Point: 8.26"@en .
<http://bio2rdf.org/drugbank_resource:57ad8968da7ad0cb58cba7e058039db9>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:5b282e6fa4562e2752afccabea3c29c1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Half-life> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-23>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:57db98e1612a44845256ccbbbc457ff8>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-5>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00105-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e39dd3e5ddfc2038fa77efd8d6d5305d>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:05261dbd457e9d2aa8254610c0f9df46>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-22>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:5ac86da3649163846e9e9d65b58c49fc>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:a6302cf127669e87e24a75b24552a9e8>	<http://www.w3.org/2000/01/rdf-schema#label>	"1000 ug/mL Injection, solution form with intramuscular route [drugbank_resource:a6302cf127669e87e24a75b24552a9e8]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-21>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-21"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-21>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-18>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00115-18"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:07769f07381a36b9cbc482dc6db9e40d>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:07769f07381a36b9cbc482dc6db9e40d"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:d56193a54171cd8858918adbb1b34e8c>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:d56193a54171cd8858918adbb1b34e8c"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e04ee332a67fe1dea4752f0a68c0a6ee>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_vocabulary:64789d808f73ebe8eac3dbded4a95da0>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"64789d808f73ebe8eac3dbded4a95da0"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-28>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:585c665fefee46ff4931f369bfe6004a>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-4>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00088-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2a828069e3c5a4b098468f8a2091e89f>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:2a828069e3c5a4b098468f8a2091e89f"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:5b47883807d5fa7a5b0b5ce2dc6e7939>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank_resource:069ab916580192548ff172f164a424bf>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00113>	<http://purl.org/dc/terms/description>	"Reduced Fab fragment of the murine IgG1 monoclonal antibody IMMU-4 (also called NP-4) with specificity for carcinoembryonic antigen (CEA) covalently labeled with Technitium 99. The molecule has a molecular weight of ~54,000 Daltons."@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-27>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:55694a43ccf43a29349054f94c2ce2e7>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-16>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-16"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e147a45842193f4b54cd46908fed6204>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-3>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00093-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:06832c77d22e34a13e2de6990e7f3cf2>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-26>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:55842b12e140e13ee25b3a59430d097e>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-20>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00091-20"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-25>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-21>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:5888181b550399d2a84e1e4db3715340>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:55f06b8fc86fce71f0db4c1832cfa819>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-18>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00115-18"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fdb8e90f512977b9fb2141486454a079>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:fdb8e90f512977b9fb2141486454a079"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-10>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Weight> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-13>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00117-13"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-11>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Monoisotopic-Weight> .
<http://bio2rdf.org/drugbank_resource:036d7e3cfbf77c5f19b4baba9ff7aed2>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-15>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-20>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:58cc96ec8bd0d25f62dde9d4e4a829dd>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_vocabulary:Biotech>	<http://www.w3.org/2000/01/rdf-schema#label>	"Biotech [drugbank_vocabulary:Biotech]"@en .
<http://bio2rdf.org/drugbank_resource:d2b048fbf48d0ab62b1014e2b38c72e9>	<http://purl.org/dc/terms/description>	"For nutritional supplementation, also for treating dietary shortage or imbalance."@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-16>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:1588f62bddb8c0b1cca8f11ce8e653b9>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:1588f62bddb8c0b1cca8f11ce8e653b9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:de11407327a5468776fbcbec28a97ca0>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-19>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-17>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:6215bb81f14ea29a233fa4efbf660bf9>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"6215bb81f14ea29a233fa4efbf660bf9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8abd75317f3f7b8f7d56e3fe7d6204bd>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:33ba430750f5d2fb06feae92f6e763cb> .
<http://bio2rdf.org/drugbank_resource:585c665fefee46ff4931f369bfe6004a>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Indication> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-17>	<http://purl.org/dc/terms/title>	"Refractivity: 54.75 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-18>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-25>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:03746a740bf18cbf4beaae7cc5b7504f>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-19>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Rotatable-Bond-Count> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-24>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-19>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-13>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Formula> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:x-hgnc>	<http://bio2rdf.org/hgnc:9358> .
<http://bio2rdf.org/drugbank:BE0000300>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"catalytic activity"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-20>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-23>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:6621165671a52f286c0f04fbfcf81106>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-2>	<http://purl.org/dc/terms/title>	"Melting Point: 287 dec \u00B0C from PhysProp"@en .
<http://bio2rdf.org/drugbank_resource:df42fd14b400446e8cc7e69facd62cba>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-22>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-21>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:6be4db795caa5a4f0e9b208f115d277b>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-18>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00114-18"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:dedcaba12fd68e71a4930ea18843aa61>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:2a828069e3c5a4b098468f8a2091e89f>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:2a828069e3c5a4b098468f8a2091e89f"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-14>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:InChI> .
<http://bio2rdf.org/drugbank_resource:003185d1d24af95f95de2d64dd76ed33>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-22>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-14>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_vocabulary:e78186eb12eeaebda8a530a67513beea>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:e02568426e5e3817cd6fcddc8dee4bee>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-13>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-3>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-15>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:InChIKey> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-12>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:DB00107_DB00917>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:DB00107_DB00917"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:8ad571235d010ca525f3733fd9b517fb>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:8ad571235d010ca525f3733fd9b517fb"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:db3cf7df3e4a56b21665da45352819bc>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"db3cf7df3e4a56b21665da45352819bc"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:00199edd2aba5de431eaa55bda5406d7>	<http://purl.org/dc/terms/description>	"Interferon alpha binds to type I interferon receptors (IFNAR1 and IFNAR2c) which upon dimerization activate two Jak (Janus kinase) tyrosine kinases (Jak1 and Tyk2). These transphosphorylate themselves and phosphorylate the receptors. The phosphorylated INFAR receptors then bind to Stat1 and Stat2 (signal transducers and activators of transcription)which dimerize and activate multiple (~100) immunomodulatory and antiviral proteins. Interferon alpha binds less stably to type I interferon receptors than interferon beta."@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-22>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:PKa-(strongest-acidic)> .
<http://bio2rdf.org/drugbank_resource:01c6a15f6a299a85cd866fc4092d0dce>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-11>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:8750c04d33b8546006e83e736eb80647>	<http://purl.org/dc/terms/title>	"300 ug/mL Injection, solution form with intravenous route"@en .
<http://bio2rdf.org/drugbank_resource:dc4a561c55d386ce9aa0ac35fa50583b>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-18>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-10>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-17>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00118-17"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:68664b41f20b902d0fcad004203c7cc8>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:6d460a13d1af93268984ab262cef479d>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-12>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:SMILES> .
<http://bio2rdf.org/drugbank_resource:6be4db795caa5a4f0e9b208f115d277b>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Mechanism-of-action> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-17>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-11>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-18>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Polarizability> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-17>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Refractivity> .
<http://bio2rdf.org/drugbank_resource:684d8812e411c70454900dc745e593c8>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank_resource:0235e5251bcfc61913eb18c0fab6a1c4>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-12>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:23e60560991f40f7f335be06f10675e1>	<http://purl.org/dc/terms/title>	"indication for drugbank:DB00106"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-16>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:405bc988f44cffeeb0d7149d00e5918b>	<http://purl.org/dc/terms/title>	"half-life for drugbank:DB00113"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-2>	<http://www.w3.org/2000/01/rdf-schema#label>	"Isoelectric Point: 9.38 [drugbank_resource:experimental-properties-DB00102-2]"@en .
<http://bio2rdf.org/drugbank_resource:aa57c62e2e58943f3ce466339bbf00eb>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:aa57c62e2e58943f3ce466339bbf00eb"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00363>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:DB00112_DB00363"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:17055fe13e90f0599fe8f9fd1c90c871>	<http://purl.org/dc/terms/title>	"mechanism-of-action for drugbank:DB00095"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-3>	<http://bio2rdf.org/drugbank_vocabulary:value>	"5.65"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-16>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Polar-Surface-Area-(PSA)> .
<http://bio2rdf.org/drugbank_resource:3669e274097fc69149d3dbad3ba6b01c>	<http://purl.org/dc/terms/title>	"absorption for drugbank:DB00102"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-13>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-15>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-18>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00093-18"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:e78186eb12eeaebda8a530a67513beea>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:International-brand> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01232>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00109_DB01232"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-14>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-9>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Traditional-IUPAC-Name> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-4>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00099-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-2>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00103-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:f6203f7c9646b21edf1fa81c5cdf94d1>	<http://bio2rdf.org/drugbank_vocabulary:company>	"Natrol"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:6d460a13d1af93268984ab262cef479d>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Mechanism-of-action> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-6>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-5>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00113-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:da9625c635b6c208626fef4666f9f883>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-7>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:4d6d8a0bb0437361e22c5fbaf04819ea>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:4d6d8a0bb0437361e22c5fbaf04819ea"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:da8dbfa1d167bdbfac5e83608be911ea>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:2d76fb5dd0f39b41fe92dc87dd6a96d9>	<http://purl.org/dc/terms/title>	"Organic cyanide salt"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-8>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:57ad8968da7ad0cb58cba7e058039db9>	<http://purl.org/dc/terms/title>	"Organotransition metal compounds"@en .
<http://bio2rdf.org/drugbank_resource:904bc2c9127fa8f18e0965559eecc60c>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:251aa2c7f843f73a59fa2779ab4a885a> .
<http://bio2rdf.org/drugbank_resource:1059233feb371b14b03a21571fa19968>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"1059233feb371b14b03a21571fa19968"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-10>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:SMILES> .
<http://bio2rdf.org/drugbank_resource:6ac630c499c16fd6e1f2a125e397688a>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:6d66b6aba13ddd36f6f9c8c32bc1927d>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Indication> .
<http://bio2rdf.org/drugbank_resource:e650b92d5679a4bc966570691fe2d7e4>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"e650b92d5679a4bc966570691fe2d7e4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c7d119b1e6d46c382382c2c17e2801ac>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"11.6 ug/.5mL"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-6>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00091-6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-9>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-29>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:MDDR-Like-Rule> .
<http://bio2rdf.org/drugbank_resource:00199edd2aba5de431eaa55bda5406d7>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-23>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00116-23"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-23>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:PKa-(strongest-basic)> .
<http://bio2rdf.org/drugbank_resource:fa8e5850916f505d7329bb36ce55c161>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:fa8e5850916f505d7329bb36ce55c161"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-10>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:627446b31de3941cb82db7d08189b597>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:6215bb81f14ea29a233fa4efbf660bf9>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Clearance> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:LogP> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-25>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Number-of-Rings> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-11>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-24>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Physiological-Charge> .
<http://bio2rdf.org/drugbank:BE0003533>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"4-nitrophenol 2-hydroxylase"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-2>	<http://www.w3.org/2000/01/rdf-schema#label>	"Hydrophobicity: -0.395 [drugbank_resource:experimental-properties-DB00096-2]"@en .
<http://bio2rdf.org/drugbank_resource:efdc5ed439af008904afce03f4dd2ec8>	<http://www.w3.org/2000/01/rdf-schema#label>	"mechanism-of-action for drugbank:DB00099 [drugbank_resource:efdc5ed439af008904afce03f4dd2ec8]"@en .
<http://bio2rdf.org/drugbank_resource:70d5905dbbb671a2bf66275527b38e09>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:db3cf7df3e4a56b21665da45352819bc>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:2619a21616645ee9827c33c6e2f65268>	<http://purl.org/dc/terms/title>	"This compound belongs to the class of organic compounds known as d-alpha-amino acids. These are alpha amino acids which have the D-configuration of the alpha-carbon atom."@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-6>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Water-Solubility> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-12>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:70f28c5b4aa0741b1c2d0997a89319ea>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:6f3fc4bb7965f22f3fc655ec5e1faab0>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:6f3fc4bb7965f22f3fc655ec5e1faab0"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2af3e19f02b1eb81db93222ed2b38a44>	<http://purl.org/dc/terms/description>	"Uterine motility depends on the formation of the contractile protein actomyosin under the influence of the Ca2+-dependent phosphorylating enzyme myosin light-chain kinase. Oxytocin promotes contractions by increasing the intracellular Ca2+, which in turn activates myosin's light chain kinase.. Oxytocin has specific receptors in the muscle lining of the uterus and the receptor concentration increases greatly during pregnancy, reaching a maximum in early labor at term."@en .
<http://bio2rdf.org/drugbank_resource:228bf0dff0e17c650e98e541c5291e94>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:228bf0dff0e17c650e98e541c5291e94"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-23>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-24>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://www.w3.org/2000/01/rdf-schema#label>	"Cytochrome P450 2D6 [drugbank:BE0002363]"@en .
<http://bio2rdf.org/drugbank_resource:64b9dc4a304f0bbee322be682a49f08b>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-1>	<http://www.w3.org/2000/01/rdf-schema#label>	"Hydrophobicity: -0.168 [drugbank_resource:experimental-properties-DB00088-1]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-4>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00116-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-6>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:IUPAC-Name> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:LogS> .
<http://bio2rdf.org/drugbank_resource:6621165671a52f286c0f04fbfcf81106>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:6621165671a52f286c0f04fbfcf81106"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-25>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:a39e93df12255155561f3d4acd297da8>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"a39e93df12255155561f3d4acd297da8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-7>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:LogP> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-26>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-26>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Ghose-Filter> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-2>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ff5b4bb2ae4fdc7811f87fd38c8b8eda>	<http://purl.org/dc/terms/description>	"The actions of supplemental L-histidine are entirely unclear. It may have some immunomodulatory as well as antioxidant activity. L-histidine may be indicated for use in some with rheumatoid arthritis. It is not indicated for treatment of anemia or uremia or for lowering serum cholesterol."@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-4>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00088-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-3>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Weight: 12294.4000 [drugbank_resource:experimental-properties-DB00102-3]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-27>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-11>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Formula> .
<http://bio2rdf.org/drugbank_resource:6d66b6aba13ddd36f6f9c8c32bc1927d>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-27>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Rule-of-Five> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-28>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0003536>	<http://purl.org/dc/terms/identifier>	"drugbank:BE0003536"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:cellular-location>	"Endoplasmic reticulum membrane"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-17>	<http://purl.org/dc/terms/title>	"InChIKey: InChIKey=HNDVDQJCIGZPNO-YFKPBYRVSA-N from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-20>	<http://www.w3.org/2000/01/rdf-schema#label>	"pKa (strongest acidic): 1.71 from ChemAxon [drugbank_resource:calculated-properties-DB00118-20]"@en .
<http://bio2rdf.org/drugbank_resource:e9ee4548d6d10b87a4a259470fe32c97>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:e9ee4548d6d10b87a4a259470fe32c97"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-29>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:246c82890dc31bdd6e899b6c63a0f254>	<http://www.w3.org/2000/01/rdf-schema#label>	"Organoheterocyclic compounds [drugbank_resource:246c82890dc31bdd6e899b6c63a0f254]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-12>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:InChI> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-16>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:LogS> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-15>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:e02568426e5e3817cd6fcddc8dee4bee>	<http://www.w3.org/2000/01/rdf-schema#label>	"Amino fatty acid [drugbank_resource:e02568426e5e3817cd6fcddc8dee4bee]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-9>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:6f3fc4bb7965f22f3fc655ec5e1faab0>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00117"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-14>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://www.w3.org/2000/01/rdf-schema#label>	"Cytochrome P450 2C9 [drugbank:BE0002793]"@en .
<http://bio2rdf.org/drugbank_resource:DB00112_DB08879>	<http://purl.org/dc/terms/title>	"DDI between Bevacizumab and Belimumab - Monoclonal Antibodies may enhance the adverse/toxic effect of Belimumab."@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-13>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:f30bb36d9cf1cde63e806eb49b64d341>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"f30bb36d9cf1cde63e806eb49b64d341"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:6205a409adf418d0390045ac349b481a>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-11>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00114-11"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-27>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:MDDR-Like-Rule> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-20>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-8>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Weight> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-8>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:IUPAC-Name> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-19>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:091b1b5a04486711c0e6615b4e552e7e>	<http://www.w3.org/2000/01/rdf-schema#label>	"Hippuric acids [drugbank_resource:091b1b5a04486711c0e6615b4e552e7e]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:LogP> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-18>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:36cf3fe3b4f939b051085b627e517597>	<http://purl.org/dc/terms/title>	"mechanism-of-action for drugbank:DB00097"@en .
<http://bio2rdf.org/drugbank_resource:627446b31de3941cb82db7d08189b597>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0000456>	<http://bio2rdf.org/drugbank_vocabulary:x-uniprot>	<http://bio2rdf.org/uniprot:MMAB_HUMAN> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-17>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-26>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Bioavailability> .
<http://bio2rdf.org/drugbank_resource:70d5905dbbb671a2bf66275527b38e09>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-27>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-27"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:96faa670b368b06113b9e58e3db1d86c>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:96faa670b368b06113b9e58e3db1d86c"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:70f28c5b4aa0741b1c2d0997a89319ea>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-26>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:77b52954fa911921450d2b426c1a7a3a>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"77b52954fa911921450d2b426c1a7a3a"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-28>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Ghose-Filter> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-27>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-7>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Traditional-IUPAC-Name> .
<http://bio2rdf.org/drugbank_resource:64b9dc4a304f0bbee322be682a49f08b>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00089-1>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00089-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"NF-25"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:e4e539077bcedbc155e950cadab01679>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"e4e539077bcedbc155e950cadab01679"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-12>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-3>	<http://www.w3.org/2000/01/rdf-schema#label>	"logS: -3.2 from ALOGPS [drugbank_resource:calculated-properties-DB00116-3]"@en .
<http://bio2rdf.org/drugbank:BE0000300>	<http://bio2rdf.org/drugbank_vocabulary:x-uniprot>	<http://bio2rdf.org/uniprot:SPEE_HUMAN> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-9>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Monoisotopic-Weight> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-11>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://purl.org/dc/terms/title>	"Cytochrome P450 2C8"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-10>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-6>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Water-Solubility> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-17>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-17"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/bindingdb:50102442>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"bindingdb"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-7>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/chemspider:82572>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"82572"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-8>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-7>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-14>	<http://bio2rdf.org/drugbank_vocabulary:value>	"207.27"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:129ef94b8ca8b89a244a3cd1c5b2c72b>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:129ef94b8ca8b89a244a3cd1c5b2c72b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/bindingdb:50271301>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"bindingdb"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-2>	<http://purl.org/dc/terms/title>	"Molecular Weight: 149 kDa"@en .
<http://bio2rdf.org/drugbank_resource:8f7450a053d86ee89751c06a230561d0>	<http://purl.org/dc/terms/title>	"Phenylalkylamine"@en .
<http://bio2rdf.org/drugbank_resource:6f3fc4bb7965f22f3fc655ec5e1faab0>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-16>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00116-16"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ae0431719c906d80aa97a27025adc99f>	<http://purl.org/dc/terms/title>	"Metallotetrapyrroles"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-20>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:H-Bond-Acceptor-Count> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01319>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:DB00109_DB01319"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/bindingdb:7953>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"bindingdb"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00099>	<http://bio2rdf.org/drugbank_vocabulary:absorption>	<http://bio2rdf.org/drugbank_resource:228bf0dff0e17c650e98e541c5291e94> .
<http://bio2rdf.org/drugbank_resource:893efa195cf56cf85e98a5c5f0867045>	<http://purl.org/dc/terms/description>	"* 0.26 L/day [Male patients who received 1 to 20 mg/kg of Avastin weekly, every 2 weeks, or every 3 weeks]\r\n* 0.21 L/day [Female patients who received 1 to 20 mg/kg of Avastin weekly, every 2 weeks, or every 3 weeks]\r\n* 0.25 L/day [Patients with higher tumor burden who received 1 to 20 mg/kg of Avastin weekly, every 2 weeks, or every 3 weeks]\r\n* 0.2 L/day [patients with tumor burdens below the median who received 1 to 20 mg/kg of Avastin weekly, every 2 weeks, or every 3 weeks]\r\n\r\nClearance varies by body weight, gender, and tumor burden. Increased clearance observed in men and in patients with higher tumor burden; however, no evidence of reduced efficacy."@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-15>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-15"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:6205a409adf418d0390045ac349b481a>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Affected-organism> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-21>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:H-Bond-Donor-Count> .
<http://bio2rdf.org/drugbank_resource:787ef58546dc52c80027a1e3a2b925b9>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:49b21ad0d38942f635877e7bbc5d7a1e> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"serine-type endopeptidase activity"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:6215bb81f14ea29a233fa4efbf660bf9>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:3465ee54a79f5fd937ce86304a05d4e3>	<http://purl.org/dc/terms/title>	"Colupressine"@en .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01264>	<http://purl.org/dc/terms/title>	"DDI between Enfuvirtide and Darunavir - May increase the serum concentration of Protease Inhibitors. Protease Inhibitors may increase the serum concentration of Enfuvirtide."@en .
<http://bio2rdf.org/drugbank_resource:3f54718d1deb0dbafe47e6e45eda5914>	<http://purl.org/dc/terms/title>	"0.05 % Emulsion form with ophthalmic route"@en .
<http://bio2rdf.org/drugbank:DB00115>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/vit_0262.shtml> .
<http://bio2rdf.org/drugbank:DB00114>	<http://www.w3.org/2000/01/rdf-schema#seeAlso>	<http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/vit_0215.shtml> .
<http://bio2rdf.org/drugbank_resource:e340b19fed6c2eaebccc1a4c652c8eb5>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:e340b19fed6c2eaebccc1a4c652c8eb5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:180176f4e85931ffb36c855eab8691da>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:180176f4e85931ffb36c855eab8691da"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-9>	<http://purl.org/dc/terms/title>	"Monoisotopic Weight: 1039.436791367 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-5>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00111-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-6>	<http://purl.org/dc/terms/title>	"IUPAC Name: (2S)-2-[(4-{[(2-amino-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl)methyl]amino}phenyl)formamido]pentanedioic acid from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:67b3d3945732c5188334e7f955ca6288>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:Small-molecule>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:Citanest-Dental>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:Citanest-Dental"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:807b0e58e0eead4b875202221ebe0f53>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:807b0e58e0eead4b875202221ebe0f53"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8750c04d33b8546006e83e736eb80647>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:8750c04d33b8546006e83e736eb80647"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:684d8812e411c70454900dc745e593c8>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-20>	<http://www.w3.org/2000/01/rdf-schema#label>	"H Bond Acceptor Count: 6 from ChemAxon [drugbank_resource:calculated-properties-DB00114-20]"@en .
<http://bio2rdf.org/drugbank_resource:99633b36b8289d3e0a8562067bd42c03>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"99633b36b8289d3e0a8562067bd42c03"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00103_DB00608>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:DB00103_DB00608"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:9ea94506ab138833cc18501d48712af4>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:fa632501828d57a2c1fda712393a3927> .
<http://bio2rdf.org/drugbank_resource:68664b41f20b902d0fcad004203c7cc8>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-1>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00092-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:cad41663894b5be906782be10b396e06>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:cad41663894b5be906782be10b396e06"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:96faa670b368b06113b9e58e3db1d86c>	<http://purl.org/dc/terms/title>	"Secondary aliphatic/aromatic amine"@en .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01072>	<http://purl.org/dc/terms/title>	"DDI between Enfuvirtide and Atazanavir - May increase the serum concentration of Protease Inhibitors. Protease Inhibitors may increase the serum concentration of Enfuvirtide."@en .
<http://bio2rdf.org/drugbank_resource:84c4d4608be206e204e18bc4fee8d4a9>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"84c4d4608be206e204e18bc4fee8d4a9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:5b282e6fa4562e2752afccabea3c29c1>	<http://purl.org/dc/terms/description>	"13.2 &plusmn; 3.2 days"@en .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:x-genbank>	<http://bio2rdf.org/genbank:J04813> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-27>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:MDDR-Like-Rule> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-20>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-20"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-8>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-2>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00090>	<http://www.w3.org/2000/01/rdf-schema#label>	"Laronidase [drugbank:DB00090]"@en .
<http://bio2rdf.org/drugbank_resource:67b3d3945732c5188334e7f955ca6288>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Indication> .
<http://bio2rdf.org/drugbank_vocabulary:ffb414ea32db58bec7ec3339a42c9dee>	<http://bio2rdf.org/drugbank_vocabulary:name>	"Profasi"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:LogS> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-17>	<http://purl.org/dc/terms/title>	"Number of Rings: 8 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-9>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:6621165671a52f286c0f04fbfcf81106>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-11>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00114-11"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-10>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:73192b1a02a81c1e485fb06abc6fdc61>	<http://bio2rdf.org/drugbank_vocabulary:name>	"Sangcya"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:x-pfam>	<http://bio2rdf.org/pfam:PF00326> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-4>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00093-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-11>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:6ac630c499c16fd6e1f2a125e397688a>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_vocabulary:Anti-tocolytic-Agents>	<http://purl.org/dc/terms/title>	"Anti-tocolytic Agents"@en .
<http://bio2rdf.org/drugbank:BE0000456>	<http://purl.org/dc/terms/identifier>	"drugbank:BE0000456"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:LogP> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-18>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:H-Bond-Acceptor-Count> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-19>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:H-Bond-Donor-Count> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-12>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-13>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:3669e274097fc69149d3dbad3ba6b01c>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-6>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00115-6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-1>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-14>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:7975713dad73e24fab2cbb6c89586ea4>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:66a4f22d1577f66fd9737b00a8525f55> .
<http://bio2rdf.org/drugbank_resource:366d45e2564940d9162a27ad0e9e3571>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-14>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:SMILES> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-11>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Traditional-IUPAC-Name> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-15>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:36cf3fe3b4f939b051085b627e517597>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-4>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00118-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:705836a5549e0548d20a0ef04e009f28>	<http://bio2rdf.org/drugbank_vocabulary:name>	"Syntocinon"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-25>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:3314d6a38b90d6a9ef0419bc7224913d>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:372918cb5733e55c6d5baa7bc6f4a30c>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-13>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Monoisotopic-Weight> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-26>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-25>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Rule-of-Five> .
<http://bio2rdf.org/drugbank_vocabulary:3465ee54a79f5fd937ce86304a05d4e3>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"3465ee54a79f5fd937ce86304a05d4e3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3732893325a7ecb9126a15736796f117>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:d46b970056d0a083cca1f813197ccf0c>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"19.2 ug/.5mL"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Water-Solubility> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-27>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:general-function>	"Amino acid transport and metabolism"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-7>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Traditional-IUPAC-Name> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-24>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Bioavailability> .
<http://bio2rdf.org/drugbank_vocabulary:0f3c814d30566a7614f1fab32f4e0302>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:0f3c814d30566a7614f1fab32f4e0302"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-8>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Weight> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-15>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Formula> .
<http://bio2rdf.org/drugbank_resource:376c6e6cad258f51a802ccce8c53ca4c>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-24>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00093-24"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-9>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Monoisotopic-Weight> .
<http://bio2rdf.org/drugbank_resource:36cf3fe3b4f939b051085b627e517597>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Mechanism-of-action> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:efd9b57513efb0eb6e90f59807e0e8d9>	<http://www.w3.org/2000/01/rdf-schema#label>	"Oxolanes [drugbank_resource:efd9b57513efb0eb6e90f59807e0e8d9]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-6>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-12>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Weight> .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:x-genbank>	<http://bio2rdf.org/genbank:D00408> .
<http://bio2rdf.org/drugbank:DB00107>	<http://bio2rdf.org/drugbank_vocabulary:enzyme>	<http://bio2rdf.org/drugbank:BE0002148> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-25>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00091-25"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-7>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-16>	<http://bio2rdf.org/drugbank_vocabulary:value>	"42.95"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-16>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:InChI> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-24>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-18>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Bioavailability> .
<http://bio2rdf.org/drugbank_resource:3549163466db2fa5b979545848c2ef00>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01264>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00109_DB01264"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:376c6e6cad258f51a802ccce8c53ca4c>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Manufacturer> .
<http://bio2rdf.org/drugbank_resource:84c4d4608be206e204e18bc4fee8d4a9>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:84c4d4608be206e204e18bc4fee8d4a9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:7fc0069b68f72ba58fdad65bec3cc1df>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:7237727df18936550876a7cb89a0aa86> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-17>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:InChIKey> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-25>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00114-1>	<http://purl.org/dc/terms/title>	"Water Solubility: Appreciable"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-26>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:6205a409adf418d0390045ac349b481a>	<http://purl.org/dc/terms/title>	"Oxacycle"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-23>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00118-23"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-6>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:IUPAC-Name> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:absorption>	<http://bio2rdf.org/drugbank_resource:069ab916580192548ff172f164a424bf> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-20>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Polarizability> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-27>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-9>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-19>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Refractivity> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-28>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-29>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Rule-of-Five> .
<http://bio2rdf.org/drugbank_resource:2ec24002f6e3cb0430a51468ee1d26da>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:3afc1cd15f9de2a07db0081098265ac4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:e78186eb12eeaebda8a530a67513beea>	<http://www.w3.org/2000/01/rdf-schema#label>	"[drugbank_vocabulary:e78186eb12eeaebda8a530a67513beea]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-18>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Polar-Surface-Area-(PSA)> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-29>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-6>	<http://bio2rdf.org/drugbank_vocabulary:value>	"[(3S)-3-amino-3-carboxypropyl]({[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl})methylsulfanium"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2ddeeca2fe9449969ab1519d768237c6>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-30>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:efd9b57513efb0eb6e90f59807e0e8d9>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"efd9b57513efb0eb6e90f59807e0e8d9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-3>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00097-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/bindingdb:50102442>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"50102442"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-15>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00117-15"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-31>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:2d6f2db0443dc24ac01149b8df7afb05>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank_resource:807b0e58e0eead4b875202221ebe0f53>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:17d453b0e97a48c6d20746adf3e8900d> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-16>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-19>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-19"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3c77091e1ee2397a2767e73267a25af5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:07769f07381a36b9cbc482dc6db9e40d>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"07769f07381a36b9cbc482dc6db9e40d"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:6f3fc4bb7965f22f3fc655ec5e1faab0>	<http://www.w3.org/2000/01/rdf-schema#label>	"Alpha-amino acid or derivatives [drugbank_resource:6f3fc4bb7965f22f3fc655ec5e1faab0]"@en .
<http://bio2rdf.org/drugbank_vocabulary:8ad571235d010ca525f3733fd9b517fb>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:8ad571235d010ca525f3733fd9b517fb"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-17>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:4a0d48b5f8e157c4bbcb34092d4edaf3>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"4a0d48b5f8e157c4bbcb34092d4edaf3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:574e7d1136f355daec35f6fd17ef29e5>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:574e7d1136f355daec35f6fd17ef29e5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-18>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-20>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Ghose-Filter> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-19>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-26>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Physiological-Charge> .
<http://bio2rdf.org/drugbank_resource:3d51d314e6796004243d124d2c5f0793>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-5>	<http://bio2rdf.org/drugbank_vocabulary:value>	"-5.8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:30d0083606d3fa4b4b602b5d3ed0feda>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-25>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:PKa-(strongest-basic)> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-20>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-21>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Rotatable-Bond-Count> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-2>	<http://purl.org/dc/terms/title>	"Hydrophobicity: -0.339"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-24>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:PKa-(strongest-acidic)> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-14>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-14"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/bindingdb:50271301>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/bindingdb:50271301"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-21>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-31>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:MDDR-Like-Rule> .
<http://bio2rdf.org/drugbank_resource:2c7d5048f3ab623475c1e9c503997a85>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-22>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:a9516c15b2a67882efd5c7a4c1fa6de4>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:a9516c15b2a67882efd5c7a4c1fa6de4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:38b20638a91b63e0378b18fb8d8f4c38>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:2c808757b9d5f22f13a70bae1f9e7737>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-7>	<http://purl.org/dc/terms/title>	"Traditional IUPAC Name: felypressin from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-27>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Number-of-Rings> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00224>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:DB00109_DB00224"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2af3e19f02b1eb81db93222ed2b38a44>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-23>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:39094d4a5017cb7945c3ca22e421306d>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:fffcf97ccb1aeb21dae91caa501b8255>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:fffcf97ccb1aeb21dae91caa501b8255"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:96faa670b368b06113b9e58e3db1d86c>	<http://www.w3.org/2000/01/rdf-schema#label>	"Secondary aliphatic/aromatic amine [drugbank_resource:96faa670b368b06113b9e58e3db1d86c]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-2>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-17>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Number-of-Rings> .
<http://bio2rdf.org/drugbank_resource:5b282e6fa4562e2752afccabea3c29c1>	<http://purl.org/dc/terms/title>	"half-life for drugbank:DB00106"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-21>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-13>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:InChIKey> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-22>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00114-22"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2d76fb5dd0f39b41fe92dc87dd6a96d9>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-7>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Traditional-IUPAC-Name> .
<http://bio2rdf.org/drugbank_resource:dc4a561c55d386ce9aa0ac35fa50583b>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:dc4a561c55d386ce9aa0ac35fa50583b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3549163466db2fa5b979545848c2ef00>	<http://purl.org/dc/terms/title>	"Monoalkyl phosphate"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00106-1>	<http://purl.org/dc/terms/title>	"Molecular Weight: 1416.0630"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:9e044243b5eb2f95578c80df6000ecdd>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:9e044243b5eb2f95578c80df6000ecdd"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-5>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-30>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Ghose-Filter> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:x-pfam>	<http://bio2rdf.org/pfam:PF02897> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:2df9c46833999f4cf9a8383d1003158e>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-31>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00117-31"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-4>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-14>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:PKa-(strongest-acidic)> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-6>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-16>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Physiological-Charge> .
<http://bio2rdf.org/drugbank_resource:2ec24002f6e3cb0430a51468ee1d26da>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00096>	<http://purl.org/dc/terms/title>	"Serum albumin"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00118-1>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Water-Solubility> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-7>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-8>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:a02555c5c58332bf7ac5fef198a34814>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:a02555c5c58332bf7ac5fef198a34814"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2970662836bc4a17c64d219c534d3f7e>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-15>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:PKa-(strongest-basic)> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-9>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-10>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00115-10"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-28>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Bioavailability> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:enzyme>	<http://bio2rdf.org/drugbank:BE0002887> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:LogP> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:enzyme>	<http://bio2rdf.org/drugbank:BE0002362> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:LogS> .
<http://bio2rdf.org/drugbank_resource:29ad2163821ce9d547ef52b7bddcf404>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-13>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:enzyme>	<http://bio2rdf.org/drugbank:BE0002363> .
<http://bio2rdf.org/drugbank_resource:225393798d1f4d7a00af1d777e454e22>	<http://www.w3.org/2000/01/rdf-schema#label>	"N-acyl-alpha-amino acid [drugbank_resource:225393798d1f4d7a00af1d777e454e22]"@en .
<http://bio2rdf.org/drugbank_resource:3c77091e1ee2397a2767e73267a25af5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:3669e274097fc69149d3dbad3ba6b01c>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Absorption> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-14>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-1>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00112-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-22>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:H-Bond-Acceptor-Count> .
<http://bio2rdf.org/drugbank_vocabulary:Drug>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:Drug"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00114-3>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-23>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:H-Bond-Donor-Count> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-15>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-21>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:MDDR-Like-Rule> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-9>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Monoisotopic-Weight> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00114-2>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-16>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:30d0083606d3fa4b4b602b5d3ed0feda>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:0d54035b86f9a43f56ecd493c3a6fd59>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:0d54035b86f9a43f56ecd493c3a6fd59"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00115-2>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:3d51d314e6796004243d124d2c5f0793>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-17>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-8>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Weight> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00115-1>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:2a828069e3c5a4b098468f8a2091e89f>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-18>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:366d45e2564940d9162a27ad0e9e3571>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:366d45e2564940d9162a27ad0e9e3571"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2c7d5048f3ab623475c1e9c503997a85>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-1>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:2696048bf20ed0e2d578eb2938c6d8d3>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-19>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-23>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00117-23"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:38b20638a91b63e0378b18fb8d8f4c38>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:2c808757b9d5f22f13a70bae1f9e7737>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:enzyme>	<http://bio2rdf.org/drugbank:BE0003612> .
<http://bio2rdf.org/drugbank_vocabulary:Angiogenesis-Inhibitors>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"Angiogenesis-Inhibitors"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00116-1>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:2619a21616645ee9827c33c6e2f65268>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-19>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Rule-of-Five> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-20>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-11>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:4dcb2d242a80267002194ce81be5670e>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#value>	"Hoffmann la roche inc"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a9ee55eb5c1344c6ecd656006a4e92f2>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:a9ee55eb5c1344c6ecd656006a4e92f2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:39094d4a5017cb7945c3ca22e421306d>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:2d6f2db0443dc24ac01149b8df7afb05>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:1588f62bddb8c0b1cca8f11ce8e653b9>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"10 [USP'U]/mL"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-3>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:7abeba6bed290a4b16075521bc0113ca>	<http://www.w3.org/2000/01/rdf-schema#label>	"Methylpyridines [drugbank_resource:7abeba6bed290a4b16075521bc0113ca]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-10>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-18>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:98458df79187b81a7709036be48a75a4>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:98458df79187b81a7709036be48a75a4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2d76fb5dd0f39b41fe92dc87dd6a96d9>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:06832c77d22e34a13e2de6990e7f3cf2>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"06832c77d22e34a13e2de6990e7f3cf2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-2>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-9>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-16>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Polarizability> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-19>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-11>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Formula> .
<http://bio2rdf.org/drugbank_resource:2ddeeca2fe9449969ab1519d768237c6>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-15>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Refractivity> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-12>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:InChI> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-3>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:285048a510ce36e96744886cc83cc631>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-8>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:2df9c46833999f4cf9a8383d1003158e>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:9d6d13e90c7dfeb0d8d2cac125c20125>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"9d6d13e90c7dfeb0d8d2cac125c20125"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-14>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Polar-Surface-Area-(PSA)> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-2>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:3afc1cd15f9de2a07db0081098265ac4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank_resource:282d8423d2c45b369fa817ef1edbccd5>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-20>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-13>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:InChIKey> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-15>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:19d3289105c9a843a041cb4f7a0883a1>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:19d3289105c9a843a041cb4f7a0883a1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00099_DB00531>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:DB00099_DB00531"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-2>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_vocabulary:Anti-Testosterone-Agents>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:Anti-Testosterone-Agents"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:129ef94b8ca8b89a244a3cd1c5b2c72b>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:129ef94b8ca8b89a244a3cd1c5b2c72b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-21>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-14>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:81987a5783579e8eae4261b8d95226da>	<http://www.w3.org/2000/01/rdf-schema#label>	"indication for drugbank:DB00109 [drugbank_resource:81987a5783579e8eae4261b8d95226da]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-1>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00093-1>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00093-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pubchem.substance:46507001>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"46507001"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-10>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:IUPAC-Name> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-1>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-13>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-22>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:328c87b1ad60e7356c52d11e15011e6f>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-4>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:246c82890dc31bdd6e899b6c63a0f254>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-23>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-12>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"P450 MP- 12/MP-20"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:366d45e2564940d9162a27ad0e9e3571>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-17>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00116-17"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-3>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-19>	<http://purl.org/dc/terms/title>	"H Bond Donor Count: 8 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-24>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00105>	<http://www.w3.org/2000/01/rdf-schema#label>	"Interferon Alfa-2b, Recombinant [drugbank:DB00105]"@en .
<http://bio2rdf.org/drugbank:BE0003533>	<http://bio2rdf.org/drugbank_vocabulary:theoretical-pi>	"8.22"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00114-1>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-27>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-10>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-10>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:SMILES> .
<http://bio2rdf.org/drugbank_resource:3314d6a38b90d6a9ef0419bc7224913d>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-6>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:IUPAC-Name> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-5>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-26>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-11>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-21>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:PKa-(strongest-basic)> .
<http://bio2rdf.org/drugbank_resource:3732893325a7ecb9126a15736796f117>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-3>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00113-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-23>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Number-of-Rings> .
<http://bio2rdf.org/drugbank_resource:80aadabf31c519e42d80748f499c7689>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"80aadabf31c519e42d80748f499c7689"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00110-1>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-3>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3181b99b434a8db59d197070956de3d9>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Mechanism-of-action> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-9>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00115-9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00095-1>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00095-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-12>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-25>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-22>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Physiological-Charge> .
<http://bio2rdf.org/drugbank_vocabulary:Vitamin-B-Complex>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:Vitamin-B-Complex"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00092>	<http://bio2rdf.org/drugbank_vocabulary:absorption>	<http://bio2rdf.org/drugbank_resource:55842b12e140e13ee25b3a59430d097e> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:LogP> .
<http://bio2rdf.org/drugbank_resource:31af673f5d82841086059243563cd4c6>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Mechanism-of-action> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-4>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-7>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-2>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00105-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-13>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:6215bb81f14ea29a233fa4efbf660bf9>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:6215bb81f14ea29a233fa4efbf660bf9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-5>	<http://purl.org/dc/terms/title>	"Molecular Formula: C42H65N11O12S2"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-2>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:ec0915fa5d5da881fd812adc490bcd65>	<http://purl.org/dc/terms/title>	"absorption for drugbank:DB00095"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-14>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-6>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-26>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Ghose-Filter> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-1>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-5>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-15>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-20>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:PKa-(strongest-acidic)> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-4>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:22f72a952683d19d554d47d3919c10f3>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-16>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/pubchem.substance:46509031>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/pubchem.substance/46509031> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-17>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Rotatable-Bond-Count> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-8>	<http://purl.org/dc/terms/title>	"Molecular Weight: 1040.219 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:328c87b1ad60e7356c52d11e15011e6f>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Manufacturer> .
<http://bio2rdf.org/drugbank:DB00093>	<http://purl.org/dc/terms/identifier>	"drugbank:DB00093"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-8>	<http://purl.org/dc/terms/title>	"Molecular Weight: 1356.3731 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-3>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:372918cb5733e55c6d5baa7bc6f4a30c>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-17>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-27>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-1>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-26>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:3549163466db2fa5b979545848c2ef00>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:3181b99b434a8db59d197070956de3d9>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-10>	<http://www.w3.org/2000/01/rdf-schema#label>	"SMILES: OC[C@H]1O[C@@H]([C@H](O)[C@@H]1OP(O)(=O)O[C@]([H])(C)CNC(=O)CC[C@]1(C)[C@@H](CC(=O)N)[C@@]2([H])N([Co]C#N)C1=C(C)/C1=N/C(=CC3=NC(=C(C)/C4=N[C@]2(C)[C@@](C)(CC(=O)N)[C@@H]4CCC(=O)N)[C@@](C)(CC(=O)N)[C@@H]3CCC(=O)N)/C(C)(C)[C@@H]1CCC(=O)N)N1C=NC2=CC(C)=C(C)C=C12 from ChemAxon [drugbank_resource:calculated-properties-DB00115-10]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-5>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-25>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:31af673f5d82841086059243563cd4c6>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-2>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00099-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-2>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:bf1a15ece689c3f449c06ebc0a90dae3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-24>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-1>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-31>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:366d45e2564940d9162a27ad0e9e3571>	<http://purl.org/dc/terms/title>	"Pyrroline"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-4>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:451abb4a53a3d4bc5e17cc485a3899b3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank_resource:24189bc5fb16bfce4551ecdfb0196def>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-30>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:7fc0069b68f72ba58fdad65bec3cc1df>	<http://www.w3.org/2000/01/rdf-schema#label>	".5 mg/mL Emulsion form with ophthalmic route [drugbank_resource:7fc0069b68f72ba58fdad65bec3cc1df]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-3>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:23e60560991f40f7f335be06f10675e1>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-29>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:bbf3cb3443969f24e50666e131185bd8>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:b8238b8599e6fdc40599cf773d5fb991>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Absorption> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:enzyme>	<http://bio2rdf.org/drugbank:BE0000300> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-12>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Weight: 155.1546 from ChemAxon [drugbank_resource:calculated-properties-DB00117-12]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-1>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:225393798d1f4d7a00af1d777e454e22>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-28>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank:DB00109>	<http://bio2rdf.org/drugbank_vocabulary:absorption>	<http://bio2rdf.org/drugbank_resource:55f06b8fc86fce71f0db4c1832cfa819> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-17>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00091-17"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Small-molecule>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:220e1c2f3029a37a26fd263b95f90c89>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-19>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:c007cc919bf71767e61e0b111723c84f>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-3>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"serine-type peptidase activity"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ea9490984599c557a86db10a8e93e890>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"ea9490984599c557a86db10a8e93e890"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-18>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:b8f9ca946fec2fca3eb84c3b8cf1ff12>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:228bf0dff0e17c650e98e541c5291e94>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00088>	<http://purl.org/dc/terms/identifier>	"drugbank:DB00088"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-2>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-17>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-3>	<http://bio2rdf.org/drugbank_vocabulary:value>	"1007.19"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-1>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01319>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:DB00109_DB01319"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-16>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/drugbank_vocabulary:molecular-weight>	"55930.5"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:DB00107_DB00834>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:DB00107_DB00834"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-25>	<http://www.w3.org/2000/01/rdf-schema#label>	"pKa (strongest basic): 9.44 from ChemAxon [drugbank_resource:calculated-properties-DB00117-25]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-23>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:80aadabf31c519e42d80748f499c7689>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:80aadabf31c519e42d80748f499c7689"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:77b52954fa911921450d2b426c1a7a3a>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:77b52954fa911921450d2b426c1a7a3a"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-3>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:ba0f878619b43a5be9083f01d8ba77fd>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-22>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:47d86c7cb8687c843b27225a6715c3c1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:eb23978cb768321237553e12616e3b84>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:eb23978cb768321237553e12616e3b84"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-15>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00091-15"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-2>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:22baeb726de652a99f0ad2fb61fac832>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-4>	<http://purl.org/dc/terms/title>	"Molecular Weight: 980.1620"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-21>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:be8afc258733f250df3262d94e93265b>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0000456>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"BE0000456"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-17>	<http://www.w3.org/2000/01/rdf-schema#label>	"Rotatable Bond Count: 7 from ChemAxon [drugbank_resource:calculated-properties-DB00118-17]"@en .
<http://bio2rdf.org/drugbank_resource:433dda4a1117986cabe237dcf80bd242>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank:DB00113>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:DB00113"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:0f3c814d30566a7614f1fab32f4e0302>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"0f3c814d30566a7614f1fab32f4e0302"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-5>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-18>	<http://purl.org/dc/terms/title>	"Rotatable Bond Count: 15 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-20>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:43ebb1f4d3ddbd9ec70fcbba40c42a45>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:DB00099_DB00290>	<http://purl.org/dc/terms/title>	"DDI between Filgrastim and Bleomycin - Filgrastim may enhance the adverse/toxic effect of Bleomycin. Specifically, the risk for pulmonary toxicity may be increased."@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-4>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:1fc54dd8ec20644e59a52e0b31197dd9>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-7>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:4a0d48b5f8e157c4bbcb34092d4edaf3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00445>	<http://www.w3.org/2000/01/rdf-schema#label>	"DDI between Bevacizumab and Epirubicin - May enhance the cardiotoxic effect of Antineoplastic Agents (Anthracycline, Systemic). [drugbank_resource:DB00112_DB00445]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00106-2>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:bf1a15ece689c3f449c06ebc0a90dae3>	<http://www.w3.org/2000/01/rdf-schema#label>	"Monosaccharides [drugbank_resource:bf1a15ece689c3f449c06ebc0a90dae3]"@en .
<http://bio2rdf.org/drugbank_resource:c0c3695e2cc0b1f8b2708aa4329a566e>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Indication> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00106-1>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"P450 form 1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-2>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:e91ecbd8702c2bd53755e648fa5c9435>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#value>	"App pharmaceuticals llc"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:5ba52774f54e88019dd4d17f32a34f7b>	<http://purl.org/dc/terms/description>	"For the treatment of adult patients with moderate to severe chronic plaque psoriasis, who are candidates for phototherapy or systemic therapy."@en .
<http://bio2rdf.org/drugbank_resource:20aa32f603258f15ceef0ba521a5bd87>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:c254aba7ca3db4f83cda45b27adb5b2b>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-21>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-2>	<http://bio2rdf.org/drugbank_vocabulary:value>	"-0.96"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-1>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-9>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-22>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00118-22"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:b86c00de25382c6ce4d94dae5e4502db>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:4aaab29fd43effbe133e376c024d5f06>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:Micronutrients>	<http://purl.org/dc/terms/title>	"Micronutrients"@en .
<http://bio2rdf.org/drugbank:BE0000456>	<http://bio2rdf.org/drugbank_vocabulary:gene-name>	"MMAB"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-4>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:c28ad3ee91a708824325b58f26c403a5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-8>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-23>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00093-23"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-3>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:c2dbd6b14df7875575496a70dff7a209>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-7>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:0d1969d27d89c3b774c942d81666c5d3>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:0d1969d27d89c3b774c942d81666c5d3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8750c04d33b8546006e83e736eb80647>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"8750c04d33b8546006e83e736eb80647"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-16>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-16"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-9>	<http://bio2rdf.org/drugbank_vocabulary:value>	"1039.44"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:913e4e077c76fcc7c941f5fbedf4db30>	<http://www.w3.org/2000/01/rdf-schema#label>	"absorption for drugbank:DB00034 [drugbank_resource:913e4e077c76fcc7c941f5fbedf4db30]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-2>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-6>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-3>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Weight: 69899.4000 [drugbank_resource:experimental-properties-DB00090-3]"@en .
<http://bio2rdf.org/drugbank_resource:3f54718d1deb0dbafe47e6e45eda5914>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-2>	<http://bio2rdf.org/drugbank_vocabulary:value>	"7.41"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-1>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-12>	<http://purl.org/dc/terms/title>	"Molecular Weight: 155.1546 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-16>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:1cb959cb5d30e328a863a3d9f64c120a>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0000300>	<http://bio2rdf.org/drugbank_vocabulary:x-pfam>	<http://bio2rdf.org/pfam:PF01564> .
<http://bio2rdf.org/drugbank_resource:4dcb2d242a80267002194ce81be5670e>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Manufacturer> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-4>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-15>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:3eff294ae1a633c8845359753061fac9>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Clearance> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-3>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:c0c3695e2cc0b1f8b2708aa4329a566e>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-14>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:4f9f96147f2386295de420eed7aa9274>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-26>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00118-26"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-13>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-5>	<http://bio2rdf.org/drugbank_vocabulary:value>	"C42H65N11O12S2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:4fcc6e9455872b18c21b74aa6b82db13>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:4d9d641daef8c178a249f1266f1150e5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Mechanism-of-action> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-20>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-1>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:42e21c05e96b3040136e54dfed4bf794>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/pubchem.compound:44176380>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/pubchem.compound/44176380> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-2>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00112-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-19>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:405bc988f44cffeeb0d7149d00e5918b>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Half-life> .
<http://bio2rdf.org/pubchem.compound:34756>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/pubchem.compound/34756> .
<http://bio2rdf.org/drugbank_resource:3314d6a38b90d6a9ef0419bc7224913d>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:3314d6a38b90d6a9ef0419bc7224913d"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:absorption>	<http://bio2rdf.org/drugbank_resource:450004b6cb1a30c3690aa11d2cd941a2> .
<http://bio2rdf.org/drugbank_resource:1f87ebefeca8e494680a6a81334c6078>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-18>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-23>	<http://bio2rdf.org/drugbank_vocabulary:value>	"4.11"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:450004b6cb1a30c3690aa11d2cd941a2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Absorption> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-29>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00114-29"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/bindingdb:7953>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/bindingdb:7953"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-17>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"EC 1.14.13.67"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:b77ba88d4df43eb6dd239cb83101c022>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-20>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:4d6d8a0bb0437361e22c5fbaf04819ea>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-2>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00107-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3eff294ae1a633c8845359753061fac9>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:3eff294ae1a633c8845359753061fac9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:enzyme>	<http://bio2rdf.org/drugbank:BE0000456> .
<http://bio2rdf.org/drugbank_resource:1c54727b6a9a48b74b53723fbee43d80>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-19>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:4d9d641daef8c178a249f1266f1150e5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:b8238b8599e6fdc40599cf773d5fb991>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-18>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:c254aba7ca3db4f83cda45b27adb5b2b>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:3f34afd99cc9695ee26d778d111874cf>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Half-life> .
<http://bio2rdf.org/pdb:PLP>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"PLP"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:4dcb2d242a80267002194ce81be5670e>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00106-2>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Formula: C72H95ClN14O14 [drugbank_resource:experimental-properties-DB00106-2]"@en .
<http://bio2rdf.org/drugbank_resource:b86c00de25382c6ce4d94dae5e4502db>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-24>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:1c7495e7ba342d224b5028d72d73010d>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:408e99a507da89ecb16b006481be4f7d>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_vocabulary:Oxytocics>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:Oxytocics"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c28ad3ee91a708824325b58f26c403a5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-23>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:1cb2d5b9df573a57849083d75e49a5fe>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/pubchem.compound:1051>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/pubchem.compound/1051> .
<http://bio2rdf.org/drugbank_resource:4f9f96147f2386295de420eed7aa9274>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Half-life> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:specific-function>	"Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. This enzyme contributes to the wide pharmacokinetics variability of the metabolism of drugs such as S- warfarin, diclofenac, phenytoin, tolbutamide and losartan"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:0f3c814d30566a7614f1fab32f4e0302>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:c2dbd6b14df7875575496a70dff7a209>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-22>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00115-1>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00115-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3732893325a7ecb9126a15736796f117>	<http://www.w3.org/2000/01/rdf-schema#label>	"Cyclosporin-backbone [drugbank_resource:3732893325a7ecb9126a15736796f117]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-21>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:a2615bbb5710b9b992785e63c058b3db>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:a2615bbb5710b9b992785e63c058b3db"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-1>	<http://purl.org/dc/terms/title>	"Melting Point: 61 \u00B0C from Beldarrain, A. et al., Biochemistry 38:7865-7873 (1999)"@en .
<http://bio2rdf.org/drugbank_resource:19d3289105c9a843a041cb4f7a0883a1>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-13>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:53ca67aedcd10f1c9afc4de0f2138502>	<http://www.w3.org/2000/01/rdf-schema#label>	"This compound belongs to the class of organic compounds known as pyridoxals and derivatives. These are compounds containing a pyridoxal moiety, which consists of a pyridine ring substituted at positions 2,3,4, and 5 by a methyl group, a hydroxyl group, a carbaldehyde group, and a hydroxymethyl group, respectively. [drugbank_resource:53ca67aedcd10f1c9afc4de0f2138502]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-12>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:df42fd14b400446e8cc7e69facd62cba>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:df42fd14b400446e8cc7e69facd62cba"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:122193da65e00a63d46700928a244018>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-11>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:4fcc6e9455872b18c21b74aa6b82db13>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Food-interaction> .
<http://bio2rdf.org/pubchem.substance:46505280>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/pubchem.substance/46505280> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-10>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/pubchem.substance:46504756>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/pubchem.substance/46504756> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00115-1>	<http://www.w3.org/2000/01/rdf-schema#label>	"Water Solubility: 1.25E+004 mg/L from MERCK INDEX (1996) [drugbank_resource:experimental-properties-DB00115-1]"@en .
<http://bio2rdf.org/drugbank_resource:efd9b57513efb0eb6e90f59807e0e8d9>	<http://purl.org/dc/terms/title>	"Oxolanes"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-21>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00091-21"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:x-uniprot>	<http://bio2rdf.org/uniprot:PPCE_HUMAN> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-17>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank:BE0003533>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"iron ion binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:42e21c05e96b3040136e54dfed4bf794>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:574e7d1136f355daec35f6fd17ef29e5>	<http://www.w3.org/2000/01/rdf-schema#label>	"Phosphoric acid ester [drugbank_resource:574e7d1136f355daec35f6fd17ef29e5]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-16>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"iron ion binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00102>	<http://bio2rdf.org/drugbank_vocabulary:absorption>	<http://bio2rdf.org/drugbank_resource:3669e274097fc69149d3dbad3ba6b01c> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-15>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"iron ion binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:180176f4e85931ffb36c855eab8691da>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0003536>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-14>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:3eff294ae1a633c8845359753061fac9>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:aa64bf1510edae009ba1d31553912173>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:aa64bf1510edae009ba1d31553912173"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3f34afd99cc9695ee26d778d111874cf>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"3f34afd99cc9695ee26d778d111874cf"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-2>	<http://purl.org/dc/terms/title>	"Hydrophobicity: -0.437"@en .
<http://bio2rdf.org/drugbank_resource:b77ba88d4df43eb6dd239cb83101c022>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-18>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:3f34afd99cc9695ee26d778d111874cf>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00106-1>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00106-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:4d6d8a0bb0437361e22c5fbaf04819ea>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:408e99a507da89ecb16b006481be4f7d> .
<http://bio2rdf.org/pubchem.compound:91443>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/pubchem.compound/91443> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-17>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:3f54718d1deb0dbafe47e6e45eda5914>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/pubchem.compound:6274>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/pubchem.compound/6274> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-16>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:405bc988f44cffeeb0d7149d00e5918b>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00103>	<http://bio2rdf.org/drugbank_vocabulary:clearance>	<http://bio2rdf.org/drugbank_resource:3eff294ae1a633c8845359753061fac9> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:cellular-location>	"Cytoplasm"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c007cc919bf71767e61e0b111723c84f>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Half-life> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-15>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:bf1a15ece689c3f449c06ebc0a90dae3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:091b1b5a04486711c0e6615b4e552e7e>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:091b1b5a04486711c0e6615b4e552e7e"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:Citanest-Dental>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:Citanest-Dental"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-22>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:5c103a2b0c3fce1acc1c2e135c6684bf> .
<http://bio2rdf.org/drugbank_resource:408e99a507da89ecb16b006481be4f7d>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:43ebb1f4d3ddbd9ec70fcbba40c42a45> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:2c808757b9d5f22f13a70bae1f9e7737> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:30d0083606d3fa4b4b602b5d3ed0feda> .
<http://bio2rdf.org/drugbank:BE0000456>	<http://bio2rdf.org/drugbank_vocabulary:x-pfam>	<http://bio2rdf.org/pfam:PF01923> .
<http://bio2rdf.org/drugbank_resource:195ccf935d3c9947bcc17b096fdca329>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-21>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-22>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00117-22"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-11>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Formula: C63H89CoN14O14P from ChemAxon [drugbank_resource:calculated-properties-DB00115-11]"@en .
<http://bio2rdf.org/drugbank_resource:180176f4e85931ffb36c855eab8691da>	<http://www.w3.org/2000/01/rdf-schema#label>	"mechanism-of-action for drugbank:DB00100 [drugbank_resource:180176f4e85931ffb36c855eab8691da]"@en .
<http://bio2rdf.org/drugbank_resource:bbf3cb3443969f24e50666e131185bd8>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-20>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/pubchem.substance:46507001>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/pubchem.substance/46507001> .
<http://bio2rdf.org/drugbank:DB00092>	<http://bio2rdf.org/drugbank_vocabulary:indication>	<http://bio2rdf.org/drugbank_resource:585c665fefee46ff4931f369bfe6004a> .
<http://bio2rdf.org/pubchem.substance:46506428>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/pubchem.substance/46506428> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:433dda4a1117986cabe237dcf80bd242> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-19>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-2>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-16>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00117-16"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-10>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:433dda4a1117986cabe237dcf80bd242> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:3d51d314e6796004243d124d2c5f0793> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:4aaab29fd43effbe133e376c024d5f06> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:47d86c7cb8687c843b27225a6715c3c1> .
<http://bio2rdf.org/drugbank_resource:30d0083606d3fa4b4b602b5d3ed0feda>	<http://purl.org/dc/terms/title>	"50 mg/mL Injection, solution form with intravenous route"@en .
<http://bio2rdf.org/drugbank_resource:b8f9ca946fec2fca3eb84c3b8cf1ff12>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"iron ion binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:e78186eb12eeaebda8a530a67513beea>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-1>	<http://purl.org/dc/terms/title>	"Melting Point: 61 \u00B0C (FAB fragment), 71 \u00B0C (whole mAb) from Vermeer, A.W.P. & Norde, W., Biophys. J. 78:394-404 (2000)"@en .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:3afc1cd15f9de2a07db0081098265ac4> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:47d86c7cb8687c843b27225a6715c3c1> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:4a0d48b5f8e157c4bbcb34092d4edaf3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00110-1>	<http://purl.org/dc/terms/title>	"Melting Point: 61 \u00B0C (FAB fragment), 71 \u00B0C (whole mAb) from Vermeer, A.W.P. & Norde, W., Biophys. J. 78:394-404 (2000)"@en .
<http://bio2rdf.org/drugbank:DB00095>	<http://bio2rdf.org/drugbank_vocabulary:indication>	<http://bio2rdf.org/drugbank_resource:5ba52774f54e88019dd4d17f32a34f7b> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00694>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:DB00112_DB00694"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00099>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:451abb4a53a3d4bc5e17cc485a3899b3> .
<http://bio2rdf.org/drugbank_resource:17055fe13e90f0599fe8f9fd1c90c871>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-14>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:dedcaba12fd68e71a4930ea18843aa61>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:dedcaba12fd68e71a4930ea18843aa61"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-1>	<http://purl.org/dc/terms/title>	"Melting Point: 61 \u00B0C (FAB fragment), 71 \u00B0C (whole mAb) from Vermeer, A.W.P. & Norde, W., Biophys. J. 78:394-404 (2000)"@en .
<http://bio2rdf.org/drugbank_resource:ba0f878619b43a5be9083f01d8ba77fd>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-13>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank:DB00110>	<http://bio2rdf.org/drugbank_vocabulary:mechanism-of-action>	<http://bio2rdf.org/drugbank_resource:6d460a13d1af93268984ab262cef479d> .
<http://bio2rdf.org/drugbank_resource:17b27330dfdb2b245beadb493e911ddb>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:47d86c7cb8687c843b27225a6715c3c1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-24>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-24"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:5295f08395d80bb2a78d48e62dbf8c19> .
<http://bio2rdf.org/drugbank_resource:be8afc258733f250df3262d94e93265b>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-12>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:3732893325a7ecb9126a15736796f117> .
<http://bio2rdf.org/drugbank_resource:433dda4a1117986cabe237dcf80bd242>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/pubchem.compound:34756>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/pubchem.compound:34756"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:4d6d8a0bb0437361e22c5fbaf04819ea> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-11>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:43ebb1f4d3ddbd9ec70fcbba40c42a45>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:da9625c635b6c208626fef4666f9f883>	<http://purl.org/dc/terms/title>	"Aryl-aldehyde"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-8>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00112>	<http://bio2rdf.org/drugbank_vocabulary:mechanism-of-action>	<http://bio2rdf.org/drugbank_resource:6be4db795caa5a4f0e9b208f115d277b> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-8>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:4a0d48b5f8e157c4bbcb34092d4edaf3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:2c808757b9d5f22f13a70bae1f9e7737> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB01177>	<http://www.w3.org/2000/01/rdf-schema#label>	"DDI between Bevacizumab and Idarubicin - May enhance the cardiotoxic effect of Antineoplastic Agents (Anthracycline, Systemic). [drugbank_resource:DB00112_DB01177]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-7>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-8>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Traditional-IUPAC-Name> .
<http://bio2rdf.org/drugbank_resource:ade41ed0b3f8ac2b059fa8aeb0cdbbb4>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:ade41ed0b3f8ac2b059fa8aeb0cdbbb4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pubchem.substance:46504756>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"46504756"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:19d3289105c9a843a041cb4f7a0883a1>	<http://purl.org/dc/terms/title>	"50 mg Powder for solution form with intramuscular route"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:14e62611474f52c8e22248963b84f59b>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-15>	<http://bio2rdf.org/drugbank_vocabulary:value>	"8.77"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:2df9c46833999f4cf9a8383d1003158e> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-19>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:H-Bond-Acceptor-Count> .
<http://bio2rdf.org/drugbank_resource:372918cb5733e55c6d5baa7bc6f4a30c>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"100 mg/mL"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-20>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:H-Bond-Donor-Count> .
<http://bio2rdf.org/drugbank_resource:ffc8ae70d9900ffb750da168c0f58cc5>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:6f3fc4bb7965f22f3fc655ec5e1faab0> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:2c7d5048f3ab623475c1e9c503997a85> .
<http://bio2rdf.org/drugbank_resource:450004b6cb1a30c3690aa11d2cd941a2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00100>	<http://bio2rdf.org/drugbank_vocabulary:indication>	<http://bio2rdf.org/drugbank_resource:592de4a57c1d28519d666f4b36fa6b2b> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:2d76fb5dd0f39b41fe92dc87dd6a96d9> .
<http://bio2rdf.org/drugbank_resource:ffa1ac4af9ac617e01349d78fdc482f1>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:2ec24002f6e3cb0430a51468ee1d26da> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-6>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-12>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:c28ad3ee91a708824325b58f26c403a5>	<http://www.w3.org/2000/01/rdf-schema#label>	"Pterins and derivatives [drugbank_resource:c28ad3ee91a708824325b58f26c403a5]"@en .
<http://bio2rdf.org/drugbank:DB00096>	<http://purl.org/dc/terms/identifier>	"drugbank:DB00096"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-23>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Physiological-Charge> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-17>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00093-17"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:451abb4a53a3d4bc5e17cc485a3899b3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:4aaab29fd43effbe133e376c024d5f06>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank:BE0003533>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:BE0003533"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fffcf97ccb1aeb21dae91caa501b8255>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-22>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:PKa-(strongest-basic)> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-11>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-7>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Water-Solubility> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-10>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00091-10"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-21>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:PKa-(strongest-acidic)> .
<http://bio2rdf.org/drugbank_resource:ffe7ffbc4b8e341c6b137f185bb434e0>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00106>	<http://bio2rdf.org/drugbank_vocabulary:half-life>	<http://bio2rdf.org/drugbank_resource:5b282e6fa4562e2752afccabea3c29c1> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:3314d6a38b90d6a9ef0419bc7224913d> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-8>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-10>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank:DB00112>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:2ddeeca2fe9449969ab1519d768237c6> .
<http://bio2rdf.org/drugbank_resource:1588f62bddb8c0b1cca8f11ce8e653b9>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-28>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:MDDR-Like-Rule> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-10>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:SMILES> .
<http://bio2rdf.org/drugbank_resource:180176f4e85931ffb36c855eab8691da>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB08879>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00112_DB08879"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:3f54718d1deb0dbafe47e6e45eda5914> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-9>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-27>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-27"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-9>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:129ef94b8ca8b89a244a3cd1c5b2c72b>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-24>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Number-of-Rings> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-1>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-10>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-26>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:indication>	<http://bio2rdf.org/drugbank_resource:67b3d3945732c5188334e7f955ca6288> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:366d45e2564940d9162a27ad0e9e3571> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-21>	<http://purl.org/dc/terms/title>	"pKa (strongest basic): 3.58 from ChemAxon"@en .
<http://bio2rdf.org/drugbank:DB00107>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:2d6f2db0443dc24ac01149b8df7afb05> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-21>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-25>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:131ed90e7634d72c92f27daf9a85454a>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:LogP> .
<http://bio2rdf.org/drugbank_resource:8ae8b01597df174d257016596812aeab>	<http://purl.org/dc/terms/title>	"Monocarboxylic acid or derivatives"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-19>	<http://www.w3.org/2000/01/rdf-schema#label>	"H Bond Donor Count: 12 from ChemAxon [drugbank_resource:calculated-properties-DB00093-19]"@en .
<http://bio2rdf.org/drugbank_resource:c987b0d07b89f29a364501bc29cfebc8>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-24>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-22>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00107>	<http://bio2rdf.org/drugbank_vocabulary:half-life>	<http://bio2rdf.org/drugbank_resource:57db98e1612a44845256ccbbbc457ff8> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-6>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:LogP> .
<http://bio2rdf.org/drugbank_resource:2d6f2db0443dc24ac01149b8df7afb05>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"2d6f2db0443dc24ac01149b8df7afb05"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:17055fe13e90f0599fe8f9fd1c90c871>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Mechanism-of-action> .
<http://bio2rdf.org/drugbank_resource:fe2051219bbed1c3f26d756ec49dea95>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:3549163466db2fa5b979545848c2ef00> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-23>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-23>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/drugbank_vocabulary:gene-sequence>	">1473 bp\nATGGATCCTTTTGTGGTCCTTGTGCTCTGTCTCTCATGTTTGCTTCTCCTTTCAATCTGG\nAGACAGAGCTCTGGGAGAGGAAAACTCCCTCCTGGCCCCACTCCTCTCCCAGTGATTGGA\nAATATCCTACAGATAGATATTAAGGATGTCAGCAAATCCTTAACCAATCTCTCAAAAATC\nTATGGCCCTGTGTTCACTCTGTATTTTGGCCTGGAACGCATGGTGGTGCTGCATGGATAT\nGAAGTGGTGAAGGAAGCCCTGATTGATCTTGGAGAGGAGTTTTCTGGAAGAGGCCATTTC\nCCACTGGCTGAAAGAGCTAACAGAGGATTTGGAATCGTTTTCAGCAATGGAAAGAGATGG\nAAGGAGATCCGGCGTTTCTCCCTCATGACGCTGCGGAATTTTGGGATGGGGAAGAGGAGC\nATTGAGGACCGTGTTCAAGAGGAAGCCCGCTGCCTTGTGGAGGAGTTGAGAAAAACCAAG\nGCTTCACCCTGTGATCCCACTTTCATCCTGGGCTGTGCTCCCTGCAATGTGATCTGCTCC\nATTATTTTCCAGAAACGTTTCGATTATAAAGATCAGCAATTTCTTAACTTGATGGAAAAA\nTTGAATGAAAACATCAGGATTGTAAGCACCCCCTGGATCCAGATATGCAATAATTTTCCC\nACTATCATTGATTATTTCCCGGGAACCCATAACAAATTACTTAAAAACCTTGCTTTTATG\nGAAAGTGATATTTTGGAGAAAGTAAAAGAACACCAAGAATCGATGGACATCAACAACCCT\nCGGGACTTTATTGATTGCTTCCTGATCAAAATGGAGAAGGAAAAGCAAAACCAACAGTCT\nGAATTCACTATTGAAAACTTGGTAATCACTGCAGCTGACTTACTTGGAGCTGGGACAGAG\nACAACAAGCACAACCCTGAGATATGCTCTCCTTCTCCTGCTGAAGCACCCAGAGGTCACA\nGCTAAAGTCCAGGAAGAGATTGAACGTGTCATTGGCAGAAACCGGAGCCCCTGCATGCAG\nGACAGGGGCCACATGCCCTACACAGATGCTGTGGTGCACGAGGTCCAGAGATACATCGAC\nCTCATCCCCACCAGCCTGCCCCATGCAGTGACCTGTGACGTTAAATTCAGAAACTACCTC\nATTCCCAAGGGCACAACCATATTAACTTCCCTCACTTCTGTGCTACATGACAACAAAGAA\nTTTCCCAACCCAGAGATGTTTGACCCTCGTCACTTTCTGGATGAAGGTGGAAATTTTAAG\nAAAAGTAACTACTTCATGCCTTTCTCAGCAGGAAAACGGATTTGTGTGGGAGAGGGCCTG\nGCCCGCATGGAGCTGTTTTTATTCCTGACCTTCATTTTACAGAACTTTAACCTGAAATCT\nCTGATTGACCCAAAGGACCTTGACACAACTCCTGTTGTCAATGGATTTGCTTCTGTCCCG\nCCCTTCTATCAGCTGTGCTTCATTCCTGTCTGA"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:17b27330dfdb2b245beadb493e911ddb>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Indication> .
<http://bio2rdf.org/drugbank_vocabulary:Biotech>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:Biotech"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:LogS> .
<http://bio2rdf.org/drugbank_resource:fe02b6034f5c4d73f73a58815355abf5>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:cad41663894b5be906782be10b396e06>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:13bf7e351282b3c815c4b958aedb585f>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-24>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:195ccf935d3c9947bcc17b096fdca329>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:67b3d3945732c5188334e7f955ca6288>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"67b3d3945732c5188334e7f955ca6288"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-25>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-29>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-26>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Rule-of-Five> .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"(S)-limonene 7-monooxygenase"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-9>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Weight> .
<http://bio2rdf.org/drugbank_resource:5b47883807d5fa7a5b0b5ce2dc6e7939>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"5b47883807d5fa7a5b0b5ce2dc6e7939"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:1588f62bddb8c0b1cca8f11ce8e653b9>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank:DB00110>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:372918cb5733e55c6d5baa7bc6f4a30c> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00694>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:DB00112_DB00694"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-26>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-28>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:129ef94b8ca8b89a244a3cd1c5b2c72b>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:6205a409adf418d0390045ac349b481a> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:39094d4a5017cb7945c3ca22e421306d> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:3c77091e1ee2397a2767e73267a25af5> .
<http://bio2rdf.org/drugbank_resource:ff5b4bb2ae4fdc7811f87fd38c8b8eda>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-27>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-27>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:1c54727b6a9a48b74b53723fbee43d80>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:1c54727b6a9a48b74b53723fbee43d80"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:DB00114"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:4d9d641daef8c178a249f1266f1150e5>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"4d9d641daef8c178a249f1266f1150e5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:180176f4e85931ffb36c855eab8691da>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Mechanism-of-action> .
<http://bio2rdf.org/drugbank:DB00090>	<http://bio2rdf.org/drugbank_vocabulary:indication>	<http://bio2rdf.org/drugbank_resource:6d66b6aba13ddd36f6f9c8c32bc1927d> .
<http://bio2rdf.org/drugbank_vocabulary:64789d808f73ebe8eac3dbded4a95da0>	<http://bio2rdf.org/drugbank_vocabulary:name>	"Raptiva"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-28>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:0f798f4d70ca79c6d20f50856c6d9d11>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-8>	<http://bio2rdf.org/drugbank_vocabulary:value>	"445.429"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-12>	<http://purl.org/dc/terms/title>	"InChI: InChI=1/C46H65N13O11S2/c47-18-8-7-14-29(40(64)52-23-38(51)62)54-45(69)35-15-9-19-59(35)46(70)34-25-72-71-24-28(48)39(63)55-31(20-26-10-3-1-4-11-26)43(67)56-32(21-27-12-5-2-6-13-27)42(66)53-30(16-17-36(49)60)41(65)57-33(22-37(50)61)44(68)58-34/h1-6,10-13,28-35H,7-9,14-25,47-48H2,(H2,49,60)(H2,50,61)(H2,51,62)(H,52,64)(H,53,66)(H,54,69)(H,55,63)(H,56,67)(H,57,65)(H,58,68)/t28-,29-,30-,31-,32-,33-,34-,35-/s2 from ChemAxon"@en .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:3c77091e1ee2397a2767e73267a25af5> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-19>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:627446b31de3941cb82db7d08189b597> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:64b9dc4a304f0bbee322be682a49f08b> .
<http://bio2rdf.org/drugbank_resource:1059233feb371b14b03a21571fa19968>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:17055fe13e90f0599fe8f9fd1c90c871>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-2>	<http://purl.org/dc/terms/title>	"Hydrophobicity: 0.209"@en .
<http://bio2rdf.org/drugbank_vocabulary:e6be3ee899ac0f450592b2c5985631de>	<http://bio2rdf.org/drugbank_vocabulary:name>	"Zenapax"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:13bf7e351282b3c815c4b958aedb585f>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank:DB00113>	<http://bio2rdf.org/drugbank_vocabulary:half-life>	<http://bio2rdf.org/drugbank_resource:405bc988f44cffeeb0d7149d00e5918b> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-1>	<http://purl.org/dc/terms/title>	"Melting Point: 61 \u00B0C (FAB fragment), 71 \u00B0C (whole mAb) from Vermeer, A.W.P. & Norde, W., Biophys. J. 78:394-404 (2000)"@en .
<http://bio2rdf.org/drugbank:DB00103>	<http://bio2rdf.org/drugbank_vocabulary:mechanism-of-action>	<http://bio2rdf.org/drugbank_resource:4d9d641daef8c178a249f1266f1150e5> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-12>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:InChI> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:64b9dc4a304f0bbee322be682a49f08b> .
<http://bio2rdf.org/drugbank_resource:b8f9ca946fec2fca3eb84c3b8cf1ff12>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:b8f9ca946fec2fca3eb84c3b8cf1ff12"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-20>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-9>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-16>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Polarizability> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-13>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:InChIKey> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-11>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Formula> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:6205a409adf418d0390045ac349b481a> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:38b20638a91b63e0378b18fb8d8f4c38> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-15>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Refractivity> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-11>	<http://purl.org/dc/terms/title>	"Monoisotopic Weight: 247.024573569 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-6>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00114-6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-21>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:17b27330dfdb2b245beadb493e911ddb>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00109>	<http://bio2rdf.org/drugbank_vocabulary:manufacturer>	<http://bio2rdf.org/drugbank_resource:4dcb2d242a80267002194ce81be5670e> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-14>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Polar-Surface-Area-(PSA)> .
<http://bio2rdf.org/drugbank_resource:fd9ee6482e9b1c5516cff7b904f27169>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-4>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00092-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-22>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:0f798f4d70ca79c6d20f50856c6d9d11>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:f2977936270a493873be5432bb760ef7>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"f2977936270a493873be5432bb760ef7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-2>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00100-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-23>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"Mephenytoin 4-hydroxylase"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:68664b41f20b902d0fcad004203c7cc8> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-23>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00118-23"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-25>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Rule-of-Five> .
<http://bio2rdf.org/drugbank:DB00096>	<http://bio2rdf.org/drugbank_vocabulary:manufacturer>	<http://bio2rdf.org/drugbank_resource:328c87b1ad60e7356c52d11e15011e6f> .
<http://bio2rdf.org/drugbank_resource:0e708564ecff800b67a0d210bc03042c>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-29>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00114-29"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-24>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:c7f12f71253c5095c8df9050b7b42f2c>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:1c54727b6a9a48b74b53723fbee43d80>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:c3ea863492592dff31fb000b21cd1a19>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank:DB00109>	<http://bio2rdf.org/drugbank_vocabulary:clearance>	<http://bio2rdf.org/drugbank_resource:6215bb81f14ea29a233fa4efbf660bf9> .
<http://bio2rdf.org/drugbank_resource:8abd75317f3f7b8f7d56e3fe7d6204bd>	<http://purl.org/dc/terms/title>	"2.9 mg/5mL Injection, solution, concentrate form with intravenous route"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-1>	<http://www.w3.org/2000/01/rdf-schema#label>	"Hydrophobicity: -0.875 [drugbank_resource:experimental-properties-DB00109-1]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-25>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-4>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Formula: C2532H3854N672O711S16 [drugbank_resource:experimental-properties-DB00088-4]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:LogP> .
<http://bio2rdf.org/drugbank_resource:eda68d4a7955df0290c1f8b709e905ec>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:eda68d4a7955df0290c1f8b709e905ec"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:6ac630c499c16fd6e1f2a125e397688a> .
<http://bio2rdf.org/drugbank_resource:fdb8e90f512977b9fb2141486454a079>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-11>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:1c7495e7ba342d224b5028d72d73010d>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00099>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:684d8812e411c70454900dc745e593c8> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-23>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Number-of-Rings> .
<http://bio2rdf.org/drugbank:DB00094>	<http://purl.org/dc/terms/title>	"Urofollitropin"@en .
<http://bio2rdf.org/drugbank_resource:fdb0a3b06aac9bbd85eeda7b1daf8545>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-12>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:fb96fa5c000dbd94c78671b5c79ff32b>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:fb96fa5c000dbd94c78671b5c79ff32b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-27>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:592de4a57c1d28519d666f4b36fa6b2b>	<http://purl.org/dc/terms/description>	"For treatment of hemophilia (Christmas disease)."@en .
<http://bio2rdf.org/drugbank_resource:0e7611deb0124f99ac54f3684b112d25>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-22>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Physiological-Charge> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-3>	<http://www.w3.org/2000/01/rdf-schema#label>	"Isoelectric Point: 8.46 [drugbank_resource:experimental-properties-DB00111-3]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-13>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-26>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank:DB00097>	<http://bio2rdf.org/drugbank_vocabulary:mechanism-of-action>	<http://bio2rdf.org/drugbank_resource:36cf3fe3b4f939b051085b627e517597> .
<http://bio2rdf.org/drugbank_resource:c7d119b1e6d46c382382c2c17e2801ac>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank:DB00096>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:5b47883807d5fa7a5b0b5ce2dc6e7939> .
<http://bio2rdf.org/drugbank_resource:5b47883807d5fa7a5b0b5ce2dc6e7939>	<http://www.w3.org/2000/01/rdf-schema#label>	"10; .22 mg/mL; mg/mL Injection, solution form with intravenous route [drugbank_resource:5b47883807d5fa7a5b0b5ce2dc6e7939]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-14>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-8>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:1cb2d5b9df573a57849083d75e49a5fe>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:70d5905dbbb671a2bf66275527b38e09> .
<http://bio2rdf.org/drugbank:DB00088>	<http://bio2rdf.org/drugbank_vocabulary:mechanism-of-action>	<http://bio2rdf.org/drugbank_resource:3181b99b434a8db59d197070956de3d9> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:70f28c5b4aa0741b1c2d0997a89319ea> .
<http://bio2rdf.org/drugbank_resource:1c54727b6a9a48b74b53723fbee43d80>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Mechanism-of-action> .
<http://bio2rdf.org/drugbank_resource:fba31fe582cac619f85335c144278e17>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:6f3fc4bb7965f22f3fc655ec5e1faab0> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-15>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-7>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank:DB00109>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:6621165671a52f286c0f04fbfcf81106> .
<http://bio2rdf.org/drugbank_resource:19d3289105c9a843a041cb4f7a0883a1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-26>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-26"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fb96fa5c000dbd94c78671b5c79ff32b>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-16>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-6>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-17>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Rotatable-Bond-Count> .
<http://bio2rdf.org/drugbank:DB00112>	<http://bio2rdf.org/drugbank_vocabulary:half-life>	<http://bio2rdf.org/drugbank_resource:4f9f96147f2386295de420eed7aa9274> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-6>	<http://purl.org/dc/terms/title>	"logP: 6.92 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-4>	<http://bio2rdf.org/drugbank_vocabulary:value>	"C2532H3854N672O711S16"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fc61d172cba7ae19145ff846ca1f0aef>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-17>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-5>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-3>	<http://purl.org/dc/terms/title>	"logS: -4.4 from ALOGPS"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-21>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:PKa-(strongest-basic)> .
<http://bio2rdf.org/drugbank_resource:0e7611deb0124f99ac54f3684b112d25>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:2c808757b9d5f22f13a70bae1f9e7737> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-20>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:PKa-(strongest-acidic)> .
<http://bio2rdf.org/drugbank_resource:eb23978cb768321237553e12616e3b84>	<http://www.w3.org/2000/01/rdf-schema#label>	"Glycosylamines [drugbank_resource:eb23978cb768321237553e12616e3b84]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-18>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:df42fd14b400446e8cc7e69facd62cba>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"df42fd14b400446e8cc7e69facd62cba"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00105>	<http://bio2rdf.org/drugbank_vocabulary:half-life>	<http://bio2rdf.org/drugbank_resource:3f34afd99cc9695ee26d778d111874cf> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:food-interaction>	<http://bio2rdf.org/drugbank_resource:4fcc6e9455872b18c21b74aa6b82db13> .
<http://bio2rdf.org/drugbank:DB00106>	<http://bio2rdf.org/drugbank_vocabulary:manufacturer>	<http://bio2rdf.org/drugbank_resource:376c6e6cad258f51a802ccce8c53ca4c> .
<http://bio2rdf.org/drugbank_resource:0e708564ecff800b67a0d210bc03042c>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Half-life> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-24>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-24"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:53ca67aedcd10f1c9afc4de0f2138502> .
<http://bio2rdf.org/drugbank:BE0000300>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"SPDSY"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:b8f9ca946fec2fca3eb84c3b8cf1ff12>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:b8f9ca946fec2fca3eb84c3b8cf1ff12"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-1>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-2>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00111-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:53e4e7c3f9db35ed7e24a59c1546788c> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-2>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:9e10be5c3dafcd8441cdeb69f72cc3f4>	<http://www.w3.org/2000/01/rdf-schema#label>	"Organooxygen compounds [drugbank_resource:9e10be5c3dafcd8441cdeb69f72cc3f4]"@en .
<http://bio2rdf.org/drugbank_resource:4f9f96147f2386295de420eed7aa9274>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00099>	<http://purl.org/dc/terms/title>	"Filgrastim"@en .
<http://bio2rdf.org/drugbank_resource:b8238b8599e6fdc40599cf773d5fb991>	<http://www.w3.org/2000/01/rdf-schema#label>	"absorption for drugbank:DB00091 [drugbank_resource:b8238b8599e6fdc40599cf773d5fb991]"@en .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:4d6d8a0bb0437361e22c5fbaf04819ea> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-3>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00115-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:220e1c2f3029a37a26fd263b95f90c89>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:220e1c2f3029a37a26fd263b95f90c89"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:57ad8968da7ad0cb58cba7e058039db9> .
<http://bio2rdf.org/drugbank_resource:da8dbfa1d167bdbfac5e83608be911ea>	<http://purl.org/dc/terms/title>	"half-life for drugbank:DB00092"@en .
<http://bio2rdf.org/drugbank_resource:c7d119b1e6d46c382382c2c17e2801ac>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-23>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00116-23"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:574e7d1136f355daec35f6fd17ef29e5> .
<http://bio2rdf.org/drugbank_resource:0f798f4d70ca79c6d20f50856c6d9d11>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-4>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00111-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-19>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:H-Bond-Donor-Count> .
<http://bio2rdf.org/drugbank_resource:c3ea863492592dff31fb000b21cd1a19>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"c3ea863492592dff31fb000b21cd1a19"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-8>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00118-8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:574e7d1136f355daec35f6fd17ef29e5> .
<http://bio2rdf.org/drugbank_resource:4fcc6e9455872b18c21b74aa6b82db13>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:c51b5b3f72bf15f717f23f1fdda6fe44>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Manufacturer> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-16>	<http://purl.org/dc/terms/title>	"Refractivity: 329.23 from ChemAxon"@en .
<http://bio2rdf.org/drugbank:BE0000456>	<http://bio2rdf.org/drugbank_vocabulary:molecular-weight>	"27389.0"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-6>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00091-6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:mechanism-of-action>	<http://bio2rdf.org/drugbank_resource:31af673f5d82841086059243563cd4c6> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-25>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-25"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c7f12f71253c5095c8df9050b7b42f2c>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:c3ea863492592dff31fb000b21cd1a19>	<http://purl.org/dc/terms/title>	"0.58 mg Solution form with intravenous route"@en .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:47d86c7cb8687c843b27225a6715c3c1> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:55694a43ccf43a29349054f94c2ce2e7> .
<http://bio2rdf.org/drugbank_resource:1059233feb371b14b03a21571fa19968>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:5888181b550399d2a84e1e4db3715340> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:58cc96ec8bd0d25f62dde9d4e4a829dd> .
<http://bio2rdf.org/drugbank_resource:fa9ea24c47c4cc6ec20e42b245e43401>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:3c77091e1ee2397a2767e73267a25af5>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:3c77091e1ee2397a2767e73267a25af5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c3ea863492592dff31fb000b21cd1a19>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:9d6d13e90c7dfeb0d8d2cac125c20125>	<http://www.w3.org/2000/01/rdf-schema#label>	"Glycosyl compounds [drugbank_resource:9d6d13e90c7dfeb0d8d2cac125c20125]"@en .
<http://bio2rdf.org/drugbank_resource:4d6d8a0bb0437361e22c5fbaf04819ea>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:6f3fc4bb7965f22f3fc655ec5e1faab0> .
<http://bio2rdf.org/drugbank_resource:fa8e5850916f505d7329bb36ce55c161>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:87f0fe251ba4940236c1e30de121922a>	<http://www.w3.org/2000/01/rdf-schema#label>	"Fatty amides [drugbank_resource:87f0fe251ba4940236c1e30de121922a]"@en .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:5ac86da3649163846e9e9d65b58c49fc> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-24>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Bioavailability> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-25>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00117-25"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:4d9d641daef8c178a249f1266f1150e5>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-18>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:H-Bond-Acceptor-Count> .
<http://bio2rdf.org/drugbank_resource:19d3289105c9a843a041cb4f7a0883a1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank_resource:1cb2d5b9df573a57849083d75e49a5fe>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:5eace972d6db7e2d3395f1ce1f56c40a> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:42e21c05e96b3040136e54dfed4bf794> .
<http://bio2rdf.org/drugbank_resource:f7f0a15346b2f02764550cb8d9f8ef30>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:c51b5b3f72bf15f717f23f1fdda6fe44>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:1059233feb371b14b03a21571fa19968>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Mechanism-of-action> .
<http://bio2rdf.org/drugbank_resource:eb23978cb768321237553e12616e3b84>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:eb23978cb768321237553e12616e3b84"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:4dcb2d242a80267002194ce81be5670e>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-3>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:0e708564ecff800b67a0d210bc03042c>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00118-1>	<http://www.w3.org/2000/01/rdf-schema#label>	"Boiling Point: 78 \u00B0C [drugbank_resource:experimental-properties-DB00118-1]"@en .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:408e99a507da89ecb16b006481be4f7d> .
<http://bio2rdf.org/drugbank_resource:f84c0f373fd98f4297607f206aadd302>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"BE0002793"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:0e7611deb0124f99ac54f3684b112d25>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-4>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Formula: C2306H3594N610O694S26 [drugbank_resource:experimental-properties-DB00092-4]"@en .
<http://bio2rdf.org/drugbank_resource:1c7495e7ba342d224b5028d72d73010d>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:5d2074ef1500127ada3cef721a746c89> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-25>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Bioavailability> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-5>	<http://bio2rdf.org/drugbank_vocabulary:value>	"5.81e-03 g/l"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-13>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:122193da65e00a63d46700928a244018>	<http://www.w3.org/2000/01/rdf-schema#label>	"Human Immunodeficiency Virus [drugbank_vocabulary:122193da65e00a63d46700928a244018]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-10>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Monoisotopic-Weight> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-14>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:half-life>	<http://bio2rdf.org/drugbank_resource:0e708564ecff800b67a0d210bc03042c> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-15>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:1c54727b6a9a48b74b53723fbee43d80>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:1c54727b6a9a48b74b53723fbee43d80"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:96b90ed2d49ca40e5c82fd787db32b84>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"96b90ed2d49ca40e5c82fd787db32b84"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00091-1>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00091-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-7>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:IUPAC-Name> .
<http://bio2rdf.org/drugbank:DB00111>	<http://bio2rdf.org/drugbank_vocabulary:half-life>	<http://bio2rdf.org/drugbank_resource:1f87ebefeca8e494680a6a81334c6078> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-16>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-12>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Formula> .
<http://bio2rdf.org/drugbank:BE0000456>	<http://bio2rdf.org/drugbank_vocabulary:gene-sequence>	">753 bp\nATGGCTGTGTGCGGCCTGGGGAGCCGTCTTGGCCTGGGGAGCCGTCTTGGCCTGCGCGGG\nTGCTTCGGCGCCGCCAGGCTCCTGTATCCCCGTTTCCAGAGCCGCGGCCCTCAGGGCGTG\nGAAGACGGGGACAGGCCACAGCCTTCCTCGAAGACACCCAGGATCCCCAAGATTTACACC\nAAAACGGGAGACAAAGGGTTTTCTAGTACCTTCACAGGAGAAAGGAGACCCAAAGATGAC\nCAAGTGTTTGAAGCCGTGGGAACTACAGATGAATTAAGTTCAGCTATTGGGTTTGCTCTG\nGAATTAGTCACAGAAAAGGGCCATACATTTGCCGAAGAGCTTCAGAAAATCCAGTGCACA\nTTGCAGGACGTCGGCTCGGCCCTGGCGACACCATGCTCCTCGGCCCGGGAGGCTCACTTA\nAAGTATACCACGTTCAAGGCGGGGCCCATCCTGGAGCTGGAGCAGTGGATCGACAAGTAC\nACCAGCCAGCTCCCACCACTCACGGCCTTCATCCTGCCTTCGGGAGGCAAGATCAGCTCG\nGCGCTGCATTTCTGCCGGGCCGTGTGCCGCCGGGCCGAGAGACGTGTGGTGCCTCTTGTC\nCAGATGGGAGAGACCGATGCGAACGTGGCCAAGTTCTTAAACAGACTCAGTGACTATCTC\nTTCACGCTAGCCAGATATGCAGCCATGAAGGAGGGGAATCAAGAGAAAATATACATGAAA\nAATGACCCATCGGCCGAGTCTGAGGGACTCTGA"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:195ccf935d3c9947bcc17b096fdca329> .
<http://bio2rdf.org/drugbank_resource:1059233feb371b14b03a21571fa19968>	<http://www.w3.org/2000/01/rdf-schema#label>	"mechanism-of-action for drugbank:DB00113 [drugbank_resource:1059233feb371b14b03a21571fa19968]"@en .
<http://bio2rdf.org/drugbank_resource:d025612c433b867a6ebb00b2532e2626>	<http://www.w3.org/2000/01/rdf-schema#label>	"half-life for drugbank:DB00099 [drugbank_resource:d025612c433b867a6ebb00b2532e2626]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-4>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00117-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-17>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:c7d119b1e6d46c382382c2c17e2801ac>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:c7d119b1e6d46c382382c2c17e2801ac"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a9a58af69a8539d913c65b788eb5b178>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"a9a58af69a8539d913c65b788eb5b178"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-18>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Rotatable-Bond-Count> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:036d7e3cfbf77c5f19b4baba9ff7aed2> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-18>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:indication>	<http://bio2rdf.org/drugbank_resource:131ed90e7634d72c92f27daf9a85454a> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:03746a740bf18cbf4beaae7cc5b7504f> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-19>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00089-1>	<http://www.w3.org/2000/01/rdf-schema#label>	"Melting Point: 61 \u00B0C (FAB fragment), 71 \u00B0C (whole mAb) from Vermeer, A.W.P. & Norde, W., Biophys. J. 78:394-404 (2000) [drugbank_resource:experimental-properties-DB00089-1]"@en .
<http://bio2rdf.org/drugbank_resource:14e62611474f52c8e22248963b84f59b>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-19>	<http://www.w3.org/2000/01/rdf-schema#label>	"Rotatable Bond Count: 4 from ChemAxon [drugbank_resource:calculated-properties-DB00114-19]"@en .
<http://bio2rdf.org/drugbank:DB00107>	<http://bio2rdf.org/drugbank_vocabulary:mechanism-of-action>	<http://bio2rdf.org/drugbank_resource:2af3e19f02b1eb81db93222ed2b38a44> .
<http://bio2rdf.org/drugbank_resource:131ed90e7634d72c92f27daf9a85454a>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Indication> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-20>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:47d86c7cb8687c843b27225a6715c3c1>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:07c2684a57210d1f5bc920d112d11ecd> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-2>	<http://bio2rdf.org/drugbank_vocabulary:value>	"0.209"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_vocabulary:Drug>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/2002/07/owl#Class> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-13>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:InChI> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:mechanism-of-action>	<http://bio2rdf.org/drugbank_resource:1c54727b6a9a48b74b53723fbee43d80> .
<http://bio2rdf.org/drugbank_resource:4a0d48b5f8e157c4bbcb34092d4edaf3>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00106>	<http://bio2rdf.org/drugbank_vocabulary:indication>	<http://bio2rdf.org/drugbank_resource:23e60560991f40f7f335be06f10675e1> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-10>	<http://bio2rdf.org/drugbank_vocabulary:value>	"NC1=NC(=O)C2=C(NCC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2)N1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f5f75e6bf165e0a25b8c2fab60ccf2e0>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-14>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:InChIKey> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-16>	<http://purl.org/dc/terms/title>	"Polarizability: 103.93 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:c987b0d07b89f29a364501bc29cfebc8>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:08f1295028a77909e61816add07f6343> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00089-1>	<http://purl.org/dc/terms/title>	"Melting Point: 61 \u00B0C (FAB fragment), 71 \u00B0C (whole mAb) from Vermeer, A.W.P. & Norde, W., Biophys. J. 78:394-404 (2000)"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-27>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Ghose-Filter> .
<http://bio2rdf.org/drugbank_resource:f31c373ea0d5f6b6f514f58cf30652a6>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:13bf7e351282b3c815c4b958aedb585f> .
<http://bio2rdf.org/drugbank_resource:1588f62bddb8c0b1cca8f11ce8e653b9>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00095>	<http://bio2rdf.org/drugbank_vocabulary:mechanism-of-action>	<http://bio2rdf.org/drugbank_resource:17055fe13e90f0599fe8f9fd1c90c871> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:06832c77d22e34a13e2de6990e7f3cf2> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:05261dbd457e9d2aa8254610c0f9df46> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-17>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Polarizability> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:129ef94b8ca8b89a244a3cd1c5b2c72b> .
<http://bio2rdf.org/drugbank_resource:cad41663894b5be906782be10b396e06>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:195ccf935d3c9947bcc17b096fdca329>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-16>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Refractivity> .
<http://bio2rdf.org/drugbank_resource:14e62611474f52c8e22248963b84f59b>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Manufacturer> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00110-1>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00110-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:4aaab29fd43effbe133e376c024d5f06>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-26>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00093-26"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:0d54035b86f9a43f56ecd493c3a6fd59> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-15>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Polar-Surface-Area-(PSA)> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:091b1b5a04486711c0e6615b4e552e7e> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:0d1969d27d89c3b774c942d81666c5d3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-10>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00224>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00109_DB00224"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:094779e1e90e423f19e46305ba872c9c> .
<http://bio2rdf.org/drugbank_resource:129ef94b8ca8b89a244a3cd1c5b2c72b>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-31>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-31"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-11>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-11>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:SMILES> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:0e7611deb0124f99ac54f3684b112d25> .
<http://bio2rdf.org/drugbank_resource:ec0915fa5d5da881fd812adc490bcd65>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"ec0915fa5d5da881fd812adc490bcd65"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f38592452c305d31bbbb2909013724ac>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-12>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:131ed90e7634d72c92f27daf9a85454a>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:13bf7e351282b3c815c4b958aedb585f>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:6ac630c499c16fd6e1f2a125e397688a>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"6ac630c499c16fd6e1f2a125e397688a"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:Xylonest-Octapressin>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Mixture> .
<http://bio2rdf.org/drugbank_resource:807b0e58e0eead4b875202221ebe0f53>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"807b0e58e0eead4b875202221ebe0f53"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00112>	<http://bio2rdf.org/drugbank_vocabulary:manufacturer>	<http://bio2rdf.org/drugbank_resource:14e62611474f52c8e22248963b84f59b> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-23>	<http://www.w3.org/2000/01/rdf-schema#label>	"pKa (strongest basic): 4.11 from ChemAxon [drugbank_resource:calculated-properties-DB00114-23]"@en .
<http://bio2rdf.org/pubchem.substance:46506428>	<http://purl.org/dc/terms/identifier>	"pubchem.substance:46506428"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00096>	<http://bio2rdf.org/drugbank_vocabulary:mechanism-of-action>	<http://bio2rdf.org/drugbank_resource:20aa32f603258f15ceef0ba521a5bd87> .
<http://bio2rdf.org/drugbank_resource:f2540530a3858d9fa40e7bfd96e4c77d>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:a2615bbb5710b9b992785e63c058b3db>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:01c6a15f6a299a85cd866fc4092d0dce> .
<http://bio2rdf.org/drugbank_resource:a02555c5c58332bf7ac5fef198a34814>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Indication> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:2970662836bc4a17c64d219c534d3f7e> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-20>	<http://purl.org/dc/terms/title>	"pKa (strongest acidic): 11.39 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-27>	<http://purl.org/dc/terms/title>	"Ghose Filter: 0 from ChemAxon"@en .
<http://bio2rdf.org/drugbank:DB00100>	<http://bio2rdf.org/drugbank_vocabulary:mechanism-of-action>	<http://bio2rdf.org/drugbank_resource:180176f4e85931ffb36c855eab8691da> .
<http://bio2rdf.org/drugbank_resource:f2977936270a493873be5432bb760ef7>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:a2d4a403a964b1f3a6d6fa73cb73921a>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"catalytic activity"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2619a21616645ee9827c33c6e2f65268>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-5>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00099-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:094779e1e90e423f19e46305ba872c9c>	<http://www.w3.org/2000/01/rdf-schema#label>	"Benzamide [drugbank_resource:094779e1e90e423f19e46305ba872c9c]"@en .
<http://bio2rdf.org/drugbank_resource:2696048bf20ed0e2d578eb2938c6d8d3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:22f72a952683d19d554d47d3919c10f3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:5eace972d6db7e2d3395f1ce1f56c40a>	<http://www.w3.org/2000/01/rdf-schema#label>	"Ketimines [drugbank_resource:5eace972d6db7e2d3395f1ce1f56c40a]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-4>	<http://purl.org/dc/terms/title>	"Molecular Formula: C204H301N51O64"@en .
<http://bio2rdf.org/drugbank_resource:433dda4a1117986cabe237dcf80bd242>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00113>	<http://bio2rdf.org/drugbank_vocabulary:mechanism-of-action>	<http://bio2rdf.org/drugbank_resource:1059233feb371b14b03a21571fa19968> .
<http://bio2rdf.org/drugbank_resource:f2a30f76a373192265e4b663c8339602>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:a39e93df12255155561f3d4acd297da8>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:f30bb36d9cf1cde63e806eb49b64d341>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:282d8423d2c45b369fa817ef1edbccd5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:Biotech>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/2002/07/owl#Class> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00095-1>	<http://purl.org/dc/terms/title>	"Melting Point: 61 \u00B0C (FAB fragment), 71 \u00B0C (whole mAb) from Vermeer, A.W.P. & Norde, W., Biophys. J. 78:394-404 (2000)"@en .
<http://bio2rdf.org/drugbank_resource:4f9f96147f2386295de420eed7aa9274>	<http://purl.org/dc/terms/title>	"half-life for drugbank:DB00112"@en .
<http://bio2rdf.org/drugbank:BE0000300>	<http://purl.org/dc/terms/title>	"Spermidine synthase"@en .
<http://bio2rdf.org/drugbank_resource:43ebb1f4d3ddbd9ec70fcbba40c42a45>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:285048a510ce36e96744886cc83cc631>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-27>	<http://www.w3.org/2000/01/rdf-schema#label>	"MDDR-Like Rule: 1 from ChemAxon [drugbank_resource:calculated-properties-DB00093-27]"@en .
<http://bio2rdf.org/drugbank_resource:f7f0a15346b2f02764550cb8d9f8ef30>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"f7f0a15346b2f02764550cb8d9f8ef30"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:9e044243b5eb2f95578c80df6000ecdd>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"9e044243b5eb2f95578c80df6000ecdd"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:Xylonest-Octapressin>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:Labor-Induction-Agents>	<http://purl.org/dc/terms/title>	"Labor Induction Agents"@en .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:220e1c2f3029a37a26fd263b95f90c89> .
<http://bio2rdf.org/drugbank_resource:a02555c5c58332bf7ac5fef198a34814>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-4>	<http://bio2rdf.org/drugbank_vocabulary:value>	"25719.7"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:433dda4a1117986cabe237dcf80bd242>	<http://purl.org/dc/terms/title>	"Alkyl phosphate"@en .
<http://bio2rdf.org/drugbank_resource:24189bc5fb16bfce4551ecdfb0196def>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank_resource:451abb4a53a3d4bc5e17cc485a3899b3>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:220e1c2f3029a37a26fd263b95f90c89>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:DB00099_DB01030>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:DB00099_DB01030"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:1fc54dd8ec20644e59a52e0b31197dd9> .
<http://bio2rdf.org/drugbank_resource:450004b6cb1a30c3690aa11d2cd941a2>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:246c82890dc31bdd6e899b6c63a0f254>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:433dda4a1117986cabe237dcf80bd242>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:433dda4a1117986cabe237dcf80bd242"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:225393798d1f4d7a00af1d777e454e22>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:a2d4a403a964b1f3a6d6fa73cb73921a>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Mechanism-of-action> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:indication>	<http://bio2rdf.org/drugbank_resource:17b27330dfdb2b245beadb493e911ddb> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:051943c0db4f9d17f7dfc49f7bb4329a> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"catalytic activity"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00090>	<http://bio2rdf.org/drugbank_vocabulary:half-life>	<http://bio2rdf.org/drugbank_resource:29ad2163821ce9d547ef52b7bddcf404> .
<http://bio2rdf.org/drugbank_resource:ade41ed0b3f8ac2b059fa8aeb0cdbbb4>	<http://www.w3.org/2000/01/rdf-schema#label>	"mechanism-of-action for drugbank:DB00117 [drugbank_resource:ade41ed0b3f8ac2b059fa8aeb0cdbbb4]"@en .
<http://bio2rdf.org/drugbank:DB00116>	<http://purl.org/dc/terms/title>	"Tetrahydrofolic acid"@en .
<http://bio2rdf.org/drugbank_resource:cad41663894b5be906782be10b396e06>	<http://purl.org/dc/terms/title>	"Aminobenzamides"@en .
<http://bio2rdf.org/drugbank_resource:2df9c46833999f4cf9a8383d1003158e>	<http://purl.org/dc/terms/title>	"Pyridine carboxaldehydes"@en .
<http://bio2rdf.org/drugbank_resource:a5a6248bbc8b4dd7520b62e64aa85462>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"catalytic activity"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:003185d1d24af95f95de2d64dd76ed33>	<http://purl.org/dc/terms/title>	"indication for drugbank:DB00112"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-22>	<http://www.w3.org/2000/01/rdf-schema#label>	"pKa (strongest basic): 1.94 from ChemAxon [drugbank_resource:calculated-properties-DB00091-22]"@en .
<http://bio2rdf.org/drugbank_resource:14e62611474f52c8e22248963b84f59b>	<http://purl.org/dc/terms/title>	"manufacturer for drugbank:DB00112"@en .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"catalytic activity"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-12>	<http://purl.org/dc/terms/title>	"InChI: InChI=1S/C15H22N6O5S/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/p+1/t7-,8+,10+,11+,14+,27?/m0/s1 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:4dcb2d242a80267002194ce81be5670e>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"4dcb2d242a80267002194ce81be5670e"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:22baeb726de652a99f0ad2fb61fac832>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:1cb959cb5d30e328a863a3d9f64c120a> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:22baeb726de652a99f0ad2fb61fac832> .
<http://bio2rdf.org/drugbank_resource:a61e3adec088927f97197e2f1513790d>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:42e21c05e96b3040136e54dfed4bf794>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:1fc54dd8ec20644e59a52e0b31197dd9>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:2af3e19f02b1eb81db93222ed2b38a44>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:a595cc1c66cf7314ca9d50542e429c85>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Mechanism-of-action> .
<http://bio2rdf.org/drugbank:DB00112>	<http://bio2rdf.org/drugbank_vocabulary:indication>	<http://bio2rdf.org/drugbank_resource:003185d1d24af95f95de2d64dd76ed33> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:22f72a952683d19d554d47d3919c10f3> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:225393798d1f4d7a00af1d777e454e22> .
<http://bio2rdf.org/drugbank_resource:a6302cf127669e87e24a75b24552a9e8>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:a57533055c136af9a471684ba442d058>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Manufacturer> .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/drugbank_vocabulary:theoretical-pi>	"7.42"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_vocabulary:705836a5549e0548d20a0ef04e009f28>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:705836a5549e0548d20a0ef04e009f28"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a6317c6254a0737c350d2f0860ea1ec3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:b508d1a45927588b684b5a6fd80aff2b>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:b508d1a45927588b684b5a6fd80aff2b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:fa342aed686575ef39a8ec9dc16cbab4>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"fa342aed686575ef39a8ec9dc16cbab4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3f34afd99cc9695ee26d778d111874cf>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00105>	<http://bio2rdf.org/drugbank_vocabulary:mechanism-of-action>	<http://bio2rdf.org/drugbank_resource:00199edd2aba5de431eaa55bda5406d7> .
<http://bio2rdf.org/drugbank_resource:3eff294ae1a633c8845359753061fac9>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:indication>	<http://bio2rdf.org/drugbank_resource:0d47651b62c008d202fcec19e0c3b7c7> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:246c82890dc31bdd6e899b6c63a0f254> .
<http://bio2rdf.org/drugbank:DB00103>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:24189bc5fb16bfce4551ecdfb0196def> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:282d8423d2c45b369fa817ef1edbccd5> .
<http://bio2rdf.org/drugbank_resource:d2b048fbf48d0ab62b1014e2b38c72e9>	<http://purl.org/dc/terms/title>	"indication for drugbank:DB00116"@en .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:2619a21616645ee9827c33c6e2f65268> .
<http://bio2rdf.org/drugbank_resource:405bc988f44cffeeb0d7149d00e5918b>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:246c82890dc31bdd6e899b6c63a0f254> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-1>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00111-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:246c82890dc31bdd6e899b6c63a0f254> .
<http://bio2rdf.org/drugbank_resource:3f54718d1deb0dbafe47e6e45eda5914>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:c254aba7ca3db4f83cda45b27adb5b2b>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:c254aba7ca3db4f83cda45b27adb5b2b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:amino-acid-sequence>	">Cytochrome P450 2D6\nMGLEALVPLAVIVAIFLLLVDLMHRRQRWAARYPPGPLPLPGLGNLLHVDFQNTPYCFDQ\nLRRRFGDVFSLQLAWTPVVVLNGLAAVREALVTHGEDTADRPPVPITQILGFGPRSQGVF\nLARYGPAWREQRRFSVSTLRNLGLGKKSLEQWVTEEAACLCAAFANHSGRPFRPNGLLDK\nAVSNVIASLTCGRRFEYDDPRFLRLLDLAQEGLKEESGFLREVLNAVPVLLHIPALAGKV\nLRFQKAFLTQLDELLTEHRMTWDPAQPPRDLTEAFLAEMEKAKGNPESSFNDENLRIVVA\nDLFSAGMVTTSTTLAWGLLLMILHPDVQRRVQQEIDDVIGQVRRPEMGDQAHMPYTTAVI\nHEVQRFGDIVPLGVTHMTSRDIEVQGFRIPKGTTLITNLSSVLKDEAVWEKPFRFHPEHF\nLDAQGHFVKPEAFLPFSAGRRACLGEPLARMELFLFFTSLLQHFSFSVPTGQPRPSHHGV\nFAFLVSPSPYELCAVPR"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:408e99a507da89ecb16b006481be4f7d>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:2970662836bc4a17c64d219c534d3f7e>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-1>	<http://www.w3.org/2000/01/rdf-schema#label>	"Melting Point: 61 \u00B0C (FAB fragment), 71 \u00B0C (whole mAb) from Vermeer, A.W.P. & Norde, W., Biophys. J. 78:394-404 (2000) [drugbank_resource:experimental-properties-DB00111-1]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-4>	<http://www.w3.org/2000/01/rdf-schema#label>	"logS: -5.3 from ALOGPS [drugbank_resource:calculated-properties-DB00091-4]"@en .
<http://bio2rdf.org/drugbank_resource:1cb959cb5d30e328a863a3d9f64c120a>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:069ab916580192548ff172f164a424bf>	<http://www.w3.org/2000/01/rdf-schema#label>	"absorption for drugbank:DB00117 [drugbank_resource:069ab916580192548ff172f164a424bf]"@en .
<http://bio2rdf.org/drugbank_resource:372918cb5733e55c6d5baa7bc6f4a30c>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"372918cb5733e55c6d5baa7bc6f4a30c"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a57533055c136af9a471684ba442d058>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-8>	<http://purl.org/dc/terms/title>	"Molecular Weight: 445.4292 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:2af3e19f02b1eb81db93222ed2b38a44>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Mechanism-of-action> .
<http://bio2rdf.org/drugbank_resource:a6317c6254a0737c350d2f0860ea1ec3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Indication> .
<http://bio2rdf.org/drugbank_resource:a595cc1c66cf7314ca9d50542e429c85>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00112>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:285048a510ce36e96744886cc83cc631> .
<http://bio2rdf.org/drugbank_resource:3afc1cd15f9de2a07db0081098265ac4>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:29ad2163821ce9d547ef52b7bddcf404>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:1f87ebefeca8e494680a6a81334c6078>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Half-life> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:0f798f4d70ca79c6d20f50856c6d9d11> .
<http://bio2rdf.org/drugbank_resource:a5a6248bbc8b4dd7520b62e64aa85462>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_vocabulary:Vitamin-B-Complex>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"Vitamin-B-Complex"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:5eace972d6db7e2d3395f1ce1f56c40a>	<http://purl.org/dc/terms/title>	"Ketimines"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-9>	<http://bio2rdf.org/drugbank_vocabulary:value>	"1202.61"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:627446b31de3941cb82db7d08189b597>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:627446b31de3941cb82db7d08189b597"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:0e7611deb0124f99ac54f3684b112d25> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-2>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00103-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:6826daa495527ec54b81079e04e89d24>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00103>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:1c7495e7ba342d224b5028d72d73010d> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:clearance>	<http://bio2rdf.org/drugbank_resource:2696048bf20ed0e2d578eb2938c6d8d3> .
<http://bio2rdf.org/drugbank_resource:2a828069e3c5a4b098468f8a2091e89f>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:228bf0dff0e17c650e98e541c5291e94>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Absorption> .
<http://bio2rdf.org/drugbank_resource:c007cc919bf71767e61e0b111723c84f>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"c007cc919bf71767e61e0b111723c84f"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3c77091e1ee2397a2767e73267a25af5>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-20>	<http://www.w3.org/2000/01/rdf-schema#label>	"pKa (strongest acidic): 3.51 from ChemAxon [drugbank_resource:calculated-properties-DB00116-20]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-5>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Formula: C42H65N11O12S2 [drugbank_resource:experimental-properties-DB00094-5]"@en .
<http://bio2rdf.org/drugbank_resource:3d51d314e6796004243d124d2c5f0793>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-5>	<http://www.w3.org/2000/01/rdf-schema#label>	"logP: -5.3 from ChemAxon [drugbank_resource:calculated-properties-DB00118-5]"@en .
<http://bio2rdf.org/drugbank_resource:1fc54dd8ec20644e59a52e0b31197dd9>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:07769f07381a36b9cbc482dc6db9e40d> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-18>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00118-18"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:96b90ed2d49ca40e5c82fd787db32b84>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:96b90ed2d49ca40e5c82fd787db32b84"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ea9490984599c557a86db10a8e93e890>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:ea9490984599c557a86db10a8e93e890"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2a828069e3c5a4b098468f8a2091e89f>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank_resource:4d9d641daef8c178a249f1266f1150e5>	<http://www.w3.org/2000/01/rdf-schema#label>	"mechanism-of-action for drugbank:DB00103 [drugbank_resource:4d9d641daef8c178a249f1266f1150e5]"@en .
<http://bio2rdf.org/drugbank:DB00094>	<http://bio2rdf.org/drugbank_vocabulary:mechanism-of-action>	<http://bio2rdf.org/drugbank_resource:0235e5251bcfc61913eb18c0fab6a1c4> .
<http://bio2rdf.org/drugbank_resource:e39dd3e5ddfc2038fa77efd8d6d5305d>	<http://purl.org/dc/terms/title>	"absorption for drugbank:DB00118"@en .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:13bf7e351282b3c815c4b958aedb585f> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-1>	<http://www.w3.org/2000/01/rdf-schema#label>	"Melting Point: 55 \u00B0C from Forastieri, H., Ingham, K.C. J. Biol. Chem. 257:7976-7981 (1982) [drugbank_resource:experimental-properties-DB00097-1]"@en .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:03746a740bf18cbf4beaae7cc5b7504f> .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:39094d4a5017cb7945c3ca22e421306d>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:a6302cf127669e87e24a75b24552a9e8>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank_resource:38b20638a91b63e0378b18fb8d8f4c38>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:20aa32f603258f15ceef0ba521a5bd87>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-4>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00115-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:gene-sequence>	">2133 bp\nATGCTGTCCTTCCAGTACCCCGACGTGTACCGCGACGAGACCGCCGTACAGGATTATCAT\nGGTCATAAAATTTGTGACCCTTACGCCTGGCTTGAAGACCCCGACAGTGAACAGACTAAG\nGCCTTTGTGGAGGCCCAGAATAAGATTACTGTGCCATTTCTTGAGCAGTGTCCCATCAGA\nGGTTTATACAAAGAGAGAATGACTGAACTATATGATTATCCCAAGTATAGTTGCCACTTC\nAAGAAAGGAAAACGGTATTTTTATTTTTACAATACAGGTTTGCAGAACCAGCGAGTATTA\nTATGTACAGGATTCCTTAGAGGGGGAGGCCAGAGTGTTCCTGGACCCCAACATACTGTCT\nGACGATGGCACAGTGGCACTCCGAGGTTATGCGTTCAGCGAAGATGGTGAATATTTTGCC\nTATGGTCTGAGTGCCAGTGGCTCAGACTGGGTGACAATCAAGTTCATGAAAGTTGATGGT\nGCCAAAGAGCTTCCAGATGTGCTTGAAAGAGTCAAGTTCAGCTGTATGGCCTGGACCCAT\nGATGGGAAGGGAATGTTCTACAACTCATACCCTCAACAGGATGGAAAAAGTGATGGCACA\nGAGACATCTACCAATCTCCACCAAAAGCTCTACTACCATGTCTTGGGAACCGATCAGTCA\nGAAGATATTTTGTGTGCTGAGTTTCCTGATGAACCTAAATGGATGGGTGGAGCTGAGTTA\nTCTGATGATGGCCGCTATGTCTTGTTATCAATAAGGGAAGGATGTGATCCAGTAAACCGA\nCTCTGGTACTGTGACCTACAGCAGGAATCCAGTGGCATCGCGGGAATCCTGAAGTGGGTA\nAAACTGATTGACAACTTTGAAGGGGAATATGACTACGTGACCAATGAGGGGACGGTGTTC\nACATTCAAGACGAATCGCCAGTCTCCCAACTATCGCGTGATCAACATTGACTTCTGGGAT\nCCTGAAGAGTCTAAGTGGAAAGTACTTGTTCCTGAGCATGAGAAAGATGTCTTAGAATGG\nATAGCTTGTGTCAGGTCCAACTTCTTGGTCTTATGCTACCTCCATGACGTCAAGAACATT\nCTGCAGCTCCATGACCTGACTACTGGTGCTCTCCTTAAGACCTTCCCGCTCGATGTCGGC\nAGCATTGTAGGGTACAGCGGTCAGAAGAAGGACACTGAAATCTTCTATCAGTTTACTTCC\nTTTTTATCTCCAGGTATCATTTATCACTGTGATCTTACCAAAGAGGAGCTGGAGCCAAGA\nGTTTTCCGAGAGGTGACCGTAAAAGGAATTGATGCTTCTGATTACCAGACAGTCCAGATT\nTTCTACCCTAGCAAGGATGGTACGAAGATTCCAATGTTCATTGTGCATAAAAAAGGCATA\nAAATTGGATGGCTCTCATCCAGCTTTCTTATATGGCTATGGCGGCTTCAACATATCCATC\nACACCCAACTACAGTGTTTCCAGGCTTATTTTTGTGAGACACATGGGTGGTATCCTGGCA\nGTGGCCAACATCAGAGGAGGTGGCGAATATGGAGAGACGTGGCATAAAGGTGGTATCTTG\nGCCAACAAACAAAACTGCTTTGATGACTTTCAGTGTGCTGCTGAGTATCTGATCAAGGAA\nGGTTACACATCTCCCAAGAGGCTGACTATTAATGGAGGTTCAAATGGAGGCCTCTTAGTG\nGCTGCTTGTGCAAATCAGAGACCTGACCTCTTTGGTTGTGTTATTGCCCAAGTTGGAGTA\nATGGACATGCTGAAGTTTCATAAATATACCATCGGCCATGCTTGGACCACTGATTATGGG\nTGCTCGGACAGCAAACAACACTTTGAATGGCTTGTCAAATACTCTCCATTGCATAATGTG\nAAGTTACCAGAAGCAGATGACATCCAGTACCCGTCCATGCTGCTCCTCACTGCTGACCAT\nGATGACCGCGTGGTCCCGCTTCACTCCCTGAAGTTCATTGCCACCCTTCAGTACATCGTG\nGGCCGCAGCAGGAAGCAAAGCAACCCCCTGCTTATCCACGTGGACACCAAGGCGGGCCAC\nGGGGCGGGGAAGCCCACAGCCAAAGTGATAGAGGAAGTCTCAGACATGTTTGCGTTCATC\nGCGCGGTGCCTGAATGTCGACTGGATTCCATAA"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00110>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:19d3289105c9a843a041cb4f7a0883a1> .
<http://bio2rdf.org/drugbank_resource:405bc988f44cffeeb0d7149d00e5918b>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:405bc988f44cffeeb0d7149d00e5918b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a61e3adec088927f97197e2f1513790d>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-1>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00088-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00114>	<http://purl.org/dc/terms/description>	"This is the active form of vitamin B6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (pyridoxamine). [PubChem]"@en .
<http://bio2rdf.org/drugbank_resource:807b0e58e0eead4b875202221ebe0f53>	<http://www.w3.org/2000/01/rdf-schema#label>	"500 ug Spray form with nasal route [drugbank_resource:807b0e58e0eead4b875202221ebe0f53]"@en .
<http://bio2rdf.org/drugbank:DB00097>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:2a828069e3c5a4b098468f8a2091e89f> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00093-1>	<http://www.w3.org/2000/01/rdf-schema#label>	"Melting Point: 222 from Boissonnas, R.and Guttmann, S.; U.S. Patent 3,232,923; February 1, 1966: assigned to Sandoz AG, Switzerland. [drugbank_resource:experimental-properties-DB00093-1]"@en .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:1cb2d5b9df573a57849083d75e49a5fe> .
<http://bio2rdf.org/drugbank:DB00105>	<http://purl.org/dc/terms/identifier>	"drugbank:DB00105"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2970662836bc4a17c64d219c534d3f7e>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_vocabulary:8550beb9aaabcff323bdfeef04608bb8>	<http://bio2rdf.org/drugbank_vocabulary:name>	"Plenaxis"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:23e60560991f40f7f335be06f10675e1>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"23e60560991f40f7f335be06f10675e1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:1cb959cb5d30e328a863a3d9f64c120a>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:x-genbank>	<http://bio2rdf.org/genbank:M20403> .
<http://bio2rdf.org/drugbank_resource:DB00115_DB00446>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:DB00115_DB00446"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3669e274097fc69149d3dbad3ba6b01c>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00107>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:1588f62bddb8c0b1cca8f11ce8e653b9> .
<http://bio2rdf.org/drugbank:DB00107>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:DB00107"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:ffb414ea32db58bec7ec3339a42c9dee>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:ffb414ea32db58bec7ec3339a42c9dee"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3669e274097fc69149d3dbad3ba6b01c>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"3669e274097fc69149d3dbad3ba6b01c"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00107_DB00917>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00107_DB00917"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pubchem.substance:46504756>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/pubchem.substance:46504756"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:36cf3fe3b4f939b051085b627e517597>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:366d45e2564940d9162a27ad0e9e3571>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:3732893325a7ecb9126a15736796f117>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:e6fc137e236497aea65dd3bb99d52e53>	<http://www.w3.org/2000/01/rdf-schema#label>	"25 mg Capsule form with oral route [drugbank_resource:e6fc137e236497aea65dd3bb99d52e53]"@en .
<http://bio2rdf.org/drugbank_resource:29ad2163821ce9d547ef52b7bddcf404>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Half-life> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-7>	<http://bio2rdf.org/drugbank_vocabulary:value>	"felypressin"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:1f87ebefeca8e494680a6a81334c6078>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0000456>	<http://bio2rdf.org/drugbank_vocabulary:transmembrane-regions>	"None"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-13>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00115-13"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:20aa32f603258f15ceef0ba521a5bd87>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Mechanism-of-action> .
<http://bio2rdf.org/drugbank_resource:372918cb5733e55c6d5baa7bc6f4a30c>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-12>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00118-12"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Enzyme> .
<http://bio2rdf.org/drugbank_resource:376c6e6cad258f51a802ccce8c53ca4c>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:2619a21616645ee9827c33c6e2f65268>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:75aa077303c09d80af404a7a6c6ac735>	<http://purl.org/dc/terms/title>	"300 ug/.5mL Injection, solution form with subcutaneous route"@en .
<http://bio2rdf.org/drugbank_resource:22f72a952683d19d554d47d3919c10f3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:Hematopoietic-Agents>	<http://purl.org/dc/terms/title>	"Hematopoietic Agents"@en .
<http://bio2rdf.org/drugbank_vocabulary:Supplements>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"Supplements"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Hematopoietic-Agents>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:Hematopoietic-Agents"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-8>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00093-8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a5a6248bbc8b4dd7520b62e64aa85462>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:a5a6248bbc8b4dd7520b62e64aa85462"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Gonadotropins>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:Gonadotropins"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Resource>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/2002/07/owl#Class> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-15>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00114-15"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a39e93df12255155561f3d4acd297da8>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank_resource:23e60560991f40f7f335be06f10675e1>	<http://www.w3.org/2000/01/rdf-schema#label>	"indication for drugbank:DB00106 [drugbank_resource:23e60560991f40f7f335be06f10675e1]"@en .
<http://bio2rdf.org/drugbank_resource:53ca67aedcd10f1c9afc4de0f2138502>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"53ca67aedcd10f1c9afc4de0f2138502"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:282d8423d2c45b369fa817ef1edbccd5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:14e62611474f52c8e22248963b84f59b>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#value>	"Roche Pharmaceuticals"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:64789d808f73ebe8eac3dbded4a95da0>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:913e4e077c76fcc7c941f5fbedf4db30>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:913e4e077c76fcc7c941f5fbedf4db30"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:23e60560991f40f7f335be06f10675e1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00114-2>	<http://purl.org/dc/terms/title>	"Melting Point: 255 \u00B0C from PhysProp"@en .
<http://bio2rdf.org/drugbank_resource:3549163466db2fa5b979545848c2ef00>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-19>	<http://www.w3.org/2000/01/rdf-schema#label>	"H Bond Donor Count: 5 from ChemAxon [drugbank_resource:calculated-properties-DB00118-19]"@en .
<http://bio2rdf.org/drugbank_resource:24189bc5fb16bfce4551ecdfb0196def>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-1>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-2>	<http://purl.org/dc/terms/title>	"Isoelectric Point: 4.30"@en .
<http://bio2rdf.org/drugbank_resource:220e1c2f3029a37a26fd263b95f90c89>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:a2615bbb5710b9b992785e63c058b3db>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-13>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00093-13"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:246c82890dc31bdd6e899b6c63a0f254>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:225393798d1f4d7a00af1d777e454e22>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00097>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00097"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:285048a510ce36e96744886cc83cc631>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank_resource:328c87b1ad60e7356c52d11e15011e6f>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-10>	<http://bio2rdf.org/drugbank_vocabulary:value>	"247.142"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:228bf0dff0e17c650e98e541c5291e94>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:ae0431719c906d80aa97a27025adc99f>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0000300>	<http://bio2rdf.org/drugbank_vocabulary:name>	"Spermidine synthase"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ae52c40c7c1761e3027e159477756625>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:23e60560991f40f7f335be06f10675e1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Indication> .
<http://bio2rdf.org/drugbank_vocabulary:Small-molecule>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/2002/07/owl#Class> .
<http://bio2rdf.org/drugbank_resource:8f7450a053d86ee89751c06a230561d0>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:8f7450a053d86ee89751c06a230561d0"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:22baeb726de652a99f0ad2fb61fac832>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:3314d6a38b90d6a9ef0419bc7224913d>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:450004b6cb1a30c3690aa11d2cd941a2>	<http://purl.org/dc/terms/description>	"Readily absorbed in the lower half of the ileum."@en .
<http://bio2rdf.org/drugbank_resource:2696048bf20ed0e2d578eb2938c6d8d3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Clearance> .
<http://bio2rdf.org/drugbank:BE0000456>	<http://bio2rdf.org/drugbank_vocabulary:theoretical-pi>	"8.78"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:ae0431719c906d80aa97a27025adc99f>	<http://www.w3.org/2000/01/rdf-schema#label>	"Metallotetrapyrroles [drugbank_resource:ae0431719c906d80aa97a27025adc99f]"@en .
<http://bio2rdf.org/drugbank_resource:DB00109_DB06290>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00109_DB06290"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-3>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00091-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ade41ed0b3f8ac2b059fa8aeb0cdbbb4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Mechanism-of-action> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-3>	<http://bio2rdf.org/drugbank_vocabulary:value>	"5.99"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:246c82890dc31bdd6e899b6c63a0f254>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"246c82890dc31bdd6e899b6c63a0f254"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2df9c46833999f4cf9a8383d1003158e>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:2df9c46833999f4cf9a8383d1003158e"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:1cb959cb5d30e328a863a3d9f64c120a>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:1cb959cb5d30e328a863a3d9f64c120a"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-7>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-3>	<http://bio2rdf.org/drugbank_vocabulary:value>	"-4.4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:31af673f5d82841086059243563cd4c6>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-1>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-18>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-18"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-3>	<http://www.w3.org/2000/01/rdf-schema#label>	"logP: -3.32 from CHMELIK,J ET AL. (1991) [drugbank_resource:experimental-properties-DB00117-3]"@en .
<http://bio2rdf.org/drugbank_resource:3181b99b434a8db59d197070956de3d9>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-1>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00099-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://www.w3.org/2000/01/rdf-schema#label>	"Cyanocobalamin [drugbank:DB00115]"@en .
<http://bio2rdf.org/drugbank_resource:a9a65e43cdc103a1f769c3625b080c1d>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:ad715d0a2b2bcdcad22b975675537588>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://www.w3.org/2000/01/rdf-schema#label>	"Cytochrome P450 2C8 [drugbank:BE0002887]"@en .
<http://bio2rdf.org/drugbank_vocabulary:Drug>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:DB00103_DB00608>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00103_DB00608"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:762a7c535540c35c3ec0a9932635da58>	<http://purl.org/dc/terms/title>	"absorption for drugbank:DB00106"@en .
<http://bio2rdf.org/drugbank_resource:ad9e59297973dcc097c2400d81b7888b>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:a9ee55eb5c1344c6ecd656006a4e92f2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-3>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00116-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"CYPIIC9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:aa57c62e2e58943f3ce466339bbf00eb>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-17>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:2ec24002f6e3cb0430a51468ee1d26da>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:ade41ed0b3f8ac2b059fa8aeb0cdbbb4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-21>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-21"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-18>	<http://purl.org/dc/terms/title>	"Bioavailability: 0 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-16>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-3>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Formula: C6538H10034N1716O2033S44 [drugbank_resource:experimental-properties-DB00112-3]"@en .
<http://bio2rdf.org/drugbank_resource:5c103a2b0c3fce1acc1c2e135c6684bf>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:5c103a2b0c3fce1acc1c2e135c6684bf"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00102>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00102"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-14>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-14"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-15>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:fa8e5850916f505d7329bb36ce55c161>	<http://purl.org/dc/terms/title>	"Corrinoids"@en .
<http://bio2rdf.org/drugbank_resource:e6fa8c632405b98301de119a72894c49>	<http://www.w3.org/2000/01/rdf-schema#label>	"Monoalkylamines [drugbank_resource:e6fa8c632405b98301de119a72894c49]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-1>	<http://purl.org/dc/terms/title>	"Melting Point: 54 \u00B0C from Link, R.P., Castellino, F.J. Arch. Biochem. Biophsy. 227:259-265 (1983)"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-14>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:DB00103_DB01118>	<http://purl.org/dc/terms/title>	"DDI between Agalsidase beta and Amiodarone - May diminish the therapeutic effect of Agalsidase Beta."@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-20>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-4>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00102-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-21>	<http://www.w3.org/2000/01/rdf-schema#label>	"pKa (strongest basic): 9.41 from ChemAxon [drugbank_resource:calculated-properties-DB00118-21]"@en .
<http://bio2rdf.org/drugbank_resource:fa8e5850916f505d7329bb36ce55c161>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"fa8e5850916f505d7329bb36ce55c161"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fba31fe582cac619f85335c144278e17>	<http://purl.org/dc/terms/title>	"100 mg Capsule form with oral route"@en .
<http://bio2rdf.org/drugbank_resource:b508d1a45927588b684b5a6fd80aff2b>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:30d0083606d3fa4b4b602b5d3ed0feda>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-22>	<http://www.w3.org/2000/01/rdf-schema#label>	"H Bond Acceptor Count: 4 from ChemAxon [drugbank_resource:calculated-properties-DB00117-22]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-4>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00107-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:d8c37e1ee64fc7f014205837681e99df>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-14>	<http://www.w3.org/2000/01/rdf-schema#label>	"InChI: InChI=1S/C8H10NO6P/c1-5-8(11)7(3-10)6(2-9-5)4-15-16(12,13)14/h2-3,11H,4H2,1H3,(H2,12,13,14) from ChemAxon [drugbank_resource:calculated-properties-DB00114-14]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-19>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-2>	<http://bio2rdf.org/drugbank_vocabulary:value>	"-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:abc4b12d5153eba9af71c2c651bd4ff1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Absorption> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-24>	<http://purl.org/dc/terms/title>	"Bioavailability: 0 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:2c7d5048f3ab623475c1e9c503997a85>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-18>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:8683be48baa0e7d62758aed2d9ccf431>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"8683be48baa0e7d62758aed2d9ccf431"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a57533055c136af9a471684ba442d058>	<http://purl.org/dc/terms/title>	"manufacturer for drugbank:DB00093"@en .
<http://bio2rdf.org/drugbank_resource:a9516c15b2a67882efd5c7a4c1fa6de4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-9>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-10>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00114-10"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:x-uniprot>	<http://bio2rdf.org/uniprot:CP3A7_HUMAN> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-3>	<http://www.w3.org/2000/01/rdf-schema#label>	"Isoelectric Point: 8.61 [drugbank_resource:experimental-properties-DB00097-3]"@en .
<http://bio2rdf.org/drugbank_resource:2d6f2db0443dc24ac01149b8df7afb05>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:96b90ed2d49ca40e5c82fd787db32b84>	<http://purl.org/dc/terms/title>	"N-substituted imidazole"@en .
<http://bio2rdf.org/drugbank_resource:2c808757b9d5f22f13a70bae1f9e7737>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-7>	<http://purl.org/dc/terms/title>	"logP: -2.1 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:b15aa7d1fbce9f1563623833e416d8f7>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:2ddeeca2fe9449969ab1519d768237c6>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB01268>	<http://purl.org/dc/terms/title>	"DDI between Bevacizumab and Sunitinib - May enhance the adverse/toxic effect of Bevacizumab. Specifically, the risk for a specific form of anemia, microangiopathic hemolytic anemia (MAHA), may be increased. Bevacizumab may enhance the hypertensive effect of SUNItinib."@en .
<http://bio2rdf.org/drugbank:BE0000300>	<http://bio2rdf.org/drugbank_vocabulary:transmembrane-regions>	"None"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2d76fb5dd0f39b41fe92dc87dd6a96d9>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-13>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:627446b31de3941cb82db7d08189b597>	<http://www.w3.org/2000/01/rdf-schema#label>	"Benzimidazoles [drugbank_resource:627446b31de3941cb82db7d08189b597]"@en .
<http://bio2rdf.org/drugbank_resource:76cc7a41e93863bcbab0bba32bc52311>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:76cc7a41e93863bcbab0bba32bc52311"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:451abb4a53a3d4bc5e17cc485a3899b3>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:451abb4a53a3d4bc5e17cc485a3899b3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:627446b31de3941cb82db7d08189b597>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"627446b31de3941cb82db7d08189b597"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-12>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:a8454a4c3a73e4a65b3965d9947cc4bd>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank_resource:e91ecbd8702c2bd53755e648fa5c9435>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:e91ecbd8702c2bd53755e648fa5c9435"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a7531086765fedefe82e0282f7a1d559>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-11>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:2df9c46833999f4cf9a8383d1003158e>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00116-1>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00116-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a78396bd0ab3d3f25852a0d4008cbdf4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-10>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-18>	<http://www.w3.org/2000/01/rdf-schema#label>	"Polarizability: 20.9 from ChemAxon [drugbank_resource:calculated-properties-DB00114-18]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-7>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_vocabulary:Anti-Testosterone-Agents>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"Anti-Testosterone-Agents"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:70f28c5b4aa0741b1c2d0997a89319ea>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-6>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-4>	<http://bio2rdf.org/drugbank_vocabulary:value>	"-0.55"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:70d5905dbbb671a2bf66275527b38e09>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-5>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:a6317c6254a0737c350d2f0860ea1ec3>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:a6317c6254a0737c350d2f0860ea1ec3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a8454a4c3a73e4a65b3965d9947cc4bd>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:d56193a54171cd8858918adbb1b34e8c>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:b15aa7d1fbce9f1563623833e416d8f7>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:b15aa7d1fbce9f1563623833e416d8f7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00097>	<http://purl.org/dc/terms/description>	"Recombinant human chorionic gonadotropin with 2 subunits, alpha = 92 residues, beta = 145 residues, each with N-and O-linked carbohydrate moieties linked to ASN-52 and ASN-78 (on alpha subunit) and ASN-13, ASN-30, SER-121, SER-127, SER-132 and SER-138 (on beta subunit). The primary structure of the alpha-chain of r-hCG is identical to that of the alpha-chain of hCG, FSH and LH."@en .
<http://bio2rdf.org/drugbank_resource:d46b970056d0a083cca1f813197ccf0c>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:99633b36b8289d3e0a8562067bd42c03>	<http://www.w3.org/2000/01/rdf-schema#label>	"half-life for drugbank:DB00103 [drugbank_resource:99633b36b8289d3e0a8562067bd42c03]"@en .
<http://bio2rdf.org/drugbank_resource:b508d1a45927588b684b5a6fd80aff2b>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Enzyme> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-9>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_vocabulary:ab9182be757cbb637b820f0951931ae2>	<http://bio2rdf.org/drugbank_vocabulary:company>	"Teva"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-8>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_vocabulary:Antifungal-Agents>	<http://purl.org/dc/terms/title>	"Antifungal Agents"@en .
<http://bio2rdf.org/drugbank_resource:c2dbd6b14df7875575496a70dff7a209>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:c2dbd6b14df7875575496a70dff7a209"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a9516c15b2a67882efd5c7a4c1fa6de4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-24>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:6d66b6aba13ddd36f6f9c8c32bc1927d>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:d2b048fbf48d0ab62b1014e2b38c72e9>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:4d9d641daef8c178a249f1266f1150e5>	<http://purl.org/dc/terms/title>	"mechanism-of-action for drugbank:DB00103"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-23>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:BE0002148"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-19>	<http://purl.org/dc/terms/title>	"H Bond Acceptor Count: 16 from ChemAxon"@en .
<http://bio2rdf.org/drugbank:BE0000300>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:BE0000300"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-22>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-1>	<http://www.w3.org/2000/01/rdf-schema#label>	"Hydrophobicity: -0.160 [drugbank_resource:experimental-properties-DB00102-1]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-26>	<http://www.w3.org/2000/01/rdf-schema#label>	"Ghose Filter: 0 from ChemAxon [drugbank_resource:calculated-properties-DB00118-26]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-28>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-28"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003533>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Enzyme> .
<http://bio2rdf.org/drugbank_resource:b15aa7d1fbce9f1563623833e416d8f7>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-21>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:0d47651b62c008d202fcec19e0c3b7c7>	<http://purl.org/dc/terms/title>	"indication for drugbank:DB00115"@en .
<http://bio2rdf.org/drugbank:BE0003536>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Enzyme> .
<http://bio2rdf.org/drugbank_resource:6f3fc4bb7965f22f3fc655ec5e1faab0>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/bindingdb:7953>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/bindingdb_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:5ba52774f54e88019dd4d17f32a34f7b>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:5ba52774f54e88019dd4d17f32a34f7b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-13>	<http://purl.org/dc/terms/title>	"InChIKey: InChIKey=SFKQVVDKFKYTNA-YVGXZPIDNA-N from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:2696048bf20ed0e2d578eb2938c6d8d3>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"2696048bf20ed0e2d578eb2938c6d8d3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-27>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank_resource:55842b12e140e13ee25b3a59430d097e>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:55842b12e140e13ee25b3a59430d097e"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:x-uniprot>	<http://bio2rdf.org/uniprot:CP3A5_HUMAN> .
<http://bio2rdf.org/drugbank_resource:d025612c433b867a6ebb00b2532e2626>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a7531086765fedefe82e0282f7a1d559>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-1>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00107-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-26>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:x-uniprot>	<http://bio2rdf.org/uniprot:CP2D6_HUMAN> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-3>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-9>	<http://bio2rdf.org/drugbank_vocabulary:value>	"1355.58"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:a78396bd0ab3d3f25852a0d4008cbdf4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-25>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:60e815570c1c11cef30f3fff503d6264> .
<http://bio2rdf.org/bindingdb:50271301>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/bindingdb_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00097>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:DB00097"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003533>	<http://bio2rdf.org/drugbank_vocabulary:gene-sequence>	">1482 bp\nCCCAGCGCACCATGTCTGCCCTCGGAGTGACCGTGGCCCTGCTGGTGTGGGCGGCCTTCC\nTCCTGCTGGTGTCCATGTGGAGGCAGGTGCACAGCAGCTGGAATCTGCCCCCAGGTCCTT\nTCCCGCTTCCCATCATCGGGAACCTCTTCCAGTTGGAATTGAAGAATATTCCCAAGTCCT\nTCACCCGGTTGGCCCAGCGCTTCGGGCCGGTGTTCACGCTGTACGTGGGCTCGCAGCGCA\nTGGTGGTGATGCACGGCTACAAGGCGGTGAAGGAAGCGCTGCTGGACTACAAGGACGAGT\nTCTCGGGCAGAGGCGACCTCCCCGCGTTCCATGCGCACAGGGACAGGGGAATCATTTTTA\nATAATGGACCTACCTGGAAGGACATCCGGCGGTTTTCCCTGACCACCCTCCGGAACTATG\nGGATGGGGAAACAGGGCAATGAGAGCCGGATCCAGAGGGAGGCCCACTTCCTGCTGGAAG\nCACTCAGGAAGACCCAAGGCCAGCCTTTCGACCCCACCTTCCTCATCGGCTGCGCGCCCT\nGCAACGTCATAGCCGACATCCTCTTCCGCAAGCATTTTGACTACAATGATGAGAAGTTTC\nTAAGGCTGATGTATTTGTTTAATGAGAACTTCCACCTACTCAGCACTCCCTGGCTCCAGC\nTTTACAATAATTTTCCCAGCTTTCTACACTACTTGCCTGGAAGCCACAGAAAAGTCATAA\nAAAATGTGGCTGAAGTAAAAGAGTATGTGTCTGAAAGGGTGAAGGAGCACCATCAATCTC\nTGGACCCCAACTGTCCCCGGGACCTCACCGACTGCCTGCTCGTGGAAATGGAGAAGGAAA\nAGCACAGTGCAGAGCGCTTGTACACAATGGACGGTATCACCGTGACTGTGGCCGACCTGT\nTCTTTGCGGGGACAGAGACCACCAGCACAACTCTGAGATATGGGCTCCTGATTCTCATGA\nAATACCCTGAGATCGAAGAGAAGCTCCATGAAGAAATTGACAGGGTGATTGGGCCAAGCC\nGAATCCCTGCCATCAAGGATAGGCAAGAGATGCCCTACATGGATGCTGTGGTGCATGAGA\nTTCAGCGGTTCATCACCCTCGTGCCCTCCAACCTGCCCCATGAAGCAACCCGAGACACCA\nTTTTCAGAGGATACCTCATCCCCAAGGGCACAGTCGTAGTGCCAACTCTGGACTCTGTTT\nTGTATGACAACCAAGAATTTCCTGATCCAGAAAAGTTTAAGCCAGAACACTTCCTGAATG\nAAAATGGAAAGTTCAAGTACAGTGACTATTTCAAGCCATTTTCCACAGGAAAACGAGTGT\nGTGCTGGAGAAGGCCTGGCTCGCATGGAGTTGTTTCTTTTGTTGTGTGCCATTTTGCAGC\nATTTTAATTTGAAGCCTCTCGTTGACCCAAAGGATATCGACCTCAGCCCTATACATATTG\nGGTTTGGCTGTATCCCACCACGTTACAAACTCTGTGTCATTC"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:x-uniprot>	<http://bio2rdf.org/uniprot:CP2C8_HUMAN> .
<http://bio2rdf.org/drugbank_resource:ae0431719c906d80aa97a27025adc99f>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:8eb135a8f519839c5f289226017b68a3>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"8eb135a8f519839c5f289226017b68a3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:17055fe13e90f0599fe8f9fd1c90c871>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:17055fe13e90f0599fe8f9fd1c90c871"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ae52c40c7c1761e3027e159477756625>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:6be4db795caa5a4f0e9b208f115d277b>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:abc4b12d5153eba9af71c2c651bd4ff1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"(S)- limonene 7-monooxygenase"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00094>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00094"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-11>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00118-11"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a9a58af69a8539d913c65b788eb5b178>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Indication> .
<http://bio2rdf.org/drugbank_vocabulary:8550beb9aaabcff323bdfeef04608bb8>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:8550beb9aaabcff323bdfeef04608bb8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:6d460a13d1af93268984ab262cef479d>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00092>	<http://purl.org/dc/terms/identifier>	"drugbank:DB00092"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:5888181b550399d2a84e1e4db3715340>	<http://purl.org/dc/terms/title>	"Imidazolyl carboxylic acid derivative"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-16>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00115-16"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-4>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Formula: C532H892N162O153S9 [drugbank_resource:experimental-properties-DB00102-4]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-26>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00093-26"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-18>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00091-18"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/bindingdb:50102442>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/bindingdb_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-11>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00117-11"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Vitamins>	<http://www.w3.org/2000/01/rdf-schema#label>	"Vitamins [drugbank_vocabulary:Vitamins]"@en .
<http://bio2rdf.org/drugbank_vocabulary:0f3c814d30566a7614f1fab32f4e0302>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:0f3c814d30566a7614f1fab32f4e0302"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003533>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:cb386ea42baf8766a3e98e9d24d46516>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-4>	<http://www.w3.org/2000/01/rdf-schema#label>	"Water Solubility: 2.69e-01 g/l from ALOGPS [drugbank_resource:calculated-properties-DB00116-4]"@en .
<http://bio2rdf.org/drugbank_resource:ad9e59297973dcc097c2400d81b7888b>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Half-life> .
<http://bio2rdf.org/drugbank_resource:a9a58af69a8539d913c65b788eb5b178>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0003536>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:ad715d0a2b2bcdcad22b975675537588>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:6ac630c499c16fd6e1f2a125e397688a>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:a9a65e43cdc103a1f769c3625b080c1d>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-10>	<http://purl.org/dc/terms/title>	"SMILES: OC[C@H]1O[C@@H]([C@H](O)[C@@H]1OP(O)(=O)O[C@]([H])(C)CNC(=O)CC[C@]1(C)[C@@H](CC(=O)N)[C@@]2([H])N([Co]C#N)C1=C(C)/C1=N/C(=CC3=NC(=C(C)/C4=N[C@]2(C)[C@@](C)(CC(=O)N)[C@@H]4CCC(=O)N)[C@@](C)(CC(=O)N)[C@@H]3CCC(=O)N)/C(C)(C)[C@@H]1CCC(=O)N)N1C=NC2=CC(C)=C(C)C=C12 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:98458df79187b81a7709036be48a75a4>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"98458df79187b81a7709036be48a75a4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8e7e8f5ff3cf3466586b956d7330151b>	<http://www.w3.org/2000/01/rdf-schema#label>	"Ketimine [drugbank_resource:8e7e8f5ff3cf3466586b956d7330151b]"@en .
<http://bio2rdf.org/drugbank_vocabulary:Indicators-and-Reagents>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:Indicators-and-Reagents"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c7f12f71253c5095c8df9050b7b42f2c>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"c7f12f71253c5095c8df9050b7b42f2c"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a9ee55eb5c1344c6ecd656006a4e92f2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:6d460a13d1af93268984ab262cef479d>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:6d460a13d1af93268984ab262cef479d"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-5>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00115-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:b15aa7d1fbce9f1563623833e416d8f7>	<http://purl.org/dc/terms/title>	"Substituted anilines"@en .
<http://bio2rdf.org/drugbank_resource:aa57c62e2e58943f3ce466339bbf00eb>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:Labor-Induction-Agents>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"Labor-Induction-Agents"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-22>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00091-22"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Biotech>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:3465ee54a79f5fd937ce86304a05d4e3>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00932>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00109_DB00932"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:913e4e077c76fcc7c941f5fbedf4db30>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-3>	<http://purl.org/dc/terms/title>	"logP: 4.37 from ALOGPS"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-15>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00118-15"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-23>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-23"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:1f87ebefeca8e494680a6a81334c6078>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"1f87ebefeca8e494680a6a81334c6078"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-7>	<http://www.w3.org/2000/01/rdf-schema#label>	"logS: -0.4 from ALOGPS [drugbank_resource:calculated-properties-DB00117-7]"@en .
<http://bio2rdf.org/drugbank_resource:Citanest-Dental-Octapressin>	<http://purl.org/dc/terms/title>	"Citanest Dental Octapressin"@en .
<http://bio2rdf.org/drugbank_resource:8399ac082eecc289dcd0ff6ce9ff3420>	<http://purl.org/dc/terms/title>	"Amino fatty acids"@en .
<http://bio2rdf.org/drugbank_resource:67b3d3945732c5188334e7f955ca6288>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00089>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:DB00089"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/chemspider:82572>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/chemspider:82572"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:molecular-weight>	"55770.0"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:3d51d314e6796004243d124d2c5f0793>	<http://www.w3.org/2000/01/rdf-schema#label>	"100 mg Capsule, liquid filled form with oral route [drugbank_resource:3d51d314e6796004243d124d2c5f0793]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-16>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00093-16"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:Xylonest-Octapressin>	<http://bio2rdf.org/drugbank_vocabulary:ingredients>	"Felypressin + Prilocaine"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:68664b41f20b902d0fcad004203c7cc8>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:f30bb36d9cf1cde63e806eb49b64d341>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:f30bb36d9cf1cde63e806eb49b64d341"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:684d8812e411c70454900dc745e593c8>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-3>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00113-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:01c6a15f6a299a85cd866fc4092d0dce>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank_resource:a9516c15b2a67882efd5c7a4c1fa6de4>	<http://purl.org/dc/terms/title>	"Metallotetrapyrrole skeleton"@en .
<http://bio2rdf.org/drugbank_resource:07769f07381a36b9cbc482dc6db9e40d>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:a61e3adec088927f97197e2f1513790d>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:00f0949724208fef8aa81b619295e0b2> .
<http://bio2rdf.org/drugbank_resource:091b1b5a04486711c0e6615b4e552e7e>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:091b1b5a04486711c0e6615b4e552e7e"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-22>	<http://www.w3.org/2000/01/rdf-schema#label>	"Physiological Charge: -2 from ChemAxon [drugbank_resource:calculated-properties-DB00116-22]"@en .
<http://bio2rdf.org/drugbank_resource:f30bb36d9cf1cde63e806eb49b64d341>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:f30bb36d9cf1cde63e806eb49b64d341"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Drug>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"Drug"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:036d7e3cfbf77c5f19b4baba9ff7aed2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:07c2684a57210d1f5bc920d112d11ecd>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-3>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00105-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:03746a740bf18cbf4beaae7cc5b7504f>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:6621165671a52f286c0f04fbfcf81106>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:08f1295028a77909e61816add07f6343>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:fffcf97ccb1aeb21dae91caa501b8255>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"fffcf97ccb1aeb21dae91caa501b8255"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:d46b970056d0a083cca1f813197ccf0c>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:d46b970056d0a083cca1f813197ccf0c"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:81987a5783579e8eae4261b8d95226da>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"81987a5783579e8eae4261b8d95226da"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00114-2>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00114-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:051943c0db4f9d17f7dfc49f7bb4329a>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-21>	<http://www.w3.org/2000/01/rdf-schema#label>	"MDDR-Like Rule: 1 from ChemAxon [drugbank_resource:calculated-properties-DB00115-21]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-10>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00117-10"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00090>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00090"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:70f28c5b4aa0741b1c2d0997a89319ea>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:70f28c5b4aa0741b1c2d0997a89319ea"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c7f12f71253c5095c8df9050b7b42f2c>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:c7f12f71253c5095c8df9050b7b42f2c"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:627446b31de3941cb82db7d08189b597>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:05261dbd457e9d2aa8254610c0f9df46>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:913e4e077c76fcc7c941f5fbedf4db30>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-15>	<http://bio2rdf.org/drugbank_vocabulary:value>	"264.79"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:b8f9ca946fec2fca3eb84c3b8cf1ff12>	<http://purl.org/dc/terms/title>	"Benzoyl derivatives"@en .
<http://bio2rdf.org/drugbank_resource:4fcc6e9455872b18c21b74aa6b82db13>	<http://www.w3.org/2000/01/rdf-schema#label>	"food-interaction for drugbank:DB00091 [drugbank_resource:4fcc6e9455872b18c21b74aa6b82db13]"@en .
<http://bio2rdf.org/drugbank_resource:64b9dc4a304f0bbee322be682a49f08b>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:06832c77d22e34a13e2de6990e7f3cf2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:fdb0a3b06aac9bbd85eeda7b1daf8545>	<http://purl.org/dc/terms/title>	"25 mg Solution form with intravenous route"@en .
<http://bio2rdf.org/drugbank_resource:069ab916580192548ff172f164a424bf>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-5>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00096-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:22f72a952683d19d554d47d3919c10f3>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:22f72a952683d19d554d47d3919c10f3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pubchem.substance:46509031>	<http://purl.org/dc/terms/identifier>	"pubchem.substance:46509031"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-16>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-16"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00107_DB00929>	<http://www.w3.org/2000/01/rdf-schema#label>	"DDI between Oxytocin and Misoprostol - May enhance the adverse/toxic effect of Oxytocin. Specifically, oxytocic effects may be enhanced. [drugbank_resource:DB00107_DB00929]"@en .
<http://bio2rdf.org/drugbank_resource:58cc96ec8bd0d25f62dde9d4e4a829dd>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"58cc96ec8bd0d25f62dde9d4e4a829dd"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Labor-Induction-Agents>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:Labor-Induction-Agents"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00092>	<http://purl.org/dc/terms/description>	"Immunosuppressive dimeric fusion protein that consists of the extracellular CD2-binding portion of the human leukocyte function antigen-3 (LFA-3) linked to the Fc (hinge, CH2 and CH3 domains) portion of human IgG1. Produced by CHO cells, mW is 91.4 kD."@en .
<http://bio2rdf.org/drugbank:BE0002793>	<http://purl.org/dc/terms/identifier>	"drugbank:BE0002793"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-17>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00114-17"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-22>	<http://purl.org/dc/terms/title>	"pKa (strongest basic): 1.94 from ChemAxon"@en .
<http://bio2rdf.org/drugbank:BE0000300>	<http://www.w3.org/2000/01/rdf-schema#label>	"Spermidine synthase [drugbank:BE0000300]"@en .
<http://bio2rdf.org/drugbank_resource:0d1969d27d89c3b774c942d81666c5d3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/pdb:SAM>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/pdb:SAM"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-27>	<http://www.w3.org/2000/01/rdf-schema#label>	"MDDR-Like Rule: 1 from ChemAxon [drugbank_resource:calculated-properties-DB00116-27]"@en .
<http://bio2rdf.org/drugbank_resource:0d47651b62c008d202fcec19e0c3b7c7>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:4dcb2d242a80267002194ce81be5670e>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:4dcb2d242a80267002194ce81be5670e"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:0235e5251bcfc61913eb18c0fab6a1c4>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"0235e5251bcfc61913eb18c0fab6a1c4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:0d54035b86f9a43f56ecd493c3a6fd59>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:ef0da8f521b780a50b08c455970978ac>	<http://purl.org/dc/terms/title>	"Vinylogous acid"@en .
<http://bio2rdf.org/drugbank_resource:6215bb81f14ea29a233fa4efbf660bf9>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:091b1b5a04486711c0e6615b4e552e7e>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:ab9182be757cbb637b820f0951931ae2>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:ab9182be757cbb637b820f0951931ae2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-3>	<http://bio2rdf.org/drugbank_vocabulary:value>	"1.87"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:6d66b6aba13ddd36f6f9c8c32bc1927d>	<http://purl.org/dc/terms/title>	"indication for drugbank:DB00090"@en .
<http://bio2rdf.org/drugbank_resource:fb96fa5c000dbd94c78671b5c79ff32b>	<http://purl.org/dc/terms/title>	"Organic phosphoric acids"@en .
<http://bio2rdf.org/drugbank_resource:6205a409adf418d0390045ac349b481a>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:094779e1e90e423f19e46305ba872c9c>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:3669e274097fc69149d3dbad3ba6b01c>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:3669e274097fc69149d3dbad3ba6b01c"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-2>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:17055fe13e90f0599fe8f9fd1c90c871>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"17055fe13e90f0599fe8f9fd1c90c871"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:29ad2163821ce9d547ef52b7bddcf404>	<http://www.w3.org/2000/01/rdf-schema#label>	"half-life for drugbank:DB00090 [drugbank_resource:29ad2163821ce9d547ef52b7bddcf404]"@en .
<http://bio2rdf.org/drugbank_resource:a6302cf127669e87e24a75b24552a9e8>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"1000 ug/mL"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:0d47651b62c008d202fcec19e0c3b7c7>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Indication> .
<http://bio2rdf.org/drugbank_resource:5eace972d6db7e2d3395f1ce1f56c40a>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:1c9905a95fe27572eaf4822554262551>	<http://www.w3.org/2000/01/rdf-schema#label>	"absorption for drugbank:DB00066 [drugbank_resource:1c9905a95fe27572eaf4822554262551]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-1>	<http://purl.org/dc/terms/title>	"Hydrophobicity: -0.300"@en .
<http://bio2rdf.org/drugbank:DB00097>	<http://www.w3.org/2000/01/rdf-schema#label>	"Choriogonadotropin alfa [drugbank:DB00097]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-12>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00116-12"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e39dd3e5ddfc2038fa77efd8d6d5305d>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"e39dd3e5ddfc2038fa77efd8d6d5305d"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:5c103a2b0c3fce1acc1c2e135c6684bf>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:ae52c40c7c1761e3027e159477756625>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:ae52c40c7c1761e3027e159477756625"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:807b0e58e0eead4b875202221ebe0f53>	<http://purl.org/dc/terms/title>	"500 ug Spray form with nasal route"@en .
<http://bio2rdf.org/drugbank:BE0003533>	<http://bio2rdf.org/drugbank_vocabulary:gene-name>	"CYP2E1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:5ba52774f54e88019dd4d17f32a34f7b>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_vocabulary:Labor-Induction-Agents>	<http://www.w3.org/2000/01/rdf-schema#label>	"Labor Induction Agents [drugbank_vocabulary:Labor-Induction-Agents]"@en .
<http://bio2rdf.org/drugbank_resource:74985c763ecb65fc6e794b1a003e061f>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:74985c763ecb65fc6e794b1a003e061f"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:0d1969d27d89c3b774c942d81666c5d3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:07c2684a57210d1f5bc920d112d11ecd>	<http://purl.org/dc/terms/title>	"Tetrapyrroles and derivatives"@en .
<http://bio2rdf.org/drugbank_resource:0d54035b86f9a43f56ecd493c3a6fd59>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:8c59273d79bb6ce81fe2a4c0596fa577>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"8c59273d79bb6ce81fe2a4c0596fa577"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:913e4e077c76fcc7c941f5fbedf4db30>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Absorption> .
<http://bio2rdf.org/drugbank_resource:1c9905a95fe27572eaf4822554262551>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"1c9905a95fe27572eaf4822554262551"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:5d2074ef1500127ada3cef721a746c89>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:00199edd2aba5de431eaa55bda5406d7>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-21>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00116-21"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:0235e5251bcfc61913eb18c0fab6a1c4>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:0235e5251bcfc61913eb18c0fab6a1c4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:091b1b5a04486711c0e6615b4e552e7e>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:fb96fa5c000dbd94c78671b5c79ff32b>	<http://www.w3.org/2000/01/rdf-schema#label>	"Organic phosphoric acids [drugbank_resource:fb96fa5c000dbd94c78671b5c79ff32b]"@en .
<http://bio2rdf.org/drugbank_resource:094779e1e90e423f19e46305ba872c9c>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-20>	<http://purl.org/dc/terms/title>	"pKa (strongest acidic): 1.71 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:069ab916580192548ff172f164a424bf>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Absorption> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"EC 1.14.13.48"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:Xylonest-Octapressin>	<http://purl.org/dc/terms/title>	"Xylonest Octapressin"@en .
<http://bio2rdf.org/drugbank:DB00111>	<http://purl.org/dc/terms/description>	"Humanized IgG1 Mab that binds to the human interleukin-2 receptor (anti-Tac or anti-CD25). Daclizumab is a composite of human (90%) and murine (10%) antibody sequences. The human sequences were derived from the constant domains of human IgG1 and the variable framework regions of the Eu myeloma antibody. The murine sequences were derived from the complementarity-determining regions of a murine anti-Tac antibody."@en .
<http://bio2rdf.org/drugbank_resource:5295f08395d80bb2a78d48e62dbf8c19>	<http://www.w3.org/2000/01/rdf-schema#label>	"Purine [drugbank_resource:5295f08395d80bb2a78d48e62dbf8c19]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-14>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00091-14"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-19>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-19"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"catalytic activity"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:00199edd2aba5de431eaa55bda5406d7>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Mechanism-of-action> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-2>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:9e10be5c3dafcd8441cdeb69f72cc3f4>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:9e10be5c3dafcd8441cdeb69f72cc3f4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:5ac86da3649163846e9e9d65b58c49fc>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:2ddeeca2fe9449969ab1519d768237c6>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"2ddeeca2fe9449969ab1519d768237c6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-1>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:635ab6dc8270d2e009be8cc273c1c0f2> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-5>	<http://purl.org/dc/terms/title>	"Water Solubility: 5.81e-03 g/l from ALOGPS"@en .
<http://bio2rdf.org/drugbank_resource:003185d1d24af95f95de2d64dd76ed33>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Indication> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/drugbank_vocabulary:theoretical-pi>	"8.25"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:5b47883807d5fa7a5b0b5ce2dc6e7939>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-4>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00116-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00091-2>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:16b5e71222ef14491ffc938517d50f8e> .
<http://bio2rdf.org/drugbank_resource:5b282e6fa4562e2752afccabea3c29c1>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:17b27330dfdb2b245beadb493e911ddb>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:17b27330dfdb2b245beadb493e911ddb"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:07769f07381a36b9cbc482dc6db9e40d>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:893efa195cf56cf85e98a5c5f0867045>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"893efa195cf56cf85e98a5c5f0867045"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:4dcb2d242a80267002194ce81be5670e>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:4dcb2d242a80267002194ce81be5670e"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01601>	<http://www.w3.org/2000/01/rdf-schema#label>	"DDI between Enfuvirtide and Lopinavir - May increase the serum concentration of Protease Inhibitors. Protease Inhibitors may increase the serum concentration of Enfuvirtide. [drugbank_resource:DB00109_DB01601]"@en .
<http://bio2rdf.org/drugbank_resource:c987b0d07b89f29a364501bc29cfebc8>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:c987b0d07b89f29a364501bc29cfebc8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:07c2684a57210d1f5bc920d112d11ecd>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:036d7e3cfbf77c5f19b4baba9ff7aed2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:0235e5251bcfc61913eb18c0fab6a1c4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Mechanism-of-action> .
<http://bio2rdf.org/drugbank_resource:5888181b550399d2a84e1e4db3715340>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:03746a740bf18cbf4beaae7cc5b7504f>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:Xylonest-Octapressin>	<http://bio2rdf.org/drugbank_vocabulary:ingredients>	"Prilocaine and Felypressin"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/chemspider:82572>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/chemspider_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:Oxytocics>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:Oxytocics"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:23e60560991f40f7f335be06f10675e1>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:23e60560991f40f7f335be06f10675e1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-28>	<http://www.w3.org/2000/01/rdf-schema#label>	"MDDR-Like Rule: 0 from ChemAxon [drugbank_resource:calculated-properties-DB00091-28]"@en .
<http://bio2rdf.org/drugbank_resource:08f1295028a77909e61816add07f6343>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-8>	<http://bio2rdf.org/drugbank_vocabulary:value>	"30-ethyl-14,17,23,32-tetrahydroxy-33-[(4E)-1-hydroxy-2-methylhex-4-en-1-yl]-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-13,16,22,31-tetraene-2,5,8,11,20,26,29-heptone"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"P450-11A"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:58cc96ec8bd0d25f62dde9d4e4a829dd>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:a9ee55eb5c1344c6ecd656006a4e92f2>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"a9ee55eb5c1344c6ecd656006a4e92f2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-21>	<http://bio2rdf.org/drugbank_vocabulary:value>	"10.18"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-24>	<http://bio2rdf.org/drugbank_vocabulary:value>	"-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:003185d1d24af95f95de2d64dd76ed33>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:7767fecbc1fcbba1764734e284afdd13>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"7767fecbc1fcbba1764734e284afdd13"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-8>	<http://bio2rdf.org/drugbank_vocabulary:value>	"399.445"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:592de4a57c1d28519d666f4b36fa6b2b>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:051943c0db4f9d17f7dfc49f7bb4329a>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:684d8812e411c70454900dc745e593c8>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"684d8812e411c70454900dc745e593c8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:574e7d1136f355daec35f6fd17ef29e5>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:c51b5b3f72bf15f717f23f1fdda6fe44>	<http://www.w3.org/2000/01/rdf-schema#label>	"manufacturer for drugbank:DB00094 [drugbank_resource:c51b5b3f72bf15f717f23f1fdda6fe44]"@en .
<http://bio2rdf.org/chemspider:6038>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/chemspider_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00110>	<http://purl.org/dc/terms/description>	"Humanized monoclonal antibody (IgG1k) produced by recombinant DNA technology, directed to an epitope in the A antigenic site of the F protein of respiratory syncytial virus (RSV). Synagis is a composite of human (95%) and murine (5%) antibody sequences. The human heavy chain sequence was derived from the constant domains of human IgG1 and the variable framework regions of the VH genes Cor (1) and Cess (2). The human lightchain sequence was derived from the constant domain of Ck and the variable framework regions of the VL gene K104 withJk-4. Palivizumab is expressed from a stable murine (mouse) myeloma cell line (NS0). Palivizumab is composed of to heavy chains (50.6 kDa each) and two light chains (27.6 kDa each), contains 1-2% carbohydrate by weight and has a molecular weight of 147.7 kDa +/- 1 kDa (MALDI-TOF)"@en .
<http://bio2rdf.org/drugbank_resource:1fc54dd8ec20644e59a52e0b31197dd9>	<http://www.w3.org/2000/01/rdf-schema#label>	"Imidazopyrimidine [drugbank_resource:1fc54dd8ec20644e59a52e0b31197dd9]"@en .
<http://bio2rdf.org/drugbank_resource:05261dbd457e9d2aa8254610c0f9df46>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01264>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:DB00109_DB01264"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-3>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00094-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-22>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00093-22"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-3>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:57ad8968da7ad0cb58cba7e058039db9>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/chemspider:4575342>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/chemspider_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-20>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00093-20"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:01c6a15f6a299a85cd866fc4092d0dce>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:d2b048fbf48d0ab62b1014e2b38c72e9>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:0235e5251bcfc61913eb18c0fab6a1c4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-5>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00094-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:06832c77d22e34a13e2de6990e7f3cf2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:57db98e1612a44845256ccbbbc457ff8>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:d2b048fbf48d0ab62b1014e2b38c72e9>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:d2b048fbf48d0ab62b1014e2b38c72e9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-27>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00118-27"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:585c665fefee46ff4931f369bfe6004a>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01232>	<http://www.w3.org/2000/01/rdf-schema#label>	"DDI between Enfuvirtide and Saquinavir - May increase the serum concentration of Protease Inhibitors. Protease Inhibitors may increase the serum concentration of Enfuvirtide. [drugbank_resource:DB00109_DB01232]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-1>	<http://bio2rdf.org/drugbank_vocabulary:value>	"-0.168"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00110_DB08879>	<http://www.w3.org/2000/01/rdf-schema#label>	"DDI between Palivizumab and Belimumab - Monoclonal Antibodies may enhance the adverse/toxic effect of Belimumab. [drugbank_resource:DB00110_DB08879]"@en .
<http://bio2rdf.org/chemspider:31983>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/chemspider_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:55842b12e140e13ee25b3a59430d097e>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:d46b970056d0a083cca1f813197ccf0c>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-23>	<http://purl.org/dc/terms/title>	"Number of Rings: 4 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:55694a43ccf43a29349054f94c2ce2e7>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:d56193a54171cd8858918adbb1b34e8c>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:3465ee54a79f5fd937ce86304a05d4e3>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:3465ee54a79f5fd937ce86304a05d4e3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:55f06b8fc86fce71f0db4c1832cfa819>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/chemspider:1022>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/chemspider_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:d025612c433b867a6ebb00b2532e2626>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:d2b048fbf48d0ab62b1014e2b38c72e9>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Indication> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-4>	<http://bio2rdf.org/drugbank_vocabulary:value>	"980.162"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00224>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:DB00109_DB00224"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-4>	<http://purl.org/dc/terms/title>	"Molecular Weight: 46548.2000"@en .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:DB00118"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00088>	<http://purl.org/dc/terms/description>	"Human Beta-glucocerebrosidase or Beta-D-glucosyl-N-acylsphingosine glucohydrolase E.C. 3.2.1.45. 497 residue protein with N-linked carbohydrates, MW=59.3 kD. Alglucerase is prepared by modification of the oligosaccharide chains of human Beta-glucocerebrosidase. The modification alters the sugar residues at the non-reducing ends of the oligosaccharide chains of the glycoprotein so that they are predominantly terminated with mannose residues"@en .
<http://bio2rdf.org/drugbank_resource:0d1969d27d89c3b774c942d81666c5d3>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"0d1969d27d89c3b774c942d81666c5d3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:1cb959cb5d30e328a863a3d9f64c120a>	<http://www.w3.org/2000/01/rdf-schema#label>	"Vinylogous acids [drugbank_resource:1cb959cb5d30e328a863a3d9f64c120a]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-21>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00118-21"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00090>	<http://purl.org/dc/terms/description>	"Human recombinant alpha-L-iduronidase, 628 residues (mature form), produced by recombinant DNAtechnology in a Chinese hamster ovary cell line. Laronidase is a glycoprotein with a molecular weight of approximately 83 kD. The predicted amino acid sequence of the recombinant form, as well as the nucleotide sequence that encodes it, are identical to a polymorphic form of human a-L-iduronidase. It contains 6 N-linked oligosaccharide modification sites."@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-1>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00097-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:5295f08395d80bb2a78d48e62dbf8c19>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:cb386ea42baf8766a3e98e9d24d46516>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank:DB00112>	<http://purl.org/dc/terms/description>	"A recombinant humanized monoclonal IgG1 antibody that binds to and inhibits the biologic activity of human vascular endothelial growth factor (VEGF). Bevacizumab contains human framework regions and the complementarity-determining regions of a murine antibody that binds to VEGF. Bevacizumab is produced in a Chinese Hamster Ovary mammalian cell expression system in a nutrient medium containing the antibiotic gentamicin and has a molecular weight of approximately 149 kilodaltons."@en .
<http://bio2rdf.org/drugbank_resource:225393798d1f4d7a00af1d777e454e22>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:225393798d1f4d7a00af1d777e454e22"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a78396bd0ab3d3f25852a0d4008cbdf4>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:a78396bd0ab3d3f25852a0d4008cbdf4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:78fce134a0e754813388f2850f268625>	<http://purl.org/dc/terms/title>	"indication for drugbank:DB00111"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-3>	<http://purl.org/dc/terms/title>	"Molecular Weight: 69899.4000"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-13>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00117-13"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:53ca67aedcd10f1c9afc4de0f2138502>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:d8c37e1ee64fc7f014205837681e99df>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:a9516c15b2a67882efd5c7a4c1fa6de4>	<http://www.w3.org/2000/01/rdf-schema#label>	"Metallotetrapyrrole skeleton [drugbank_resource:a9516c15b2a67882efd5c7a4c1fa6de4]"@en .
<http://bio2rdf.org/drugbank_resource:17b27330dfdb2b245beadb493e911ddb>	<http://purl.org/dc/terms/description>	"For nutritional supplementation and for treating dietary shortage or imbalance."@en .
<http://bio2rdf.org/drugbank_resource:53e4e7c3f9db35ed7e24a59c1546788c>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-7>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00114-7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:7aa53fec8bf96c3555379e2680167034>	<http://purl.org/dc/terms/description>	"19.4 \u00B1 5.4 hours (range from 11 to 36 hours)"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-2>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00103>	<http://purl.org/dc/terms/identifier>	"drugbank:DB00103"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-2>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-2>	<http://purl.org/dc/terms/title>	"Hydrophobicity: -0.395"@en .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:name>	"Cytochrome P450 3A7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-3>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-8>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Weight: 399.445 from ChemAxon [drugbank_resource:calculated-properties-DB00118-8]"@en .
<http://bio2rdf.org/drugbank:BE0000300>	<http://bio2rdf.org/drugbank_vocabulary:general-function>	"Amino acid transport and metabolism"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-1>	<http://www.w3.org/2000/01/rdf-schema#label>	"Water Solubility: 4.56E+004 mg/L (at 25 \u00B0C) from YALKOWSKY,SH & DANNENFELSER,RM (1992) [drugbank_resource:experimental-properties-DB00117-1]"@en .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00118"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:07c2684a57210d1f5bc920d112d11ecd>	<http://www.w3.org/2000/01/rdf-schema#label>	"Tetrapyrroles and derivatives [drugbank_resource:07c2684a57210d1f5bc920d112d11ecd]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-8>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00114-8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-20>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00114-20"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:d8c37e1ee64fc7f014205837681e99df>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Mechanism-of-action> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-28>	<http://purl.org/dc/terms/title>	"MDDR-Like Rule: 0 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-3>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-3>	<http://purl.org/dc/terms/title>	"Isoelectric Point: 5.65"@en .
<http://bio2rdf.org/drugbank_resource:e4e539077bcedbc155e950cadab01679>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:e4e539077bcedbc155e950cadab01679"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fe2051219bbed1c3f26d756ec49dea95>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:fe2051219bbed1c3f26d756ec49dea95"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:986ea485795ab092b3199f449ca4056e>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"986ea485795ab092b3199f449ca4056e"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-17>	<http://www.w3.org/2000/01/rdf-schema#label>	"InChIKey: InChIKey=HNDVDQJCIGZPNO-YFKPBYRVSA-N from ChemAxon [drugbank_resource:calculated-properties-DB00117-17]"@en .
<http://bio2rdf.org/bindingdb:50102442>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/bindingdb:50102442"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-21>	<http://www.w3.org/2000/01/rdf-schema#label>	"Rotatable Bond Count: 3 from ChemAxon [drugbank_resource:calculated-properties-DB00117-21]"@en .
<http://bio2rdf.org/drugbank_resource:450004b6cb1a30c3690aa11d2cd941a2>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:450004b6cb1a30c3690aa11d2cd941a2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:06832c77d22e34a13e2de6990e7f3cf2>	<http://purl.org/dc/terms/title>	"Pyrrolines"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-4>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00111-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00103>	<http://purl.org/dc/terms/description>	"Recombinant human alpha-galactosidase A. The mature protein is composed of 2 subunits of 398 residues. Protein is glycosylated and produced by CHO cells"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-30>	<http://www.w3.org/2000/01/rdf-schema#label>	"Ghose Filter: 0 from ChemAxon [drugbank_resource:calculated-properties-DB00117-30]"@en .
<http://bio2rdf.org/drugbank_resource:7aa53fec8bf96c3555379e2680167034>	<http://www.w3.org/2000/01/rdf-schema#label>	"half-life for drugbank:DB00100 [drugbank_resource:7aa53fec8bf96c3555379e2680167034]"@en .
<http://bio2rdf.org/drugbank_resource:24189bc5fb16bfce4551ecdfb0196def>	<http://www.w3.org/2000/01/rdf-schema#label>	"5 mg/mL Injection, powder, lyophilized, for solution form with intravenous route [drugbank_resource:24189bc5fb16bfce4551ecdfb0196def]"@en .
<http://bio2rdf.org/drugbank_resource:eb2ea139d16c3216009f5eb2eceb62c8>	<http://purl.org/dc/terms/title>	"Vinylogous amides"@en .
<http://bio2rdf.org/chemspider:82572>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0000300>	<http://bio2rdf.org/drugbank_vocabulary:theoretical-pi>	"5.17"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:57ad8968da7ad0cb58cba7e058039db9>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:57ad8968da7ad0cb58cba7e058039db9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e650b92d5679a4bc966570691fe2d7e4>	<http://www.w3.org/2000/01/rdf-schema#label>	"Dialkyl phosphate [drugbank_resource:e650b92d5679a4bc966570691fe2d7e4]"@en .
<http://bio2rdf.org/drugbank_resource:7aa53fec8bf96c3555379e2680167034>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"7aa53fec8bf96c3555379e2680167034"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:6d460a13d1af93268984ab262cef479d>	<http://purl.org/dc/terms/description>	"Palivizumab binds to the fusion glycoprotein of RSV. This prevents its binding and uptake by host cellular receptors."@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-15>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00116-15"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://purl.org/dc/terms/title>	"Cyanocobalamin"@en .
<http://bio2rdf.org/drugbank_resource:5eace972d6db7e2d3395f1ce1f56c40a>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:5eace972d6db7e2d3395f1ce1f56c40a"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:80aadabf31c519e42d80748f499c7689>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:80aadabf31c519e42d80748f499c7689"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"P450-PCN3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00110>	<http://purl.org/dc/terms/title>	"Palivizumab"@en .
<http://bio2rdf.org/drugbank_resource:450004b6cb1a30c3690aa11d2cd941a2>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"450004b6cb1a30c3690aa11d2cd941a2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-15>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00116-15"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-20>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00118-20"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Dietary-Supplements>	<http://www.w3.org/2000/01/rdf-schema#label>	"Dietary Supplements [drugbank_vocabulary:Dietary-Supplements]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00114-1>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00114-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/chemspider:4575342>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:7b6b9c68c4dd8e5a8f74e987f9a92ce7>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"7b6b9c68c4dd8e5a8f74e987f9a92ce7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pdb:THL>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:2ec24002f6e3cb0430a51468ee1d26da>	<http://www.w3.org/2000/01/rdf-schema#label>	"Benzoic acid or derivatives [drugbank_resource:2ec24002f6e3cb0430a51468ee1d26da]"@en .
<http://bio2rdf.org/drugbank_resource:131ed90e7634d72c92f27daf9a85454a>	<http://purl.org/dc/terms/description>	"For treatment of transplant (kidney, liver, and heart) rejection, rheumatoid arthritis, severe psoriasis."@en .
<http://bio2rdf.org/drugbank_resource:e9ee4548d6d10b87a4a259470fe32c97>	<http://www.w3.org/2000/01/rdf-schema#label>	"manufacturer for drugbank:DB00115 [drugbank_resource:e9ee4548d6d10b87a4a259470fe32c97]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-6>	<http://bio2rdf.org/drugbank_vocabulary:value>	"(2S)-2-[(4-{[(2-amino-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl)methyl]amino}phenyl)formamido]pentanedioic acid"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-1>	<http://bio2rdf.org/drugbank_vocabulary:value>	"-2.7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/chemspider:6038>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:47d86c7cb8687c843b27225a6715c3c1>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:47d86c7cb8687c843b27225a6715c3c1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:d025612c433b867a6ebb00b2532e2626>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:d025612c433b867a6ebb00b2532e2626"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00099>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00099"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:enzyme>	<http://bio2rdf.org/drugbank:BE0003533> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-18>	<http://purl.org/dc/terms/title>	"H Bond Acceptor Count: 10 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_vocabulary:Angiogenesis-Inducing-Agents>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:Angiogenesis-Inducing-Agents"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/chemspider:1022>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:53ca67aedcd10f1c9afc4de0f2138502>	<http://purl.org/dc/terms/title>	"This compound belongs to the class of organic compounds known as pyridoxals and derivatives. These are compounds containing a pyridoxal moiety, which consists of a pyridine ring substituted at positions 2,3,4, and 5 by a methyl group, a hydroxyl group, a carbaldehyde group, and a hydroxymethyl group, respectively."@en .
<http://bio2rdf.org/drugbank_resource:d56193a54171cd8858918adbb1b34e8c>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank:DB00111>	<http://purl.org/dc/terms/identifier>	"drugbank:DB00111"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:d46b970056d0a083cca1f813197ccf0c>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/pdb:PLP>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:d2b048fbf48d0ab62b1014e2b38c72e9>	<http://www.w3.org/2000/01/rdf-schema#label>	"indication for drugbank:DB00116 [drugbank_resource:d2b048fbf48d0ab62b1014e2b38c72e9]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-29>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00117-29"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8ae8b01597df174d257016596812aeab>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"8ae8b01597df174d257016596812aeab"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pdb:SAM>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:d025612c433b867a6ebb00b2532e2626>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Half-life> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-10>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-10"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00110>	<http://purl.org/dc/terms/identifier>	"drugbank:DB00110"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:372918cb5733e55c6d5baa7bc6f4a30c>	<http://purl.org/dc/terms/title>	"100 mg/mL Injection, solution form with intramuscular route"@en .
<http://bio2rdf.org/chemspider:31983>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00114-3>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00114-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:Xylonest-Octapressin>	<http://www.w3.org/2000/01/rdf-schema#label>	"Xylonest Octapressin [drugbank_resource:Xylonest-Octapressin]"@en .
<http://bio2rdf.org/drugbank_resource:fe02b6034f5c4d73f73a58815355abf5>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"fe02b6034f5c4d73f73a58815355abf5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:cb386ea42baf8766a3e98e9d24d46516>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:ec0915fa5d5da881fd812adc490bcd65>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:ec0915fa5d5da881fd812adc490bcd65"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-13>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00091-13"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-1>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:03d0e81bee43c6985ded5b95d4334a53> .
<http://bio2rdf.org/drugbank_resource:e9f580ccd34b70a11720b2f316225025>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"e9f580ccd34b70a11720b2f316225025"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:036d7e3cfbf77c5f19b4baba9ff7aed2>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:036d7e3cfbf77c5f19b4baba9ff7aed2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:locus>	"22q13.1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pdb:CNC>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:eda68d4a7955df0290c1f8b709e905ec>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"eda68d4a7955df0290c1f8b709e905ec"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:f6203f7c9646b21edf1fa81c5cdf94d1>	<http://purl.org/dc/terms/title>	"Sam-Sulfate"@en .
<http://bio2rdf.org/drugbank_vocabulary:Antifungal-Agents>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:Antifungal-Agents"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pdb:HIS>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:451abb4a53a3d4bc5e17cc485a3899b3>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:451abb4a53a3d4bc5e17cc485a3899b3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-2>	<http://www.w3.org/2000/01/rdf-schema#label>	"Isoelectric Point: 7.41 [drugbank_resource:experimental-properties-DB00088-2]"@en .
<http://bio2rdf.org/drugbank_resource:aa57c62e2e58943f3ce466339bbf00eb>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:aa57c62e2e58943f3ce466339bbf00eb"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://purl.org/dc/terms/title>	"Prolyl endopeptidase"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-21>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00093-21"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-5>	<http://purl.org/dc/terms/title>	"Molecular Formula: C6332H9808N1678O1989S42"@en .
<http://bio2rdf.org/drugbank_resource:3732893325a7ecb9126a15736796f117>	<http://purl.org/dc/terms/title>	"Cyclosporin-backbone"@en .
<http://bio2rdf.org/drugbank:DB00111>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:DB00111"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00091>	<http://purl.org/dc/terms/identifier>	"drugbank:DB00091"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:01c6a15f6a299a85cd866fc4092d0dce>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"100 mg/mL"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Angiogenesis-Inducing-Agents>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:Angiogenesis-Inducing-Agents"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:913e4e077c76fcc7c941f5fbedf4db30>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:913e4e077c76fcc7c941f5fbedf4db30"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ad9e59297973dcc097c2400d81b7888b>	<http://purl.org/dc/terms/description>	"3.8 +/- 0.6 hrs"@en .
<http://bio2rdf.org/drugbank_resource:68664b41f20b902d0fcad004203c7cc8>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"68664b41f20b902d0fcad004203c7cc8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:0d47651b62c008d202fcec19e0c3b7c7>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"0d47651b62c008d202fcec19e0c3b7c7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00445>	<http://purl.org/dc/terms/title>	"DDI between Bevacizumab and Epirubicin - May enhance the cardiotoxic effect of Antineoplastic Agents (Anthracycline, Systemic)."@en .
<http://bio2rdf.org/drugbank_resource:6621165671a52f286c0f04fbfcf81106>	<http://purl.org/dc/terms/title>	"108 mg Powder for solution form with subcutaneous route"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-1>	<http://www.w3.org/2000/01/rdf-schema#label>	"Hydrophobicity: -0.432 [drugbank_resource:experimental-properties-DB00092-1]"@en .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:enzyme>	<http://bio2rdf.org/drugbank:BE0002793> .
<http://bio2rdf.org/pubchem.compound:34756>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"34756"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:enzyme>	<http://bio2rdf.org/drugbank:BE0003536> .
<http://bio2rdf.org/drugbank_resource:9e10be5c3dafcd8441cdeb69f72cc3f4>	<http://purl.org/dc/terms/title>	"Organooxygen compounds"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-4>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00094-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c51b5b3f72bf15f717f23f1fdda6fe44>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#value>	"Serono laboratories inc"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:787ef58546dc52c80027a1e3a2b925b9>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:787ef58546dc52c80027a1e3a2b925b9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f38592452c305d31bbbb2909013724ac>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:f38592452c305d31bbbb2909013724ac"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3669e274097fc69149d3dbad3ba6b01c>	<http://www.w3.org/2000/01/rdf-schema#label>	"absorption for drugbank:DB00102 [drugbank_resource:3669e274097fc69149d3dbad3ba6b01c]"@en .
<http://bio2rdf.org/drugbank_resource:68664b41f20b902d0fcad004203c7cc8>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:68664b41f20b902d0fcad004203c7cc8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-15>	<http://bio2rdf.org/drugbank_vocabulary:value>	"C6H9N3O2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:31af673f5d82841086059243563cd4c6>	<http://purl.org/dc/terms/title>	"mechanism-of-action for drugbank:DB00114"@en .
<http://bio2rdf.org/drugbank_resource:807b0e58e0eead4b875202221ebe0f53>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"500 ug"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2696048bf20ed0e2d578eb2938c6d8d3>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:2696048bf20ed0e2d578eb2938c6d8d3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Oxytocics>	<http://purl.org/dc/terms/title>	"Oxytocics"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-19>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-19"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00114-2>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00114-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c007cc919bf71767e61e0b111723c84f>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:c007cc919bf71767e61e0b111723c84f"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-1>	<http://www.w3.org/2000/01/rdf-schema#label>	"Melting Point: 61 \u00B0C from Beldarrain, A. et al., Biochemistry 38:7865-7873 (1999) [drugbank_resource:experimental-properties-DB00105-1]"@en .
<http://bio2rdf.org/pdb:THL>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/pdb_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:ff5b4bb2ae4fdc7811f87fd38c8b8eda>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:ff5b4bb2ae4fdc7811f87fd38c8b8eda"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-27>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00114-27"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00117>	<http://purl.org/dc/terms/title>	"L-Histidine"@en .
<http://bio2rdf.org/chemspider:31983>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"chemspider"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-7>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00118-7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:b508d1a45927588b684b5a6fd80aff2b>	<http://purl.org/dc/terms/title>	"Organic phosphate"@en .
<http://bio2rdf.org/chemspider:82572>	<http://purl.org/dc/terms/identifier>	"chemspider:82572"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:3465ee54a79f5fd937ce86304a05d4e3>	<http://bio2rdf.org/drugbank_vocabulary:company>	"Joullie"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:Citanest-Dental-Octapressin>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:Citanest-Dental-Octapressin"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00932>	<http://purl.org/dc/terms/title>	"DDI between Enfuvirtide and Tipranavir - May increase the serum concentration of Protease Inhibitors. Protease Inhibitors may increase the serum concentration of Enfuvirtide."@en .
<http://bio2rdf.org/drugbank_vocabulary:Indicators-and-Reagents>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:Indicators-and-Reagents"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8683be48baa0e7d62758aed2d9ccf431>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:8683be48baa0e7d62758aed2d9ccf431"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:6215bb81f14ea29a233fa4efbf660bf9>	<http://www.w3.org/2000/01/rdf-schema#label>	"clearance for drugbank:DB00109 [drugbank_resource:6215bb81f14ea29a233fa4efbf660bf9]"@en .
<http://bio2rdf.org/drugbank:BE0003533>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"BE0003533"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:39094d4a5017cb7945c3ca22e421306d>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:39094d4a5017cb7945c3ca22e421306d"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/chemspider:1022>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"chemspider"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:67b3d3945732c5188334e7f955ca6288>	<http://purl.org/dc/terms/description>	"For use as an alternative to adrenaline as a localising agent, provided that local ischaemia is not essential."@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-1>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00103-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-27>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00091-27"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:df42fd14b400446e8cc7e69facd62cba>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:df42fd14b400446e8cc7e69facd62cba"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-17>	<http://purl.org/dc/terms/title>	"Rotatable Bond Count: 19 from ChemAxon"@en .
<http://bio2rdf.org/chemspider:6038>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"chemspider"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:6d66b6aba13ddd36f6f9c8c32bc1927d>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"6d66b6aba13ddd36f6f9c8c32bc1927d"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pdb:PLP>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/pdb_vocabulary:Resource> .
<http://bio2rdf.org/pdb:SAM>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/pdb_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:e328a6cf619c4105669d93dc30d36096>	<http://bio2rdf.org/drugbank_vocabulary:company>	"Genzyme"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-4>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:16b5e71222ef14491ffc938517d50f8e> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-12>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-12"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-18>	<http://bio2rdf.org/drugbank_vocabulary:value>	"20.9"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-8>	<http://bio2rdf.org/drugbank_vocabulary:value>	"1040.22"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:01c6a15f6a299a85cd866fc4092d0dce>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:01c6a15f6a299a85cd866fc4092d0dce"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/chemspider:4575342>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"chemspider"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3549163466db2fa5b979545848c2ef00>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"3549163466db2fa5b979545848c2ef00"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00363>	<http://purl.org/dc/terms/title>	"DDI between Bevacizumab and Clozapine - Myelosuppressive Agents may enhance the adverse/toxic effect of CloZAPine. Specifically, the risk for agranulocytosis may be increased."@en .
<http://bio2rdf.org/drugbank_resource:5295f08395d80bb2a78d48e62dbf8c19>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"5295f08395d80bb2a78d48e62dbf8c19"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8eb135a8f519839c5f289226017b68a3>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:8eb135a8f519839c5f289226017b68a3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00109>	<http://bio2rdf.org/drugbank_vocabulary:enzyme>	<http://bio2rdf.org/drugbank:BE0003536> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:enzyme>	<http://bio2rdf.org/drugbank:BE0002638> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-22>	<http://bio2rdf.org/drugbank_vocabulary:value>	"-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00109>	<http://bio2rdf.org/drugbank_vocabulary:enzyme>	<http://bio2rdf.org/drugbank:BE0003533> .
<http://bio2rdf.org/pdb:CNC>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/pdb_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-14>	<http://bio2rdf.org/drugbank_vocabulary:value>	"182.63"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:ad715d0a2b2bcdcad22b975675537588>	<http://www.w3.org/2000/01/rdf-schema#label>	"Phenylalkylamines [drugbank_resource:ad715d0a2b2bcdcad22b975675537588]"@en .
<http://bio2rdf.org/pdb:HIS>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/pdb_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0003533>	<http://bio2rdf.org/drugbank_vocabulary:locus>	"10q24.3-qter"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00112>	<http://purl.org/dc/terms/title>	"Bevacizumab"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-20>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00117-20"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"metabolism"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fe2051219bbed1c3f26d756ec49dea95>	<http://www.w3.org/2000/01/rdf-schema#label>	"Methionine or derivatives [drugbank_resource:fe2051219bbed1c3f26d756ec49dea95]"@en .
<http://bio2rdf.org/chemspider:82572>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"chemspider"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"metabolism"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"P450-DB1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/bindingdb:50271301>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"metabolism"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-3>	<http://bio2rdf.org/drugbank_vocabulary:value>	"-3.2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pubchem.substance:46505280>	<http://purl.org/dc/terms/identifier>	"pubchem.substance:46505280"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-18>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-18"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/bindingdb:7953>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-15>	<http://purl.org/dc/terms/title>	"Refractivity: 264.79 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:246c82890dc31bdd6e899b6c63a0f254>	<http://purl.org/dc/terms/title>	"Organoheterocyclic compounds"@en .
<http://bio2rdf.org/pubchem.compound:44176380>	<http://purl.org/dc/terms/identifier>	"pubchem.compound:44176380"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:051943c0db4f9d17f7dfc49f7bb4329a>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"051943c0db4f9d17f7dfc49f7bb4329a"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:4a0d48b5f8e157c4bbcb34092d4edaf3>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:4a0d48b5f8e157c4bbcb34092d4edaf3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:b8f9ca946fec2fca3eb84c3b8cf1ff12>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"b8f9ca946fec2fca3eb84c3b8cf1ff12"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-21>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00116-21"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Supplements>	<http://purl.org/dc/terms/title>	"Supplements"@en .
<http://bio2rdf.org/drugbank_resource:42e21c05e96b3040136e54dfed4bf794>	<http://www.w3.org/2000/01/rdf-schema#label>	"Carbohydrates and carbohydrate conjugates [drugbank_resource:42e21c05e96b3040136e54dfed4bf794]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-15>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00093-15"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"oxidoreductase activity"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003533>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"oxidoreductase activity"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fa8e5850916f505d7329bb36ce55c161>	<http://www.w3.org/2000/01/rdf-schema#label>	"Corrinoids [drugbank_resource:fa8e5850916f505d7329bb36ce55c161]"@en .
<http://bio2rdf.org/bindingdb:50102442>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00398>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:DB00112_DB00398"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:00199edd2aba5de431eaa55bda5406d7>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"00199edd2aba5de431eaa55bda5406d7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a78396bd0ab3d3f25852a0d4008cbdf4>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:a78396bd0ab3d3f25852a0d4008cbdf4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:73192b1a02a81c1e485fb06abc6fdc61>	<http://www.w3.org/2000/01/rdf-schema#label>	"Sangcya [drugbank_vocabulary:73192b1a02a81c1e485fb06abc6fdc61]"@en .
<http://bio2rdf.org/drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:ffb414ea32db58bec7ec3339a42c9dee>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:ffb414ea32db58bec7ec3339a42c9dee"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-14>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00117-14"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"oxidoreductase activity"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e39dd3e5ddfc2038fa77efd8d6d5305d>	<http://www.w3.org/2000/01/rdf-schema#label>	"absorption for drugbank:DB00118 [drugbank_resource:e39dd3e5ddfc2038fa77efd8d6d5305d]"@en .
<http://bio2rdf.org/drugbank_resource:Xylonest-Octapressin>	<http://bio2rdf.org/drugbank_vocabulary:ingredient>	<http://bio2rdf.org/drugbank_resource:Prilocaine> .
<http://bio2rdf.org/drugbank_resource:4d6d8a0bb0437361e22c5fbaf04819ea>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"4d6d8a0bb0437361e22c5fbaf04819ea"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Small-molecule>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:Small-molecule"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ef0da8f521b780a50b08c455970978ac>	<http://www.w3.org/2000/01/rdf-schema#label>	"Vinylogous acid [drugbank_resource:ef0da8f521b780a50b08c455970978ac]"@en .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00114"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00114>	<http://purl.org/dc/terms/identifier>	"drugbank:DB00114"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a595cc1c66cf7314ca9d50542e429c85>	<http://purl.org/dc/terms/title>	"mechanism-of-action for drugbank:DB00106"@en .
<http://bio2rdf.org/drugbank_resource:84e1544b4af68672a960baf683724f87>	<http://purl.org/dc/terms/title>	"Aralkylamines"@en .
<http://bio2rdf.org/drugbank_resource:5ac86da3649163846e9e9d65b58c49fc>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"5ac86da3649163846e9e9d65b58c49fc"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:88491d7d06bc30fa9586740372808b10>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:88491d7d06bc30fa9586740372808b10"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:transmembrane-regions>	"None"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-2>	<http://bio2rdf.org/drugbank_vocabulary:value>	"-0.395"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:transmembrane-regions>	"None"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:Xylonest-Octapressin>	<http://bio2rdf.org/drugbank_vocabulary:ingredient>	<http://bio2rdf.org/drugbank_resource:Felypressin> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-2>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00112-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f2540530a3858d9fa40e7bfd96e4c77d>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"f2540530a3858d9fa40e7bfd96e4c77d"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:transmembrane-regions>	"None"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-4>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Weight: 18.8 kDa [drugbank_resource:experimental-properties-DB00099-4]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-2>	<http://bio2rdf.org/drugbank_vocabulary:value>	"-0.339"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"(R)-limonene 6-monooxygenase"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-3>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00109-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003533>	<http://purl.org/dc/terms/title>	"Cytochrome P450 2E1"@en .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"metabolism"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-1>	<http://www.w3.org/2000/01/rdf-schema#label>	"Melting Point: 54 \u00B0C from Link, R.P., Castellino, F.J. Arch. Biochem. Biophsy. 227:259-265 (1983) [drugbank_resource:experimental-properties-DB00100-1]"@en .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"(R)-limonene 6-monooxygenase"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:amino-acid-sequence>	">Prolyl endopeptidase\nMLSFQYPDVYRDETAVQDYHGHKICDPYAWLEDPDSEQTKAFVEAQNKITVPFLEQCPIR\nGLYKERMTELYDYPKYSCHFKKGKRYFYFYNTGLQNQRVLYVQDSLEGEARVFLDPNILS\nDDGTVALRGYAFSEDGEYFAYGLSASGSDWVTIKFMKVDGAKELPDVLERVKFSCMAWTH\nDGKGMFYNSYPQQDGKSDGTETSTNLHQKLYYHVLGTDQSEDILCAEFPDEPKWMGGAEL\nSDDGRYVLLSIREGCDPVNRLWYCDLQQESSGIAGILKWVKLIDNFEGEYDYVTNEGTVF\nTFKTNRQSPNYRVINIDFWDPEESKWKVLVPEHEKDVLEWIACVRSNFLVLCYLHDVKNI\nLQLHDLTTGALLKTFPLDVGSIVGYSGQKKDTEIFYQFTSFLSPGIIYHCDLTKEELEPR\nVFREVTVKGIDASDYQTVQIFYPSKDGTKIPMFIVHKKGIKLDGSHPAFLYGYGGFNISI\nTPNYSVSRLIFVRHMGGILAVANIRGGGEYGETWHKGGILANKQNCFDDFQCAAEYLIKE\nGYTSPKRLTINGGSNGGLLVAACANQRPDLFGCVIAQVGVMDMLKFHKYTIGHAWTTDYG\nCSDSKQHFEWLVKYSPLHNVKLPEADDIQYPSMLLLTADHDDRVVPLHSLKFIATLQYIV\nGRSRKQSNPLLIHVDTKAGHGAGKPTAKVIEEVSDMFAFIARCLNVDWIP"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-2>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00092-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-1>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-2>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-5>	<http://bio2rdf.org/drugbank_vocabulary:value>	"3.84e-02 g/l"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-3>	<http://purl.org/dc/terms/title>	"Isoelectric Point: 7.50"@en .
<http://bio2rdf.org/drugbank_resource:76cc7a41e93863bcbab0bba32bc52311>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"100 ug/g"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-27>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00114-27"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/BE0002793> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:theoretical-pi>	"7.26"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:a2d4a403a964b1f3a6d6fa73cb73921a>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:a2d4a403a964b1f3a6d6fa73cb73921a"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00110-1>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00110-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/BE0003536> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:BE0002887"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0000456>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"Cob(I)alamin adenosyltransferase"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003533>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/BE0003533> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-12>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00115-12"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00094>	<http://bio2rdf.org/drugbank_vocabulary:absorption>	<http://bio2rdf.org/drugbank_resource:1c9905a95fe27572eaf4822554262551> .
<http://bio2rdf.org/drugbank_resource:2970662836bc4a17c64d219c534d3f7e>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:2970662836bc4a17c64d219c534d3f7e"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-15>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00118-15"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c0c3695e2cc0b1f8b2708aa4329a566e>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:c0c3695e2cc0b1f8b2708aa4329a566e"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:6d66b6aba13ddd36f6f9c8c32bc1927d>	<http://www.w3.org/2000/01/rdf-schema#label>	"indication for drugbank:DB00090 [drugbank_resource:6d66b6aba13ddd36f6f9c8c32bc1927d]"@en .
<http://bio2rdf.org/drugbank_resource:6d66b6aba13ddd36f6f9c8c32bc1927d>	<http://purl.org/dc/terms/description>	"For the treatment of mucopolysaccharidosis"@en .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:transmembrane-regions>	"None"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:762a7c535540c35c3ec0a9932635da58>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:762a7c535540c35c3ec0a9932635da58"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-9>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:1588f62bddb8c0b1cca8f11ce8e653b9>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:1588f62bddb8c0b1cca8f11ce8e653b9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ff5b4bb2ae4fdc7811f87fd38c8b8eda>	<http://purl.org/dc/terms/title>	"indication for drugbank:DB00117"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-4>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00091-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-1>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00109-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00115-2>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:6582579647e05e995194d39ef64fda56> .
<http://bio2rdf.org/drugbank_resource:77b52954fa911921450d2b426c1a7a3a>	<http://www.w3.org/2000/01/rdf-schema#label>	"Tetrahydrofolic acid [drugbank_resource:77b52954fa911921450d2b426c1a7a3a]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00114-2>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:6582579647e05e995194d39ef64fda56> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-2>	<http://www.w3.org/2000/01/rdf-schema#label>	"Hydrophobicity: -0.339 [drugbank_resource:experimental-properties-DB00105-2]"@en .
<http://bio2rdf.org/drugbank_resource:76cc7a41e93863bcbab0bba32bc52311>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"76cc7a41e93863bcbab0bba32bc52311"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:376c6e6cad258f51a802ccce8c53ca4c>	<http://www.w3.org/2000/01/rdf-schema#label>	"manufacturer for drugbank:DB00106 [drugbank_resource:376c6e6cad258f51a802ccce8c53ca4c]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-2>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:6582579647e05e995194d39ef64fda56> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"oxidoreductase activity"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-27>	<http://www.w3.org/2000/01/rdf-schema#label>	"Number of Rings: 1 from ChemAxon [drugbank_resource:calculated-properties-DB00117-27]"@en .
<http://bio2rdf.org/drugbank_resource:8399ac082eecc289dcd0ff6ce9ff3420>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"8399ac082eecc289dcd0ff6ce9ff3420"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fd9ee6482e9b1c5516cff7b904f27169>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:fd9ee6482e9b1c5516cff7b904f27169"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-27>	<http://purl.org/dc/terms/title>	"Rule of Five: 1 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-10>	<http://bio2rdf.org/drugbank_vocabulary:value>	"1201.84"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-20>	<http://www.w3.org/2000/01/rdf-schema#label>	"Ghose Filter: 0 from ChemAxon [drugbank_resource:calculated-properties-DB00115-20]"@en .
<http://bio2rdf.org/drugbank:DB00103>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:DB00103"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ae0431719c906d80aa97a27025adc99f>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"ae0431719c906d80aa97a27025adc99f"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:1c9905a95fe27572eaf4822554262551>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:1c9905a95fe27572eaf4822554262551"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:908621b9e3153f791dd6dbd4ef6d62a5>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:908621b9e3153f791dd6dbd4ef6d62a5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ae52c40c7c1761e3027e159477756625>	<http://purl.org/dc/terms/title>	"1-ribofuranosylbenzimidazole"@en .
<http://bio2rdf.org/drugbank_resource:DB00112_DB01268>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00112_DB01268"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-5>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-1>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00102-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-4>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-20>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00115-20"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:x-taxonomy>	<http://bio2rdf.org/taxonomy:9606> .
<http://bio2rdf.org/drugbank_resource:58cc96ec8bd0d25f62dde9d4e4a829dd>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:58cc96ec8bd0d25f62dde9d4e4a829dd"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-31>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00117-31"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c007cc919bf71767e61e0b111723c84f>	<http://www.w3.org/2000/01/rdf-schema#label>	"half-life for drugbank:DB00097 [drugbank_resource:c007cc919bf71767e61e0b111723c84f]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-21>	<http://www.w3.org/2000/01/rdf-schema#label>	"pKa (strongest basic): 3.58 from ChemAxon [drugbank_resource:calculated-properties-DB00116-21]"@en .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:x-taxonomy>	<http://bio2rdf.org/taxonomy:9606> .
<http://bio2rdf.org/drugbank_vocabulary:abd3e42d8c67111954c278994aa4591d>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"abd3e42d8c67111954c278994aa4591d"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:x-taxonomy>	<http://bio2rdf.org/taxonomy:9606> .
<http://bio2rdf.org/drugbank_resource:2970662836bc4a17c64d219c534d3f7e>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:2970662836bc4a17c64d219c534d3f7e"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:42e21c05e96b3040136e54dfed4bf794>	<http://purl.org/dc/terms/title>	"Carbohydrates and carbohydrate conjugates"@en .
<http://bio2rdf.org/drugbank_resource:97f751c9423321c8864c0243afcff111>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:97f751c9423321c8864c0243afcff111"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-26>	<http://purl.org/dc/terms/title>	"Bioavailability: 1 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:036d7e3cfbf77c5f19b4baba9ff7aed2>	<http://www.w3.org/2000/01/rdf-schema#label>	"Aryl-aldehydes [drugbank_resource:036d7e3cfbf77c5f19b4baba9ff7aed2]"@en .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:locus>	"6q22"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f5f75e6bf165e0a25b8c2fab60ccf2e0>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:f5f75e6bf165e0a25b8c2fab60ccf2e0"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-7>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00093-7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2a828069e3c5a4b098468f8a2091e89f>	<http://purl.org/dc/terms/title>	"250 ug/.5mL Injection, solution form with subcutaneous route"@en .
<http://bio2rdf.org/drugbank_resource:2d76fb5dd0f39b41fe92dc87dd6a96d9>	<http://www.w3.org/2000/01/rdf-schema#label>	"Organic cyanide salt [drugbank_resource:2d76fb5dd0f39b41fe92dc87dd6a96d9]"@en .
<http://bio2rdf.org/drugbank_resource:70f28c5b4aa0741b1c2d0997a89319ea>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"70f28c5b4aa0741b1c2d0997a89319ea"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-2>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00092-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-5>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00100-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/drugbank_vocabulary:cellular-location>	"Endoplasmic reticulum"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:87f0fe251ba4940236c1e30de121922a>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:87f0fe251ba4940236c1e30de121922a"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:08f1295028a77909e61816add07f6343>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:08f1295028a77909e61816add07f6343"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00116>	<http://purl.org/dc/terms/identifier>	"drugbank:DB00116"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-20>	<http://www.w3.org/2000/01/rdf-schema#label>	"Polarizability: 14.67 from ChemAxon [drugbank_resource:calculated-properties-DB00117-20]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-4>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00105-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"Quinine 3-monooxygenase"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:5c103a2b0c3fce1acc1c2e135c6684bf>	<http://www.w3.org/2000/01/rdf-schema#label>	"1,2-diols [drugbank_resource:5c103a2b0c3fce1acc1c2e135c6684bf]"@en .
<http://bio2rdf.org/drugbank_resource:efd9b57513efb0eb6e90f59807e0e8d9>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:efd9b57513efb0eb6e90f59807e0e8d9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2ddeeca2fe9449969ab1519d768237c6>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:2ddeeca2fe9449969ab1519d768237c6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:68664b41f20b902d0fcad004203c7cc8>	<http://www.w3.org/2000/01/rdf-schema#label>	"Hippuric acid [drugbank_resource:68664b41f20b902d0fcad004203c7cc8]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-12>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-12"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"BE0003612"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-23>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-23"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://purl.org/dc/terms/description>	"Cyanocobalamin (commonly known as Vitamin B12) is the most chemically complex of all the vitamins. Cyanocobalamin's structure is based on a corrin ring, which, although similar to the porphyrin ring found in heme, chlorophyll, and cytochrome, has two of the pyrrole rings directly bonded. The central metal ion is Co (cobalt). Cyanocobalamin cannot be made by plants or by animals, as the only type of organisms that have the enzymes required for the synthesis of cyanocobalamin are bacteria and archaea. Higher plants do not concentrate cyanocobalamin from the soil and so are a poor source of the substance as compared with animal tissues. Cyanocobalamin is naturally found in foods including meat (especially liver and shellfish), eggs, and milk products. [HMDB]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-1>	<http://purl.org/dc/terms/title>	"Water Solubility: 4.56E+004 mg/L (at 25 \u00B0C) from YALKOWSKY,SH & DANNENFELSER,RM (1992)"@en .
<http://bio2rdf.org/drugbank_resource:c51b5b3f72bf15f717f23f1fdda6fe44>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:c51b5b3f72bf15f717f23f1fdda6fe44"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:cellular-location>	"Endoplasmic reticulum"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-4>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00099-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-11>	<http://www.w3.org/2000/01/rdf-schema#label>	"Monoisotopic Weight: 247.024573569 from ChemAxon [drugbank_resource:calculated-properties-DB00114-11]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00106-2>	<http://purl.org/dc/terms/title>	"Molecular Formula: C72H95ClN14O14"@en .
<http://bio2rdf.org/drugbank_resource:3181b99b434a8db59d197070956de3d9>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:3181b99b434a8db59d197070956de3d9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-2>	<http://www.w3.org/2000/01/rdf-schema#label>	"logP: -2 from ALOGPS [drugbank_resource:calculated-properties-DB00118-2]"@en .
<http://bio2rdf.org/drugbank_resource:d2b048fbf48d0ab62b1014e2b38c72e9>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"d2b048fbf48d0ab62b1014e2b38c72e9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0000456>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:9be1f0fbe27fc41feab5fa848add809b>	<http://purl.org/dc/terms/description>	"For diagnosis of prostate cancer and detection of intra-pelvic metastases."@en .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:x-taxonomy>	<http://bio2rdf.org/taxonomy:9606> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-5>	<http://www.w3.org/2000/01/rdf-schema#label>	"Water Solubility: 3.84e-02 g/l from ALOGPS [drugbank_resource:calculated-properties-DB00115-5]"@en .
<http://bio2rdf.org/drugbank_resource:6be4db795caa5a4f0e9b208f115d277b>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"6be4db795caa5a4f0e9b208f115d277b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-15>	<http://bio2rdf.org/drugbank_vocabulary:value>	"96.23"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://purl.org/dc/terms/Dataset> .
<http://bio2rdf.org/drugbank:DB00109>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00109"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00118-1>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00118-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:220e1c2f3029a37a26fd263b95f90c89>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"220e1c2f3029a37a26fd263b95f90c89"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-4>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:x-taxonomy>	<http://bio2rdf.org/taxonomy:9606> .
<http://bio2rdf.org/drugbank_resource:c007cc919bf71767e61e0b111723c84f>	<http://purl.org/dc/terms/description>	"The mean terminal half-life is about 29 \u00B1 6 hours (initial half-life is 4.5 \u00B1 0.5 hours)."@en .
<http://bio2rdf.org/drugbank_vocabulary:e6be3ee899ac0f450592b2c5985631de>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"e6be3ee899ac0f450592b2c5985631de"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-17>	<http://purl.org/dc/terms/title>	"Polarizability: 131.92 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-7>	<http://purl.org/dc/terms/title>	"Traditional IUPAC Name: [(1R,2R,3S,4S,8S,9S,14S,18R,19R)-4,9,14-tris(2-carbamoylethyl)-3,8,19-tris(carbamoylmethyl)-18-(2-{[(2R)-2-({[(2R,3S,4R,5S)-5-(5,6-dimethyl-1,3-benzodiazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy(hydroxy)phosphoryl}oxy)propyl]carbamoyl}ethyl)-2,3,6,8,13,13,16,18-octamethyl-20,21,22,23-tetraazapentacyclo[15.2.1.1\u00B2,\u2075.1\u2077,\u00B9\u2070.1\u00B9\u00B2,\u00B9\u2075]tricosa-5(23),6,10(22),11,15(21),16-hexaen-20-yl]cobaltcarbonitrile from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:5eace972d6db7e2d3395f1ce1f56c40a>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:5eace972d6db7e2d3395f1ce1f56c40a"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:43ebb1f4d3ddbd9ec70fcbba40c42a45>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:43ebb1f4d3ddbd9ec70fcbba40c42a45"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-4>	<http://purl.org/dc/terms/title>	"Molecular Formula: C2029H3080N544O587S27"@en .
<http://bio2rdf.org/drugbank:BE0000456>	<http://bio2rdf.org/drugbank_vocabulary:cellular-location>	"Mitochondrion (Probable)"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0000456>	<http://bio2rdf.org/drugbank_vocabulary:name>	"Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-4>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00109-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:6215bb81f14ea29a233fa4efbf660bf9>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:6215bb81f14ea29a233fa4efbf660bf9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-1>	<http://www.w3.org/2000/01/rdf-schema#label>	"Hydrophobicity: -0.307 [drugbank_resource:experimental-properties-DB00103-1]"@en .
<http://bio2rdf.org/drugbank_resource:2c7d5048f3ab623475c1e9c503997a85>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"2c7d5048f3ab623475c1e9c503997a85"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-17>	<http://purl.org/dc/terms/title>	"Rotatable Bond Count: 7 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-11>	<http://purl.org/dc/terms/title>	"Molecular Formula: C19H23N7O6 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:f31c373ea0d5f6b6f514f58cf30652a6>	<http://www.w3.org/2000/01/rdf-schema#label>	"mechanism-of-action for drugbank:DB00092 [drugbank_resource:f31c373ea0d5f6b6f514f58cf30652a6]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-3>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00112-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ae0431719c906d80aa97a27025adc99f>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:ae0431719c906d80aa97a27025adc99f"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00091-1>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00091-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:efdc5ed439af008904afce03f4dd2ec8>	<http://purl.org/dc/terms/description>	"Filgrastim binds to the G-CSF receptor and stimulates the production of neutrophils in the bone marrow. As a G-CSF analog, it controls proliferation of committed progenitor cells and influences their maturation into mature neutrophils. Filgrastim also stimulates the release of neutrophils from bone marrow storage pools and reduces their maturation time. Filgrastim acts to increase the phagocytic activity of mature neutrophils. In patients receiving cytotoxic chemotherapy, Filgrastim can accelerate neutrophil recovery, leading to a reduction in duration of the neutropenic phase"@en .
<http://bio2rdf.org/drugbank:DB00111>	<http://www.w3.org/2000/01/rdf-schema#label>	"Daclizumab [drugbank:DB00111]"@en .
<http://bio2rdf.org/drugbank_resource:20aa32f603258f15ceef0ba521a5bd87>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:20aa32f603258f15ceef0ba521a5bd87"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/BE0002638> .
<http://bio2rdf.org/pubchem.substance:46506428>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/pubchem.substance:46506428"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:da9625c635b6c208626fef4666f9f883>	<http://www.w3.org/2000/01/rdf-schema#label>	"Aryl-aldehyde [drugbank_resource:da9625c635b6c208626fef4666f9f883]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-8>	<http://purl.org/dc/terms/title>	"Traditional IUPAC Name: 30-ethyl-14,17,23,32-tetrahydroxy-33-[(4E)-1-hydroxy-2-methylhex-4-en-1-yl]-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-13,16,22,31-tetraene-2,5,8,11,20,26,29-heptone from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-16>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00118-16"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:53e4e7c3f9db35ed7e24a59c1546788c>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:53e4e7c3f9db35ed7e24a59c1546788c"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-3>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00107-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-13>	<http://bio2rdf.org/drugbank_vocabulary:value>	"InChIKey=MSTNYGQPCMXVAQ-KIYNQFGBSA-N"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:d46b970056d0a083cca1f813197ccf0c>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:f302a4399eb77cf92256045001dbcc5c> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-2>	<http://bio2rdf.org/drugbank_vocabulary:value>	"4.3"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-2>	<http://bio2rdf.org/drugbank_vocabulary:value>	"5.17"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:99633b36b8289d3e0a8562067bd42c03>	<http://purl.org/dc/terms/description>	"45-102 min"@en .
<http://bio2rdf.org/drugbank_resource:228bf0dff0e17c650e98e541c5291e94>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:228bf0dff0e17c650e98e541c5291e94"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-9>	<http://www.w3.org/2000/01/rdf-schema#label>	"Monoisotopic Weight: 1039.436791367 from ChemAxon [drugbank_resource:calculated-properties-DB00093-9]"@en .
<http://bio2rdf.org/drugbank_resource:20aa32f603258f15ceef0ba521a5bd87>	<http://purl.org/dc/terms/title>	"mechanism-of-action for drugbank:DB00096"@en .
<http://bio2rdf.org/drugbank_resource:e91ecbd8702c2bd53755e648fa5c9435>	<http://purl.org/dc/terms/title>	"manufacturer for drugbank:DB00104"@en .
<http://bio2rdf.org/drugbank_resource:7abeba6bed290a4b16075521bc0113ca>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:7abeba6bed290a4b16075521bc0113ca"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:transmembrane-regions>	"None"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-5>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-1>	<http://www.w3.org/2000/01/rdf-schema#label>	"Hydrophobicity: -0.300 [drugbank_resource:experimental-properties-DB00090-1]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-19>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00115-19"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:1059233feb371b14b03a21571fa19968>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:1059233feb371b14b03a21571fa19968"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a9a58af69a8539d913c65b788eb5b178>	<http://purl.org/dc/terms/title>	"indication for drugbank:DB00107"@en .
<http://bio2rdf.org/pdb:SAM>	<http://purl.org/dc/terms/identifier>	"pdb:SAM"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00105>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:DB00105"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:069ab916580192548ff172f164a424bf>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:069ab916580192548ff172f164a424bf"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-13>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00115-13"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-8>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00116-8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-29>	<http://purl.org/dc/terms/title>	"Rule of Five: 1 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-2>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00090-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-5>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Formula: C6398H9900N1714O1995S54 [drugbank_resource:experimental-properties-DB00113-5]"@en .
<http://bio2rdf.org/drugbank_resource:7975713dad73e24fab2cbb6c89586ea4>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:7975713dad73e24fab2cbb6c89586ea4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-10>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00118-10"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fe02b6034f5c4d73f73a58815355abf5>	<http://purl.org/dc/terms/title>	"300 ug/.5mL Injection, solution form with intravenous; subcutaneous route"@en .
<http://bio2rdf.org/drugbank:BE0000300>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-21>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00114-21"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f84c0f373fd98f4297607f206aadd302>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:f84c0f373fd98f4297607f206aadd302"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f30bb36d9cf1cde63e806eb49b64d341>	<http://purl.org/dc/terms/title>	"Organic cations"@en .
<http://bio2rdf.org/drugbank_resource:29ad2163821ce9d547ef52b7bddcf404>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:29ad2163821ce9d547ef52b7bddcf404"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:180176f4e85931ffb36c855eab8691da>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"180176f4e85931ffb36c855eab8691da"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fffcf97ccb1aeb21dae91caa501b8255>	<http://www.w3.org/2000/01/rdf-schema#label>	"Aniline [drugbank_resource:fffcf97ccb1aeb21dae91caa501b8255]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-14>	<http://purl.org/dc/terms/title>	"SMILES: N[C@@H](CC1=CN=CN1)C(O)=O from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:e91ecbd8702c2bd53755e648fa5c9435>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"e91ecbd8702c2bd53755e648fa5c9435"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:b86c00de25382c6ce4d94dae5e4502db>	<http://purl.org/dc/terms/title>	"Benzoyl"@en .
<http://bio2rdf.org/drugbank_resource:684d8812e411c70454900dc745e593c8>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:684d8812e411c70454900dc745e593c8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Dietary-Supplements>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:Dietary-Supplements"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Drug>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:Drug"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-11>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00093-11"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-1>	<http://www.w3.org/2000/01/rdf-schema#label>	"Melting Point: 61 \u00B0C (FAB fragment), 71 \u00B0C (whole mAb) from Vermeer, A.W.P. & Norde, W., Biophys. J. 78:394-404 (2000) [drugbank_resource:experimental-properties-DB00113-1]"@en .
<http://bio2rdf.org/drugbank_resource:22baeb726de652a99f0ad2fb61fac832>	<http://www.w3.org/2000/01/rdf-schema#label>	"Hippuric acid or derivatives [drugbank_resource:22baeb726de652a99f0ad2fb61fac832]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-3>	<http://purl.org/dc/terms/title>	"Molecular Weight: 55597.4000"@en .
<http://bio2rdf.org/drugbank_resource:2d6f2db0443dc24ac01149b8df7afb05>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:2d6f2db0443dc24ac01149b8df7afb05"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-4>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:b8238b8599e6fdc40599cf773d5fb991>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"b8238b8599e6fdc40599cf773d5fb991"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:129ef94b8ca8b89a244a3cd1c5b2c72b>	<http://purl.org/dc/terms/title>	"1,2-diol"@en .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00932>	<http://www.w3.org/2000/01/rdf-schema#label>	"DDI between Enfuvirtide and Tipranavir - May increase the serum concentration of Protease Inhibitors. Protease Inhibitors may increase the serum concentration of Enfuvirtide. [drugbank_resource:DB00109_DB00932]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-3>	<http://purl.org/dc/terms/title>	"Isoelectric Point: 8.46"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-9>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00091-9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:db3cf7df3e4a56b21665da45352819bc>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:db3cf7df3e4a56b21665da45352819bc"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-28>	<http://purl.org/dc/terms/title>	"Bioavailability: 1 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-14>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-14"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-5>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Formula: C860H1353N229O255S9 [drugbank_resource:experimental-properties-DB00105-5]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-13>	<http://www.w3.org/2000/01/rdf-schema#label>	"Monoisotopic Weight: 155.069476547 from ChemAxon [drugbank_resource:calculated-properties-DB00117-13]"@en .
<http://bio2rdf.org/drugbank_resource:0d54035b86f9a43f56ecd493c3a6fd59>	<http://www.w3.org/2000/01/rdf-schema#label>	"Benzenoids [drugbank_resource:0d54035b86f9a43f56ecd493c3a6fd59]"@en .
<http://bio2rdf.org/drugbank_resource:6be4db795caa5a4f0e9b208f115d277b>	<http://purl.org/dc/terms/title>	"mechanism-of-action for drugbank:DB00112"@en .
<http://bio2rdf.org/drugbank_resource:2c808757b9d5f22f13a70bae1f9e7737>	<http://www.w3.org/2000/01/rdf-schema#label>	"Primary aliphatic amine [drugbank_resource:2c808757b9d5f22f13a70bae1f9e7737]"@en .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:gene-name>	"PREP"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-3>	<http://www.w3.org/2000/01/rdf-schema#label>	"Isoelectric Point: 7.50 [drugbank_resource:experimental-properties-DB00094-3]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-5>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00097-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00091-2>	<http://purl.org/dc/terms/title>	"caco2 Permeability: -6.05 from ADME Research, USCD"@en .
<http://bio2rdf.org/drugbank_resource:f84c0f373fd98f4297607f206aadd302>	<http://purl.org/dc/terms/title>	"Pyrimidone"@en .
<http://bio2rdf.org/pubchem.compound:6274>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/pubchem.compound:6274"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-7>	<http://purl.org/dc/terms/title>	"IUPAC Name: 30-ethyl-14,17,23,32-tetrahydroxy-33-[(4E)-1-hydroxy-2-methylhex-4-en-1-yl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-13,16,22,31-tetraene-2,5,8,11,20,26,29-heptone from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:85745be17d6c5d398a5d3540508f1a44>	<http://purl.org/dc/terms/title>	"Methylpyridine"@en .
<http://bio2rdf.org/drugbank_resource:Citanest-Dental-Octapressin>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"Citanest-Dental-Octapressin"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-5>	<http://purl.org/dc/terms/title>	"logP: -5.3 from ChemAxon"@en .
<http://bio2rdf.org/chemspider:31983>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"31983"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:70d5905dbbb671a2bf66275527b38e09>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:70d5905dbbb671a2bf66275527b38e09"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:cellular-location>	"Endoplasmic reticulum"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-2>	<http://bio2rdf.org/drugbank_vocabulary:value>	"7.86"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-21>	<http://bio2rdf.org/drugbank_vocabulary:value>	"3.69"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:cellular-location>	"Endoplasmic reticulum"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:cellular-location>	"Endoplasmic reticulum"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-11>	<http://purl.org/dc/terms/title>	"Molecular Formula: C63H89CoN14O14P from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:6be4db795caa5a4f0e9b208f115d277b>	<http://purl.org/dc/terms/description>	"Bevacizumab contains human framework regions with antigen binding regions of a humanised murine antibody that binds to VEGF. Bevacizumab is produced by recombinant DNA technology in a Chinese hamster ovary mammalian cell expression system in a nutrient medium containing the antibiotic gentamicin and is purified by a process that includes specific viral inactivation and removal steps. Bevacizumab binds VEGF and prevents the interaction of VEGF to its receptors (Flt-1 and KDR) on the surface of endothelial cells. This prevents blood vessel proliferation and in response retardation of metastatic tumor growth occurs."@en .
<http://bio2rdf.org/drugbank_resource:8750c04d33b8546006e83e736eb80647>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"300 ug/mL"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-26>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00116-26"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:75aa077303c09d80af404a7a6c6ac735>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"300 ug/.5mL"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:99633b36b8289d3e0a8562067bd42c03>	<http://purl.org/dc/terms/title>	"half-life for drugbank:DB00103"@en .
<http://bio2rdf.org/drugbank_resource:ae52c40c7c1761e3027e159477756625>	<http://www.w3.org/2000/01/rdf-schema#label>	"1-ribofuranosylbenzimidazole [drugbank_resource:ae52c40c7c1761e3027e159477756625]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-2>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00107-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00100>	<http://purl.org/dc/terms/identifier>	"drugbank:DB00100"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-18>	<http://www.w3.org/2000/01/rdf-schema#label>	"H Bond Acceptor Count: 12 from ChemAxon [drugbank_resource:calculated-properties-DB00116-18]"@en .
<http://bio2rdf.org/drugbank_resource:4aaab29fd43effbe133e376c024d5f06>	<http://www.w3.org/2000/01/rdf-schema#label>	"Secondary amine [drugbank_resource:4aaab29fd43effbe133e376c024d5f06]"@en .
<http://bio2rdf.org/drugbank_resource:85e4414ae6d2bc12695a4539100e286f>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"85e4414ae6d2bc12695a4539100e286f"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:4d9d641daef8c178a249f1266f1150e5>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:4d9d641daef8c178a249f1266f1150e5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-5>	<http://purl.org/dc/terms/title>	"Molecular Formula: C1105H1770N318O336S26"@en .
<http://bio2rdf.org/drugbank:DB00092>	<http://purl.org/dc/terms/title>	"Alefacept"@en .
<http://bio2rdf.org/drugbank_resource:DB00115_DB00446>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00115_DB00446"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"Nifedipine oxidase"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"protein metabolism"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-5>	<http://bio2rdf.org/drugbank_vocabulary:value>	"-1.6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00503>	<http://www.w3.org/2000/01/rdf-schema#label>	"DDI between Enfuvirtide and Ritonavir - May increase the serum concentration of Protease Inhibitors. Protease Inhibitors may increase the serum concentration of Enfuvirtide. [drugbank_resource:DB00109_DB00503]"@en .
<http://bio2rdf.org/drugbank_resource:DB00109_DB06290>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:DB00109_DB06290"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:abd3e42d8c67111954c278994aa4591d>	<http://www.w3.org/2000/01/rdf-schema#label>	"Replagal [drugbank_vocabulary:abd3e42d8c67111954c278994aa4591d]"@en .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00363>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00112_DB00363"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f31c373ea0d5f6b6f514f58cf30652a6>	<http://purl.org/dc/terms/title>	"mechanism-of-action for drugbank:DB00092"@en .
<http://bio2rdf.org/drugbank_resource:1c54727b6a9a48b74b53723fbee43d80>	<http://www.w3.org/2000/01/rdf-schema#label>	"mechanism-of-action for drugbank:DB00091 [drugbank_resource:1c54727b6a9a48b74b53723fbee43d80]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-19>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00116-19"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:9e044243b5eb2f95578c80df6000ecdd>	<http://purl.org/dc/terms/title>	"Optison"@en .
<http://bio2rdf.org/drugbank_resource:3549163466db2fa5b979545848c2ef00>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:3549163466db2fa5b979545848c2ef00"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-25>	<http://www.w3.org/2000/01/rdf-schema#label>	"Bioavailability: 0 from ChemAxon [drugbank_resource:calculated-properties-DB00091-25]"@en .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"CYPIIIA4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00118>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:00199edd2aba5de431eaa55bda5406d7>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:00199edd2aba5de431eaa55bda5406d7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00117>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-15>	<http://www.w3.org/2000/01/rdf-schema#label>	"Refractivity: 264.79 from ChemAxon [drugbank_resource:calculated-properties-DB00093-15]"@en .
<http://bio2rdf.org/drugbank_resource:180176f4e85931ffb36c855eab8691da>	<http://purl.org/dc/terms/description>	"Coagulation Factor IX is an important protein in the process of hemostasis and normal blood clotting. Factor IX is plays an important intermediate role in the blood coagulation cascade. It is located within the blood plasma as a zymogen, an antecedent to enzymatic function, in its inactivated state. Factor IX is dependent on the presence of Vitamin K, and is activated to a serine protease by the function of Coagulation Factor XIa. Factor XIa cleaves the peptide bond associated with protein activation in Factor IX, leaving Factor IX with two exposed chains, a light chain and a heavy chain. These two chains are held together by several disulfide bonds that reinforce the structure of Factor IX's activated form. After being activated, Factor IX forms a complex with calcium ions, membrane phospholipids and Coagulation Factor VIII to activate Coagulation Factor X. The activation of Factor X then performs a similarly integral step in the blood coagulation cascade. The ultimate result of phenotypically normal coagulation factors is the creation of platelets for normal blood clotting."@en .
<http://bio2rdf.org/drugbank:DB00116>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"metabolism"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:78c0a8b73fca87dcc5402f26970c94a4>	<http://purl.org/dc/terms/title>	"half-life for drugbank:DB00115"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-5>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Formula: C2936H4624N786O889S41 [drugbank_resource:experimental-properties-DB00096-5]"@en .
<http://bio2rdf.org/drugbank:DB00115>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-19>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-19"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00118>	<http://purl.org/dc/terms/identifier>	"drugbank:DB00118"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00114>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:4f9f96147f2386295de420eed7aa9274>	<http://purl.org/dc/terms/description>	"approximately 20 days (range: 11\u201350 days)"@en .
<http://bio2rdf.org/drugbank_resource:9ea94506ab138833cc18501d48712af4>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:9ea94506ab138833cc18501d48712af4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00113>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-2>	<http://www.w3.org/2000/01/rdf-schema#label>	"Isoelectric Point: 4.30 [drugbank_resource:experimental-properties-DB00109-2]"@en .
<http://bio2rdf.org/drugbank:DB00112>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:282d8423d2c45b369fa817ef1edbccd5>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:282d8423d2c45b369fa817ef1edbccd5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:450004b6cb1a30c3690aa11d2cd941a2>	<http://purl.org/dc/terms/title>	"absorption for drugbank:DB00115"@en .
<http://bio2rdf.org/drugbank:DB00111>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:DB00110_DB08879>	<http://purl.org/dc/terms/title>	"DDI between Palivizumab and Belimumab - Monoclonal Antibodies may enhance the adverse/toxic effect of Belimumab."@en .
<http://bio2rdf.org/drugbank:DB00110>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank:DB00109>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank:DB00107>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank:DB00106>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:6d460a13d1af93268984ab262cef479d>	<http://www.w3.org/2000/01/rdf-schema#label>	"mechanism-of-action for drugbank:DB00110 [drugbank_resource:6d460a13d1af93268984ab262cef479d]"@en .
<http://bio2rdf.org/drugbank:DB00105>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:2af3e19f02b1eb81db93222ed2b38a44>	<http://purl.org/dc/terms/title>	"mechanism-of-action for drugbank:DB00107"@en .
<http://bio2rdf.org/drugbank_resource:408e99a507da89ecb16b006481be4f7d>	<http://purl.org/dc/terms/title>	"Primary aromatic amine"@en .
<http://bio2rdf.org/drugbank:DB00095>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:DB00095"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:85e4414ae6d2bc12695a4539100e286f>	<http://purl.org/dc/terms/title>	"mechanism-of-action for drugbank:DB00115"@en .
<http://bio2rdf.org/drugbank:DB00103>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-26>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00116-26"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:7b6b9c68c4dd8e5a8f74e987f9a92ce7>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:7b6b9c68c4dd8e5a8f74e987f9a92ce7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-7>	<http://bio2rdf.org/drugbank_vocabulary:value>	"SAMe"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00102>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:08f1295028a77909e61816add07f6343>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:08f1295028a77909e61816add07f6343"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:47d86c7cb8687c843b27225a6715c3c1>	<http://www.w3.org/2000/01/rdf-schema#label>	"Carboxylic acids [drugbank_resource:47d86c7cb8687c843b27225a6715c3c1]"@en .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"Debrisoquine 4-hydroxylase"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00100>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:7b6b9c68c4dd8e5a8f74e987f9a92ce7>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:7b6b9c68c4dd8e5a8f74e987f9a92ce7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00099>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:e6fc137e236497aea65dd3bb99d52e53>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"e6fc137e236497aea65dd3bb99d52e53"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-9>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00117-9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00107_DB00834>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00107_DB00834"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00097>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00118-1>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00118-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-2>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00109-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00096>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:8e7e8f5ff3cf3466586b956d7330151b>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"8e7e8f5ff3cf3466586b956d7330151b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00095>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:5b282e6fa4562e2752afccabea3c29c1>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:5b282e6fa4562e2752afccabea3c29c1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:01c6a15f6a299a85cd866fc4092d0dce>	<http://www.w3.org/2000/01/rdf-schema#label>	"100 mg/mL Solution form with oral route [drugbank_resource:01c6a15f6a299a85cd866fc4092d0dce]"@en .
<http://bio2rdf.org/drugbank_vocabulary:Micronutrients>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"Micronutrients"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00094>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-5>	<http://purl.org/dc/terms/title>	"Molecular Formula: C2936H4624N786O889S41"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00115-1>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00115-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00093>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:abc4b12d5153eba9af71c2c651bd4ff1>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"abc4b12d5153eba9af71c2c651bd4ff1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Nutraceutical>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:Nutraceutical"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-14>	<http://purl.org/dc/terms/title>	"Polar Surface Area (PSA): 182.63 from ChemAxon"@en .
<http://bio2rdf.org/drugbank:DB00092>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_vocabulary:0f3c814d30566a7614f1fab32f4e0302>	<http://purl.org/dc/terms/title>	"Fertinex"@en .
<http://bio2rdf.org/drugbank_resource:DB00115_DB00446>	<http://www.w3.org/2000/01/rdf-schema#label>	"DDI between Cyanocobalamin and Chloramphenicol - May diminish the therapeutic effect of Vitamin B12. [drugbank_resource:DB00115_DB00446]"@en .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00115"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00093"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00091>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:d8c37e1ee64fc7f014205837681e99df>	<http://purl.org/dc/terms/description>	"Binds selectively to cell-surface prostate-specific membrane antigen (PSMA) expressed on prostate tissues and tumors."@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-21>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00093-21"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00090>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-7>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00093-7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-25>	<http://purl.org/dc/terms/title>	"Bioavailability: 0 from ChemAxon"@en .
<http://bio2rdf.org/drugbank:DB00089>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-2>	<http://purl.org/dc/terms/title>	"Hydrophobicity: -0.258"@en .
<http://bio2rdf.org/drugbank:DB00088>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-5>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-5>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-4>	<http://purl.org/dc/terms/title>	"Molecular Weight: 25719.7000"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00089-1>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00089-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00099>	<http://www.w3.org/2000/01/rdf-schema#label>	"Filgrastim [drugbank:DB00099]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-3>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00115-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:6f3fc4bb7965f22f3fc655ec5e1faab0>	<http://purl.org/dc/terms/title>	"Alpha-amino acid or derivatives"@en .
<http://bio2rdf.org/drugbank:DB00117>	<http://purl.org/dc/terms/description>	"An essential amino acid that is required for the production of histamine. [PubChem]"@en .
<http://bio2rdf.org/drugbank_resource:7767fecbc1fcbba1764734e284afdd13>	<http://purl.org/dc/terms/description>	"* 0.29 +/- 0.04 L/h [healthy down-regulated females]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-24>	<http://purl.org/dc/terms/title>	"Bioavailability: 0 from ChemAxon"@en .
<http://bio2rdf.org/drugbank:DB00109>	<http://purl.org/dc/terms/description>	"36 residue synthetic peptide that inhibits HIV-1 fusion with CD4 cells. N-terminal acetylated, C-terminal amide."@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-20>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00118-20"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:1cb2d5b9df573a57849083d75e49a5fe>	<http://www.w3.org/2000/01/rdf-schema#label>	"Hydroxypyridines [drugbank_resource:1cb2d5b9df573a57849083d75e49a5fe]"@en .
<http://bio2rdf.org/drugbank_resource:2696048bf20ed0e2d578eb2938c6d8d3>	<http://purl.org/dc/terms/description>	"Following intravenous administration, the blood clearance of cyclosporine (assay: HPLC) is approximately 5 to 7 mL/min/kg in adult recipients of renal or liver allografts. Blood cyclosporine clearance appears to be slightly slower in cardiac transplant patients. The following are clearance parameters (CL/F) for select patient populations:\r\n * 593 \u00B1 204 mL/min [De novo renal transplant patients, 597\u00B1174 mg/day] \r\n * 492 \u00B1 140 mL/min [Stable renal transplant patients, 344\u00B1122 mg/day] \r\n * 577 \u00B1 309 mL/min [De novo liver transplant, 458\u00B1190 mg/day] \r\n * 613 \u00B1 196 mL/min [De novo rheumatoid arthritis, 182\u00B155.6 mg/day] \r\n * 723 \u00B1 186 mL/min [De novo psoriasis, 189\u00B169.8 mg/day] \t\r\n * 285 \u00B1 94 mL/min [Stable Liver Transplant, Age 2 - 8, Dosed T.I.D 101\u00B125 mg/day] \r\n * 378 \u00B1 80 mL/min [Stable Liver Transplant, Age 8 - 15, Dosed B.I.D 188\u00B155 mg/day] \t \r\n * 171 mL/min [Stable liver transplant, Age 3, Dosed B.I.D 120 mg/day]\r\n * 328 \u00B1 121 mL/min [Stable liver transplant, Age 8 - 15, Dosed B.I.D 158\u00B155 mg/day] \t\r\n * 418 \u00B1 143 mL/min [Stable renal transplant, Age 7 - 15, Dosed B.I.D 328\u00B183 mg/day]"@en .
<http://bio2rdf.org/drugbank_resource:f2540530a3858d9fa40e7bfd96e4c77d>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:f2540530a3858d9fa40e7bfd96e4c77d"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0000456>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"EC 2.5.1.17"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-5>	<http://bio2rdf.org/drugbank_vocabulary:value>	"-4.2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fc61d172cba7ae19145ff846ca1f0aef>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:fc61d172cba7ae19145ff846ca1f0aef"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-3>	<http://www.w3.org/2000/01/rdf-schema#label>	"Isoelectric Point: 5.65 [drugbank_resource:experimental-properties-DB00099-3]"@en .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"S- mephenytoin 4-hydroxylase"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-8>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Weight: 1040.219 from ChemAxon [drugbank_resource:calculated-properties-DB00093-8]"@en .
<http://bio2rdf.org/drugbank_resource:DB00109_DB03880>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00109_DB03880"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-26>	<http://purl.org/dc/terms/title>	"Physiological Charge: 0 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:f5f75e6bf165e0a25b8c2fab60ccf2e0>	<http://www.w3.org/2000/01/rdf-schema#label>	"Cyanide salts [drugbank_resource:f5f75e6bf165e0a25b8c2fab60ccf2e0]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00115-1>	<http://purl.org/dc/terms/title>	"Water Solubility: 1.25E+004 mg/L from MERCK INDEX (1996)"@en .
<http://bio2rdf.org/drugbank_vocabulary:64789d808f73ebe8eac3dbded4a95da0>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:64789d808f73ebe8eac3dbded4a95da0"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-8>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00116-8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c7d119b1e6d46c382382c2c17e2801ac>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:c7d119b1e6d46c382382c2c17e2801ac"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-1>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00105-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:9e044243b5eb2f95578c80df6000ecdd>	<http://bio2rdf.org/drugbank_vocabulary:name>	"Optison"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-25>	<http://purl.org/dc/terms/title>	"Rule of Five: 1 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:e4e539077bcedbc155e950cadab01679>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:e4e539077bcedbc155e950cadab01679"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Vitamins>	<http://purl.org/dc/terms/title>	"Vitamins"@en .
<http://bio2rdf.org/drugbank_resource:fa9ea24c47c4cc6ec20e42b245e43401>	<http://www.w3.org/2000/01/rdf-schema#label>	"indication for drugbank:DB00103 [drugbank_resource:fa9ea24c47c4cc6ec20e42b245e43401]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-8>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:9e10be5c3dafcd8441cdeb69f72cc3f4>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"9e10be5c3dafcd8441cdeb69f72cc3f4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:0235e5251bcfc61913eb18c0fab6a1c4>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:0235e5251bcfc61913eb18c0fab6a1c4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-11>	<http://purl.org/dc/terms/title>	"Molecular Formula: C46H65N13O11S2 from ChemAxon"@en .
<http://bio2rdf.org/drugbank:DB00089>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00089"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:23e60560991f40f7f335be06f10675e1>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:23e60560991f40f7f335be06f10675e1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/chemspider:6038>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/chemspider:6038"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://purl.org/dc/terms/identifier>	"drugbank:BE0002887"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:da8dbfa1d167bdbfac5e83608be911ea>	<http://purl.org/dc/terms/description>	"~270 hours"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-4>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Weight: 66472.2000 [drugbank_resource:experimental-properties-DB00096-4]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-3>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-15>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00114-15"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:77b52954fa911921450d2b426c1a7a3a>	<http://purl.org/dc/terms/title>	"Tetrahydrofolic acid"@en .
<http://bio2rdf.org/drugbank_vocabulary:908621b9e3153f791dd6dbd4ef6d62a5>	<http://purl.org/dc/terms/title>	"CEA-Scan"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-4>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Weight: 980.1620 [drugbank_resource:experimental-properties-DB00094-4]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-14>	<http://www.w3.org/2000/01/rdf-schema#label>	"SMILES: N[C@@H](CC1=CN=CN1)C(O)=O from ChemAxon [drugbank_resource:calculated-properties-DB00117-14]"@en .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:x-chemspider>	<http://bio2rdf.org/chemspider:4575342> .
<http://bio2rdf.org/drugbank_resource:30d0083606d3fa4b4b602b5d3ed0feda>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:30d0083606d3fa4b4b602b5d3ed0feda"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-2>	<http://bio2rdf.org/drugbank_vocabulary:value>	"-0.330"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pubchem.compound:6274>	<http://bio2rdf.org/skos:exactMatch>	<http://rdf.ncbi.nlm.nih.gov/pubchem/compound/6274> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-29>	<http://purl.org/dc/terms/title>	"MDDR-Like Rule: 0 from ChemAxon"@en .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"metabolism"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-3>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00096-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pubchem.compound:91443>	<http://bio2rdf.org/skos:exactMatch>	<http://rdf.ncbi.nlm.nih.gov/pubchem/compound/91443> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-24>	<http://purl.org/dc/terms/title>	"Bioavailability: 1 from ChemAxon"@en .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:x-chemspider>	<http://bio2rdf.org/chemspider:1022> .
<http://bio2rdf.org/pubchem.compound:6274>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"6274"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-23>	<http://purl.org/dc/terms/title>	"pKa (strongest basic): 4.11 from ChemAxon"@en .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:x-chemspider>	<http://bio2rdf.org/chemspider:6038> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00503>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:DB00109_DB00503"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:fe02b6034f5c4d73f73a58815355abf5>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:fe02b6034f5c4d73f73a58815355abf5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:amino-acid-sequence>	">Cytochrome P450 2C8\nMEPFVVLVLCLSFMLLFSLWRQSCRRRKLPPGPTPLPIIGNMLQIDVKDICKSFTNFSKV\nYGPVFTVYFGMNPIVVFHGYEAVKEALIDNGEEFSGRGNSPISQRITKGLGIISSNGKRW\nKEIRRFSLTTLRNFGMGKRSIEDRVQEEAHCLVEELRKTKASPCDPTFILGCAPCNVICS\nVVFQKRFDYKDQNFLTLMKRFNENFRILNSPWIQVCNNFPLLIDCFPGTHNKVLKNVALT\nRSYIREKVKEHQASLDVNNPRDFIDCFLIKMEQEKDNQKSEFNIENLVGTVADLFVAGTE\nTTSTTLRYGLLLLLKHPEVTAKVQEEIDHVIGRHRSPCMQDRSHMPYTDAVVHEIQRYSD\nLVPTGVPHAVTTDTKFRNYLIPKGTTIMALLTSVLHDDKEFPNPNIFDPGHFLDKNGNFK\nKSDYFMPFSAGKRICAGEGLARMELFLFLTTILQNFNLKSVDDLKNLNTTAVTKGIVSLP\nPSYQICFIPV"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2ddeeca2fe9449969ab1519d768237c6>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"100 mg/4mL"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:x-chemspider>	<http://bio2rdf.org/chemspider:82572> .
<http://bio2rdf.org/drugbank_vocabulary:Hematopoietic-Agents>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"Hematopoietic-Agents"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:x-uniprot>	<http://bio2rdf.org/uniprot:P10632> .
<http://bio2rdf.org/drugbank_resource:5888181b550399d2a84e1e4db3715340>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"5888181b550399d2a84e1e4db3715340"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-20>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00091-20"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:773530fb248596d00289b12dba48a0cc>	<http://www.w3.org/2000/01/rdf-schema#label>	"Monocarboxylic acids and derivatives [drugbank_resource:773530fb248596d00289b12dba48a0cc]"@en .
<http://bio2rdf.org/drugbank_resource:fc61d172cba7ae19145ff846ca1f0aef>	<http://purl.org/dc/terms/title>	"This compound belongs to the class of organic compounds known as tetrahydrofolic acids. These are heterocyclic compounds based on the 5,6,7,8-tetrahydropteroic acid skeleton conjugated with at least one L-glutamic acid unit."@en .
<http://bio2rdf.org/drugbank_resource:de11407327a5468776fbcbec28a97ca0>	<http://purl.org/dc/terms/title>	"Hydroxypyridine"@en .
<http://bio2rdf.org/pubchem.compound:44176380>	<http://bio2rdf.org/skos:exactMatch>	<http://rdf.ncbi.nlm.nih.gov/pubchem/compound/44176380> .
<http://bio2rdf.org/drugbank_resource:c7d119b1e6d46c382382c2c17e2801ac>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"c7d119b1e6d46c382382c2c17e2801ac"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pubchem.compound:34756>	<http://bio2rdf.org/skos:exactMatch>	<http://rdf.ncbi.nlm.nih.gov/pubchem/compound/34756> .
<http://bio2rdf.org/drugbank_resource:408e99a507da89ecb16b006481be4f7d>	<http://www.w3.org/2000/01/rdf-schema#label>	"Primary aromatic amine [drugbank_resource:408e99a507da89ecb16b006481be4f7d]"@en .
<http://bio2rdf.org/drugbank_resource:195ccf935d3c9947bcc17b096fdca329>	<http://www.w3.org/2000/01/rdf-schema#label>	"Alpha-amino acid [drugbank_resource:195ccf935d3c9947bcc17b096fdca329]"@en .
<http://bio2rdf.org/drugbank_resource:17b27330dfdb2b245beadb493e911ddb>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"17b27330dfdb2b245beadb493e911ddb"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-18>	<http://purl.org/dc/terms/title>	"Polarizability: 20.9 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:2c7d5048f3ab623475c1e9c503997a85>	<http://www.w3.org/2000/01/rdf-schema#label>	"Benzimidazole [drugbank_resource:2c7d5048f3ab623475c1e9c503997a85]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-5>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:1cb2d5b9df573a57849083d75e49a5fe>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:1cb2d5b9df573a57849083d75e49a5fe"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:ab9182be757cbb637b820f0951931ae2>	<http://www.w3.org/2000/01/rdf-schema#label>	"Bedodeka [drugbank_vocabulary:ab9182be757cbb637b820f0951931ae2]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-2>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Resource>	<http://semanticscience.org/resource/is-member-of>	<http://bio2rdf.org/lsr:drugbank> .
<http://bio2rdf.org/drugbank_vocabulary:705836a5549e0548d20a0ef04e009f28>	<http://www.w3.org/2000/01/rdf-schema#label>	"Syntocinon [drugbank_vocabulary:705836a5549e0548d20a0ef04e009f28]"@en .
<http://bio2rdf.org/pubchem.compound:1051>	<http://bio2rdf.org/skos:exactMatch>	<http://rdf.ncbi.nlm.nih.gov/pubchem/compound/1051> .
<http://bio2rdf.org/drugbank_resource:eda68d4a7955df0290c1f8b709e905ec>	<http://purl.org/dc/terms/title>	"mechanism-of-action for drugbank:DB00090"@en .
<http://bio2rdf.org/drugbank_resource:d8c37e1ee64fc7f014205837681e99df>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-4>	<http://purl.org/dc/terms/title>	"Molecular Weight: 142612.1000"@en .
<http://bio2rdf.org/drugbank:DB00107>	<http://www.w3.org/2000/01/rdf-schema#label>	"Oxytocin [drugbank:DB00107]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-20>	<http://bio2rdf.org/drugbank_vocabulary:value>	"3.51"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"P450 IIC2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-2>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00116-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"peptidase activity"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-25>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-25"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00107>	<http://purl.org/dc/terms/title>	"Oxytocin"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-10>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00116-10"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:57db98e1612a44845256ccbbbc457ff8>	<http://purl.org/dc/terms/title>	"half-life for drugbank:DB00107"@en .
<http://bio2rdf.org/drugbank_vocabulary:ab9182be757cbb637b820f0951931ae2>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:ab9182be757cbb637b820f0951931ae2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:x-bindingdb>	<http://bio2rdf.org/bindingdb:7953> .
<http://bio2rdf.org/drugbank_resource:913e4e077c76fcc7c941f5fbedf4db30>	<http://purl.org/dc/terms/title>	"absorption for drugbank:DB00034"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-16>	<http://bio2rdf.org/drugbank_vocabulary:value>	"40.37"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:3d51d314e6796004243d124d2c5f0793>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:3d51d314e6796004243d124d2c5f0793"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:5ba52774f54e88019dd4d17f32a34f7b>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"5ba52774f54e88019dd4d17f32a34f7b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:80e4560d8a88ff69231ec21ee09506be>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:80e4560d8a88ff69231ec21ee09506be"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0000456>	<http://bio2rdf.org/drugbank_vocabulary:x-taxonomy>	<http://bio2rdf.org/taxonomy:9606> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-4>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:e78186eb12eeaebda8a530a67513beea>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"e78186eb12eeaebda8a530a67513beea"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-12>	<http://bio2rdf.org/drugbank_vocabulary:value>	"CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:7fc0069b68f72ba58fdad65bec3cc1df>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:7fc0069b68f72ba58fdad65bec3cc1df"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:38b20638a91b63e0378b18fb8d8f4c38>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"38b20638a91b63e0378b18fb8d8f4c38"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:78c0a8b73fca87dcc5402f26970c94a4>	<http://purl.org/dc/terms/description>	"Approximately 6 days (400 days in the liver)."@en .
<http://bio2rdf.org/drugbank_resource:8750c04d33b8546006e83e736eb80647>	<http://www.w3.org/2000/01/rdf-schema#label>	"300 ug/mL Injection, solution form with intravenous route [drugbank_resource:8750c04d33b8546006e83e736eb80647]"@en .
<http://bio2rdf.org/drugbank_resource:1c7495e7ba342d224b5028d72d73010d>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"1c7495e7ba342d224b5028d72d73010d"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-12>	<http://bio2rdf.org/drugbank_vocabulary:value>	"InChI=1S/C62H90N13O14P.CN.Co/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;1-2;/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H15,63,64,65,66,67,68,69,71,72,73,74,77,78,79,80,81,82,83,85,86);;/q;;+1/p-1/t31-,34-,35-,36-,37+,41-,52-,53-,56-,57+,59-,60+,61+,62+;;/m1../s1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ffa1ac4af9ac617e01349d78fdc482f1>	<http://www.w3.org/2000/01/rdf-schema#label>	"indication for drugbank:DB00096 [drugbank_resource:ffa1ac4af9ac617e01349d78fdc482f1]"@en .
<http://bio2rdf.org/drugbank:DB00106>	<http://bio2rdf.org/drugbank_vocabulary:x-bindingdb>	<http://bio2rdf.org/bindingdb:50102442> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-5>	<http://www.w3.org/2000/01/rdf-schema#label>	"logP: -5.8 from ChemAxon [drugbank_resource:calculated-properties-DB00093-5]"@en .
<http://bio2rdf.org/pdb:THL>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"pdb"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00109>	<http://bio2rdf.org/drugbank_vocabulary:x-bindingdb>	<http://bio2rdf.org/bindingdb:50271301> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-4>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-10>	<http://bio2rdf.org/drugbank_vocabulary:value>	"(2S)-2-amino-3-(1H-imidazol-5-yl)propanoic acid"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-27>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00116-27"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a2d4a403a964b1f3a6d6fa73cb73921a>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"a2d4a403a964b1f3a6d6fa73cb73921a"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-11>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Formula: C19H23N7O6 from ChemAxon [drugbank_resource:calculated-properties-DB00116-11]"@en .
<http://bio2rdf.org/pdb:SAM>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"pdb"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00100>	<http://purl.org/dc/terms/description>	"Human Factor IX protein, produced by recombinant DNA technology for use in therapy of factor IX deficiency, known as hemophilia B or Christmas disease. Coagulation Factor IX (Recombinant) is a glycoprotein with an approximate molecular mass of 55,000 Da consisting of 415 amino acids in a single chain. It has a primary amino acid sequence that is identical to the Ala 148 allelic form of plasma-derived factor IX."@en .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"metabolism"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-2>	<http://www.w3.org/2000/01/rdf-schema#label>	"Hydrophobicity: 0.209 [drugbank_resource:experimental-properties-DB00099-2]"@en .
<http://bio2rdf.org/pdb:PLP>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"pdb"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e340b19fed6c2eaebccc1a4c652c8eb5>	<http://purl.org/dc/terms/description>	"5 days"@en .
<http://bio2rdf.org/drugbank_resource:d2b048fbf48d0ab62b1014e2b38c72e9>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-12>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00091-12"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:7b6b9c68c4dd8e5a8f74e987f9a92ce7>	<http://purl.org/dc/terms/title>	"Organic transition metal moeity"@en .
<http://bio2rdf.org/drugbank_vocabulary:f6203f7c9646b21edf1fa81c5cdf94d1>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:f6203f7c9646b21edf1fa81c5cdf94d1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00102>	<http://purl.org/dc/terms/description>	"Becaplermin is produced by recombinant DNA technology by insertion of the gene for the B chain of platelet derived growth factor (PDGF) into the yeast, Saccharomyces cerevisiae. Becaplermin has a molecular weight of approximately 25 KD and is a homodimer composed of two identical polypeptide chains that are bound together by disulfide bonds"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00095-1>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00095-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"P450 MP-4/MP-8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:d56193a54171cd8858918adbb1b34e8c>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0003533>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"metabolism"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:d46b970056d0a083cca1f813197ccf0c>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_vocabulary:Micronutrients>	<http://www.w3.org/2000/01/rdf-schema#label>	"Micronutrients [drugbank_vocabulary:Micronutrients]"@en .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"metabolism"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:d025612c433b867a6ebb00b2532e2626>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:aa57c62e2e58943f3ce466339bbf00eb>	<http://purl.org/dc/terms/title>	"Tetrahydrofolic acids"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-7>	<http://bio2rdf.org/drugbank_vocabulary:value>	"tetrahydrofolic acid"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-8>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a57533055c136af9a471684ba442d058>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#value>	"Novartis pharmaceuticals corp"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-12>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00091-12"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pdb:HIS>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"pdb"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:aa57c62e2e58943f3ce466339bbf00eb>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"aa57c62e2e58943f3ce466339bbf00eb"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:1c7495e7ba342d224b5028d72d73010d>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:1c7495e7ba342d224b5028d72d73010d"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-1>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00094-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pdb:CNC>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"pdb"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:0d54035b86f9a43f56ecd493c3a6fd59>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:0d54035b86f9a43f56ecd493c3a6fd59"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/drugbank_vocabulary:specific-function>	"Responsible for the metabolism of a number of therapeutic agents such as the anticonvulsant drug S-mephenytoin, omeprazole, proguanil, certain barbiturates, diazepam, propranolol, citalopram and imipramine"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2d6f2db0443dc24ac01149b8df7afb05>	<http://purl.org/dc/terms/title>	"10 [USP'U]/mL Injection form with intramuscular; intravenous route"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-4>	<http://purl.org/dc/terms/title>	"Water Solubility: 4.53e-02 g/l from ALOGPS"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-19>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00093-19"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-15>	<http://www.w3.org/2000/01/rdf-schema#label>	"pKa (strongest basic): 8.77 from ChemAxon [drugbank_resource:calculated-properties-DB00115-15]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-2>	<http://purl.org/dc/terms/title>	"Isoelectric Point: 9.09"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-5>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-8>	<http://www.w3.org/2000/01/rdf-schema#label>	"Water Solubility: 6.20e+01 g/l from ALOGPS [drugbank_resource:calculated-properties-DB00117-8]"@en .
<http://bio2rdf.org/drugbank_resource:8bb9fceb6f80460936af862e9f7d1d94>	<http://purl.org/dc/terms/title>	"Pyridoxal"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-4>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:88491d7d06bc30fa9586740372808b10>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:88491d7d06bc30fa9586740372808b10"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00103_DB00608>	<http://purl.org/dc/terms/title>	"DDI between Agalsidase beta and Chloroquine - May diminish the therapeutic effect of Agalsidase Beta."@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00118-1>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00118-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-8>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00118-8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:29ad2163821ce9d547ef52b7bddcf404>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"29ad2163821ce9d547ef52b7bddcf404"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Micronutrients>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:Micronutrients"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:0f798f4d70ca79c6d20f50856c6d9d11>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"0f798f4d70ca79c6d20f50856c6d9d11"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-26>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00114-26"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-5>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00105-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-3>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00090-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-31>	<http://purl.org/dc/terms/title>	"MDDR-Like Rule: 0 from ChemAxon"@en .
<http://bio2rdf.org/pubchem.substance:46504756>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"pubchem.substance"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003533>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-17>	<http://www.w3.org/2000/01/rdf-schema#label>	"Polarizability: 131.92 from ChemAxon [drugbank_resource:calculated-properties-DB00091-17]"@en .
<http://bio2rdf.org/drugbank_resource:ea9490984599c557a86db10a8e93e890>	<http://www.w3.org/2000/01/rdf-schema#label>	"Secondary alcohols [drugbank_resource:ea9490984599c557a86db10a8e93e890]"@en .
<http://bio2rdf.org/drugbank_vocabulary:Indicators-and-Reagents>	<http://www.w3.org/2000/01/rdf-schema#label>	"Indicators and Reagents [drugbank_vocabulary:Indicators-and-Reagents]"@en .
<http://bio2rdf.org/drugbank_resource:b8238b8599e6fdc40599cf773d5fb991>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:b8238b8599e6fdc40599cf773d5fb991"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-27>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00118-27"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:e6be3ee899ac0f450592b2c5985631de>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:e6be3ee899ac0f450592b2c5985631de"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-2>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00113-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/chemspider:82572>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/pubchem.substance:46505280>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"pubchem.substance"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:b508d1a45927588b684b5a6fd80aff2b>	<http://www.w3.org/2000/01/rdf-schema#label>	"Organic phosphate [drugbank_resource:b508d1a45927588b684b5a6fd80aff2b]"@en .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:cb386ea42baf8766a3e98e9d24d46516>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-15>	<http://www.w3.org/2000/01/rdf-schema#label>	"InChIKey: InChIKey=NGVDGCNFYWLIFO-UHFFFAOYSA-N from ChemAxon [drugbank_resource:calculated-properties-DB00114-15]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-4>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00092-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-3>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00102-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e91ecbd8702c2bd53755e648fa5c9435>	<http://www.w3.org/2000/01/rdf-schema#label>	"manufacturer for drugbank:DB00104 [drugbank_resource:e91ecbd8702c2bd53755e648fa5c9435]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-5>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00114-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/chemspider:6038>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-8>	<http://purl.org/dc/terms/title>	"Molecular Weight: 399.445 from ChemAxon"@en .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:x-chemspider>	<http://bio2rdf.org/chemspider:31983> .
<http://bio2rdf.org/pubchem.substance:46506428>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"pubchem.substance"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:70f28c5b4aa0741b1c2d0997a89319ea>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:70f28c5b4aa0741b1c2d0997a89319ea"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:773530fb248596d00289b12dba48a0cc>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:773530fb248596d00289b12dba48a0cc"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-16>	<http://bio2rdf.org/drugbank_vocabulary:value>	"116.95"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-6>	<http://www.w3.org/2000/01/rdf-schema#label>	"logP: -3.1 from ALOGPS [drugbank_resource:calculated-properties-DB00117-6]"@en .
<http://bio2rdf.org/drugbank_resource:85745be17d6c5d398a5d3540508f1a44>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:85745be17d6c5d398a5d3540508f1a44"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:fa342aed686575ef39a8ec9dc16cbab4>	<http://purl.org/dc/terms/title>	"Biocilin"@en .
<http://bio2rdf.org/pubchem.substance:46507001>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"pubchem.substance"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:9ea94506ab138833cc18501d48712af4>	<http://purl.org/dc/terms/title>	"10 [iU]/mL Injection form with intravenous route"@en .
<http://bio2rdf.org/drugbank_resource:7aa53fec8bf96c3555379e2680167034>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:7aa53fec8bf96c3555379e2680167034"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/chemspider:4575342>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-2>	<http://www.w3.org/2000/01/rdf-schema#label>	"Isoelectric Point: 7.86 [drugbank_resource:experimental-properties-DB00092-2]"@en .
<http://bio2rdf.org/drugbank_resource:84c4d4608be206e204e18bc4fee8d4a9>	<http://www.w3.org/2000/01/rdf-schema#label>	"Cobalamin derivatives [drugbank_resource:84c4d4608be206e204e18bc4fee8d4a9]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-17>	<http://bio2rdf.org/drugbank_vocabulary:value>	"54.75"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-4>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01072>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:DB00109_DB01072"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-4>	<http://purl.org/dc/terms/title>	"logS: -4.5 from ALOGPS"@en .
<http://bio2rdf.org/chemspider:31983>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-15>	<http://purl.org/dc/terms/title>	"InChIKey: InChIKey=NGVDGCNFYWLIFO-UHFFFAOYSA-N from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-13>	<http://www.w3.org/2000/01/rdf-schema#label>	"InChIKey: InChIKey=SEKGMJVHSBBHRD-WZHZPDAFSA-M from ChemAxon [drugbank_resource:calculated-properties-DB00115-13]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-1>	<http://purl.org/dc/terms/title>	"Hydrophobicity: -0.875"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00114-2>	<http://www.w3.org/2000/01/rdf-schema#label>	"Melting Point: 255 \u00B0C from PhysProp [drugbank_resource:experimental-properties-DB00114-2]"@en .
<http://bio2rdf.org/drugbank_resource:913e4e077c76fcc7c941f5fbedf4db30>	<http://purl.org/dc/terms/description>	"Absorption is high (greater than 80%) when administered intramuscularly or subcutaneously."@en .
<http://bio2rdf.org/drugbank_resource:be8afc258733f250df3262d94e93265b>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:be8afc258733f250df3262d94e93265b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-2>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00097-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:Xylonest-Octapressin>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:Xylonest-Octapressin"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/chemspider:1022>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:88491d7d06bc30fa9586740372808b10>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"88491d7d06bc30fa9586740372808b10"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00091-1>	<http://purl.org/dc/terms/title>	"Melting Point: 148-151 \u00B0C"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-19>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00117-19"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fe02b6034f5c4d73f73a58815355abf5>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:fe02b6034f5c4d73f73a58815355abf5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pubchem.substance:46509031>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/pubchem.substance:46509031"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:228bf0dff0e17c650e98e541c5291e94>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"228bf0dff0e17c650e98e541c5291e94"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8ae8b01597df174d257016596812aeab>	<http://www.w3.org/2000/01/rdf-schema#label>	"Monocarboxylic acid or derivatives [drugbank_resource:8ae8b01597df174d257016596812aeab]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-2>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-1>	<http://www.w3.org/2000/01/rdf-schema#label>	"Hydrophobicity: -2.7 [drugbank_resource:experimental-properties-DB00107-1]"@en .
<http://bio2rdf.org/drugbank_resource:094779e1e90e423f19e46305ba872c9c>	<http://purl.org/dc/terms/title>	"Benzamide"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00091-2>	<http://bio2rdf.org/drugbank_vocabulary:value>	"-6.05"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/drugbank_vocabulary:name>	"Cytochrome P450 2C19"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"EC 1.14.14.1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:74985c763ecb65fc6e794b1a003e061f>	<http://www.w3.org/2000/01/rdf-schema#label>	"Aliphatic heteromonocyclic compound [drugbank_resource:74985c763ecb65fc6e794b1a003e061f]"@en .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"EC 1.14.14.1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-6>	<http://www.w3.org/2000/01/rdf-schema#label>	"logP: 6.92 from ChemAxon [drugbank_resource:calculated-properties-DB00091-6]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-1>	<http://bio2rdf.org/drugbank_vocabulary:value>	"61 \u00B0C"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"EC 1.14.14.1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00093-1>	<http://bio2rdf.org/drugbank_vocabulary:value>	"222"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-3>	<http://bio2rdf.org/drugbank_vocabulary:value>	"5.67"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-12>	<http://www.w3.org/2000/01/rdf-schema#label>	"InChI: InChI=1S/C19H23N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,11-12,21,23H,5-8H2,(H,24,29)(H,27,28)(H,31,32)(H4,20,22,25,26,30)/t11?,12-/m0/s1 from ChemAxon [drugbank_resource:calculated-properties-DB00116-12]"@en .
<http://bio2rdf.org/drugbank_resource:8c59273d79bb6ce81fe2a4c0596fa577>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:8c59273d79bb6ce81fe2a4c0596fa577"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:4dcb2d242a80267002194ce81be5670e>	<http://www.w3.org/2000/01/rdf-schema#label>	"manufacturer for drugbank:DB00109 [drugbank_resource:4dcb2d242a80267002194ce81be5670e]"@en .
<http://bio2rdf.org/drugbank_resource:e9ee4548d6d10b87a4a259470fe32c97>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#value>	"Par pharmaceutical inc"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-10>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-10"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:e6be3ee899ac0f450592b2c5985631de>	<http://www.w3.org/2000/01/rdf-schema#label>	"Zenapax [drugbank_vocabulary:e6be3ee899ac0f450592b2c5985631de]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-13>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00116-13"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-20>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00116-20"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00106>	<http://purl.org/dc/terms/title>	"Abarelix"@en .
<http://bio2rdf.org/drugbank_resource:1f87ebefeca8e494680a6a81334c6078>	<http://www.w3.org/2000/01/rdf-schema#label>	"half-life for drugbank:DB00111 [drugbank_resource:1f87ebefeca8e494680a6a81334c6078]"@en .
<http://bio2rdf.org/drugbank_resource:e340b19fed6c2eaebccc1a4c652c8eb5>	<http://purl.org/dc/terms/title>	"half-life for drugbank:DB00095"@en .
<http://bio2rdf.org/drugbank_resource:fba31fe582cac619f85335c144278e17>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"100 mg"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-3>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00117-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:d025612c433b867a6ebb00b2532e2626>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"d025612c433b867a6ebb00b2532e2626"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-27>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00117-27"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00363>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:DB00112_DB00363"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pdb:THL>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"THL"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB01177>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:DB00112_DB01177"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-3>	<http://www.w3.org/2000/01/rdf-schema#label>	"Isoelectric Point: 5.99 [drugbank_resource:experimental-properties-DB00105-3]"@en .
<http://bio2rdf.org/drugbank_resource:c3ea863492592dff31fb000b21cd1a19>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"0.58 mg"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Small-molecule>	<http://www.w3.org/2000/01/rdf-schema#label>	"Small molecule [drugbank_vocabulary:Small-molecule]"@en .
<http://bio2rdf.org/chemspider:6038>	<http://purl.org/dc/terms/identifier>	"chemspider:6038"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Oxytocics>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"Oxytocics"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00091-1>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00091-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-12>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00093-12"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00095>	<http://purl.org/dc/terms/identifier>	"drugbank:DB00095"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:cad41663894b5be906782be10b396e06>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"cad41663894b5be906782be10b396e06"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:70f28c5b4aa0741b1c2d0997a89319ea>	<http://www.w3.org/2000/01/rdf-schema#label>	"Pyrrolidines [drugbank_resource:70f28c5b4aa0741b1c2d0997a89319ea]"@en .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:molecular-weight>	"55825.0"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-3>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00100-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pubchem.substance:46509031>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"pubchem.substance"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-1>	<http://purl.org/dc/terms/title>	"Hydrophobicity: -0.432"@en .
<http://bio2rdf.org/drugbank_vocabulary:6826daa495527ec54b81079e04e89d24>	<http://www.w3.org/2000/01/rdf-schema#label>	"Biosechs [drugbank_vocabulary:6826daa495527ec54b81079e04e89d24]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-4>	<http://bio2rdf.org/drugbank_vocabulary:value>	"19271.0"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:97f751c9423321c8864c0243afcff111>	<http://purl.org/dc/terms/title>	"Imidolactams"@en .
<http://bio2rdf.org/drugbank:DB00118>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-9>	<http://bio2rdf.org/drugbank_vocabulary:value>	"pyridoxal phosphate"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0000300>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"Putrescine aminopropyltransferase"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:DB00117"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-26>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-26"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fdb0a3b06aac9bbd85eeda7b1daf8545>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"fdb0a3b06aac9bbd85eeda7b1daf8545"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pubchem.compound:91443>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"91443"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/drugbank_vocabulary:name>	"Cytochrome P450 3A4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-26>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00118-26"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0000456>	<http://www.w3.org/2000/01/rdf-schema#label>	"Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial [drugbank:BE0000456]"@en .
<http://bio2rdf.org/drugbank_vocabulary:aa64bf1510edae009ba1d31553912173>	<http://purl.org/dc/terms/title>	"ProstaScint"@en .
<http://bio2rdf.org/drugbank_resource:fdb8e90f512977b9fb2141486454a079>	<http://purl.org/dc/terms/title>	"clearance for drugbank:DB00089"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-5>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00100-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:4f9f96147f2386295de420eed7aa9274>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"4f9f96147f2386295de420eed7aa9274"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00111>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00090>	<http://purl.org/dc/terms/identifier>	"drugbank:DB00090"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00110>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-16>	<http://purl.org/dc/terms/title>	"Polar Surface Area (PSA): 116.95 from ChemAxon"@en .
<http://bio2rdf.org/drugbank:DB00113>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:DB00099_DB01030>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00099_DB01030"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:efdc5ed439af008904afce03f4dd2ec8>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:efdc5ed439af008904afce03f4dd2ec8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-7>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00114-7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00112>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:3afc1cd15f9de2a07db0081098265ac4>	<http://www.w3.org/2000/01/rdf-schema#label>	"50 mg/mL Injection form with intravenous route [drugbank_resource:3afc1cd15f9de2a07db0081098265ac4]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-28>	<http://www.w3.org/2000/01/rdf-schema#label>	"Ghose Filter: 0 from ChemAxon [drugbank_resource:calculated-properties-DB00114-28]"@en .
<http://bio2rdf.org/drugbank:DB00115>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:87f0fe251ba4940236c1e30de121922a>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"87f0fe251ba4940236c1e30de121922a"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-3>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:molecular-weight>	"57109.0"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-9>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Weight: 1202.6112 from ChemAxon [drugbank_resource:calculated-properties-DB00091-9]"@en .
<http://bio2rdf.org/drugbank_resource:DB00109_DB06290>	<http://www.w3.org/2000/01/rdf-schema#label>	"DDI between Enfuvirtide and Simeprevir - Enfuvirtide may increase the serum concentration of Protease Inhibitors. Protease Inhibitors may increase the serum concentration of Enfuvirtide. [drugbank_resource:DB00109_DB06290]"@en .
<http://bio2rdf.org/drugbank:DB00114>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:4d6d8a0bb0437361e22c5fbaf04819ea>	<http://www.w3.org/2000/01/rdf-schema#label>	"N-substituted imidazoles [drugbank_resource:4d6d8a0bb0437361e22c5fbaf04819ea]"@en .
<http://bio2rdf.org/drugbank:DB00117>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-24>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00114-24"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00116>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-22>	<http://purl.org/dc/terms/title>	"pKa (strongest acidic): 1.68 from ChemAxon"@en .
<http://bio2rdf.org/drugbank:DB00100>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00099>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-23>	<http://purl.org/dc/terms/title>	"Physiological Charge: 0 from ChemAxon"@en .
<http://bio2rdf.org/drugbank:BE0000300>	<http://bio2rdf.org/drugbank_vocabulary:x-taxonomy>	<http://bio2rdf.org/taxonomy:9606> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-5>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00103>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"BE0002362"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-7>	<http://purl.org/dc/terms/title>	"Traditional IUPAC Name: tetrahydrofolic acid from ChemAxon"@en .
<http://bio2rdf.org/drugbank:DB00102>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00106>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00095-1>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00095-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:13bf7e351282b3c815c4b958aedb585f>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:13bf7e351282b3c815c4b958aedb585f"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-11>	<http://bio2rdf.org/drugbank_vocabulary:value>	"C63H89CoN14O14P"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00105>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:78c0a8b73fca87dcc5402f26970c94a4>	<http://www.w3.org/2000/01/rdf-schema#label>	"half-life for drugbank:DB00115 [drugbank_resource:78c0a8b73fca87dcc5402f26970c94a4]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-5>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00118-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00109>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00107>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:e6fa8c632405b98301de119a72894c49>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:e6fa8c632405b98301de119a72894c49"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/bindingdb:7953>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank:DB00091>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:db3cf7df3e4a56b21665da45352819bc>	<http://www.w3.org/2000/01/rdf-schema#label>	"This compound belongs to the class of organic compounds known as glycosylamines. These are compounds consisting of an\u00A0amine\u00A0with a\u00A0beta-N-glycosidic bond\u00A0to a carbohydrate, thus forming a cyclic\u00A0hemiaminal ether\u00A0bond (alpha-amino ether). [drugbank_resource:db3cf7df3e4a56b21665da45352819bc]"@en .
<http://bio2rdf.org/bindingdb:50271301>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank:DB00090>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00093>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:23e60560991f40f7f335be06f10675e1>	<http://purl.org/dc/terms/description>	"For palliative treatment of advanced prostate cancer."@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-5>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Formula: C845H1343N223O243S9 [drugbank_resource:experimental-properties-DB00099-5]"@en .
<http://bio2rdf.org/bindingdb:50102442>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank:DB00092>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB01268>	<http://www.w3.org/2000/01/rdf-schema#label>	"DDI between Bevacizumab and Sunitinib - May enhance the adverse/toxic effect of Bevacizumab. Specifically, the risk for a specific form of anemia, microangiopathic hemolytic anemia (MAHA), may be increased. Bevacizumab may enhance the hypertensive effect of SUNItinib. [drugbank_resource:DB00112_DB01268]"@en .
<http://bio2rdf.org/drugbank:DB00095>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-14>	<http://bio2rdf.org/drugbank_vocabulary:value>	"N[C@@H](CC1=CN=CN1)C(O)=O"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00094>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:904bc2c9127fa8f18e0965559eecc60c>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00097>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:893efa195cf56cf85e98a5c5f0867045>	<http://www.w3.org/2000/01/rdf-schema#label>	"clearance for drugbank:DB00112 [drugbank_resource:893efa195cf56cf85e98a5c5f0867045]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00091-2>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00091-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-26>	<http://www.w3.org/2000/01/rdf-schema#label>	"Physiological Charge: 0 from ChemAxon [drugbank_resource:calculated-properties-DB00117-26]"@en .
<http://bio2rdf.org/drugbank:DB00096>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-25>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00091-25"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-26>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00117-26"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ffc8ae70d9900ffb750da168c0f58cc5>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:ffc8ae70d9900ffb750da168c0f58cc5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:be8afc258733f250df3262d94e93265b>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"be8afc258733f250df3262d94e93265b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8f7450a053d86ee89751c06a230561d0>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-4>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00694>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00112_DB00694"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:003185d1d24af95f95de2d64dd76ed33>	<http://purl.org/dc/terms/description>	"As part of combination therapy for metastatic colorectal cancer and HER2-negative metastatic breast cancer."@en .
<http://bio2rdf.org/drugbank:DB00089>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-1>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00111-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8eb135a8f519839c5f289226017b68a3>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00088>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:a6317c6254a0737c350d2f0860ea1ec3>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"a6317c6254a0737c350d2f0860ea1ec3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-20>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00117-20"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:b508d1a45927588b684b5a6fd80aff2b>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:8e7e8f5ff3cf3466586b956d7330151b>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:8e7e8f5ff3cf3466586b956d7330151b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pdb:THL>	<http://purl.org/dc/terms/identifier>	"pdb:THL"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ffe7ffbc4b8e341c6b137f185bb434e0>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:ffe7ffbc4b8e341c6b137f185bb434e0"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-16>	<http://purl.org/dc/terms/title>	"InChI: InChI=1S/C6H9N3O2/c7-5(6(10)11)1-4-2-8-3-9-4/h2-3,5H,1,7H2,(H,8,9)(H,10,11)/t5-/m0/s1 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:5ba52774f54e88019dd4d17f32a34f7b>	<http://www.w3.org/2000/01/rdf-schema#label>	"indication for drugbank:DB00095 [drugbank_resource:5ba52774f54e88019dd4d17f32a34f7b]"@en .
<http://bio2rdf.org/drugbank_resource:ad9e59297973dcc097c2400d81b7888b>	<http://www.w3.org/2000/01/rdf-schema#label>	"half-life for drugbank:DB00109 [drugbank_resource:ad9e59297973dcc097c2400d81b7888b]"@en .
<http://bio2rdf.org/drugbank_resource:8e7e8f5ff3cf3466586b956d7330151b>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://purl.org/dc/terms/title>	"Cytochrome P450 3A4"@en .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:locus>	"10q24"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:b15aa7d1fbce9f1563623833e416d8f7>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:39094d4a5017cb7945c3ca22e421306d>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:39094d4a5017cb7945c3ca22e421306d"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:4aaab29fd43effbe133e376c024d5f06>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:4aaab29fd43effbe133e376c024d5f06"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/bindingdb:50271301>	<http://purl.org/dc/terms/identifier>	"bindingdb:50271301"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:6f3fc4bb7965f22f3fc655ec5e1faab0>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:6f3fc4bb7965f22f3fc655ec5e1faab0"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-2>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00117-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Angiogenesis-Inhibitors>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:Angiogenesis-Inhibitors"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f7f0a15346b2f02764550cb8d9f8ef30>	<http://purl.org/dc/terms/title>	"D-alpha-amino acids"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-10>	<http://bio2rdf.org/drugbank_vocabulary:value>	"OC[C@H]1O[C@@H]([C@H](O)[C@@H]1OP(O)(=O)O[C@]([H])(C)CNC(=O)CC[C@]1(C)[C@@H](CC(=O)N)[C@@]2([H])N([Co]C#N)C1=C(C)/C1=N/C(=CC3=NC(=C(C)/C4=N[C@]2(C)[C@@](C)(CC(=O)N)[C@@H]4CCC(=O)N)[C@@](C)(CC(=O)N)[C@@H]3CCC(=O)N)/C(C)(C)[C@@H]1CCC(=O)N)N1C=NC2=CC(C)=C(C)C=C12"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21>	<http://purl.org/dc/terms/title>	"Humans and other mammals"@en .
<http://bio2rdf.org/drugbank_resource:a9516c15b2a67882efd5c7a4c1fa6de4>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"a9516c15b2a67882efd5c7a4c1fa6de4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-8>	<http://bio2rdf.org/drugbank_vocabulary:value>	"[(4-formyl-5-hydroxy-6-methylpyridin-3-yl)methoxy]phosphonic acid"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ae52c40c7c1761e3027e159477756625>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:8c59273d79bb6ce81fe2a4c0596fa577>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ae0431719c906d80aa97a27025adc99f>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:8bb9fceb6f80460936af862e9f7d1d94>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003612>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-3>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00097-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8abd75317f3f7b8f7d56e3fe7d6204bd>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-1>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:795d73be198310a4681989a95b5ddc5b> .
<http://bio2rdf.org/drugbank_resource:DB00107_DB00929>	<http://purl.org/dc/terms/title>	"DDI between Oxytocin and Misoprostol - May enhance the adverse/toxic effect of Oxytocin. Specifically, oxytocic effects may be enhanced."@en .
<http://bio2rdf.org/drugbank_resource:20aa32f603258f15ceef0ba521a5bd87>	<http://purl.org/dc/terms/description>	"Serum albumin acts as a high molecular weight, very soluble osmolyte. Serum albumin also acts as a protein drug carrier in plasma, and transports hemin, steroids, thyroid hormones and fatty acids. It binds many other substances, such as unconjugated bilirubin, calcium ions, and other fat soluble hormones."@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-12>	<http://purl.org/dc/terms/title>	"InChI: InChI=1S/C19H23N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,11-12,21,23H,5-8H2,(H,24,29)(H,27,28)(H,31,32)(H4,20,22,25,26,30)/t11?,12-/m0/s1 from ChemAxon"@en .
<http://bio2rdf.org/drugbank:BE0002363>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:8ae8b01597df174d257016596812aeab>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:dedcaba12fd68e71a4930ea18843aa61>	<http://purl.org/dc/terms/title>	"Organosulfur compound"@en .
<http://bio2rdf.org/drugbank_resource:fb96fa5c000dbd94c78671b5c79ff32b>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"fb96fa5c000dbd94c78671b5c79ff32b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e6fa8c632405b98301de119a72894c49>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:e6fa8c632405b98301de119a72894c49"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8683be48baa0e7d62758aed2d9ccf431>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:8683be48baa0e7d62758aed2d9ccf431"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-10>	<http://www.w3.org/2000/01/rdf-schema#label>	"IUPAC Name: (2S)-2-amino-3-(1H-imidazol-5-yl)propanoic acid from ChemAxon [drugbank_resource:calculated-properties-DB00117-10]"@en .
<http://bio2rdf.org/drugbank_vocabulary:122193da65e00a63d46700928a244018>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:122193da65e00a63d46700928a244018"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:893efa195cf56cf85e98a5c5f0867045>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:53e4e7c3f9db35ed7e24a59c1546788c>	<http://www.w3.org/2000/01/rdf-schema#label>	"Cobalamin [drugbank_resource:53e4e7c3f9db35ed7e24a59c1546788c]"@en .
<http://bio2rdf.org/drugbank_resource:24189bc5fb16bfce4551ecdfb0196def>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:24189bc5fb16bfce4551ecdfb0196def"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:88491d7d06bc30fa9586740372808b10>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-4>	<http://bio2rdf.org/drugbank_vocabulary:value>	"66472.2"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:e4e539077bcedbc155e950cadab01679>	<http://purl.org/dc/terms/title>	"mechanism-of-action for drugbank:DB00109"@en .
<http://bio2rdf.org/drugbank_resource:87f0fe251ba4940236c1e30de121922a>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:87f0fe251ba4940236c1e30de121922a"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ad715d0a2b2bcdcad22b975675537588>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:ade41ed0b3f8ac2b059fa8aeb0cdbbb4>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:ad9e59297973dcc097c2400d81b7888b>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:8750c04d33b8546006e83e736eb80647>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:87f0fe251ba4940236c1e30de121922a>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8683be48baa0e7d62758aed2d9ccf431>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:abc4b12d5153eba9af71c2c651bd4ff1>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-1>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00109-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:4fcc6e9455872b18c21b74aa6b82db13>	<http://purl.org/dc/terms/title>	"food-interaction for drugbank:DB00091"@en .
<http://bio2rdf.org/drugbank_resource:433dda4a1117986cabe237dcf80bd242>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:433dda4a1117986cabe237dcf80bd242"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:e328a6cf619c4105669d93dc30d36096>	<http://bio2rdf.org/drugbank_vocabulary:name>	"Ceredase"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-15>	<http://bio2rdf.org/drugbank_vocabulary:value>	"InChIKey=NGVDGCNFYWLIFO-UHFFFAOYSA-N"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ff5b4bb2ae4fdc7811f87fd38c8b8eda>	<http://www.w3.org/2000/01/rdf-schema#label>	"indication for drugbank:DB00117 [drugbank_resource:ff5b4bb2ae4fdc7811f87fd38c8b8eda]"@en .
<http://bio2rdf.org/drugbank_resource:a57533055c136af9a471684ba442d058>	<http://www.w3.org/2000/01/rdf-schema#label>	"manufacturer for drugbank:DB00093 [drugbank_resource:a57533055c136af9a471684ba442d058]"@en .
<http://bio2rdf.org/pubchem.compound:1051>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/pubchem.compound_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:85745be17d6c5d398a5d3540508f1a44>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-12>	<http://bio2rdf.org/drugbank_vocabulary:value>	"155.155"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:913e4e077c76fcc7c941f5fbedf4db30>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"tetrapyrrole binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00095-1>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:22b41fe3e89493aa212ff1166d0a9104> .
<http://bio2rdf.org/drugbank_resource:c007cc919bf71767e61e0b111723c84f>	<http://purl.org/dc/terms/title>	"half-life for drugbank:DB00097"@en .
<http://bio2rdf.org/drugbank_resource:85e4414ae6d2bc12695a4539100e286f>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:17055fe13e90f0599fe8f9fd1c90c871>	<http://purl.org/dc/terms/description>	"Efalizumab binds to CD11a, a subunit of leukocyte function antigen-1 (LFA-1), which is expressed on all leukocytes. As a result efalizumab decreases cell surface expression of CD11a."@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-12>	<http://www.w3.org/2000/01/rdf-schema#label>	"SMILES: CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O from ChemAxon [drugbank_resource:calculated-properties-DB00114-12]"@en .
<http://bio2rdf.org/drugbank_resource:a9a58af69a8539d913c65b788eb5b178>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:84c4d4608be206e204e18bc4fee8d4a9>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ef0da8f521b780a50b08c455970978ac>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:ef0da8f521b780a50b08c455970978ac"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-1>	<http://bio2rdf.org/drugbank_vocabulary:value>	"62 \u00B0C"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a9a65e43cdc103a1f769c3625b080c1d>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/pubchem.compound:44176380>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/pubchem.compound_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:84e1544b4af68672a960baf683724f87>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e91ecbd8702c2bd53755e648fa5c9435>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:e91ecbd8702c2bd53755e648fa5c9435"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00095>	<http://www.w3.org/2000/01/rdf-schema#label>	"Efalizumab [drugbank:DB00095]"@en .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01232>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction> .
<http://bio2rdf.org/drugbank_resource:aa57c62e2e58943f3ce466339bbf00eb>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/pubchem.compound:34756>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/pubchem.compound_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0000456>	<http://purl.org/dc/terms/title>	"Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial"@en .
<http://bio2rdf.org/drugbank_resource:39094d4a5017cb7945c3ca22e421306d>	<http://www.w3.org/2000/01/rdf-schema#label>	"Phosphoethanolamines [drugbank_resource:39094d4a5017cb7945c3ca22e421306d]"@en .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01264>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction> .
<http://bio2rdf.org/drugbank_resource:a9ee55eb5c1344c6ecd656006a4e92f2>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:8399ac082eecc289dcd0ff6ce9ff3420>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00110_DB08879>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01319>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:BE0002363"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01601>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB03880>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction> .
<http://bio2rdf.org/drugbank_resource:dc4a561c55d386ce9aa0ac35fa50583b>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"dc4a561c55d386ce9aa0ac35fa50583b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00105>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00105"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-10>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00115-10"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB06290>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction> .
<http://bio2rdf.org/pubchem.substance:46506428>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/pubchem.substance_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:a8454a4c3a73e4a65b3965d9947cc4bd>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:1fc54dd8ec20644e59a52e0b31197dd9>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:1fc54dd8ec20644e59a52e0b31197dd9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:specific-function>	"Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. In the epoxidation of arachidonic acid it generates only 14,15- and 11,12-cis-epoxyeicosatrienoic acids. It is the principal enzyme responsible for the metabolism the anti- cancer drug paclitaxel (taxol)"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pubchem.substance:46507001>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/pubchem.substance_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:a9516c15b2a67882efd5c7a4c1fa6de4>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-13>	<http://www.w3.org/2000/01/rdf-schema#label>	"InChI: InChI=1/C62H111N11O12/c1-25-27-28-40(15)52(75)51-56(79)65-43(26-2)58(81)67(18)33-48(74)68(19)44(29-34(3)4)55(78)66-49(38(11)12)61(84)69(20)45(30-35(5)6)54(77)63-41(16)53(76)64-42(17)57(80)70(21)46(31-36(7)8)59(82)71(22)47(32-37(9)10)60(83)72(23)50(39(13)14)62(85)73(51)24/h25,27,34-47,49-52,75H,26,28-33H2,1-24H3,(H,63,77)(H,64,76)(H,65,79)(H,66,78)/b27-25+ from ChemAxon [drugbank_resource:calculated-properties-DB00091-13]"@en .
<http://bio2rdf.org/drugbank_resource:81ce8d1a0627bc88956132de1e1a93c2>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pubchem.compound:91443>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/pubchem.compound_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00363>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00220>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction> .
<http://bio2rdf.org/pubchem.compound:6274>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/pubchem.compound_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00398>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:ade41ed0b3f8ac2b059fa8aeb0cdbbb4>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:ade41ed0b3f8ac2b059fa8aeb0cdbbb4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00224>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00445>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-10>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00093-10"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00503>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction> .
<http://bio2rdf.org/drugbank_resource:70d5905dbbb671a2bf66275527b38e09>	<http://purl.org/dc/terms/title>	"Monosaccharide phosphate"@en .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00694>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:ba0f878619b43a5be9083f01d8ba77fd>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:ba0f878619b43a5be9083f01d8ba77fd"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00677>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-7>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00115-7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00762>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00932>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction> .
<http://bio2rdf.org/drugbank_resource:2696048bf20ed0e2d578eb2938c6d8d3>	<http://www.w3.org/2000/01/rdf-schema#label>	"clearance for drugbank:DB00091 [drugbank_resource:2696048bf20ed0e2d578eb2938c6d8d3]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00089-1>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:22b41fe3e89493aa212ff1166d0a9104> .
<http://bio2rdf.org/drugbank_resource:a7531086765fedefe82e0282f7a1d559>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:55842b12e140e13ee25b3a59430d097e>	<http://purl.org/dc/terms/title>	"absorption for drugbank:DB00092"@en .
<http://bio2rdf.org/drugbank_resource:DB00112_DB01177>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:81987a5783579e8eae4261b8d95226da>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pubchem.substance:46504756>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/pubchem.substance_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01072>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-4>	<http://bio2rdf.org/drugbank_vocabulary:value>	"-4.5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB01268>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-3>	<http://purl.org/dc/terms/title>	"Molecular Weight: 4491.8760"@en .
<http://bio2rdf.org/drugbank_resource:a78396bd0ab3d3f25852a0d4008cbdf4>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00091-1>	<http://www.w3.org/2000/01/rdf-schema#label>	"Melting Point: 148-151 \u00B0C [drugbank_resource:experimental-properties-DB00091-1]"@en .
<http://bio2rdf.org/pubchem.substance:46505280>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/pubchem.substance_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:094779e1e90e423f19e46305ba872c9c>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"094779e1e90e423f19e46305ba872c9c"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00100>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:DB00100"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a5a6248bbc8b4dd7520b62e64aa85462>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:80e4560d8a88ff69231ec21ee09506be>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-13>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00118-13"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"BE0002148"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Gonadotropins>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:Gonadotropins"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-21>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-21"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00092>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00092"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"tetrapyrrole binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"tetrapyrrole binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:80aadabf31c519e42d80748f499c7689>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a61e3adec088927f97197e2f1513790d>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"tetrapyrrole binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:807b0e58e0eead4b875202221ebe0f53>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:05261dbd457e9d2aa8254610c0f9df46>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:05261dbd457e9d2aa8254610c0f9df46"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a6317c6254a0737c350d2f0860ea1ec3>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-9>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00117-9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00363>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction> .
<http://bio2rdf.org/drugbank_resource:3eff294ae1a633c8845359753061fac9>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"3eff294ae1a633c8845359753061fac9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a6302cf127669e87e24a75b24552a9e8>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-21>	<http://www.w3.org/2000/01/rdf-schema#label>	"pKa (strongest acidic): 3.69 from ChemAxon [drugbank_resource:calculated-properties-DB00091-21]"@en .
<http://bio2rdf.org/pdb:HIS>	<http://purl.org/dc/terms/identifier>	"pdb:HIS"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00398>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00220>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:ab9182be757cbb637b820f0951931ae2>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"ab9182be757cbb637b820f0951931ae2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00097>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/kegg_resource:bio2rdf.dataset.kegg.R3> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00445>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-6>	<http://purl.org/dc/terms/title>	"IUPAC Name: [(3S)-3-amino-3-carboxypropyl]({[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl})methylsulfanium from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-29>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00117-29"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-3>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00102-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00224>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-20>	<http://www.w3.org/2000/01/rdf-schema#label>	"H Bond Donor Count: 5 from ChemAxon [drugbank_resource:calculated-properties-DB00091-20]"@en .
<http://bio2rdf.org/drugbank_resource:7fc0069b68f72ba58fdad65bec3cc1df>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00694>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00503>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00095>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/kegg_resource:bio2rdf.dataset.kegg.R3> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00762>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-24>	<http://bio2rdf.org/drugbank_vocabulary:value>	"1"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_vocabulary:3465ee54a79f5fd937ce86304a05d4e3>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:3465ee54a79f5fd937ce86304a05d4e3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00677>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB01177>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction> .
<http://bio2rdf.org/drugbank_resource:a57533055c136af9a471684ba442d058>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-23>	<http://bio2rdf.org/drugbank_vocabulary:value>	"3"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00932>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-5>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00113-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00093>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/kegg_resource:bio2rdf.dataset.kegg.R3> .
<http://bio2rdf.org/pubchem.substance:46509031>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/pubchem.substance_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-22>	<http://bio2rdf.org/drugbank_vocabulary:value>	"1"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB01268>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01072>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00092>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/kegg_resource:bio2rdf.dataset.kegg.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-5>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00093-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a595cc1c66cf7314ca9d50542e429c85>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00118-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Boiling-Point> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-1>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:3882183530fd4e3524747147c05a8899> .
<http://bio2rdf.org/drugbank:DB00091>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/kegg_resource:bio2rdf.dataset.kegg.R3> .
<http://bio2rdf.org/drugbank_resource:7abeba6bed290a4b16075521bc0113ca>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00090>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/kegg_resource:bio2rdf.dataset.kegg.R3> .
<http://bio2rdf.org/drugbank_resource:19d3289105c9a843a041cb4f7a0883a1>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"50 mg"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-27>	<http://bio2rdf.org/drugbank_vocabulary:value>	"1"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank:DB00118>	<http://purl.org/dc/terms/description>	"Physiologic methyl radical donor involved in enzymatic transmethylation reactions and present in all living organisms. It possesses anti-inflammatory activity and has been used in treatment of chronic liver disease. (From Merck, 11th ed)"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-26>	<http://bio2rdf.org/drugbank_vocabulary:value>	"0"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank:DB00089>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/kegg_resource:bio2rdf.dataset.kegg.R3> .
<http://bio2rdf.org/drugbank_resource:7b6b9c68c4dd8e5a8f74e987f9a92ce7>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8eb135a8f519839c5f289226017b68a3>	<http://www.w3.org/2000/01/rdf-schema#label>	"half-life for drugbank:DB00110 [drugbank_resource:8eb135a8f519839c5f289226017b68a3]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-19>	<http://purl.org/dc/terms/title>	"Rule of Five: 0 from ChemAxon"@en .
<http://bio2rdf.org/drugbank:DB00088>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/kegg_resource:bio2rdf.dataset.kegg.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-25>	<http://bio2rdf.org/drugbank_vocabulary:value>	"1"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:7aa53fec8bf96c3555379e2680167034>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Vitamins>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"Vitamins"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a2615bbb5710b9b992785e63c058b3db>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:7a67baa1bb7b49a978b39d77e07946e0>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:PKa> .
<http://bio2rdf.org/drugbank_resource:76cc7a41e93863bcbab0bba32bc52311>	<http://www.w3.org/2000/01/rdf-schema#label>	"100 ug/g Gel form with topical route [drugbank_resource:76cc7a41e93863bcbab0bba32bc52311]"@en .
<http://bio2rdf.org/drugbank_resource:abc4b12d5153eba9af71c2c651bd4ff1>	<http://purl.org/dc/terms/title>	"absorption for drugbank:DB00097"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-17>	<http://bio2rdf.org/drugbank_vocabulary:value>	"7"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:a2d4a403a964b1f3a6d6fa73cb73921a>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:5295f08395d80bb2a78d48e62dbf8c19>	<http://purl.org/dc/terms/title>	"Purine"@en .
<http://bio2rdf.org/drugbank_resource:c3ea863492592dff31fb000b21cd1a19>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:c3ea863492592dff31fb000b21cd1a19"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a39e93df12255155561f3d4acd297da8>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:DB00107_DB00429>	<http://purl.org/dc/terms/title>	"DDI between Oxytocin and Carboprost Tromethamine - May enhance the adverse/toxic effect of Oxytocic Agents. Specifically, oxytocic effects may be enhanced."@en .
<http://bio2rdf.org/drugbank_resource:3f34afd99cc9695ee26d778d111874cf>	<http://purl.org/dc/terms/title>	"half-life for drugbank:DB00105"@en .
<http://bio2rdf.org/drugbank_resource:a02555c5c58332bf7ac5fef198a34814>	<http://www.w3.org/2000/01/rdf-schema#label>	"indication for drugbank:DB00105 [drugbank_resource:a02555c5c58332bf7ac5fef198a34814]"@en .
<http://bio2rdf.org/drugbank_vocabulary:Conditionally-Essential-Amino-Acids>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"Conditionally-Essential-Amino-Acids"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:78fce134a0e754813388f2850f268625>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-18>	<http://bio2rdf.org/drugbank_vocabulary:value>	"10"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank:DB00117>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/kegg_resource:bio2rdf.dataset.kegg.R3> .
<http://bio2rdf.org/drugbank_resource:Citanest-Dental-Octapressin>	<http://www.w3.org/2000/01/rdf-schema#label>	"Citanest Dental Octapressin [drugbank_resource:Citanest-Dental-Octapressin]"@en .
<http://bio2rdf.org/drugbank_resource:7975713dad73e24fab2cbb6c89586ea4>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fba31fe582cac619f85335c144278e17>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"fba31fe582cac619f85335c144278e17"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-19>	<http://bio2rdf.org/drugbank_vocabulary:value>	"5"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:a02555c5c58332bf7ac5fef198a34814>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:78c0a8b73fca87dcc5402f26970c94a4>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/kegg_resource:bio2rdf.dataset.kegg.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-3>	<http://www.w3.org/2000/01/rdf-schema#label>	"logP: 1.87 from ALOGPS [drugbank_resource:calculated-properties-DB00115-3]"@en .
<http://bio2rdf.org/drugbank_resource:405bc988f44cffeeb0d7149d00e5918b>	<http://purl.org/dc/terms/description>	"Approximately 1 hour"@en .
<http://bio2rdf.org/drugbank_resource:Xylonest-Octapressin>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00114>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/kegg_resource:bio2rdf.dataset.kegg.R3> .
<http://bio2rdf.org/drugbank:DB00113>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/kegg_resource:bio2rdf.dataset.kegg.R3> .
<http://bio2rdf.org/drugbank_resource:2d6f2db0443dc24ac01149b8df7afb05>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:2d6f2db0443dc24ac01149b8df7afb05"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00112>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/kegg_resource:bio2rdf.dataset.kegg.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-16>	<http://purl.org/dc/terms/title>	"Polarizability: 40.37 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:a78396bd0ab3d3f25852a0d4008cbdf4>	<http://www.w3.org/2000/01/rdf-schema#label>	"Cyclosporins [drugbank_resource:a78396bd0ab3d3f25852a0d4008cbdf4]"@en .
<http://bio2rdf.org/drugbank_resource:77b52954fa911921450d2b426c1a7a3a>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00091-1>	<http://bio2rdf.org/drugbank_vocabulary:value>	"148-151 \u00B0C"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00111>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/kegg_resource:bio2rdf.dataset.kegg.R3> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01232>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:DB00110_DB08879>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction> .
<http://bio2rdf.org/drugbank_resource:904bc2c9127fa8f18e0965559eecc60c>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:904bc2c9127fa8f18e0965559eecc60c"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:7767fecbc1fcbba1764734e284afdd13>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00110>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/kegg_resource:bio2rdf.dataset.kegg.R3> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01264>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:787ef58546dc52c80027a1e3a2b925b9>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00109>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/kegg_resource:bio2rdf.dataset.kegg.R3> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01319>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:705836a5549e0548d20a0ef04e009f28>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:705836a5549e0548d20a0ef04e009f28"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-4>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Weight: 25719.7000 [drugbank_resource:experimental-properties-DB00097-4]"@en .
<http://bio2rdf.org/drugbank_resource:fa9ea24c47c4cc6ec20e42b245e43401>	<http://purl.org/dc/terms/description>	"For treatment of Fabry's disease (alpha-galactosidase A deficiency)"@en .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01601>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00107>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/kegg_resource:bio2rdf.dataset.kegg.R3> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00363>	<http://www.w3.org/2000/01/rdf-schema#label>	"DDI between Bevacizumab and Clozapine - Myelosuppressive Agents may enhance the adverse/toxic effect of CloZAPine. Specifically, the risk for agranulocytosis may be increased. [drugbank_resource:DB00112_DB00363]"@en .
<http://bio2rdf.org/drugbank_resource:76cc7a41e93863bcbab0bba32bc52311>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00106>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/kegg_resource:bio2rdf.dataset.kegg.R3> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB03880>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:f2a30f76a373192265e4b663c8339602>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:f2a30f76a373192265e4b663c8339602"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB06290>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00105>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/kegg_resource:bio2rdf.dataset.kegg.R3> .
<http://bio2rdf.org/drugbank_resource:81ce8d1a0627bc88956132de1e1a93c2>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"81ce8d1a0627bc88956132de1e1a93c2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:773530fb248596d00289b12dba48a0cc>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00103>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/kegg_resource:bio2rdf.dataset.kegg.R3> .
<http://bio2rdf.org/drugbank:DB00102>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/kegg_resource:bio2rdf.dataset.kegg.R3> .
<http://bio2rdf.org/drugbank_resource:98458df79187b81a7709036be48a75a4>	<http://purl.org/dc/terms/description>	"Tetrahydrofolate is transported across cells by receptor-mediated endocytosis where it is needed to maintain normal erythropoiesis, synthesize purine and thymidylate nucleic acids, interconvert amino acids, methylate tRNA, and generate and use formate."@en .
<http://bio2rdf.org/drugbank:DB00100>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/kegg_resource:bio2rdf.dataset.kegg.R3> .
<http://bio2rdf.org/drugbank_resource:75aa077303c09d80af404a7a6c6ac735>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00103_DB00608>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:DB00103_DB00608"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-10>	<http://purl.org/dc/terms/title>	"Molecular Weight: 247.1419 from ChemAxon"@en .
<http://bio2rdf.org/drugbank:DB00099>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/kegg_resource:bio2rdf.dataset.kegg.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-30>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-30"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a9516c15b2a67882efd5c7a4c1fa6de4>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:a9516c15b2a67882efd5c7a4c1fa6de4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8abd75317f3f7b8f7d56e3fe7d6204bd>	<http://www.w3.org/2000/01/rdf-schema#label>	"2.9 mg/5mL Injection, solution, concentrate form with intravenous route [drugbank_resource:8abd75317f3f7b8f7d56e3fe7d6204bd]"@en .
<http://bio2rdf.org/drugbank_resource:762a7c535540c35c3ec0a9932635da58>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-3>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:7975713dad73e24fab2cbb6c89586ea4>	<http://purl.org/dc/terms/title>	"480 ug/.8mL Injection, solution form with intravenous; subcutaneous route"@en .
<http://bio2rdf.org/drugbank_resource:a5a6248bbc8b4dd7520b62e64aa85462>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:a5a6248bbc8b4dd7520b62e64aa85462"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00106-2>	<http://bio2rdf.org/drugbank_vocabulary:value>	"C72H95ClN14O14"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-3>	<http://www.w3.org/2000/01/rdf-schema#label>	"logP: 4.37 from ALOGPS [drugbank_resource:calculated-properties-DB00091-3]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-4>	<http://purl.org/dc/terms/title>	"Water Solubility: 2.69e-01 g/l from ALOGPS"@en .
<http://bio2rdf.org/drugbank_resource:57db98e1612a44845256ccbbbc457ff8>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"57db98e1612a44845256ccbbbc457ff8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:74985c763ecb65fc6e794b1a003e061f>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-3>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00117-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00103_DB01118>	<http://www.w3.org/2000/01/rdf-schema#label>	"DDI between Agalsidase beta and Amiodarone - May diminish the therapeutic effect of Agalsidase Beta. [drugbank_resource:DB00103_DB01118]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-14>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-14"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00115_DB01394>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:DB00115_DB01394"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:42e21c05e96b3040136e54dfed4bf794>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"42e21c05e96b3040136e54dfed4bf794"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00103_DB00608>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:0235e5251bcfc61913eb18c0fab6a1c4>	<http://purl.org/dc/terms/description>	"FSH binds to the follicle stimulating hormone receptor which is a G-coupled transmembrane receptor. Binding of the FSH to its receptor seems to induce phosphorylation and activation of the PI3K (Phosphatidylinositol-3-kinase) and Akt signaling pathway, which is known to regulate many other metabolic and related survival/maturation functions in cells."@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-1>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:22b41fe3e89493aa212ff1166d0a9104> .
<http://bio2rdf.org/drugbank_resource:DB00103_DB01118>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:DB00099_DB00290>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction> .
<http://bio2rdf.org/drugbank_resource:DB00099_DB00531>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-3>	<http://purl.org/dc/terms/title>	"Molecular Weight: 1007.1870"@en .
<http://bio2rdf.org/drugbank_resource:DB00099_DB01030>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction> .
<http://bio2rdf.org/drugbank_vocabulary:8550beb9aaabcff323bdfeef04608bb8>	<http://bio2rdf.org/drugbank_vocabulary:company>	"Praecis Pharmaceuticals"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-1>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:351cbcbf5dda0a2c58b401c8cd10b485> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-1>	<http://purl.org/dc/terms/title>	"Hydrophobicity: -0.168"@en .
<http://bio2rdf.org/drugbank_resource:0d47651b62c008d202fcec19e0c3b7c7>	<http://purl.org/dc/terms/description>	"For treatment of pernicious anemia (due to lack of or inhibition of intrinsic factor) and for prevention and treatment of vitamin B 12 deficiency."@en .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"P-450MP"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-1>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:22b41fe3e89493aa212ff1166d0a9104> .
<http://bio2rdf.org/drugbank_resource:904bc2c9127fa8f18e0965559eecc60c>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"25 mg"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-25>	<http://purl.org/dc/terms/title>	"Rule of Five: 0 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:4aaab29fd43effbe133e376c024d5f06>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"4aaab29fd43effbe133e376c024d5f06"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:6205a409adf418d0390045ac349b481a>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:6205a409adf418d0390045ac349b481a"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:f6203f7c9646b21edf1fa81c5cdf94d1>	<http://bio2rdf.org/drugbank_vocabulary:name>	"Sam-Sulfate"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:BE0002638"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-1>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:22b41fe3e89493aa212ff1166d0a9104> .
<http://bio2rdf.org/drugbank_resource:64b9dc4a304f0bbee322be682a49f08b>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:64b9dc4a304f0bbee322be682a49f08b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e02568426e5e3817cd6fcddc8dee4bee>	<http://purl.org/dc/terms/title>	"Amino fatty acid"@en .
<http://bio2rdf.org/drugbank_resource:00199edd2aba5de431eaa55bda5406d7>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:00199edd2aba5de431eaa55bda5406d7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:53ca67aedcd10f1c9afc4de0f2138502>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:53ca67aedcd10f1c9afc4de0f2138502"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00092>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:DB00092"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:762a7c535540c35c3ec0a9932635da58>	<http://purl.org/dc/terms/description>	"Following IM administration of 100 mg, abarelix is absorbed slowly with a mean peak concentration of 43.4 ng/mL observed approximately 3 days after the injection."@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00110-1>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:22b41fe3e89493aa212ff1166d0a9104> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-14>	<http://www.w3.org/2000/01/rdf-schema#label>	"Polar Surface Area (PSA): 207.27 from ChemAxon [drugbank_resource:calculated-properties-DB00116-14]"@en .
<http://bio2rdf.org/drugbank_resource:405bc988f44cffeeb0d7149d00e5918b>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"405bc988f44cffeeb0d7149d00e5918b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-20>	<http://purl.org/dc/terms/title>	"H Bond Donor Count: 5 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_vocabulary:Nutraceutical>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"Nutraceutical"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-9>	<http://purl.org/dc/terms/title>	"Monoisotopic Weight: 399.145063566 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:9ea94506ab138833cc18501d48712af4>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"10 [iU]/mL"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-2>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00106-1>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00106-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pdb:PLP>	<http://purl.org/dc/terms/identifier>	"pdb:PLP"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-19>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-4>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-21>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00762>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:DB00112_DB00762"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-6>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00117-6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-20>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-6>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00116-6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-23>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_vocabulary:Labor-Induction-Agents>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:Labor-Induction-Agents"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-17>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00115-17"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:abd3e42d8c67111954c278994aa4591d>	<http://bio2rdf.org/drugbank_vocabulary:name>	"Replagal"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:x-uniprot>	<http://bio2rdf.org/uniprot:P24462> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-22>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:efd9b57513efb0eb6e90f59807e0e8d9>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:efd9b57513efb0eb6e90f59807e0e8d9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-25>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-19>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00091-19"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-1>	<http://bio2rdf.org/drugbank_vocabulary:value>	"-0.875"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-24>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-8>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:6d460a13d1af93268984ab262cef479d>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:6d460a13d1af93268984ab262cef479d"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:b77ba88d4df43eb6dd239cb83101c022>	<http://purl.org/dc/terms/title>	"Pteridines and derivatives"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-12>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:5ac86da3649163846e9e9d65b58c49fc>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:5ac86da3649163846e9e9d65b58c49fc"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-4>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-11>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:36cf3fe3b4f939b051085b627e517597>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"36cf3fe3b4f939b051085b627e517597"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-3>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-14>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00089-1>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00089-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2970662836bc4a17c64d219c534d3f7e>	<http://www.w3.org/2000/01/rdf-schema#label>	"Methionine and derivatives [drugbank_resource:2970662836bc4a17c64d219c534d3f7e]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-13>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-1>	<http://bio2rdf.org/drugbank_vocabulary:value>	"-0.307"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-16>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:x-uniprot>	<http://bio2rdf.org/uniprot:P20815> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-19>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00114-19"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:705836a5549e0548d20a0ef04e009f28>	<http://bio2rdf.org/drugbank_vocabulary:company>	"Sandoz"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-9>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-15>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-18>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-17>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-4>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00106-1>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Weight: 1416.0630 [drugbank_resource:experimental-properties-DB00106-1]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-3>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"PE"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-6>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:8abd75317f3f7b8f7d56e3fe7d6204bd>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:8abd75317f3f7b8f7d56e3fe7d6204bd"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8e7e8f5ff3cf3466586b956d7330151b>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:8e7e8f5ff3cf3466586b956d7330151b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Small-molecule>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:Small-molecule"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-5>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-8>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-7>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00694>	<http://www.w3.org/2000/01/rdf-schema#label>	"DDI between Bevacizumab and Daunorubicin - May enhance the cardiotoxic effect of Antineoplastic Agents (Anthracycline, Systemic). [drugbank_resource:DB00112_DB00694]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-5>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00099-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a9ee55eb5c1344c6ecd656006a4e92f2>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:a9ee55eb5c1344c6ecd656006a4e92f2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-16>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00118-16"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:1cb959cb5d30e328a863a3d9f64c120a>	<http://purl.org/dc/terms/title>	"Vinylogous acids"@en .
<http://bio2rdf.org/drugbank_resource:84e1544b4af68672a960baf683724f87>	<http://www.w3.org/2000/01/rdf-schema#label>	"Aralkylamines [drugbank_resource:84e1544b4af68672a960baf683724f87]"@en .
<http://bio2rdf.org/drugbank_vocabulary:Supplements>	<http://www.w3.org/2000/01/rdf-schema#label>	"Supplements [drugbank_vocabulary:Supplements]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-10>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-17>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00093-17"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:0d1969d27d89c3b774c942d81666c5d3>	<http://purl.org/dc/terms/title>	"Transition metal cyanide salt"@en .
<http://bio2rdf.org/drugbank_resource:DB00107_DB00429>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:DB00107_DB00429"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ffa1ac4af9ac617e01349d78fdc482f1>	<http://purl.org/dc/terms/title>	"indication for drugbank:DB00096"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-9>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-22>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00114-1>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00114-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e8fbddfaa9a4fe87d9328de7cf8cd326>	<http://purl.org/dc/terms/title>	"300 ug/mL Injection, solution form with intravenous; subcutaneous route"@en .
<http://bio2rdf.org/drugbank_vocabulary:e328a6cf619c4105669d93dc30d36096>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:e328a6cf619c4105669d93dc30d36096"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-21>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-21"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:7975713dad73e24fab2cbb6c89586ea4>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"480 ug/.8mL"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-2>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-21>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-7>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00091-7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-24>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_vocabulary:Drug>	<http://purl.org/dc/terms/title>	"Drug"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-23>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:08f1295028a77909e61816add07f6343>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"08f1295028a77909e61816add07f6343"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00106-1>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00106-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-26>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-3>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00103-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a39e93df12255155561f3d4acd297da8>	<http://www.w3.org/2000/01/rdf-schema#label>	"5 mg Powder for solution form with intravenous route [drugbank_resource:a39e93df12255155561f3d4acd297da8]"@en .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"Taurochenodeoxycholate 6-alpha- hydroxylase"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-25>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-18>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-18"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-24>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00116-24"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8bb9fceb6f80460936af862e9f7d1d94>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:8bb9fceb6f80460936af862e9f7d1d94"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-28>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00110>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00110"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:01c6a15f6a299a85cd866fc4092d0dce>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:01c6a15f6a299a85cd866fc4092d0dce"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-27>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:f2977936270a493873be5432bb760ef7>	<http://purl.org/dc/terms/title>	"1000 ug/mL Injection, solution form with intramuscular; subcutaneous route"@en .
<http://bio2rdf.org/drugbank_resource:DB00103_DB00608>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-7>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-14>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:DB00103_DB01118>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-13>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-16>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-7>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00116-7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:molecular-weight>	"57525.0"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:DB00099_DB00290>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:fdb8e90f512977b9fb2141486454a079>	<http://www.w3.org/2000/01/rdf-schema#label>	"clearance for drugbank:DB00089 [drugbank_resource:fdb8e90f512977b9fb2141486454a079]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-15>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:a9ee55eb5c1344c6ecd656006a4e92f2>	<http://purl.org/dc/terms/title>	"Aminobenzoic acid or derivatives"@en .
<http://bio2rdf.org/drugbank_resource:03746a740bf18cbf4beaae7cc5b7504f>	<http://www.w3.org/2000/01/rdf-schema#label>	"Pyrimidine [drugbank_resource:03746a740bf18cbf4beaae7cc5b7504f]"@en .
<http://bio2rdf.org/drugbank_resource:DB00099_DB00531>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:036d7e3cfbf77c5f19b4baba9ff7aed2>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"036d7e3cfbf77c5f19b4baba9ff7aed2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:22baeb726de652a99f0ad2fb61fac832>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:22baeb726de652a99f0ad2fb61fac832"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-18>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_vocabulary:ab9182be757cbb637b820f0951931ae2>	<http://bio2rdf.org/drugbank_vocabulary:name>	"Bedodeka"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00099_DB01030>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-17>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-20>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:fd9ee6482e9b1c5516cff7b904f27169>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:fd9ee6482e9b1c5516cff7b904f27169"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-6>	<http://bio2rdf.org/drugbank_vocabulary:value>	"(2S)-6-amino-2-{[(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-13,16-dibenzyl-10-(2-carbamoylethyl)-7-(carbamoylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl]pyrrolidin-2-yl]formamido}-N-(carbamoylmethyl)hexanamide"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-2>	<http://purl.org/dc/terms/title>	"Hydrophobicity: -0.330"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-19>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00103>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00103"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:4d6d8a0bb0437361e22c5fbaf04819ea>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:4d6d8a0bb0437361e22c5fbaf04819ea"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c987b0d07b89f29a364501bc29cfebc8>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:ea9490984599c557a86db10a8e93e890>	<http://purl.org/dc/terms/title>	"Secondary alcohols"@en .
<http://bio2rdf.org/drugbank:BE0003533>	<http://purl.org/dc/terms/identifier>	"drugbank:BE0003533"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:762a7c535540c35c3ec0a9932635da58>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"762a7c535540c35c3ec0a9932635da58"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:6ac630c499c16fd6e1f2a125e397688a>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:6ac630c499c16fd6e1f2a125e397688a"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:cad41663894b5be906782be10b396e06>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:ffc8ae70d9900ffb750da168c0f58cc5>	<http://purl.org/dc/terms/title>	"Thia fatty acids"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-26>	<http://bio2rdf.org/drugbank_vocabulary:value>	"1"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:36cf3fe3b4f939b051085b627e517597>	<http://purl.org/dc/terms/description>	"Choriogonadotropin alfa binds to the Follicle stimulating hormone receptor which results in ovulation in the absence of sufficient endogenous Luteinizing hormone."@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-14>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00114-14"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:85745be17d6c5d398a5d3540508f1a44>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"85745be17d6c5d398a5d3540508f1a44"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0000300>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"BE0000300"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-25>	<http://bio2rdf.org/drugbank_vocabulary:value>	"1"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-10>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:e6fa8c632405b98301de119a72894c49>	<http://purl.org/dc/terms/title>	"Monoalkylamines"@en .
<http://bio2rdf.org/drugbank_resource:7767fecbc1fcbba1764734e284afdd13>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:7767fecbc1fcbba1764734e284afdd13"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-4>	<http://bio2rdf.org/drugbank_vocabulary:value>	"C43H66N12O12S2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-12>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-11>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:name>	"Cytochrome P450 2C8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-29>	<http://bio2rdf.org/drugbank_vocabulary:value>	"0"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:96b90ed2d49ca40e5c82fd787db32b84>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:96b90ed2d49ca40e5c82fd787db32b84"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00109>	<http://purl.org/dc/terms/title>	"Enfuvirtide"@en .
<http://bio2rdf.org/drugbank_resource:ad9e59297973dcc097c2400d81b7888b>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"ad9e59297973dcc097c2400d81b7888b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-28>	<http://bio2rdf.org/drugbank_vocabulary:value>	"0"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:ec0915fa5d5da881fd812adc490bcd65>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:ec0915fa5d5da881fd812adc490bcd65"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:eb23978cb768321237553e12616e3b84>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"eb23978cb768321237553e12616e3b84"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e52e95d4f4c438c7fbf93397e39c26e3>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"e52e95d4f4c438c7fbf93397e39c26e3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00107_DB00429>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-27>	<http://bio2rdf.org/drugbank_vocabulary:value>	"1"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00224>	<http://www.w3.org/2000/01/rdf-schema#label>	"DDI between Enfuvirtide and Indinavir - May increase the serum concentration of Protease Inhibitors. Protease Inhibitors may increase the serum concentration of Enfuvirtide. [drugbank_resource:DB00109_DB00224]"@en .
<http://bio2rdf.org/drugbank_resource:DB00107_DB00834>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction> .
<http://bio2rdf.org/drugbank_resource:ef0da8f521b780a50b08c455970978ac>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:ef0da8f521b780a50b08c455970978ac"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-1>	<http://www.w3.org/2000/01/rdf-schema#label>	"Melting Point: 62 \u00B0C from Flora, K. et al., Biophys J. 75:1084-1096 (1998) [drugbank_resource:experimental-properties-DB00096-1]"@en .
<http://bio2rdf.org/chemspider:4575342>	<http://purl.org/dc/terms/identifier>	"chemspider:4575342"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:77b52954fa911921450d2b426c1a7a3a>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:77b52954fa911921450d2b426c1a7a3a"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00107_DB00917>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction> .
<http://bio2rdf.org/drugbank_resource:285048a510ce36e96744886cc83cc631>	<http://www.w3.org/2000/01/rdf-schema#label>	"400 mg/16mL Injection, solution form with intravenous route [drugbank_resource:285048a510ce36e96744886cc83cc631]"@en .
<http://bio2rdf.org/drugbank_resource:DB00107_DB00929>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction> .
<http://bio2rdf.org/drugbank_resource:f2a30f76a373192265e4b663c8339602>	<http://purl.org/dc/terms/description>	"For topical treatment of skin ulcers (from diabetes)"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-5>	<http://purl.org/dc/terms/title>	"Molecular Formula: C2041H3136N558O641S25"@en .
<http://bio2rdf.org/drugbank_resource:c7d119b1e6d46c382382c2c17e2801ac>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-26>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-26"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-17>	<http://www.w3.org/2000/01/rdf-schema#label>	"Rotatable Bond Count: 19 from ChemAxon [drugbank_resource:calculated-properties-DB00093-17]"@en .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"BE0002887"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00114-3>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00114-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-15>	<http://purl.org/dc/terms/title>	"Refractivity: 121.39 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:c7f12f71253c5095c8df9050b7b42f2c>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:Citanest-Octapressin>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:22baeb726de652a99f0ad2fb61fac832>	<http://purl.org/dc/terms/title>	"Hippuric acid or derivatives"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-21>	<http://bio2rdf.org/drugbank_vocabulary:value>	"3"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-19>	<http://www.w3.org/2000/01/rdf-schema#label>	"H Bond Donor Count: 8 from ChemAxon [drugbank_resource:calculated-properties-DB00116-19]"@en .
<http://bio2rdf.org/drugbank:BE0003533>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-19>	<http://bio2rdf.org/drugbank_vocabulary:value>	"4"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:0d47651b62c008d202fcec19e0c3b7c7>	<http://www.w3.org/2000/01/rdf-schema#label>	"indication for drugbank:DB00115 [drugbank_resource:0d47651b62c008d202fcec19e0c3b7c7]"@en .
<http://bio2rdf.org/drugbank_resource:c3ea863492592dff31fb000b21cd1a19>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:e9f580ccd34b70a11720b2f316225025>	<http://www.w3.org/2000/01/rdf-schema#label>	"clearance for drugbank:DB00099 [drugbank_resource:e9f580ccd34b70a11720b2f316225025]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-20>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-20"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-17>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00116-17"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8eb135a8f519839c5f289226017b68a3>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:8eb135a8f519839c5f289226017b68a3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-20>	<http://bio2rdf.org/drugbank_vocabulary:value>	"6"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:451abb4a53a3d4bc5e17cc485a3899b3>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"451abb4a53a3d4bc5e17cc485a3899b3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-25>	<http://www.w3.org/2000/01/rdf-schema#label>	"Rule of Five: 0 from ChemAxon [drugbank_resource:calculated-properties-DB00093-25]"@en .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/drugbank_vocabulary:molecular-weight>	"57344.0"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank:BE0000300>	<http://bio2rdf.org/drugbank_vocabulary:gene-name>	"SRM"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-10>	<http://purl.org/dc/terms/title>	"Monoisotopic Weight: 1201.841368071 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-13>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-13"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-2>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00100-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-6>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a9a58af69a8539d913c65b788eb5b178>	<http://purl.org/dc/terms/description>	"Used for labor induction, augmentation of labor, postpartum abbreviation of third stage of labor, postpartum control of uterine bleeding, termination of pregnancy and for the evaluation of fetal respiratory capability. Oxytocin cannot be used for elective induction of labor, there must be a clear medical requirement."@en .
<http://bio2rdf.org/drugbank_resource:Citanest-Dental-Octapressin>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-2>	<http://purl.org/dc/terms/title>	"Isoelectric Point: 7.86"@en .
<http://bio2rdf.org/drugbank_resource:c51b5b3f72bf15f717f23f1fdda6fe44>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:43ebb1f4d3ddbd9ec70fcbba40c42a45>	<http://www.w3.org/2000/01/rdf-schema#label>	"Imidazolyl carboxylic acids and derivatives [drugbank_resource:43ebb1f4d3ddbd9ec70fcbba40c42a45]"@en .
<http://bio2rdf.org/drugbank_resource:Citanest-Dental>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f2a30f76a373192265e4b663c8339602>	<http://www.w3.org/2000/01/rdf-schema#label>	"indication for drugbank:DB00102 [drugbank_resource:f2a30f76a373192265e4b663c8339602]"@en .
<http://bio2rdf.org/drugbank_resource:0235e5251bcfc61913eb18c0fab6a1c4>	<http://www.w3.org/2000/01/rdf-schema#label>	"mechanism-of-action for drugbank:DB00094 [drugbank_resource:0235e5251bcfc61913eb18c0fab6a1c4]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-14>	<http://purl.org/dc/terms/title>	"InChI: InChI=1S/C8H10NO6P/c1-5-8(11)7(3-10)6(2-9-5)4-15-16(12,13)14/h2-3,11H,4H2,1H3,(H2,12,13,14) from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:366d45e2564940d9162a27ad0e9e3571>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:366d45e2564940d9162a27ad0e9e3571"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a39e93df12255155561f3d4acd297da8>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"5 mg"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-6>	<http://bio2rdf.org/drugbank_vocabulary:value>	"6.92"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"EC 1.14.13.80"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:9d6d13e90c7dfeb0d8d2cac125c20125>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:9d6d13e90c7dfeb0d8d2cac125c20125"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:d8c37e1ee64fc7f014205837681e99df>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"d8c37e1ee64fc7f014205837681e99df"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:5d2074ef1500127ada3cef721a746c89>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:5d2074ef1500127ada3cef721a746c89"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-8>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:122193da65e00a63d46700928a244018>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"122193da65e00a63d46700928a244018"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:cad41663894b5be906782be10b396e06>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:cad41663894b5be906782be10b396e06"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c254aba7ca3db4f83cda45b27adb5b2b>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00110-1>	<http://www.w3.org/2000/01/rdf-schema#label>	"Melting Point: 61 \u00B0C (FAB fragment), 71 \u00B0C (whole mAb) from Vermeer, A.W.P. & Norde, W., Biophys. J. 78:394-404 (2000) [drugbank_resource:experimental-properties-DB00110-1]"@en .
<http://bio2rdf.org/drugbank_resource:fd9ee6482e9b1c5516cff7b904f27169>	<http://www.w3.org/2000/01/rdf-schema#label>	"N-acyl-alpha amino acids [drugbank_resource:fd9ee6482e9b1c5516cff7b904f27169]"@en .
<http://bio2rdf.org/drugbank_vocabulary:HIV-Fusion-Inhibitors>	<http://www.w3.org/2000/01/rdf-schema#label>	"HIV Fusion Inhibitors [drugbank_vocabulary:HIV-Fusion-Inhibitors]"@en .
<http://bio2rdf.org/drugbank_vocabulary:Anti-tocolytic-Agents>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"Anti-tocolytic-Agents"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c2dbd6b14df7875575496a70dff7a209>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:372918cb5733e55c6d5baa7bc6f4a30c>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:372918cb5733e55c6d5baa7bc6f4a30c"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:gene-name>	"CYP2C8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-1>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00117-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:96b90ed2d49ca40e5c82fd787db32b84>	<http://www.w3.org/2000/01/rdf-schema#label>	"N-substituted imidazole [drugbank_resource:96b90ed2d49ca40e5c82fd787db32b84]"@en .
<http://bio2rdf.org/drugbank_resource:e6fc137e236497aea65dd3bb99d52e53>	<http://purl.org/dc/terms/title>	"25 mg Capsule form with oral route"@en .
<http://bio2rdf.org/drugbank_resource:c28ad3ee91a708824325b58f26c403a5>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-5>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:9ea94506ab138833cc18501d48712af4>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-4>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00117-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:9e10be5c3dafcd8441cdeb69f72cc3f4>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c0c3695e2cc0b1f8b2708aa4329a566e>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-12>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00114-12"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-2>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00093-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f2540530a3858d9fa40e7bfd96e4c77d>	<http://purl.org/dc/terms/title>	"Organometallic compound"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-5>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00093-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:9d6d13e90c7dfeb0d8d2cac125c20125>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a6302cf127669e87e24a75b24552a9e8>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:a6302cf127669e87e24a75b24552a9e8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-4>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-5>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00118-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3d51d314e6796004243d124d2c5f0793>	<http://purl.org/dc/terms/title>	"100 mg Capsule, liquid filled form with oral route"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-14>	<http://bio2rdf.org/drugbank_vocabulary:value>	"InChI=1S/C8H10NO6P/c1-5-8(11)7(3-10)6(2-9-5)4-15-16(12,13)14/h2-3,11H,4H2,1H3,(H2,12,13,14)"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-11>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00115-11"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:be8afc258733f250df3262d94e93265b>	<http://www.w3.org/2000/01/rdf-schema#label>	"Pyridoxals and derivatives [drugbank_resource:be8afc258733f250df3262d94e93265b]"@en .
<http://bio2rdf.org/drugbank_resource:9be1f0fbe27fc41feab5fa848add809b>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00099_DB01030>	<http://purl.org/dc/terms/title>	"DDI between Filgrastim and Topotecan - Filgrastim may enhance the adverse/toxic effect of Topotecan."@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-9>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00115-9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-11>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-11"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:627446b31de3941cb82db7d08189b597>	<http://purl.org/dc/terms/title>	"Benzimidazoles"@en .
<http://bio2rdf.org/drugbank_resource:bf1a15ece689c3f449c06ebc0a90dae3>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:da8dbfa1d167bdbfac5e83608be911ea>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"da8dbfa1d167bdbfac5e83608be911ea"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-27>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-27"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pubchem.substance:46509031>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"46509031"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01232>	<http://purl.org/dc/terms/title>	"DDI between Enfuvirtide and Saquinavir - May increase the serum concentration of Protease Inhibitors. Protease Inhibitors may increase the serum concentration of Enfuvirtide."@en .
<http://bio2rdf.org/drugbank_resource:c007cc919bf71767e61e0b111723c84f>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/chemspider:1022>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"1022"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:99633b36b8289d3e0a8562067bd42c03>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-7>	<http://www.w3.org/2000/01/rdf-schema#label>	"logP: -2.1 from ChemAxon [drugbank_resource:calculated-properties-DB00114-7]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-4>	<http://bio2rdf.org/drugbank_vocabulary:value>	"2.69e-01 g/l"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:42e21c05e96b3040136e54dfed4bf794>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:42e21c05e96b3040136e54dfed4bf794"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-3>	<http://purl.org/dc/terms/title>	"Isoelectric Point: 5.67"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-26>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00091-26"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-3>	<http://www.w3.org/2000/01/rdf-schema#label>	"logS: -4.4 from ALOGPS [drugbank_resource:calculated-properties-DB00093-3]"@en .
<http://bio2rdf.org/drugbank_resource:fa8e5850916f505d7329bb36ce55c161>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:fa8e5850916f505d7329bb36ce55c161"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a6317c6254a0737c350d2f0860ea1ec3>	<http://purl.org/dc/terms/title>	"indication for drugbank:DB00113"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-19>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00118-19"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:9a71495dd3f52eed3f338a39501d4bfa>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e04ee332a67fe1dea4752f0a68c0a6ee>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"300 ug/.5mL"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01319>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00109_DB01319"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:986ea485795ab092b3199f449ca4056e>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:06832c77d22e34a13e2de6990e7f3cf2>	<http://www.w3.org/2000/01/rdf-schema#label>	"Pyrrolines [drugbank_resource:06832c77d22e34a13e2de6990e7f3cf2]"@en .
<http://bio2rdf.org/drugbank_resource:98458df79187b81a7709036be48a75a4>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:be8afc258733f250df3262d94e93265b>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-5>	<http://purl.org/dc/terms/title>	"Water Solubility: 3.84e-02 g/l from ALOGPS"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-27>	<http://bio2rdf.org/drugbank_vocabulary:value>	"1"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-22>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-22"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-26>	<http://bio2rdf.org/drugbank_vocabulary:value>	"0"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-4>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00097-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-14>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00117-14"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:986ea485795ab092b3199f449ca4056e>	<http://purl.org/dc/terms/description>	"Zenepax binds with high-affinity to the Tac subunit of the high-affinity IL-2 receptor complex and inhibits IL-2 binding. The IL-2 receptor (Tac) subunit is expressed on activated but not resting lymphocytes."@en .
<http://bio2rdf.org/drugbank_resource:1c7495e7ba342d224b5028d72d73010d>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"35 mg"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:efdc5ed439af008904afce03f4dd2ec8>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"efdc5ed439af008904afce03f4dd2ec8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:97f751c9423321c8864c0243afcff111>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-2>	<http://purl.org/dc/terms/title>	"logP: -2 from ALOGPS"@en .
<http://bio2rdf.org/drugbank_resource:07c2684a57210d1f5bc920d112d11ecd>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"07c2684a57210d1f5bc920d112d11ecd"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00107_DB00429>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:96faa670b368b06113b9e58e3db1d86c>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-27>	<http://bio2rdf.org/drugbank_vocabulary:value>	"1"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:96b90ed2d49ca40e5c82fd787db32b84>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-26>	<http://bio2rdf.org/drugbank_vocabulary:value>	"0"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:DB00107_DB00834>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:fa9ea24c47c4cc6ec20e42b245e43401>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:fa9ea24c47c4cc6ec20e42b245e43401"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:bbf3cb3443969f24e50666e131185bd8>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:DB00107_DB00917>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:DB00107_DB00929>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:9e10be5c3dafcd8441cdeb69f72cc3f4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-31>	<http://bio2rdf.org/drugbank_vocabulary:value>	"0"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank:DB00095>	<http://purl.org/dc/terms/description>	"Humanized IgG1 kappa isotype monoclonal antibody that binds to human CD11a. Efalizumab has a molecular weight of approximately 150 kilodaltons and is produced in a Chinese hamster ovary mammalian cell expression system in a nutrient medium containing the antibiotic gentamicin."@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00114-2>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00114-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-2>	<http://www.w3.org/2000/01/rdf-schema#label>	"Hydrophobicity: -0.330 [drugbank_resource:experimental-properties-DB00094-2]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-9>	<http://www.w3.org/2000/01/rdf-schema#label>	"Traditional IUPAC Name: pyridoxal phosphate from ChemAxon [drugbank_resource:calculated-properties-DB00114-9]"@en .
<http://bio2rdf.org/drugbank_resource:fdb0a3b06aac9bbd85eeda7b1daf8545>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:fdb0a3b06aac9bbd85eeda7b1daf8545"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-30>	<http://bio2rdf.org/drugbank_vocabulary:value>	"0"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:9ea94506ab138833cc18501d48712af4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:9be1f0fbe27fc41feab5fa848add809b>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Indication> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://purl.org/dc/terms/identifier>	"drugbank:BE0002363"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-21>	<http://bio2rdf.org/drugbank_vocabulary:value>	"9.41"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:9a71495dd3f52eed3f338a39501d4bfa>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:fe2051219bbed1c3f26d756ec49dea95>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:fe2051219bbed1c3f26d756ec49dea95"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-21>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00114-21"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-29>	<http://bio2rdf.org/drugbank_vocabulary:value>	"1"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_vocabulary:8ad571235d010ca525f3733fd9b517fb>	<http://purl.org/dc/terms/title>	"Amevive"@en .
<http://bio2rdf.org/drugbank_resource:b8f9ca946fec2fca3eb84c3b8cf1ff12>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-28>	<http://bio2rdf.org/drugbank_vocabulary:value>	"1"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:99633b36b8289d3e0a8562067bd42c03>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Half-life> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00220>	<http://purl.org/dc/terms/title>	"DDI between Enfuvirtide and Nelfinavir - May increase the serum concentration of Protease Inhibitors. Protease Inhibitors may increase the serum concentration of Enfuvirtide."@en .
<http://bio2rdf.org/drugbank_resource:DB00112_DB08879>	<http://www.w3.org/2000/01/rdf-schema#label>	"DDI between Bevacizumab and Belimumab - Monoclonal Antibodies may enhance the adverse/toxic effect of Belimumab. [drugbank_resource:DB00112_DB08879]"@en .
<http://bio2rdf.org/drugbank_resource:e04ee332a67fe1dea4752f0a68c0a6ee>	<http://www.w3.org/2000/01/rdf-schema#label>	"300 ug/.5mL Injection, solution form with intravenous route [drugbank_resource:e04ee332a67fe1dea4752f0a68c0a6ee]"@en .
<http://bio2rdf.org/drugbank_resource:f31c373ea0d5f6b6f514f58cf30652a6>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"f31c373ea0d5f6b6f514f58cf30652a6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00089-1>	<http://bio2rdf.org/drugbank_vocabulary:value>	"61 \u00B0C (FAB fragment), 71 \u00B0C (whole mAb)"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ba0f878619b43a5be9083f01d8ba77fd>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00220>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:DB00109_DB00220"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:31af673f5d82841086059243563cd4c6>	<http://purl.org/dc/terms/description>	"Pyridoxal Phosphate is a coenzyme of many enzymatic reactions. It is the active form of vitamin B6 which comprises three natural organic compounds, pyridoxal, pyridoxamine and pyridoxine. Pyridoxal phosphate acts as a coenzyme in all transamination reactions, and in some decarboxylation and deamination reactions of amino acids. The aldehyde group of pyridoxal phosphate forms a Schiff-base linkage with the epsilon-amino group of a specific lysine group of the aminotransferase enzyme. The alpha-amino group of the amino acid substrate displaces the epsilon-amino group of the active-site lysine residue. The resulting aldimine becomes deprotonated to become a quinoid intermediate, which in turn accepts a proton at a different position to become a ketimine. The resulting ketimine is hydrolysed so that the amino group remains on the protein complex."@en .
<http://bio2rdf.org/drugbank_resource:78fce134a0e754813388f2850f268625>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:78fce134a0e754813388f2850f268625"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-22>	<http://bio2rdf.org/drugbank_vocabulary:value>	"4"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_vocabulary:64789d808f73ebe8eac3dbded4a95da0>	<http://purl.org/dc/terms/title>	"Raptiva"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-23>	<http://bio2rdf.org/drugbank_vocabulary:value>	"3"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:9be1f0fbe27fc41feab5fa848add809b>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:Xylonest-Octapressin>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:Xylonest-Octapressin"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-21>	<http://bio2rdf.org/drugbank_vocabulary:value>	"3"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:31af673f5d82841086059243563cd4c6>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:31af673f5d82841086059243563cd4c6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00091-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Caco2-Permeability> .
<http://bio2rdf.org/drugbank_resource:97f751c9423321c8864c0243afcff111>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"CYPIIIA5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:b86c00de25382c6ce4d94dae5e4502db>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:b8238b8599e6fdc40599cf773d5fb991>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:0235e5251bcfc61913eb18c0fab6a1c4>	<http://purl.org/dc/terms/title>	"mechanism-of-action for drugbank:DB00094"@en .
<http://bio2rdf.org/drugbank_resource:57db98e1612a44845256ccbbbc457ff8>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:57db98e1612a44845256ccbbbc457ff8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:9d6d13e90c7dfeb0d8d2cac125c20125>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:3732893325a7ecb9126a15736796f117>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:3732893325a7ecb9126a15736796f117"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"cation binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:Citanest-Octapressin>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:08f1295028a77909e61816add07f6343>	<http://purl.org/dc/terms/title>	"Pyrimidones"@en .
<http://bio2rdf.org/drugbank_resource:58cc96ec8bd0d25f62dde9d4e4a829dd>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:58cc96ec8bd0d25f62dde9d4e4a829dd"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-1>	<http://bio2rdf.org/drugbank_vocabulary:value>	"-0.432"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"oxidoreductase activity"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:069ab916580192548ff172f164a424bf>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"069ab916580192548ff172f164a424bf"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://purl.org/dc/terms/title>	"Cytochrome P450 2D6"@en .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"oxidoreductase activity"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:96b90ed2d49ca40e5c82fd787db32b84>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:Citanest-Dental-Octapressin>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Mixture> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"oxidoreductase activity"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:96faa670b368b06113b9e58e3db1d86c>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:DB00099_DB00531>	<http://purl.org/dc/terms/title>	"DDI between Filgrastim and Cyclophosphamide - Filgrastim may enhance the adverse/toxic effect of Cyclophosphamide. Specifically, the risk of pulmonary toxicity may be enhanced."@en .
<http://bio2rdf.org/drugbank_resource:Citanest-Dental>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Mixture> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-27>	<http://bio2rdf.org/drugbank_vocabulary:value>	"1"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:DB00099_DB00290>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:DB00099_DB00290"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-26>	<http://bio2rdf.org/drugbank_vocabulary:value>	"0"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00118-1>	<http://purl.org/dc/terms/title>	"Boiling Point: 78 \u00B0C"@en .
<http://bio2rdf.org/pubchem.compound:1051>	<http://purl.org/dc/terms/identifier>	"pubchem.compound:1051"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-25>	<http://bio2rdf.org/drugbank_vocabulary:value>	"0"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_vocabulary:fa342aed686575ef39a8ec9dc16cbab4>	<http://www.w3.org/2000/01/rdf-schema#label>	"Biocilin [drugbank_vocabulary:fa342aed686575ef39a8ec9dc16cbab4]"@en .
<http://bio2rdf.org/drugbank_resource:b77ba88d4df43eb6dd239cb83101c022>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3>	<http://www.w3.org/ns/dcat#distribution>	<http://download.bio2rdf.org/release/3/drugbank/drugbank.nq.gz> .
<http://bio2rdf.org/drugbank_resource:78fce134a0e754813388f2850f268625>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:78fce134a0e754813388f2850f268625"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-16>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00116-16"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:f6203f7c9646b21edf1fa81c5cdf94d1>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:f6203f7c9646b21edf1fa81c5cdf94d1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:7abeba6bed290a4b16075521bc0113ca>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"7abeba6bed290a4b16075521bc0113ca"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-3>	<http://purl.org/dc/terms/title>	"logP: 1.87 from ALOGPS"@en .
<http://bio2rdf.org/drugbank_resource:f2977936270a493873be5432bb760ef7>	<http://www.w3.org/2000/01/rdf-schema#label>	"1000 ug/mL Injection, solution form with intramuscular; subcutaneous route [drugbank_resource:f2977936270a493873be5432bb760ef7]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-25>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:DB00103_DB01118>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:DB00103_DB01118"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-18>	<http://bio2rdf.org/drugbank_vocabulary:value>	"92"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-10>	<http://bio2rdf.org/drugbank_vocabulary:value>	"NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Anti-tocolytic-Agents>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:Anti-tocolytic-Agents"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-5>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Formula: C6332H9808N1678O1989S42 [drugbank_resource:experimental-properties-DB00111-5]"@en .
<http://bio2rdf.org/drugbank_resource:e02568426e5e3817cd6fcddc8dee4bee>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:e02568426e5e3817cd6fcddc8dee4bee"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-19>	<http://purl.org/dc/terms/title>	"Rotatable Bond Count: 4 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-24>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:Citanest-Octapressin>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Mixture> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-4>	<http://bio2rdf.org/drugbank_vocabulary:value>	"C532H892N162O153S9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-10>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00116-10"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-27>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-24>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00117-24"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-18>	<http://bio2rdf.org/drugbank_vocabulary:value>	"12"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-2>	<http://bio2rdf.org/drugbank_vocabulary:value>	"-1.1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-19>	<http://bio2rdf.org/drugbank_vocabulary:value>	"8"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_vocabulary:Vasoconstrictor-Agents>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:Vasoconstrictor-Agents"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-1>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00096-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-26>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:1c54727b6a9a48b74b53723fbee43d80>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"1c54727b6a9a48b74b53723fbee43d80"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-29>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:Citanest-Octapressin>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:Citanest-Octapressin"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:eda68d4a7955df0290c1f8b709e905ec>	<http://purl.org/dc/terms/description>	"Laronidase catalyses the hydrolysis of terminal alpha-L-iduronic acid residues of dermatan sulfate and heparin sulfate."@en .
<http://bio2rdf.org/drugbank_resource:6215bb81f14ea29a233fa4efbf660bf9>	<http://purl.org/dc/terms/description>	"* 24.8 +/- 4.1 mL/h/kg [HIV-1 infected adult and pediatric subjects following a 90-mg single SC dose of enfuvirtide]\r\n* 30.6 +/- 10.6 mL/h/kg [Following 90-mg twice daily dosing of FUZEON SC in combination with other antiretroviral agents in HIV-1 infected subjects]\r\n* 40 +/- 17 mL/h/kg [pediatric patients in the presence of concomitant medications including antiretroviral agents receiving the 2 mg/kg twice daily dose]"@en .
<http://bio2rdf.org/drugbank_resource:Citanest-Dental>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-13>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Formula: C8H10NO6P from ChemAxon [drugbank_resource:calculated-properties-DB00114-13]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-28>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:2c808757b9d5f22f13a70bae1f9e7737>	<http://purl.org/dc/terms/title>	"Primary aliphatic amine"@en .
<http://bio2rdf.org/drugbank_resource:Citanest-Dental-Octapressin>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-14>	<http://purl.org/dc/terms/title>	"InChIKey: InChIKey=PMATZTZNYRCHOR-IMVLJIQENA-N from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-31>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-24>	<http://bio2rdf.org/drugbank_vocabulary:value>	"0"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-2>	<http://bio2rdf.org/drugbank_vocabulary:value>	"-0.437"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-30>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:2c808757b9d5f22f13a70bae1f9e7737>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:2c808757b9d5f22f13a70bae1f9e7737"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-23>	<http://bio2rdf.org/drugbank_vocabulary:value>	"3"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-17>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:5ba52774f54e88019dd4d17f32a34f7b>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:5ba52774f54e88019dd4d17f32a34f7b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00094>	<http://purl.org/dc/terms/description>	"Urofollitropin is a purified form of follicle-stimulating hormone (FSH) that is manufactured by extraction from human urine and then purified. It consists of two non-covalently linked, non-identical glycoproteins designated as the alpha- and beta- subunits. The alpha- and beta- subunits have 92 and 111 amino acids. The alpha subunit is glycosylated at Asn 51 and Asn 78 while the beta subunit is glycosylated at Asn 7 and Asn 24. Urofollitropin is important in the development of follicles produced by the ovaries. Given by subcutaneous injection, it is used in combination with human chorionic gonadotropin (hCG) to assist in ovulation and fertility. Urofollitropin may also be used to cause the ovary to produce several follicles, which can then be harvested for use in gamete intrafallopian transfer (GIFT) or in vitro fertilization (IVF)."@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-16>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-11>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-11"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-19>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:96b90ed2d49ca40e5c82fd787db32b84>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-8>	<http://bio2rdf.org/drugbank_vocabulary:value>	"6.20e+01 g/l"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:gene-name>	"CYP2C9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-18>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:96faa670b368b06113b9e58e3db1d86c>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/drugbank_vocabulary:gene-sequence>	">1512 bp\nATGGCTCTCATCCCAGACTTGGCCATGGAAACCTGGCTTCTCCTGGCTGTCAGCCTGGTG\nCTCCTCTATCTATATGGAACCCATTCACATGGACTTTTTAAGAAGCTTGGAATTCCAGGG\nCCCACACCTCTGCCTTTTTTGGGAAATATTTTGTCCTACCATAAGGGCTTTTGTATGTTT\nGACATGGAATGTCATAAAAAGTATGGAAAAGTGTGGGGCTTTTATGATGGTCAACAGCCT\nGTGCTGGCTATCACAGATCCTGACATGATCAAAACAGTGCTAGTGAAAGAATGTTATTCT\nGTCTTCACAAACCGGAGGCCTTTTGGTCCAGTGGGATTTATGAAAAGTGCCATCTCTATA\nGCTGAGGATGAAGAATGGAAGAGATTACGATCATTGCTGTCTCCAACCTTCACCAGTGGA\nAAACTCAAGGAGATGGTCCCTATCATTGCCCAGTATGGAGATGTGTTGGTGAGAAATCTG\nAGGCGGGAAGCAGAGACAGGCAAGCCTGTCACCTTGAAAGACGTCTTTGGGGCCTACAGC\nATGGATGTGATCACTAGCACATCATTTGGAGTGAACATCGACTCTCTCAACAATCCACAA\nGACCCCTTTGTGGAAAACACCAAGAAGCTTTTAAGATTTGATTTTTTGGATCCATTCTTT\nCTCTCAATAACAGTCTTTCCATTCCTCATCCCAATTCTTGAAGTATTAAATATCTGTGTG\nTTTCCAAGAGAAGTTACAAATTTTTTAAGAAAATCTGTAAAAAGGATGAAAGAAAGTCGC\nCTCGAAGATACACAAAAGCACCGAGTGGATTTCCTTCAGCTGATGATTGACTCTCAGAAT\nTCAAAAGAAACTGAGTCCCACAAAGCTCTGTCCGATCTGGAGCTCGTGGCCCAATCAATT\nATCTTTATTTTTGCTGGCTATGAAACCACGAGCAGTGTTCTCTCCTTCATTATGTATGAA\nCTGGCCACTCACCCTGATGTCCAGCAGAAACTGCAGGAGGAAATTGATGCAGTTTTACCC\nAATAAGGCACCACCCACCTATGATACTGTGCTACAGATGGAGTATCTTGACATGGTGGTG\nAATGAAACGCTCAGATTATTCCCAATTGCTATGAGACTTGAGAGGGTCTGCAAAAAAGAT\nGTTGAGATCAATGGGATGTTCATTCCCAAAGGGGTGGTGGTGATGATTCCAAGCTATGCT\nCTTCACCGTGACCCAAAGTACTGGACAGAGCCTGAGAAGTTCCTCCCTGAAAGATTCAGC\nAAGAAGAACAAGGACAACATAGATCCTTACATATACACACCCTTTGGAAGTGGACCCAGA\nAACTGCATTGGCATGAGGTTTGCTCTCATGAACATGAAACTTGCTCTAATCAGAGTCCTT\nCAGAACTTCTCCTTCAAACCTTGTAAAGAAACACAGATCCCCCTGAAATTAAGCTTAGGA\nGGACTTCTTCAACCAGAAAAACCCGTTGTTCTAAAGGTTGAGTCAAGGGATGGCACCGTA\nAGTGGAGCCTGA"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-21>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:07769f07381a36b9cbc482dc6db9e40d>	<http://purl.org/dc/terms/title>	"Thia fatty acid"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-20>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:68664b41f20b902d0fcad004203c7cc8>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:68664b41f20b902d0fcad004203c7cc8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2a828069e3c5a4b098468f8a2091e89f>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"250 ug/.5mL"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-23>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:4f9f96147f2386295de420eed7aa9274>	<http://www.w3.org/2000/01/rdf-schema#label>	"half-life for drugbank:DB00112 [drugbank_resource:4f9f96147f2386295de420eed7aa9274]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-10>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00091-10"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-22>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"oxidoreductase activity"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00112>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00112"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-18>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00091-18"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:58cc96ec8bd0d25f62dde9d4e4a829dd>	<http://www.w3.org/2000/01/rdf-schema#label>	"Secondary alkylarylamines [drugbank_resource:58cc96ec8bd0d25f62dde9d4e4a829dd]"@en .
<http://bio2rdf.org/drugbank_resource:03746a740bf18cbf4beaae7cc5b7504f>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:03746a740bf18cbf4beaae7cc5b7504f"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-9>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:DB00107_DB00429>	<http://www.w3.org/2000/01/rdf-schema#label>	"DDI between Oxytocin and Carboprost Tromethamine - May enhance the adverse/toxic effect of Oxytocic Agents. Specifically, oxytocic effects may be enhanced. [drugbank_resource:DB00107_DB00429]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-17>	<http://bio2rdf.org/drugbank_vocabulary:value>	"9"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-8>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:6205a409adf418d0390045ac349b481a>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"6205a409adf418d0390045ac349b481a"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-15>	<http://purl.org/dc/terms/title>	"Polar Surface Area (PSA): 292.76 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-11>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:DB00107_DB00429>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:DB00107_DB00429"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-10>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-13>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:5d2074ef1500127ada3cef721a746c89>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"5d2074ef1500127ada3cef721a746c89"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:efdc5ed439af008904afce03f4dd2ec8>	<http://purl.org/dc/terms/title>	"mechanism-of-action for drugbank:DB00099"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-6>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00118-6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-12>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-21>	<http://bio2rdf.org/drugbank_vocabulary:value>	"1"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-7>	<http://www.w3.org/2000/01/rdf-schema#label>	"Traditional IUPAC Name: tetrahydrofolic acid from ChemAxon [drugbank_resource:calculated-properties-DB00116-7]"@en .
<http://bio2rdf.org/drugbank_resource:da9625c635b6c208626fef4666f9f883>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"da9625c635b6c208626fef4666f9f883"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-15>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:fdb0a3b06aac9bbd85eeda7b1daf8545>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:fdb0a3b06aac9bbd85eeda7b1daf8545"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:9e10be5c3dafcd8441cdeb69f72cc3f4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB06290>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:DB00109_DB06290"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-14>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:99633b36b8289d3e0a8562067bd42c03>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-26>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-2>	<http://purl.org/dc/terms/title>	"Hydrophobicity: -0.431"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-11>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-11"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:9a71495dd3f52eed3f338a39501d4bfa>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:dc4a561c55d386ce9aa0ac35fa50583b>	<http://www.w3.org/2000/01/rdf-schema#label>	"manufacturer for drugbank:DB00091 [drugbank_resource:dc4a561c55d386ce9aa0ac35fa50583b]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00095-1>	<http://bio2rdf.org/drugbank_vocabulary:value>	"61 \u00B0C (FAB fragment), 71 \u00B0C (whole mAb)"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-25>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-3>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-24>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00093-24"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00107_DB00834>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-16>	<http://bio2rdf.org/drugbank_vocabulary:value>	"2"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-27>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:DB00107_DB00429>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:98458df79187b81a7709036be48a75a4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Mechanism-of-action> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-5>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:DB00107_DB00929>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00118>	<http://www.w3.org/2000/01/rdf-schema#label>	"S-Adenosylmethionine [drugbank:DB00118]"@en .
<http://bio2rdf.org/drugbank_resource:986ea485795ab092b3199f449ca4056e>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Mechanism-of-action> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-4>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-29>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-29"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00107_DB00917>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0000300>	<http://purl.org/dc/terms/identifier>	"drugbank:BE0000300"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-7>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-20>	<http://bio2rdf.org/drugbank_vocabulary:value>	"0"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:84e1544b4af68672a960baf683724f87>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:84e1544b4af68672a960baf683724f87"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8ae8b01597df174d257016596812aeab>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:8ae8b01597df174d257016596812aeab"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-6>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-19>	<http://bio2rdf.org/drugbank_vocabulary:value>	"0"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-5>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:122193da65e00a63d46700928a244018>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:122193da65e00a63d46700928a244018"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-17>	<http://bio2rdf.org/drugbank_vocabulary:value>	"8"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-19>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-18>	<http://bio2rdf.org/drugbank_vocabulary:value>	"0"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01319>	<http://www.w3.org/2000/01/rdf-schema#label>	"DDI between Enfuvirtide and Fosamprenavir - May increase the serum concentration of Protease Inhibitors. Protease Inhibitors may increase the serum concentration of Enfuvirtide. [drugbank_resource:DB00109_DB01319]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-18>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:97f751c9423321c8864c0243afcff111>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:HIV-Fusion-Inhibitors>	<http://purl.org/dc/terms/title>	"HIV Fusion Inhibitors"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-24>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00114-24"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-20>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:ffc8ae70d9900ffb750da168c0f58cc5>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"ffc8ae70d9900ffb750da168c0f58cc5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-2>	<http://bio2rdf.org/drugbank_vocabulary:value>	"9.38"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:2a828069e3c5a4b098468f8a2091e89f>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"2a828069e3c5a4b098468f8a2091e89f"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:98458df79187b81a7709036be48a75a4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:3314d6a38b90d6a9ef0419bc7224913d>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:3314d6a38b90d6a9ef0419bc7224913d"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-3>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00112-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-2>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:986ea485795ab092b3199f449ca4056e>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:9ea94506ab138833cc18501d48712af4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-22>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-25>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00118-25"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:405bc988f44cffeeb0d7149d00e5918b>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:405bc988f44cffeeb0d7149d00e5918b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-21>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:9d6d13e90c7dfeb0d8d2cac125c20125>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-24>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:85e4414ae6d2bc12695a4539100e286f>	<http://purl.org/dc/terms/description>	"Vitamin B12 is used in the body in two forms: Methylcobalamin and 5-deoxyadenosyl cobalamin. The enzyme methionine synthase needs methylcobalamin as a cofactor. This enzyme is involved in the conversion of the amino acid homocysteine into methionine. Methionine in turn is required for DNA methylation. 5-Deoxyadenosyl cobalamin is a cofactor needed by the enzyme that converts L-methylmalonyl-CoA to succinyl-CoA. This conversion is an important step in the extraction of energy from proteins and fats. Furthermore, succinyl CoA is necessary for the production of hemoglobin, the substances that carries oxygen in red blood cells."@en .
<http://bio2rdf.org/drugbank_resource:3549163466db2fa5b979545848c2ef00>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:3549163466db2fa5b979545848c2ef00"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-1>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00102-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-23>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:1588f62bddb8c0b1cca8f11ce8e653b9>	<http://purl.org/dc/terms/title>	"10 [USP'U]/mL Injection, solution form with intramuscular; intravenous route"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-11>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-1>	<http://bio2rdf.org/drugbank_vocabulary:value>	"61 \u00B0C (FAB fragment), 71 \u00B0C (whole mAb)"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-10>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-19>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-19"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-6>	<http://purl.org/dc/terms/title>	"IUPAC Name: [(1R,2R,3S,4S,8S,9S,14S,18R,19R)-4,9,14-tris(2-carbamoylethyl)-3,8,19-tris(carbamoylmethyl)-18-(2-{[(2R)-2-[({[(2R,3S,4R,5S)-5-(5,6-dimethyl-1H-1,3-benzodiazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy}(hydroxy)phosphoryl)oxy]propyl]carbamoyl}ethyl)-2,3,6,8,13,13,16,18-octamethyl-20,21,22,23-tetraazapentacyclo[15.2.1.1\u00B2,\u2075.1\u2077,\u00B9\u2070.1\u00B9\u00B2,\u00B9\u2075]tricosa-5(23),6,10(22),11,15(21),16-hexaen-20-yl]cobaltcarbonitrile from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-13>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_vocabulary:Conditionally-Essential-Amino-Acids>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:Conditionally-Essential-Amino-Acids"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:dc4a561c55d386ce9aa0ac35fa50583b>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#value>	"Apotex inc"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-23>	<http://www.w3.org/2000/01/rdf-schema#label>	"H Bond Donor Count: 3 from ChemAxon [drugbank_resource:calculated-properties-DB00117-23]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-12>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:6be4db795caa5a4f0e9b208f115d277b>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:6be4db795caa5a4f0e9b208f115d277b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00110-1>	<http://bio2rdf.org/drugbank_vocabulary:value>	"61 \u00B0C (FAB fragment), 71 \u00B0C (whole mAb)"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-15>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0003533>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"cation binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-14>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"cation binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-1>	<http://bio2rdf.org/drugbank_vocabulary:value>	"61 \u00B0C (FAB fragment), 71 \u00B0C (whole mAb)"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-17>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Biotech>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:Biotech"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-16>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"cation binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:1059233feb371b14b03a21571fa19968>	<http://purl.org/dc/terms/title>	"mechanism-of-action for drugbank:DB00113"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-3>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-24>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00091-24"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:036d7e3cfbf77c5f19b4baba9ff7aed2>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:036d7e3cfbf77c5f19b4baba9ff7aed2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:282d8423d2c45b369fa817ef1edbccd5>	<http://purl.org/dc/terms/title>	"Substituted aniline"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-3>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-21>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00115-2>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00115-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3f54718d1deb0dbafe47e6e45eda5914>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"3f54718d1deb0dbafe47e6e45eda5914"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-5>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:dedcaba12fd68e71a4930ea18843aa61>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:dedcaba12fd68e71a4930ea18843aa61"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:5ba52774f54e88019dd4d17f32a34f7b>	<http://purl.org/dc/terms/title>	"indication for drugbank:DB00095"@en .
<http://bio2rdf.org/drugbank_resource:7975713dad73e24fab2cbb6c89586ea4>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"7975713dad73e24fab2cbb6c89586ea4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-4>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:ad715d0a2b2bcdcad22b975675537588>	<http://purl.org/dc/terms/title>	"Phenylalkylamines"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-7>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"ion binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ff5b4bb2ae4fdc7811f87fd38c8b8eda>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:ff5b4bb2ae4fdc7811f87fd38c8b8eda"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-6>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"ion binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-9>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"ion binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"tetrapyrrole binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Nutraceutical>	<http://purl.org/dc/terms/title>	"nutraceutical"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-8>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00677>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:DB00109_DB00677"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-14>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:a61e3adec088927f97197e2f1513790d>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"a61e3adec088927f97197e2f1513790d"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-17>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00117-17"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-13>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0003533>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"tetrapyrrole binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ec0915fa5d5da881fd812adc490bcd65>	<http://www.w3.org/2000/01/rdf-schema#label>	"absorption for drugbank:DB00095 [drugbank_resource:ec0915fa5d5da881fd812adc490bcd65]"@en .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01601>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:DB00109_DB01601"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-18>	<http://www.w3.org/2000/01/rdf-schema#label>	"Polar Surface Area (PSA): 92 from ChemAxon [drugbank_resource:calculated-properties-DB00117-18]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-16>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_vocabulary:8550beb9aaabcff323bdfeef04608bb8>	<http://www.w3.org/2000/01/rdf-schema#label>	"Plenaxis [drugbank_vocabulary:8550beb9aaabcff323bdfeef04608bb8]"@en .
<http://bio2rdf.org/drugbank_resource:76cc7a41e93863bcbab0bba32bc52311>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:b368929b1fa997f2cd3b30bde051c56f> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-12>	<http://bio2rdf.org/drugbank_vocabulary:value>	"C62H111N11O12"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-15>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-18>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:cb386ea42baf8766a3e98e9d24d46516>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:cb386ea42baf8766a3e98e9d24d46516"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:6826daa495527ec54b81079e04e89d24>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"6826daa495527ec54b81079e04e89d24"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"tetrapyrrole binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e340b19fed6c2eaebccc1a4c652c8eb5>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"e340b19fed6c2eaebccc1a4c652c8eb5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8e7e8f5ff3cf3466586b956d7330151b>	<http://purl.org/dc/terms/title>	"Ketimine"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-17>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:38b20638a91b63e0378b18fb8d8f4c38>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:38b20638a91b63e0378b18fb8d8f4c38"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fe02b6034f5c4d73f73a58815355abf5>	<http://www.w3.org/2000/01/rdf-schema#label>	"300 ug/.5mL Injection, solution form with intravenous; subcutaneous route [drugbank_resource:fe02b6034f5c4d73f73a58815355abf5]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-17>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00117-17"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01072>	<http://www.w3.org/2000/01/rdf-schema#label>	"DDI between Enfuvirtide and Atazanavir - May increase the serum concentration of Protease Inhibitors. Protease Inhibitors may increase the serum concentration of Enfuvirtide. [drugbank_resource:DB00109_DB01072]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-27>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-27"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Vitamin-B-Complex>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:Vitamin-B-Complex"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-20>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-19>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:ffa1ac4af9ac617e01349d78fdc482f1>	<http://purl.org/dc/terms/description>	"For treatment of severe blood loss, hypervolemia, hypoproteinemia."@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-6>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-5>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"ion binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:131ed90e7634d72c92f27daf9a85454a>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:131ed90e7634d72c92f27daf9a85454a"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-8>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_vocabulary:8550beb9aaabcff323bdfeef04608bb8>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:8550beb9aaabcff323bdfeef04608bb8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a9ee55eb5c1344c6ecd656006a4e92f2>	<http://www.w3.org/2000/01/rdf-schema#label>	"Aminobenzoic acid or derivatives [drugbank_resource:a9ee55eb5c1344c6ecd656006a4e92f2]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-7>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/pubchem.compound:44176380>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/pubchem.compound:44176380"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-10>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:433dda4a1117986cabe237dcf80bd242>	<http://www.w3.org/2000/01/rdf-schema#label>	"Alkyl phosphate [drugbank_resource:433dda4a1117986cabe237dcf80bd242]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-19>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00116-19"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pubchem.compound:91443>	<http://purl.org/dc/terms/identifier>	"pubchem.compound:91443"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-9>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:3181b99b434a8db59d197070956de3d9>	<http://purl.org/dc/terms/description>	"Alglucerase catalyzes the hydrolysis of the glycolipid, glucocerebroside, to glucose and ceramide as part of the normal degradation pathway for membrane lipids."@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-12>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00107>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00107"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://purl.org/dc/terms/Dataset> .
<http://bio2rdf.org/drugbank_resource:3c77091e1ee2397a2767e73267a25af5>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:3c77091e1ee2397a2767e73267a25af5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e8fbddfaa9a4fe87d9328de7cf8cd326>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"300 ug/mL"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-11>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-24>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0000300>	<http://bio2rdf.org/drugbank_vocabulary:organism>	"Human"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pubchem.substance:46505280>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"46505280"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-23>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:1f87ebefeca8e494680a6a81334c6078>	<http://purl.org/dc/terms/title>	"half-life for drugbank:DB00111"@en .
<http://bio2rdf.org/drugbank_resource:da8dbfa1d167bdbfac5e83608be911ea>	<http://www.w3.org/2000/01/rdf-schema#label>	"half-life for drugbank:DB00092 [drugbank_resource:da8dbfa1d167bdbfac5e83608be911ea]"@en .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:BE0003536"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:5d2074ef1500127ada3cef721a746c89>	<http://purl.org/dc/terms/title>	"Benzimidazole ribonucleosides and ribonucleotides"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-26>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:2d76fb5dd0f39b41fe92dc87dd6a96d9>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"2d76fb5dd0f39b41fe92dc87dd6a96d9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-25>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-19>	<http://purl.org/dc/terms/title>	"H Bond Donor Count: 5 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-28>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/chemspider:31983>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/chemspider:31983"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Resource>	<http://www.w3.org/2000/01/rdf-schema#label>	"drugbank resource [drugbank_vocabulary:Resource]" .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-27>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-12>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-12"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2ddeeca2fe9449969ab1519d768237c6>	<http://www.w3.org/2000/01/rdf-schema#label>	"100 mg/4mL Injection, solution form with intravenous route [drugbank_resource:2ddeeca2fe9449969ab1519d768237c6]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-4>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-11>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00091-11"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-24>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-24"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-29>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_vocabulary:Enzyme-Inhibitors>	<http://www.w3.org/2000/01/rdf-schema#label>	"Enzyme Inhibitors [drugbank_vocabulary:Enzyme-Inhibitors]"@en .
<http://bio2rdf.org/drugbank:DB00094>	<http://purl.org/dc/terms/identifier>	"drugbank:DB00094"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-3>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00090-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-16>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0000456>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:BE0000456"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00103_DB01118>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-15>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:DB00103_DB00608>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-18>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:d46b970056d0a083cca1f813197ccf0c>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:93c392ef94d70fc29c467d485b49f786> .
<http://bio2rdf.org/drugbank_resource:7fc0069b68f72ba58fdad65bec3cc1df>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:eb670a907e9a4e83aa692353515a741c> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:x-genatlas>	<http://bio2rdf.org/genatlas:PREP> .
<http://bio2rdf.org/drugbank:BE0000300>	<http://bio2rdf.org/drugbank_vocabulary:x-genatlas>	<http://bio2rdf.org/genatlas:SRM> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:fd9ee6482e9b1c5516cff7b904f27169> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-17>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:category>	<http://bio2rdf.org/drugbank_vocabulary:Supplements> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-20>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:405bc988f44cffeeb0d7149d00e5918b>	<http://www.w3.org/2000/01/rdf-schema#label>	"half-life for drugbank:DB00113 [drugbank_resource:405bc988f44cffeeb0d7149d00e5918b]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-22>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00114-22"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-19>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:DB00115"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:category>	<http://bio2rdf.org/drugbank_vocabulary:Micronutrients> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-22>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-15>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-15"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00112>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:fdb0a3b06aac9bbd85eeda7b1daf8545> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:fffcf97ccb1aeb21dae91caa501b8255> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-21>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-16>	<http://bio2rdf.org/drugbank_vocabulary:value>	"103.93"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-11>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Formula: C46H65N13O11S2 from ChemAxon [drugbank_resource:calculated-properties-DB00093-11]"@en .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:ffe7ffbc4b8e341c6b137f185bb434e0> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:category>	<http://bio2rdf.org/drugbank_vocabulary:Dietary-Supplements> .
<http://bio2rdf.org/drugbank:DB00103>	<http://bio2rdf.org/drugbank_vocabulary:brand>	<http://bio2rdf.org/drugbank_vocabulary:abd3e42d8c67111954c278994aa4591d> .
<http://bio2rdf.org/drugbank_resource:DB00107_DB00929>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:DB00107_DB00929"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00088>	<http://bio2rdf.org/drugbank_vocabulary:brand>	<http://bio2rdf.org/drugbank_vocabulary:e328a6cf619c4105669d93dc30d36096> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-9>	<http://purl.org/dc/terms/title>	"logP: -3.6 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-23>	<http://www.w3.org/2000/01/rdf-schema#label>	"Number of Rings: 3 from ChemAxon [drugbank_resource:calculated-properties-DB00118-23]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-7>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:7b6b9c68c4dd8e5a8f74e987f9a92ce7>	<http://www.w3.org/2000/01/rdf-schema#label>	"Organic transition metal moeity [drugbank_resource:7b6b9c68c4dd8e5a8f74e987f9a92ce7]"@en .
<http://bio2rdf.org/drugbank_resource:f2a30f76a373192265e4b663c8339602>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"f2a30f76a373192265e4b663c8339602"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:brand>	<http://bio2rdf.org/drugbank_vocabulary:ab9182be757cbb637b820f0951931ae2> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-10>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-17>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-17"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-17>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00091-17"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:5d2074ef1500127ada3cef721a746c89>	<http://www.w3.org/2000/01/rdf-schema#label>	"Benzimidazole ribonucleosides and ribonucleotides [drugbank_resource:5d2074ef1500127ada3cef721a746c89]"@en .
<http://bio2rdf.org/drugbank_resource:DB00099_DB00531>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-3>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:fba31fe582cac619f85335c144278e17> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-5>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00114-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00099_DB00290>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-11>	<http://purl.org/dc/terms/title>	"SMILES: CCC1NC(=O)C(C(O)C(C)CC=CC)N(C)C(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-12>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_vocabulary:Vitamins>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:Vitamins"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0000300>	<http://bio2rdf.org/drugbank_vocabulary:gene-sequence>	">909 bp\nATGGAGCCCGGCCCCGACGGCCCCGCCGCCTCCGGCCCCGCCGCCATCCGCGAGGGCTGG\nTTCCGCGAGACCTGCAGCCTGTGGCCCGGCCAGGCCCTGTCGCTGCAGGTGGAGCAGCTG\nCTCCACCACCGGCGCTCGCGCTACCAGGACATCCTCGTCTTCCGCAGTAAGACCTATGGC\nAACGTGCTGGTGTTGGACGGTGTCATCCAGTGCACGGAGAGAGACGAGTTCTCCTACCAG\nGAGATGATCGCCAACCTGCCTCTCTGCAGCCACCCCAACCCGCGAAAGGTGCTGATCATC\nGGGGGCGGAGATGGAGGTGTCCTGCGGGAGGTGGTGAAGCACCCCTCCGTGGAGTCCGTG\nGTCCAGTGTGAGATCGACGAGGATGTCATCCAAGTCTCCAAGAAGTTCCTGCCAGGCATG\nGCCATTGGCTACTCTAGCTCGAAGGTGACCCTACATGTGGGTGACGGTTTTGAGTTCATG\nAAACAGAATCAGGATGCCTTCGACGTGATCATCACTGACTCCTCAGACCCCATGGGCCCC\nGCCGAAAGTCTCTTCAAGGAGTCCTATTACCAGCTCATGAAGACAGCCCTCAAGGAAGAT\nGGTGTCCTCTGCTGCCAGGGCGAGTGCGAGTGGCTGCACCTGGACCTCATCAAGGAGATG\nCGGCAGTTCTGCCAGTCCCTGTTCCCCGTGGTGGCCTATGCCTACTGCACCATCCCCACC\nTACCCCAGCGGCCAGATCGGCTTCATGCTGTGCAGCAAGAACCCGAGCACGAACTTCCAG\nGAGCCGGTGCAGCCGCTGACACAGCAGCAGGTGGCGCAGATGCAGCTGAAGTACTACAAC\nTCCGACGTGCACCGCGCCGCCTTTGTGCTGCCCGAGTTTGCCCGCAAGGCCCTGAATGAT\nGTGAGCTGA"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-11>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:DB00099_DB01030>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-3>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00100-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00099>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:fe02b6034f5c4d73f73a58815355abf5> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-14>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-13>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-16>	<http://www.w3.org/2000/01/rdf-schema#label>	"InChI: InChI=1S/C6H9N3O2/c7-5(6(10)11)1-4-2-8-3-9-4/h2-3,5H,1,7H2,(H,8,9)(H,10,11)/t5-/m0/s1 from ChemAxon [drugbank_resource:calculated-properties-DB00117-16]"@en .
<http://bio2rdf.org/drugbank_resource:DB00099_DB00290>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00099_DB00290"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00114>	<http://purl.org/dc/terms/title>	"Pyridoxal Phosphate"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-24>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00118-24"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:376c6e6cad258f51a802ccce8c53ca4c>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"376c6e6cad258f51a802ccce8c53ca4c"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-10>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00093-10"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-19>	<http://bio2rdf.org/drugbank_vocabulary:value>	"12"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:c254aba7ca3db4f83cda45b27adb5b2b>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"c254aba7ca3db4f83cda45b27adb5b2b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00089>	<http://bio2rdf.org/drugbank_vocabulary:brand>	<http://bio2rdf.org/drugbank_vocabulary:aa64bf1510edae009ba1d31553912173> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-2>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a8454a4c3a73e4a65b3965d9947cc4bd>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"100 mg"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:0f798f4d70ca79c6d20f50856c6d9d11>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:0f798f4d70ca79c6d20f50856c6d9d11"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-2>	<http://bio2rdf.org/drugbank_vocabulary:value>	"-0.431"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-25>	<http://bio2rdf.org/drugbank_vocabulary:value>	"0"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:7aa53fec8bf96c3555379e2680167034>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Half-life> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"proteolysis"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fdb0a3b06aac9bbd85eeda7b1daf8545>	<http://www.w3.org/2000/01/rdf-schema#label>	"25 mg Solution form with intravenous route [drugbank_resource:fdb0a3b06aac9bbd85eeda7b1daf8545]"@en .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/drugbank_vocabulary:gene-name>	"CYP3A4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ffe7ffbc4b8e341c6b137f185bb434e0>	<http://purl.org/dc/terms/title>	"Oxacyclic compounds"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-24>	<http://bio2rdf.org/drugbank_vocabulary:value>	"0"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-17>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-17"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:1fc54dd8ec20644e59a52e0b31197dd9>	<http://purl.org/dc/terms/title>	"Imidazopyrimidine"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-29>	<http://www.w3.org/2000/01/rdf-schema#label>	"MDDR-Like Rule: 0 from ChemAxon [drugbank_resource:calculated-properties-DB00114-29]"@en .
<http://bio2rdf.org/drugbank_resource:0d1969d27d89c3b774c942d81666c5d3>	<http://www.w3.org/2000/01/rdf-schema#label>	"Transition metal cyanide salt [drugbank_resource:0d1969d27d89c3b774c942d81666c5d3]"@en .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:f2540530a3858d9fa40e7bfd96e4c77d> .
<http://bio2rdf.org/drugbank_resource:285048a510ce36e96744886cc83cc631>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:285048a510ce36e96744886cc83cc631"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:7fc0069b68f72ba58fdad65bec3cc1df>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:f2977936270a493873be5432bb760ef7> .
<http://bio2rdf.org/drugbank:DB00089>	<http://bio2rdf.org/drugbank_vocabulary:clearance>	<http://bio2rdf.org/drugbank_resource:fdb8e90f512977b9fb2141486454a079> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-23>	<http://bio2rdf.org/drugbank_vocabulary:value>	"4"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:55f06b8fc86fce71f0db4c1832cfa819>	<http://purl.org/dc/terms/description>	"After a 90 mg single subcutaneous injection of Enfuvirtide into the abdomen in 12 HIV-1 infected subjects, the mean peak concentration is 4.59+/-1.5 ug/ml and the median time to peak concentration was 8 hours (ranged from 3 to12 hours)."@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-22>	<http://bio2rdf.org/drugbank_vocabulary:value>	"2"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:787ef58546dc52c80027a1e3a2b925b9>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank_resource:0d47651b62c008d202fcec19e0c3b7c7>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00111>	<http://bio2rdf.org/drugbank_vocabulary:brand>	<http://bio2rdf.org/drugbank_vocabulary:e6be3ee899ac0f450592b2c5985631de> .
<http://bio2rdf.org/drugbank_resource:7a67baa1bb7b49a978b39d77e07946e0>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:0d1969d27d89c3b774c942d81666c5d3>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Angiogenesis-Inducing-Agents>	<http://purl.org/dc/terms/title>	"Angiogenesis Inducing Agents"@en .
<http://bio2rdf.org/drugbank_vocabulary:3465ee54a79f5fd937ce86304a05d4e3>	<http://bio2rdf.org/drugbank_vocabulary:name>	"Colupressine"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a2d4a403a964b1f3a6d6fa73cb73921a>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:a2d4a403a964b1f3a6d6fa73cb73921a"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:f7f0a15346b2f02764550cb8d9f8ef30> .
<http://bio2rdf.org/drugbank_resource:762a7c535540c35c3ec0a9932635da58>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Absorption> .
<http://bio2rdf.org/drugbank_resource:67b3d3945732c5188334e7f955ca6288>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:67b3d3945732c5188334e7f955ca6288"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-17>	<http://bio2rdf.org/drugbank_vocabulary:value>	"19"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:f84c0f373fd98f4297607f206aadd302> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-2>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:7767fecbc1fcbba1764734e284afdd13>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Clearance> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:f5f75e6bf165e0a25b8c2fab60ccf2e0> .
<http://bio2rdf.org/drugbank_resource:807b0e58e0eead4b875202221ebe0f53>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-6>	<http://purl.org/dc/terms/title>	"IUPAC Name: (2S)-6-amino-2-{[(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-13,16-dibenzyl-10-(2-carbamoylethyl)-7-(carbamoylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl]pyrrolidin-2-yl]formamido}-N-(carbamoylmethyl)hexanamide from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:0d54035b86f9a43f56ecd493c3a6fd59>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:80aadabf31c519e42d80748f499c7689>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:fb96fa5c000dbd94c78671b5c79ff32b> .
<http://bio2rdf.org/drugbank_resource:78c0a8b73fca87dcc5402f26970c94a4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Half-life> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:fb96fa5c000dbd94c78671b5c79ff32b> .
<http://bio2rdf.org/drugbank_resource:7abeba6bed290a4b16075521bc0113ca>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-12>	<http://bio2rdf.org/drugbank_vocabulary:value>	"InChI=1S/C19H23N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,11-12,21,23H,5-8H2,(H,24,29)(H,27,28)(H,31,32)(H4,20,22,25,26,30)/t11?,12-/m0/s1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00110>	<http://www.w3.org/2000/01/rdf-schema#label>	"Palivizumab [drugbank:DB00110]"@en .
<http://bio2rdf.org/drugbank_resource:77b52954fa911921450d2b426c1a7a3a>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-5>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00091-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e8fbddfaa9a4fe87d9328de7cf8cd326>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:e8fbddfaa9a4fe87d9328de7cf8cd326"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:fc61d172cba7ae19145ff846ca1f0aef> .
<http://bio2rdf.org/drugbank_resource:Citanest-Octapressin>	<http://bio2rdf.org/drugbank_vocabulary:ingredients>	"Felypressin + Prilocaine"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:fa8e5850916f505d7329bb36ce55c161> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-9>	<http://purl.org/dc/terms/title>	"Traditional IUPAC Name: pyridoxal phosphate from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:7a67baa1bb7b49a978b39d77e07946e0>	<http://purl.org/dc/terms/title>	"N-glycosyl compound"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-9>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:7b6b9c68c4dd8e5a8f74e987f9a92ce7>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-18>	<http://bio2rdf.org/drugbank_vocabulary:value>	"13"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-24>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00117-24"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:1cb2d5b9df573a57849083d75e49a5fe>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:1cb2d5b9df573a57849083d75e49a5fe"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00089>	<http://bio2rdf.org/drugbank_vocabulary:category>	<http://bio2rdf.org/drugbank_vocabulary:Indicators-and-Reagents> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00762>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-10>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-10"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:category>	<http://bio2rdf.org/drugbank_vocabulary:Antifungal-Agents> .
<http://bio2rdf.org/drugbank:DB00107>	<http://bio2rdf.org/drugbank_vocabulary:brand>	<http://bio2rdf.org/drugbank_vocabulary:705836a5549e0548d20a0ef04e009f28> .
<http://bio2rdf.org/drugbank_resource:7975713dad73e24fab2cbb6c89586ea4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-15>	<http://bio2rdf.org/drugbank_vocabulary:value>	"121.39"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00694>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:specific-function>	"Cleaves peptide bonds on the C-terminal side of prolyl residues within peptides that are up to approximately 30 amino acids long"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-16>	<http://www.w3.org/2000/01/rdf-schema#label>	"Polar Surface Area (PSA): 116.95 from ChemAxon [drugbank_resource:calculated-properties-DB00114-16]"@en .
<http://bio2rdf.org/drugbank_resource:DB00112_DB01268>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:80aadabf31c519e42d80748f499c7689>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Indication> .
<http://bio2rdf.org/drugbank:DB00092>	<http://bio2rdf.org/drugbank_vocabulary:mechanism-of-action>	<http://bio2rdf.org/drugbank_resource:f31c373ea0d5f6b6f514f58cf30652a6> .
<http://bio2rdf.org/drugbank:DB00113>	<http://bio2rdf.org/drugbank_vocabulary:brand>	<http://bio2rdf.org/drugbank_vocabulary:908621b9e3153f791dd6dbd4ef6d62a5> .
<http://bio2rdf.org/drugbank_resource:Citanest-Dental-Octapressin>	<http://bio2rdf.org/drugbank_vocabulary:ingredients>	"Felypressin + Prilocaine"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB01177>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:094779e1e90e423f19e46305ba872c9c>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:Citanest-Dental>	<http://bio2rdf.org/drugbank_vocabulary:ingredients>	"Felypressin + Prilocaine"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-2>	<http://www.w3.org/2000/01/rdf-schema#label>	"Isoelectric Point: 5.51 [drugbank_resource:experimental-properties-DB00107-2]"@en .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00363>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:5b47883807d5fa7a5b0b5ce2dc6e7939>	<http://purl.org/dc/terms/title>	"10; .22 mg/mL; mg/mL Injection, solution form with intravenous route"@en .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:f7f0a15346b2f02764550cb8d9f8ef30> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-22>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-22"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:091b1b5a04486711c0e6615b4e552e7e>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-3>	<http://purl.org/dc/terms/title>	"Molecular Formula: C6538H10034N1716O2033S44"@en .
<http://bio2rdf.org/drugbank_resource:81ce8d1a0627bc88956132de1e1a93c2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-27>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00445>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:96faa670b368b06113b9e58e3db1d86c>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"96faa670b368b06113b9e58e3db1d86c"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-26>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:indication>	<http://bio2rdf.org/drugbank_resource:ff5b4bb2ae4fdc7811f87fd38c8b8eda> .
<http://bio2rdf.org/drugbank_resource:c987b0d07b89f29a364501bc29cfebc8>	<http://www.w3.org/2000/01/rdf-schema#label>	"Aminopyrimidines and derivatives [drugbank_resource:c987b0d07b89f29a364501bc29cfebc8]"@en .
<http://bio2rdf.org/drugbank:DB00097>	<http://bio2rdf.org/drugbank_vocabulary:category>	<http://bio2rdf.org/drugbank_vocabulary:Gonadotropins> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00398>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00398>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00112_DB00398"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:f38592452c305d31bbbb2909013724ac> .
<http://bio2rdf.org/drugbank_resource:a9a65e43cdc103a1f769c3625b080c1d>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"a9a65e43cdc103a1f769c3625b080c1d"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-4>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:051943c0db4f9d17f7dfc49f7bb4329a>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:051943c0db4f9d17f7dfc49f7bb4329a"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-24>	<http://bio2rdf.org/drugbank_vocabulary:value>	"1"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-4>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00100-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:abd3e42d8c67111954c278994aa4591d>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:abd3e42d8c67111954c278994aa4591d"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:category>	<http://bio2rdf.org/drugbank_vocabulary:Vasoconstrictor-Agents> .
<http://bio2rdf.org/drugbank:DB00106>	<http://bio2rdf.org/drugbank_vocabulary:brand>	<http://bio2rdf.org/drugbank_vocabulary:8550beb9aaabcff323bdfeef04608bb8> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-3>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-23>	<http://bio2rdf.org/drugbank_vocabulary:value>	"0"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:1c54727b6a9a48b74b53723fbee43d80>	<http://purl.org/dc/terms/description>	"Cyclosporine binds to cyclophilin. The complex then inhibits calcineurin which is normally responsible for activating transcription of interleukin 2. Cyclosporine also inhibits lymphokine production and interleukin release. In ophthalmic applications, the precise mechanism of action is not known. Cyclosporine emulsion is thought to act as a partial immunomodulator in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca."@en .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:f30bb36d9cf1cde63e806eb49b64d341> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-6>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-1>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:81987a5783579e8eae4261b8d95226da>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Indication> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-5>	<http://purl.org/dc/terms/title>	"logP: -4.2 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:08f1295028a77909e61816add07f6343>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-5>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:fa9ea24c47c4cc6ec20e42b245e43401>	<http://purl.org/dc/terms/title>	"indication for drugbank:DB00103"@en .
<http://bio2rdf.org/drugbank_resource:773530fb248596d00289b12dba48a0cc>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank:BE0000300>	<http://bio2rdf.org/drugbank_vocabulary:x-uniprot>	<http://bio2rdf.org/uniprot:P19623> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-8>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-28>	<http://bio2rdf.org/drugbank_vocabulary:value>	"0"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-19>	<http://bio2rdf.org/drugbank_vocabulary:value>	"38.06"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank:DB00096>	<http://bio2rdf.org/drugbank_vocabulary:brand>	<http://bio2rdf.org/drugbank_vocabulary:9e044243b5eb2f95578c80df6000ecdd> .
<http://bio2rdf.org/drugbank:BE0003533>	<http://bio2rdf.org/drugbank_vocabulary:transmembrane-regions>	"None"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-7>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-27>	<http://bio2rdf.org/drugbank_vocabulary:value>	"0"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:07c2684a57210d1f5bc920d112d11ecd>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/drugbank_vocabulary:transmembrane-regions>	"None"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:76cc7a41e93863bcbab0bba32bc52311>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-26>	<http://bio2rdf.org/drugbank_vocabulary:value>	"0"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-1>	<http://purl.org/dc/terms/title>	"Melting Point: 55 \u00B0C from Forastieri, H., Ingham, K.C. J. Biol. Chem. 257:7976-7981 (1982)"@en .
<http://bio2rdf.org/drugbank_resource:80e4560d8a88ff69231ec21ee09506be>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-18>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00117-18"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0000456>	<http://bio2rdf.org/drugbank_vocabulary:x-genecards>	<http://bio2rdf.org/genecards:MMAB> .
<http://bio2rdf.org/drugbank_resource:07769f07381a36b9cbc482dc6db9e40d>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:category>	<http://bio2rdf.org/drugbank_vocabulary:Enzyme-Inhibitors> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-25>	<http://bio2rdf.org/drugbank_vocabulary:value>	"0"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank:DB00109>	<http://bio2rdf.org/drugbank_vocabulary:category>	<http://bio2rdf.org/drugbank_vocabulary:HIV-Fusion-Inhibitors> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:transmembrane-regions>	"None"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00115-2>	<http://www.w3.org/2000/01/rdf-schema#label>	"Melting Point: > 300 \u00B0C from PhysProp [drugbank_resource:experimental-properties-DB00115-2]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-4>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00093-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00092>	<http://bio2rdf.org/drugbank_vocabulary:brand>	<http://bio2rdf.org/drugbank_vocabulary:8ad571235d010ca525f3733fd9b517fb> .
<http://bio2rdf.org/drugbank_resource:de11407327a5468776fbcbec28a97ca0>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"de11407327a5468776fbcbec28a97ca0"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003533>	<http://bio2rdf.org/drugbank_vocabulary:molecular-weight>	"56848.4"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:24189bc5fb16bfce4551ecdfb0196def>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"5 mg/mL"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00112>	<http://bio2rdf.org/drugbank_vocabulary:category>	<http://bio2rdf.org/drugbank_vocabulary:Angiogenesis-Inhibitors> .
<http://bio2rdf.org/drugbank:DB00096>	<http://bio2rdf.org/drugbank_vocabulary:indication>	<http://bio2rdf.org/drugbank_resource:ffa1ac4af9ac617e01349d78fdc482f1> .
<http://bio2rdf.org/drugbank_resource:bbf3cb3443969f24e50666e131185bd8>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"bbf3cb3443969f24e50666e131185bd8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-19>	<http://bio2rdf.org/drugbank_vocabulary:value>	"16"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank:DB00107>	<http://bio2rdf.org/drugbank_vocabulary:category>	<http://bio2rdf.org/drugbank_vocabulary:Labor-Induction-Agents> .
<http://bio2rdf.org/drugbank_resource:069ab916580192548ff172f164a424bf>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:75aa077303c09d80af404a7a6c6ac735>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-20>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-20"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:06832c77d22e34a13e2de6990e7f3cf2>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00107>	<http://bio2rdf.org/drugbank_vocabulary:category>	<http://bio2rdf.org/drugbank_vocabulary:Oxytocics> .
<http://bio2rdf.org/drugbank_resource:81987a5783579e8eae4261b8d95226da>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:74985c763ecb65fc6e794b1a003e061f>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:31af673f5d82841086059243563cd4c6>	<http://www.w3.org/2000/01/rdf-schema#label>	"mechanism-of-action for drugbank:DB00114 [drugbank_resource:31af673f5d82841086059243563cd4c6]"@en .
<http://bio2rdf.org/drugbank_resource:051943c0db4f9d17f7dfc49f7bb4329a>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-13>	<http://bio2rdf.org/drugbank_vocabulary:value>	"C8H10NO6P"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ea9490984599c557a86db10a8e93e890>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:ea9490984599c557a86db10a8e93e890"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:450004b6cb1a30c3690aa11d2cd941a2>	<http://www.w3.org/2000/01/rdf-schema#label>	"absorption for drugbank:DB00115 [drugbank_resource:450004b6cb1a30c3690aa11d2cd941a2]"@en .
<http://bio2rdf.org/drugbank:DB00103>	<http://bio2rdf.org/drugbank_vocabulary:indication>	<http://bio2rdf.org/drugbank_resource:fa9ea24c47c4cc6ec20e42b245e43401> .
<http://bio2rdf.org/drugbank_resource:4aaab29fd43effbe133e376c024d5f06>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:4aaab29fd43effbe133e376c024d5f06"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:81ce8d1a0627bc88956132de1e1a93c2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:75aa077303c09d80af404a7a6c6ac735>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-20>	<http://bio2rdf.org/drugbank_vocabulary:value>	"5"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-18>	<http://bio2rdf.org/drugbank_vocabulary:value>	"15"^^<http://www.w3.org/2001/XMLSchema#integer> .
<http://bio2rdf.org/drugbank_resource:762a7c535540c35c3ec0a9932635da58>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:a9a58af69a8539d913c65b788eb5b178>	<http://www.w3.org/2000/01/rdf-schema#label>	"indication for drugbank:DB00107 [drugbank_resource:a9a58af69a8539d913c65b788eb5b178]"@en .
<http://bio2rdf.org/drugbank:DB00099>	<http://bio2rdf.org/drugbank_vocabulary:category>	<http://bio2rdf.org/drugbank_vocabulary:Hematopoietic-Agents> .
<http://bio2rdf.org/drugbank_resource:05261dbd457e9d2aa8254610c0f9df46>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:category>	<http://bio2rdf.org/drugbank_vocabulary:Dietary-Supplements> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:category>	<http://bio2rdf.org/drugbank_vocabulary:Micronutrients> .
<http://bio2rdf.org/drugbank_resource:fd9ee6482e9b1c5516cff7b904f27169>	<http://purl.org/dc/terms/title>	"N-acyl-alpha amino acids"@en .
<http://bio2rdf.org/drugbank:DB00102>	<http://bio2rdf.org/drugbank_vocabulary:category>	<http://bio2rdf.org/drugbank_vocabulary:Angiogenesis-Inducing-Agents> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:category>	<http://bio2rdf.org/drugbank_vocabulary:Conditionally-Essential-Amino-Acids> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00503>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00109_DB00503"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:category>	<http://bio2rdf.org/drugbank_vocabulary:Dietary-Supplements> .
<http://bio2rdf.org/drugbank_resource:03746a740bf18cbf4beaae7cc5b7504f>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:76cc7a41e93863bcbab0bba32bc52311>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:f5f75e6bf165e0a25b8c2fab60ccf2e0>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"f5f75e6bf165e0a25b8c2fab60ccf2e0"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:6826daa495527ec54b81079e04e89d24>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:6826daa495527ec54b81079e04e89d24"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-28>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-28"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:category>	<http://bio2rdf.org/drugbank_vocabulary:Micronutrients> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:category>	<http://bio2rdf.org/drugbank_vocabulary:Dietary-Supplements> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:ffe7ffbc4b8e341c6b137f185bb434e0> .
<http://bio2rdf.org/drugbank_resource:14e62611474f52c8e22248963b84f59b>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:14e62611474f52c8e22248963b84f59b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:category>	<http://bio2rdf.org/drugbank_vocabulary:Micronutrients> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:ffc8ae70d9900ffb750da168c0f58cc5> .
<http://bio2rdf.org/drugbank_resource:773530fb248596d00289b12dba48a0cc>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-1>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:category>	<http://bio2rdf.org/drugbank_vocabulary:Supplements> .
<http://bio2rdf.org/drugbank:DB00102>	<http://bio2rdf.org/drugbank_vocabulary:indication>	<http://bio2rdf.org/drugbank_resource:f2a30f76a373192265e4b663c8339602> .
<http://bio2rdf.org/drugbank_resource:DB00110_DB08879>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:category>	<http://bio2rdf.org/drugbank_vocabulary:Supplements> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:fe2051219bbed1c3f26d756ec49dea95> .
<http://bio2rdf.org/drugbank:DB00107>	<http://bio2rdf.org/drugbank_vocabulary:category>	<http://bio2rdf.org/drugbank_vocabulary:Anti-tocolytic-Agents> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"tetrapyrrole binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:category>	<http://bio2rdf.org/drugbank_vocabulary:Supplements> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:category>	<http://bio2rdf.org/drugbank_vocabulary:Vitamins> .
<http://bio2rdf.org/drugbank_resource:036d7e3cfbf77c5f19b4baba9ff7aed2>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00106>	<http://bio2rdf.org/drugbank_vocabulary:category>	<http://bio2rdf.org/drugbank_vocabulary:Anti-Testosterone-Agents> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:category>	<http://bio2rdf.org/drugbank_vocabulary:Vitamin-B-Complex> .
<http://bio2rdf.org/drugbank_resource:80e4560d8a88ff69231ec21ee09506be>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:brand>	<http://bio2rdf.org/drugbank_vocabulary:73192b1a02a81c1e485fb06abc6fdc61> .
<http://bio2rdf.org/drugbank_resource:8f7450a053d86ee89751c06a230561d0>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:8f7450a053d86ee89751c06a230561d0"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:category>	<http://bio2rdf.org/drugbank_vocabulary:Vitamin-B-Complex> .
<http://bio2rdf.org/drugbank_resource:a39e93df12255155561f3d4acd297da8>	<http://purl.org/dc/terms/title>	"5 mg Powder for solution form with intravenous route"@en .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:ef0da8f521b780a50b08c455970978ac> .
<http://bio2rdf.org/drugbank_resource:01c6a15f6a299a85cd866fc4092d0dce>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:eb2ea139d16c3216009f5eb2eceb62c8> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:eb23978cb768321237553e12616e3b84> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00091-1> .
<http://bio2rdf.org/drugbank:DB00090>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-1> .
<http://bio2rdf.org/drugbank:DB00090>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-2> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00091-2> .
<http://bio2rdf.org/drugbank:DB00090>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-3> .
<http://bio2rdf.org/drugbank:DB00090>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-4> .
<http://bio2rdf.org/drugbank_resource:0235e5251bcfc61913eb18c0fab6a1c4>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-5>	<http://bio2rdf.org/drugbank_vocabulary:value>	"C2041H3136N558O641S25"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:74985c763ecb65fc6e794b1a003e061f>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-1>	<http://purl.org/dc/terms/title>	"Melting Point: 55 \u00B0C from Forastieri, H., Ingham, K.C. J. Biol. Chem. 257:7976-7981 (1982)"@en .
<http://bio2rdf.org/drugbank_resource:a2615bbb5710b9b992785e63c058b3db>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:93c392ef94d70fc29c467d485b49f786> .
<http://bio2rdf.org/drugbank_resource:78fce134a0e754813388f2850f268625>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:003185d1d24af95f95de2d64dd76ed33>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:122193da65e00a63d46700928a244018>	<http://purl.org/dc/terms/title>	"Human Immunodeficiency Virus"@en .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:efd9b57513efb0eb6e90f59807e0e8d9> .
<http://bio2rdf.org/drugbank_resource:7975713dad73e24fab2cbb6c89586ea4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:e6fa8c632405b98301de119a72894c49> .
<http://bio2rdf.org/drugbank:DB00096>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-1> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB06290>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00096>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-2> .
<http://bio2rdf.org/drugbank_resource:7a67baa1bb7b49a978b39d77e07946e0>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:ea9490984599c557a86db10a8e93e890> .
<http://bio2rdf.org/drugbank:DB00096>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-3> .
<http://bio2rdf.org/drugbank:DB00094>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-1> .
<http://bio2rdf.org/drugbank:DB00094>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-2> .
<http://bio2rdf.org/drugbank:DB00096>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-4> .
<http://bio2rdf.org/drugbank:DB00094>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-3> .
<http://bio2rdf.org/drugbank:DB00096>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-5> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB03880>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00094>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-4> .
<http://bio2rdf.org/drugbank_resource:7aa53fec8bf96c3555379e2680167034>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00094>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-5> .
<http://bio2rdf.org/drugbank_resource:00199edd2aba5de431eaa55bda5406d7>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:e6fc137e236497aea65dd3bb99d52e53> .
<http://bio2rdf.org/drugbank_resource:cad41663894b5be906782be10b396e06>	<http://www.w3.org/2000/01/rdf-schema#label>	"Aminobenzamides [drugbank_resource:cad41663894b5be906782be10b396e06]"@en .
<http://bio2rdf.org/drugbank:DB00095>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00095-1> .
<http://bio2rdf.org/drugbank_resource:a8454a4c3a73e4a65b3965d9947cc4bd>	<http://www.w3.org/2000/01/rdf-schema#label>	"100 mg Powder for solution form with intramuscular route [drugbank_resource:a8454a4c3a73e4a65b3965d9947cc4bd]"@en .
<http://bio2rdf.org/drugbank:DB00088>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-4> .
<http://bio2rdf.org/drugbank_resource:78fce134a0e754813388f2850f268625>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Indication> .
<http://bio2rdf.org/drugbank_resource:131ed90e7634d72c92f27daf9a85454a>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"131ed90e7634d72c92f27daf9a85454a"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01264>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:7767fecbc1fcbba1764734e284afdd13>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:7abeba6bed290a4b16075521bc0113ca>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank:DB00089>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00089-1> .
<http://bio2rdf.org/drugbank_resource:a8454a4c3a73e4a65b3965d9947cc4bd>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:a8454a4c3a73e4a65b3965d9947cc4bd"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:807b0e58e0eead4b875202221ebe0f53>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank_resource:1f87ebefeca8e494680a6a81334c6078>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:1f87ebefeca8e494680a6a81334c6078"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00097>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-5> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00093-1> .
<http://bio2rdf.org/drugbank:DB00092>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-1> .
<http://bio2rdf.org/drugbank_resource:77b52954fa911921450d2b426c1a7a3a>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01232>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:e6be3ee899ac0f450592b2c5985631de>	<http://bio2rdf.org/drugbank_vocabulary:company>	"Hoffmann-La Roche Inc"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00092>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-2> .
<http://bio2rdf.org/drugbank:DB00092>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-3> .
<http://bio2rdf.org/drugbank_vocabulary:Vasoconstrictor-Agents>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:Vasoconstrictor-Agents"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:57ad8968da7ad0cb58cba7e058039db9>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"57ad8968da7ad0cb58cba7e058039db9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00092>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-4> .
<http://bio2rdf.org/drugbank:BE0000456>	<http://bio2rdf.org/drugbank_vocabulary:organism>	"Human"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"transition metal ion binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01601>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00097>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-1> .
<http://bio2rdf.org/drugbank:DB00088>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-1> .
<http://bio2rdf.org/drugbank:DB00097>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-2> .
<http://bio2rdf.org/drugbank:DB00088>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-2> .
<http://bio2rdf.org/drugbank:DB00097>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-3> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"transition metal ion binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00097>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-4> .
<http://bio2rdf.org/drugbank:DB00088>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-3> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01319>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:7b6b9c68c4dd8e5a8f74e987f9a92ce7>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:787ef58546dc52c80027a1e3a2b925b9>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00118-1> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"transition metal ion binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a6302cf127669e87e24a75b24552a9e8>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:93c392ef94d70fc29c467d485b49f786> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00677>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:7fc0069b68f72ba58fdad65bec3cc1df>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank:DB00099>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-1> .
<http://bio2rdf.org/drugbank:DB00099>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-2> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00503>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-2>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00111-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00100>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-2> .
<http://bio2rdf.org/drugbank:DB00099>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-3> .
<http://bio2rdf.org/drugbank_resource:78c0a8b73fca87dcc5402f26970c94a4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00099>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-4> .
<http://bio2rdf.org/drugbank:DB00100>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-3> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01264>	<http://www.w3.org/2000/01/rdf-schema#label>	"DDI between Enfuvirtide and Darunavir - May increase the serum concentration of Protease Inhibitors. Protease Inhibitors may increase the serum concentration of Enfuvirtide. [drugbank_resource:DB00109_DB01264]"@en .
<http://bio2rdf.org/drugbank:DB00100>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-4> .
<http://bio2rdf.org/drugbank:DB00099>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-5> .
<http://bio2rdf.org/drugbank_resource:3732893325a7ecb9126a15736796f117>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"3732893325a7ecb9126a15736796f117"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00100>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-5> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01072>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00099>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:e8fbddfaa9a4fe87d9328de7cf8cd326> .
<http://bio2rdf.org/pubchem.compound:1051>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/pubchem.compound:1051"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-5>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:c78f5087e52c969400b9d748ae4a9485> .
<http://bio2rdf.org/drugbank:DB00100>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-1> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:da9625c635b6c208626fef4666f9f883> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"physiological process"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00932>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:904bc2c9127fa8f18e0965559eecc60c>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:00f0949724208fef8aa81b619295e0b2> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:e02568426e5e3817cd6fcddc8dee4bee> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-6>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:c78f5087e52c969400b9d748ae4a9485> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:df42fd14b400446e8cc7e69facd62cba> .
<http://bio2rdf.org/drugbank_resource:b508d1a45927588b684b5a6fd80aff2b>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"b508d1a45927588b684b5a6fd80aff2b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:e02568426e5e3817cd6fcddc8dee4bee> .
<http://bio2rdf.org/drugbank_resource:8683be48baa0e7d62758aed2d9ccf431>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Absorption> .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:general-function>	"Secondary metabolites biosynthesis, transport and catabolism"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/bindingdb:7953>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"7953"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:e147a45842193f4b54cd46908fed6204> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"physiological process"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c3ea863492592dff31fb000b21cd1a19>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:49b21ad0d38942f635877e7bbc5d7a1e> .
<http://bio2rdf.org/drugbank_resource:6205a409adf418d0390045ac349b481a>	<http://www.w3.org/2000/01/rdf-schema#label>	"Oxacycle [drugbank_resource:6205a409adf418d0390045ac349b481a]"@en .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"physiological process"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8e7e8f5ff3cf3466586b956d7330151b>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00224>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:brand>	<http://bio2rdf.org/drugbank_vocabulary:f6203f7c9646b21edf1fa81c5cdf94d1> .
<http://bio2rdf.org/drugbank_resource:75aa077303c09d80af404a7a6c6ac735>	<http://www.w3.org/2000/01/rdf-schema#label>	"300 ug/.5mL Injection, solution form with subcutaneous route [drugbank_resource:75aa077303c09d80af404a7a6c6ac735]"@en .
<http://bio2rdf.org/drugbank_resource:88491d7d06bc30fa9586740372808b10>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank_resource:220e1c2f3029a37a26fd263b95f90c89>	<http://www.w3.org/2000/01/rdf-schema#label>	"Organic cation [drugbank_resource:220e1c2f3029a37a26fd263b95f90c89]"@en .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:de11407327a5468776fbcbec28a97ca0> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00220>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:general-function>	"Secondary metabolites biosynthesis, transport and catabolism"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00099>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:e04ee332a67fe1dea4752f0a68c0a6ee> .
<http://bio2rdf.org/drugbank_resource:fe02b6034f5c4d73f73a58815355abf5>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"300 ug/.5mL"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8eb135a8f519839c5f289226017b68a3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:general-function>	"Secondary metabolites biosynthesis, transport and catabolism"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:e650b92d5679a4bc966570691fe2d7e4> .
<http://bio2rdf.org/drugbank_resource:53e4e7c3f9db35ed7e24a59c1546788c>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:53e4e7c3f9db35ed7e24a59c1546788c"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-4>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:c78f5087e52c969400b9d748ae4a9485> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"cellular protein metabolism"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8ae8b01597df174d257016596812aeab>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"physiological process"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a595cc1c66cf7314ca9d50542e429c85>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:a595cc1c66cf7314ca9d50542e429c85"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8750c04d33b8546006e83e736eb80647>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"transition metal ion binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-19>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00118-19"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2a828069e3c5a4b098468f8a2091e89f>	<http://www.w3.org/2000/01/rdf-schema#label>	"250 ug/.5mL Injection, solution form with subcutaneous route [drugbank_resource:2a828069e3c5a4b098468f8a2091e89f]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-3>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:e6fa8c632405b98301de119a72894c49> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:ea9490984599c557a86db10a8e93e890> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-2>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:131ed90e7634d72c92f27daf9a85454a>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:131ed90e7634d72c92f27daf9a85454a"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00099>	<http://bio2rdf.org/drugbank_vocabulary:clearance>	<http://bio2rdf.org/drugbank_resource:e9f580ccd34b70a11720b2f316225025> .
<http://bio2rdf.org/drugbank_resource:8abd75317f3f7b8f7d56e3fe7d6204bd>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank_resource:ade41ed0b3f8ac2b059fa8aeb0cdbbb4>	<http://purl.org/dc/terms/description>	"Since the actions of supplemental L-histidine are unclear, any postulated mechanism is entirely speculative. However, some facts are known about L-histidine and some of its metabolites, such as histamine and trans-urocanic acid, which suggest that supplemental L-histidine may one day be shown to have immunomodulatory and/or antioxidant activities. Low free histidine has been found in the serum of some rheumatoid arthritis patients. Serum concentrations of other amino acids have been found to be normal in these patients. L-histidine is an excellent chelating agent for such metals as copper, iron and zinc. Copper and iron participate in a reaction (Fenton reaction) that generates potent reactive oxygen species that could be destructive to tissues, including joints. <br/>L-histidine is the obligate precursor of histamine, which is produced via the decarboxylation of the amino acid. In experimental animals, tissue histamine levels increase as the amount of dietary L-histidine increases. It is likely that this would be the case in humans as well. Histamine is known to possess immunomodulatory and antioxidant activity. Suppressor T cells have H2 receptors, and histamine activates them. Promotion of suppressor T cell activity could be beneficial in rheumatoid arthritis. Further, histamine has been shown to down-regulate the production of reactive oxygen species in phagocytic cells, such as monocytes, by binding to the H2 receptors on these cells. Decreased reactive oxygen species production by phagocytes could play antioxidant, anti-inflammatory and immunomodulatory roles in such diseases as rheumatoid arthritis. <br/>This latter mechanism is the rationale for the use of histamine itself in several clinical trials studying histamine for the treatment of certain types of cancer and viral diseases. In these trials, down-regulation by histamine of reactive oxygen species formation appears to inhibit the suppression of natural killer (NK) cells and cytotoxic T lymphocytes, allowing these cells to be more effective in attacking cancer cells and virally infected cells."@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-5>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8bb9fceb6f80460936af862e9f7d1d94>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:ade41ed0b3f8ac2b059fa8aeb0cdbbb4>	<http://purl.org/dc/terms/title>	"mechanism-of-action for drugbank:DB00117"@en .
<http://bio2rdf.org/drugbank_resource:87f0fe251ba4940236c1e30de121922a>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:1c7495e7ba342d224b5028d72d73010d>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:76ef13d358eacf63a71abd72dcbb5fbf> .
<http://bio2rdf.org/drugbank_resource:5295f08395d80bb2a78d48e62dbf8c19>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:5295f08395d80bb2a78d48e62dbf8c19"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-4>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8c59273d79bb6ce81fe2a4c0596fa577>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-9>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00093-9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:ea9490984599c557a86db10a8e93e890> .
<http://bio2rdf.org/drugbank_resource:DB00110_DB08879>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:DB00110_DB08879"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-4>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-11>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Formula: C15H23N6O5S from ChemAxon [drugbank_resource:calculated-properties-DB00118-11]"@en .
<http://bio2rdf.org/drugbank:DB00092>	<http://bio2rdf.org/drugbank_vocabulary:half-life>	<http://bio2rdf.org/drugbank_resource:da8dbfa1d167bdbfac5e83608be911ea> .
<http://bio2rdf.org/drugbank_resource:893efa195cf56cf85e98a5c5f0867045>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Clearance> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-8>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00091-8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00115-2>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00115-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00112>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-1> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-3>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00111>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-3> .
<http://bio2rdf.org/drugbank:DB00110>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00110-1> .
<http://bio2rdf.org/drugbank:DB00111>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-4> .
<http://bio2rdf.org/drugbank:DB00111>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-5> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-1>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-5>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00115-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-19>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-19"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:19d3289105c9a843a041cb4f7a0883a1>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:76ef13d358eacf63a71abd72dcbb5fbf> .
<http://bio2rdf.org/drugbank:DB00113>	<http://purl.org/dc/terms/title>	"Arcitumomab"@en .
<http://bio2rdf.org/drugbank:DB00111>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-1> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:e6fa8c632405b98301de119a72894c49> .
<http://bio2rdf.org/drugbank:DB00111>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-2> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-5>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00109>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:DB00109"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:85745be17d6c5d398a5d3540508f1a44>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-2>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00088-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:787ef58546dc52c80027a1e3a2b925b9>	<http://www.w3.org/2000/01/rdf-schema#label>	"300 \u00B5g Solution form with intravenous route [drugbank_resource:787ef58546dc52c80027a1e3a2b925b9]"@en .
<http://bio2rdf.org/pubchem.substance:46505280>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/pubchem.substance:46505280"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:42e21c05e96b3040136e54dfed4bf794>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:42e21c05e96b3040136e54dfed4bf794"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:manufacturer>	<http://bio2rdf.org/drugbank_resource:dc4a561c55d386ce9aa0ac35fa50583b> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-5>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00099>	<http://bio2rdf.org/drugbank_vocabulary:brand>	<http://bio2rdf.org/drugbank_vocabulary:fa342aed686575ef39a8ec9dc16cbab4> .
<http://bio2rdf.org/drugbank_resource:DB00107_DB00929>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00107_DB00929"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-2>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-4>	<http://bio2rdf.org/drugbank_vocabulary:value>	"46548.2"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-16>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00115-16"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-1>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-1> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-2> .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"CYPIIC19"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-27>	<http://purl.org/dc/terms/title>	"MDDR-Like Rule: 1 from ChemAxon"@en .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-2>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:e147a45842193f4b54cd46908fed6204> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00116-1> .
<http://bio2rdf.org/drugbank_resource:366d45e2564940d9162a27ad0e9e3571>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"366d45e2564940d9162a27ad0e9e3571"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00398>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:DB00112_DB00398"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-15>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Formula: C6H9N3O2 from ChemAxon [drugbank_resource:calculated-properties-DB00117-15]"@en .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00114-1> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-1>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00099_DB00531>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:DB00099_DB00531"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00114-2> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:e02568426e5e3817cd6fcddc8dee4bee> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00114-3> .
<http://bio2rdf.org/drugbank:DB00105>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-1> .
<http://bio2rdf.org/drugbank:DB00117>	<http://purl.org/dc/terms/identifier>	"drugbank:DB00117"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00106>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00106-1> .
<http://bio2rdf.org/drugbank:DB00105>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-2> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:dedcaba12fd68e71a4930ea18843aa61> .
<http://bio2rdf.org/drugbank_vocabulary:0f3c814d30566a7614f1fab32f4e0302>	<http://bio2rdf.org/drugbank_vocabulary:company>	"Serono S.A."^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00106>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00106-2> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-4>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00105>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-3> .
<http://bio2rdf.org/drugbank:DB00105>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-4> .
<http://bio2rdf.org/drugbank:DB00099>	<http://bio2rdf.org/drugbank_vocabulary:mechanism-of-action>	<http://bio2rdf.org/drugbank_resource:efdc5ed439af008904afce03f4dd2ec8> .
<http://bio2rdf.org/drugbank:DB00105>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-5> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00115-1> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-3>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-2>	<http://purl.org/dc/terms/title>	"Isoelectric Point: 5.51"@en .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00115-2> .
<http://bio2rdf.org/drugbank_resource:4aaab29fd43effbe133e376c024d5f06>	<http://purl.org/dc/terms/title>	"Secondary amine"@en .
<http://bio2rdf.org/drugbank_resource:19d3289105c9a843a041cb4f7a0883a1>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:19d3289105c9a843a041cb4f7a0883a1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-16>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00114-16"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:574e7d1136f355daec35f6fd17ef29e5>	<http://purl.org/dc/terms/title>	"Phosphoric acid ester"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-3>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:6be4db795caa5a4f0e9b208f115d277b>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:6be4db795caa5a4f0e9b208f115d277b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00109>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-4> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-19>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-19"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8399ac082eecc289dcd0ff6ce9ff3420>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:8f7450a053d86ee89751c06a230561d0>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-3>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:c78f5087e52c969400b9d748ae4a9485> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-2>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-7>	<http://www.w3.org/2000/01/rdf-schema#label>	"IUPAC Name: 30-ethyl-14,17,23,32-tetrahydroxy-33-[(4E)-1-hydroxy-2-methylhex-4-en-1-yl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-13,16,22,31-tetraene-2,5,8,11,20,26,29-heptone from ChemAxon [drugbank_resource:calculated-properties-DB00091-7]"@en .
<http://bio2rdf.org/drugbank:DB00113>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-3> .
<http://bio2rdf.org/drugbank:DB00112>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-2> .
<http://bio2rdf.org/drugbank:DB00107>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-1> .
<http://bio2rdf.org/drugbank:DB00103>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-1> .
<http://bio2rdf.org/drugbank:DB00102>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-1> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:mechanism-of-action>	<http://bio2rdf.org/drugbank_resource:e52e95d4f4c438c7fbf93397e39c26e3> .
<http://bio2rdf.org/drugbank:DB00113>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-4> .
<http://bio2rdf.org/drugbank:DB00112>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-3> .
<http://bio2rdf.org/drugbank:DB00109>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-1> .
<http://bio2rdf.org/drugbank:DB00107>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-2> .
<http://bio2rdf.org/drugbank:DB00103>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-2> .
<http://bio2rdf.org/drugbank:DB00102>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-2> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:db3cf7df3e4a56b21665da45352819bc> .
<http://bio2rdf.org/drugbank:DB00113>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-5> .
<http://bio2rdf.org/drugbank:DB00109>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-2> .
<http://bio2rdf.org/drugbank:DB00107>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-3> .
<http://bio2rdf.org/drugbank_resource:dedcaba12fd68e71a4930ea18843aa61>	<http://www.w3.org/2000/01/rdf-schema#label>	"Organosulfur compound [drugbank_resource:dedcaba12fd68e71a4930ea18843aa61]"@en .
<http://bio2rdf.org/drugbank:DB00103>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-3> .
<http://bio2rdf.org/drugbank:DB00102>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-7>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00117-7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00109>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-3> .
<http://bio2rdf.org/drugbank:DB00107>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-4> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-5>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00103>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-4> .
<http://bio2rdf.org/drugbank:DB00102>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-4> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-4>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:c78f5087e52c969400b9d748ae4a9485> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00677>	<http://purl.org/dc/terms/title>	"DDI between Enfuvirtide and Isoflurophate - Enfuvirtide may increase the serum concentration of Protease Inhibitors. Protease Inhibitors may increase the serum concentration of Enfuvirtide."@en .
<http://bio2rdf.org/drugbank:DB00095>	<http://bio2rdf.org/drugbank_vocabulary:half-life>	<http://bio2rdf.org/drugbank_resource:e340b19fed6c2eaebccc1a4c652c8eb5> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-4> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-5> .
<http://bio2rdf.org/drugbank:DB00113>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-1> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-7>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00113>	<http://bio2rdf.org/drugbank_vocabulary:experimental-properties>	<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-2> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-4>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00096>	<http://purl.org/dc/terms/description>	"A sterile non-pyrogenic suspension of microspheres of human serum albumin with perflutren (a highly fluorinated small molecule) for contrast enhancement during indicated ultrasound imaging procedures."@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-24>	<http://www.w3.org/2000/01/rdf-schema#label>	"Bioavailability: 0 from ChemAxon [drugbank_resource:calculated-properties-DB00093-24]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-5>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:84c4d4608be206e204e18bc4fee8d4a9>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-4>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:904bc2c9127fa8f18e0965559eecc60c>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://purl.org/dc/terms/identifier>	"drugbank:BE0002638"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00109>	<http://bio2rdf.org/drugbank_vocabulary:mechanism-of-action>	<http://bio2rdf.org/drugbank_resource:e4e539077bcedbc155e950cadab01679> .
<http://bio2rdf.org/drugbank:BE0000456>	<http://bio2rdf.org/drugbank_vocabulary:x-genbank>	<http://bio2rdf.org/genbank:AF550404> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-1>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:84e1544b4af68672a960baf683724f87>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00095-1>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-1>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:85745be17d6c5d398a5d3540508f1a44>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00090>	<http://bio2rdf.org/drugbank_vocabulary:mechanism-of-action>	<http://bio2rdf.org/drugbank_resource:eda68d4a7955df0290c1f8b709e905ec> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00093-1>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-11>	<http://bio2rdf.org/drugbank_vocabulary:value>	"CCC1NC(=O)C(C(O)C(C)CC=CC)N(C)C(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:904bc2c9127fa8f18e0965559eecc60c>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank:DB00107>	<http://bio2rdf.org/drugbank_vocabulary:manufacturer>	<http://bio2rdf.org/drugbank_resource:e91ecbd8702c2bd53755e648fa5c9435> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-3>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:003185d1d24af95f95de2d64dd76ed33>	<http://www.w3.org/2000/01/rdf-schema#label>	"indication for drugbank:DB00112 [drugbank_resource:003185d1d24af95f95de2d64dd76ed33]"@en .
<http://bio2rdf.org/drugbank_resource:a6302cf127669e87e24a75b24552a9e8>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:c5eeb0cb7807d3f1cec573ef5532f521> .
<http://bio2rdf.org/drugbank_resource:85e4414ae6d2bc12695a4539100e286f>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/pdb:CNC>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"CNC"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-4>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Weight: 46548.2000 [drugbank_resource:experimental-properties-DB00100-4]"@en .
<http://bio2rdf.org/drugbank_resource:228bf0dff0e17c650e98e541c5291e94>	<http://purl.org/dc/terms/description>	"Absorption and clearance of Neupogen follows first-order pharmacokinetic modeling without apparent concentration dependence. When 3.45 mcg/kg and 11.5 mcg/kg of Neupogen is subcutaneously administered, the maximum serum concentration is 4 and 49 ng/mL\u201A respectively\u201A within 2 to 8 hours. Neupogen does not accumulate. It is estimated that when filgrastim is subcutaneously administered, the absolute bioavailability is approximately 62% and 71% for 375 mcg and 750 mcg doses respectively. When 5 mcg/kg tbo-filgrastim is subcutaneously administered, the absolute bioavailability is 33%. It takes 4-6 hours for tho-filgrastim to reach maximum concentration. Like Neupogen, accumulation was not observed."@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-2>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-4>	<http://bio2rdf.org/drugbank_vocabulary:value>	"1.19e+00 g/l"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"physiological process"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-2>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-4>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00091-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-1>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8683be48baa0e7d62758aed2d9ccf431>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00097>	<http://bio2rdf.org/drugbank_vocabulary:brand>	<http://bio2rdf.org/drugbank_vocabulary:ffb414ea32db58bec7ec3339a42c9dee> .
<http://bio2rdf.org/drugbank:BE0000300>	<http://bio2rdf.org/drugbank_vocabulary:x-genecards>	<http://bio2rdf.org/genecards:SRM> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-4>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-13>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-13"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:efd9b57513efb0eb6e90f59807e0e8d9> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-3>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00115-1>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00115-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:31af673f5d82841086059243563cd4c6>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:31af673f5d82841086059243563cd4c6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:85e4414ae6d2bc12695a4539100e286f>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Mechanism-of-action> .
<http://bio2rdf.org/drugbank:BE0003612>	<http://www.w3.org/2000/01/rdf-schema#label>	"Cytochrome P450 3A7 [drugbank:BE0003612]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-4>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8399ac082eecc289dcd0ff6ce9ff3420>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:da9625c635b6c208626fef4666f9f883>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:da9625c635b6c208626fef4666f9f883"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8f7450a053d86ee89751c06a230561d0>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:01c6a15f6a299a85cd866fc4092d0dce>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:49b21ad0d38942f635877e7bbc5d7a1e> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:manufacturer>	<http://bio2rdf.org/drugbank_resource:e9ee4548d6d10b87a4a259470fe32c97> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-3>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f38592452c305d31bbbb2909013724ac>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:f38592452c305d31bbbb2909013724ac"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00091-2>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:01c6a15f6a299a85cd866fc4092d0dce>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:251aa2c7f843f73a59fa2779ab4a885a> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00091-2>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00091-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:eb23978cb768321237553e12616e3b84> .
<http://bio2rdf.org/drugbank_resource:003185d1d24af95f95de2d64dd76ed33>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:003185d1d24af95f95de2d64dd76ed33"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00091-1>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00089-1>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8399ac082eecc289dcd0ff6ce9ff3420>	<http://www.w3.org/2000/01/rdf-schema#label>	"Amino fatty acids [drugbank_resource:8399ac082eecc289dcd0ff6ce9ff3420]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-2>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00099-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:84c4d4608be206e204e18bc4fee8d4a9>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:225393798d1f4d7a00af1d777e454e22>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:225393798d1f4d7a00af1d777e454e22"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-4>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00103_DB01118>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00103_DB01118"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-2>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:84e1544b4af68672a960baf683724f87>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:a8454a4c3a73e4a65b3965d9947cc4bd>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:c5eeb0cb7807d3f1cec573ef5532f521> .
<http://bio2rdf.org/drugbank_resource:285048a510ce36e96744886cc83cc631>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:fa632501828d57a2c1fda712393a3927> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-1>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://purl.org/dc/terms/identifier>	"drugbank:BE0002148"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-1>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-4>	<http://www.w3.org/2000/01/rdf-schema#label>	"Water Solubility: 4.53e-02 g/l from ALOGPS [drugbank_resource:calculated-properties-DB00093-4]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-27>	<http://purl.org/dc/terms/title>	"MDDR-Like Rule: 1 from ChemAxon"@en .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"S-mephenytoin 4-hydroxylase"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8eb135a8f519839c5f289226017b68a3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Half-life> .
<http://bio2rdf.org/drugbank_resource:f38592452c305d31bbbb2909013724ac>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"f38592452c305d31bbbb2909013724ac"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-3>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:893efa195cf56cf85e98a5c5f0867045>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:8e7e8f5ff3cf3466586b956d7330151b>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-27>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00116-27"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-4>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:c78f5087e52c969400b9d748ae4a9485> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-2>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:3465ee54a79f5fd937ce86304a05d4e3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-18>	<http://purl.org/dc/terms/title>	"H Bond Acceptor Count: 13 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:efdc5ed439af008904afce03f4dd2ec8>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:094779e1e90e423f19e46305ba872c9c>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:094779e1e90e423f19e46305ba872c9c"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a595cc1c66cf7314ca9d50542e429c85>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"a595cc1c66cf7314ca9d50542e429c85"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:efd9b57513efb0eb6e90f59807e0e8d9>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fa9ea24c47c4cc6ec20e42b245e43401>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"fa9ea24c47c4cc6ec20e42b245e43401"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8abd75317f3f7b8f7d56e3fe7d6204bd>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:a39e93df12255155561f3d4acd297da8>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:fa632501828d57a2c1fda712393a3927> .
<http://bio2rdf.org/drugbank_resource:8ae8b01597df174d257016596812aeab>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:74985c763ecb65fc6e794b1a003e061f>	<http://purl.org/dc/terms/title>	"Aliphatic heteromonocyclic compound"@en .
<http://bio2rdf.org/drugbank_resource:2ddeeca2fe9449969ab1519d768237c6>	<http://purl.org/dc/terms/title>	"100 mg/4mL Injection, solution form with intravenous route"@en .
<http://bio2rdf.org/drugbank_vocabulary:3465ee54a79f5fd937ce86304a05d4e3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Name> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:absorption>	<http://bio2rdf.org/drugbank_resource:e39dd3e5ddfc2038fa77efd8d6d5305d> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-9>	<http://bio2rdf.org/drugbank_vocabulary:value>	"399.145"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:8750c04d33b8546006e83e736eb80647>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01319>	<http://purl.org/dc/terms/title>	"DDI between Enfuvirtide and Fosamprenavir - May increase the serum concentration of Protease Inhibitors. Protease Inhibitors may increase the serum concentration of Enfuvirtide."@en .
<http://bio2rdf.org/drugbank_resource:1588f62bddb8c0b1cca8f11ce8e653b9>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:b8bd6b6d11ddec6e6466cff8d0a20424> .
<http://bio2rdf.org/drugbank_resource:9ea94506ab138833cc18501d48712af4>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:9ea94506ab138833cc18501d48712af4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ef0da8f521b780a50b08c455970978ac>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-5>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-3>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:c78f5087e52c969400b9d748ae4a9485> .
<http://bio2rdf.org/drugbank_resource:8bb9fceb6f80460936af862e9f7d1d94>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:78fce134a0e754813388f2850f268625>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"78fce134a0e754813388f2850f268625"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:87f0fe251ba4940236c1e30de121922a>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0003536>	<http://purl.org/dc/terms/title>	"Cytochrome P450 2C19"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-4>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:8c59273d79bb6ce81fe2a4c0596fa577>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:bbf3cb3443969f24e50666e131185bd8>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:bbf3cb3443969f24e50666e131185bd8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-12>	<http://www.w3.org/2000/01/rdf-schema#label>	"InChI: InChI=1S/C62H90N13O14P.CN.Co/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;1-2;/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H15,63,64,65,66,67,68,69,71,72,73,74,77,78,79,80,81,82,83,85,86);;/q;;+1/p-1/t31-,34-,35-,36-,37+,41-,52-,53-,56-,57+,59-,60+,61+,62+;;/m1../s1 from ChemAxon [drugbank_resource:calculated-properties-DB00115-12]"@en .
<http://bio2rdf.org/drugbank_resource:80e4560d8a88ff69231ec21ee09506be>	<http://www.w3.org/2000/01/rdf-schema#label>	"This compound belongs to the class of organic compounds known as cobalamin derivatives. These are organic compounds containing a corrin ring, a cobalt atom, an a nucleotide moiety. Cobalamin Derivatives are actually derived from vitamin B12. [drugbank_resource:80e4560d8a88ff69231ec21ee09506be]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-7>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-5>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:88491d7d06bc30fa9586740372808b10>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:574e7d1136f355daec35f6fd17ef29e5>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"574e7d1136f355daec35f6fd17ef29e5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-6>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:a5a6248bbc8b4dd7520b62e64aa85462>	<http://www.w3.org/2000/01/rdf-schema#label>	"Imidolactam [drugbank_resource:a5a6248bbc8b4dd7520b62e64aa85462]"@en .
<http://bio2rdf.org/drugbank_vocabulary:64789d808f73ebe8eac3dbded4a95da0>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Name> .
<http://bio2rdf.org/drugbank_resource:eda68d4a7955df0290c1f8b709e905ec>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-9>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:450004b6cb1a30c3690aa11d2cd941a2>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:450004b6cb1a30c3690aa11d2cd941a2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-8>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-1>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00117-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:da9625c635b6c208626fef4666f9f883>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:da9625c635b6c208626fef4666f9f883"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e650b92d5679a4bc966570691fe2d7e4>	<http://purl.org/dc/terms/title>	"Dialkyl phosphate"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-22>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-21>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:ec0915fa5d5da881fd812adc490bcd65>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c28ad3ee91a708824325b58f26c403a5>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:c28ad3ee91a708824325b58f26c403a5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a6302cf127669e87e24a75b24552a9e8>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:a6302cf127669e87e24a75b24552a9e8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:eb2ea139d16c3216009f5eb2eceb62c8>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-24>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-23>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:eb23978cb768321237553e12616e3b84>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-26>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:0e708564ecff800b67a0d210bc03042c>	<http://www.w3.org/2000/01/rdf-schema#label>	"half-life for drugbank:DB00091 [drugbank_resource:0e708564ecff800b67a0d210bc03042c]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-25>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"heme binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-3>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-2>	<http://www.w3.org/2000/01/rdf-schema#label>	"Hydrophobicity: -0.423 [drugbank_resource:experimental-properties-DB00113-2]"@en .
<http://bio2rdf.org/drugbank_resource:2af3e19f02b1eb81db93222ed2b38a44>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-27>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:e9f580ccd34b70a11720b2f316225025>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00094>	<http://www.w3.org/2000/01/rdf-schema#label>	"Urofollitropin [drugbank:DB00094]"@en .
<http://bio2rdf.org/drugbank_resource:4a0d48b5f8e157c4bbcb34092d4edaf3>	<http://www.w3.org/2000/01/rdf-schema#label>	"Phosphoethanolamine [drugbank_resource:4a0d48b5f8e157c4bbcb34092d4edaf3]"@en .
<http://bio2rdf.org/drugbank_vocabulary:64789d808f73ebe8eac3dbded4a95da0>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:ea9490984599c557a86db10a8e93e890>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-15>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-24>	<http://www.w3.org/2000/01/rdf-schema#label>	"Physiological Charge: -2 from ChemAxon [drugbank_resource:calculated-properties-DB00114-24]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-14>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-9>	<http://purl.org/dc/terms/title>	"Monoisotopic Weight: 1355.575230332 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-17>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0003533>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"heme binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-16>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:e91ecbd8702c2bd53755e648fa5c9435>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-26>	<http://purl.org/dc/terms/title>	"Rule of Five: 0 from ChemAxon"@en .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"heme binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-19>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:e9ee4548d6d10b87a4a259470fe32c97>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:07c2684a57210d1f5bc920d112d11ecd>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:07c2684a57210d1f5bc920d112d11ecd"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00090>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:DB00090"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:gene-sequence>	">1494 bp\nATGGGGCTAGAAGCACTGGTGCCCCTGGCCGTGATAGTGGCCATCTTCCTGCTCCTGGTG\nGACCTGATGCACCGGCGCCAACGCTGGGCTGCACGCTACCCACCAGGCCCCCTGCCACTG\nCCCGGGCTGGGCAACCTGCTGCATGTGGACTTCCAGAACACACCATACTGCTTCGACCAG\nTTGCGGCGCCGCTTCGGGGACGTGTTCAGCCTGCAGCTGGCCTGGACGCCGGTGGTCGTG\nCTCAATGGGCTGGCGGCCGTGCGCGAGGCGCTGGTGACCCACGGCGAGGACACCGCCGAC\nCGCCCGCCTGTGCCCATCACCCAGATCCTGGGTTTCGGGCCGCGTTCCCAAGGGGTGTTC\nCTGGCGCGCTATGGGCCCGCGTGGCGCGAGCAGAGGCGCTTCTCCGTGTCCACCTTGCGC\nAACTTGGGCCTGGGCAAGAAGTCGCTGGAGCAGTGGGTGACCGAGGAGGCCGCCTGCCTT\nTGTGCCGCCTTCGCCAACCACTCCGGACGCCCCTTTCGCCCCAACGGTCTCTTGGACAAA\nGCCGTGAGCAACGTGATCGCCTCCCTCACCTGCGGGCGCCGCTTCGAGTACGACGACCCT\nCGCTTCCTCAGGCTGCTGGACCTAGCTCAGGAGGGACTGAAGGAGGAGTCGGGCTTTCTG\nCGCGAGGTGCTGAATGCTGTCCCCGTCCTCCTGCATATCCCAGCGCTGGCTGGCAAGGTC\nCTACGCTTCCAAAAGGCTTTCCTGACCCAGCTGGATGAGCTGCTAACTGAGCACAGGATG\nACCTGGGACCCAGCCCAGCCCCCCCGAGACCTGACTGAGGCCTTCCTGGCAGAGATGGAG\nAAGGCCAAGGGGAACCCTGAGAGCAGCTTCAATGATGAGAACCTGCGCATAGTGGTGGCT\nGACCTGTTCTCTGCCGGGATGGTGACCACCTCGACCACGCTGGCCTGGGGCCTCCTGCTC\nATGATCCTACATCCGGATGTGCAGCGCCGTGTCCAACAGGAGATCGACGACGTGATAGGG\nCAGGTGCGGCGACCAGAGATGGGTGACCAGGCTCACATGCCCTACACCACTGCCGTGATT\nCATGAGGTGCAGCGCTTTGGGGACATCGTCCCCCTGGGTATGACCCATATGACATCCCGT\nGACATCGAAGTACAGGGCTTCCGCATCCCTAAGGGAACGACACTCATCACCAACCTGTCA\nTCGGTGCTGAAGGATGAGGCCGTCTGGGAGAAGCCCTTCCGCTTCCACCCCGAACACTTC\nCTGGATGCCCAGGGCCACTTTGTGAAGCCGGAGGCCTTCCTGCCTTTCTCAGCAGGCCGC\nCGTGCATGCCTCGGGGAGCCCCTGGCCCGCATGGAGCTCTTCCTCTTCTTCACCTCCCTG\nCTGCAGCACTTCAGCTTCTCGGTGCCCACTGGACAGCCCCGGCCCAGCCACCATGGTGTC\nTTTGCTTTCCTGGTGAGCCCATCCCCCTATGAGCTTTGTGCTGTGCCCCGCTAG"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2a828069e3c5a4b098468f8a2091e89f>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-18>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-1>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00105-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-20>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-3>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:c78f5087e52c969400b9d748ae4a9485> .
<http://bio2rdf.org/drugbank_resource:55694a43ccf43a29349054f94c2ce2e7>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:55694a43ccf43a29349054f94c2ce2e7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2970662836bc4a17c64d219c534d3f7e>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:6826daa495527ec54b81079e04e89d24>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Name> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-4>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:c78f5087e52c969400b9d748ae4a9485> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-2>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:05261dbd457e9d2aa8254610c0f9df46>	<http://www.w3.org/2000/01/rdf-schema#label>	"Aldehyde [drugbank_resource:05261dbd457e9d2aa8254610c0f9df46]"@en .
<http://bio2rdf.org/drugbank_resource:9be1f0fbe27fc41feab5fa848add809b>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:9be1f0fbe27fc41feab5fa848add809b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:29ad2163821ce9d547ef52b7bddcf404>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-7>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:e8fbddfaa9a4fe87d9328de7cf8cd326>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-4>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00105-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-5>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:c78f5087e52c969400b9d748ae4a9485> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-16>	<http://purl.org/dc/terms/title>	"Physiological Charge: 2 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:b8238b8599e6fdc40599cf773d5fb991>	<http://purl.org/dc/terms/description>	"The absorption of cyclosporine from the gastrointestinal tract is incomplete and variable. The extent of absorption is dependent on the individual patient, the patient population, and the formulation. The absolute bioavailability of cyclosproine administered as Sandimmune\u00AE is dependent on the patient population, estimated to be less than 10% in liver transplant patients and as great as 89% in some renal transplant patients. Compared to an intravenous infusion, the absolute bioavailability of the oral solution is approximately 30% based upon the results in 2 patients. The cyclosporine capsules and oral solution are bioequivalent. The time of peak blood concentrations (Tmax) following oral administration of cyclosporine [modified] ranged from 1.5 - 2.0 hours."@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-6>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:e9ee4548d6d10b87a4a259470fe32c97>	<http://purl.org/dc/terms/title>	"manufacturer for drugbank:DB00115"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-25>	<http://purl.org/dc/terms/title>	"Rule of Five: 0 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:db3cf7df3e4a56b21665da45352819bc>	<http://purl.org/dc/terms/title>	"This compound belongs to the class of organic compounds known as glycosylamines. These are compounds consisting of an\u00A0amine\u00A0with a\u00A0beta-N-glycosidic bond\u00A0to a carbohydrate, thus forming a cyclic\u00A0hemiaminal ether\u00A0bond (alpha-amino ether)."@en .
<http://bio2rdf.org/drugbank_resource:285048a510ce36e96744886cc83cc631>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-9>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:e6fa8c632405b98301de119a72894c49>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00102>	<http://www.w3.org/2000/01/rdf-schema#label>	"Becaplermin [drugbank:DB00102]"@en .
<http://bio2rdf.org/drugbank_resource:9a71495dd3f52eed3f338a39501d4bfa>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"9a71495dd3f52eed3f338a39501d4bfa"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:84c4d4608be206e204e18bc4fee8d4a9>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:84c4d4608be206e204e18bc4fee8d4a9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:282d8423d2c45b369fa817ef1edbccd5>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:6826daa495527ec54b81079e04e89d24>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-8>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:gene-name>	"CYP3A7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:285048a510ce36e96744886cc83cc631>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"285048a510ce36e96744886cc83cc631"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-11>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0000300>	<http://bio2rdf.org/drugbank_vocabulary:x-hgnc>	<http://bio2rdf.org/hgnc:11296> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-10>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:e6fc137e236497aea65dd3bb99d52e53>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-27>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00093-27"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:9be1f0fbe27fc41feab5fa848add809b>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:9be1f0fbe27fc41feab5fa848add809b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:1588f62bddb8c0b1cca8f11ce8e653b9>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:93c392ef94d70fc29c467d485b49f786> .
<http://bio2rdf.org/drugbank_resource:2696048bf20ed0e2d578eb2938c6d8d3>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-13>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:2619a21616645ee9827c33c6e2f65268>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-12>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-17>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00115-17"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:55694a43ccf43a29349054f94c2ce2e7>	<http://www.w3.org/2000/01/rdf-schema#label>	"Monoalkyl phosphates [drugbank_resource:55694a43ccf43a29349054f94c2ce2e7]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-12>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00117-12"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:e328a6cf619c4105669d93dc30d36096>	<http://purl.org/dc/terms/title>	"Ceredase"@en .
<http://bio2rdf.org/drugbank_resource:e650b92d5679a4bc966570691fe2d7e4>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01601>	<http://purl.org/dc/terms/title>	"DDI between Enfuvirtide and Lopinavir - May increase the serum concentration of Protease Inhibitors. Protease Inhibitors may increase the serum concentration of Enfuvirtide."@en .
<http://bio2rdf.org/drugbank_resource:180176f4e85931ffb36c855eab8691da>	<http://purl.org/dc/terms/title>	"mechanism-of-action for drugbank:DB00100"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-21>	<http://purl.org/dc/terms/title>	"MDDR-Like Rule: 1 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-13>	<http://bio2rdf.org/drugbank_vocabulary:value>	"InChIKey=MEFKEPWMEQBLKI-AIRLBKTGSA-O"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e52e95d4f4c438c7fbf93397e39c26e3>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0000300>	<http://bio2rdf.org/drugbank_vocabulary:x-gi>	<http://bio2rdf.org/gi:531202> .
<http://bio2rdf.org/drugbank_resource:e4e539077bcedbc155e950cadab01679>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Hematopoietic-Agents>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:Hematopoietic-Agents"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:24189bc5fb16bfce4551ecdfb0196def>	<http://purl.org/dc/terms/title>	"5 mg/mL Injection, powder, lyophilized, for solution form with intravenous route"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-5>	<http://bio2rdf.org/drugbank_vocabulary:value>	"C845H1343N223O243S9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-23>	<http://purl.org/dc/terms/title>	"Number of Rings: 3 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:246c82890dc31bdd6e899b6c63a0f254>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:19d3289105c9a843a041cb4f7a0883a1>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:c5eeb0cb7807d3f1cec573ef5532f521> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-1>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00113-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:24189bc5fb16bfce4551ecdfb0196def>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:fa632501828d57a2c1fda712393a3927> .
<http://bio2rdf.org/drugbank_resource:e340b19fed6c2eaebccc1a4c652c8eb5>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-2>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:c78f5087e52c969400b9d748ae4a9485> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01072>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00109_DB01072"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-3>	<http://bio2rdf.org/drugbank_vocabulary:value>	"4.37"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-23>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00091-23"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-6>	<http://www.w3.org/2000/01/rdf-schema#label>	"Water Solubility: 5.70e+00 g/l from ALOGPS [drugbank_resource:calculated-properties-DB00114-6]"@en .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01232>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:DB00109_DB01232"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-4>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00115-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e39dd3e5ddfc2038fa77efd8d6d5305d>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-3>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00099-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-14>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00118-14"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:13bf7e351282b3c815c4b958aedb585f>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"13bf7e351282b3c815c4b958aedb585f"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00095>	<http://bio2rdf.org/drugbank_vocabulary:absorption>	<http://bio2rdf.org/drugbank_resource:ec0915fa5d5da881fd812adc490bcd65> .
<http://bio2rdf.org/drugbank_resource:5ac86da3649163846e9e9d65b58c49fc>	<http://www.w3.org/2000/01/rdf-schema#label>	"Transition metal cyanide salts [drugbank_resource:5ac86da3649163846e9e9d65b58c49fc]"@en .
<http://bio2rdf.org/drugbank_resource:67b3d3945732c5188334e7f955ca6288>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:67b3d3945732c5188334e7f955ca6288"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-7>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:24189bc5fb16bfce4551ecdfb0196def>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00088>	<http://www.w3.org/2000/01/rdf-schema#label>	"Alglucerase [drugbank:DB00088]"@en .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:x-pfam>	<http://bio2rdf.org/pfam:PF00067> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-5>	<http://purl.org/dc/terms/title>	"pKa: 2.76 (at 0 \u00B0C) from KORTUM,G ET AL (1961)"@en .
<http://bio2rdf.org/drugbank_resource:9a71495dd3f52eed3f338a39501d4bfa>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:9a71495dd3f52eed3f338a39501d4bfa"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:23e60560991f40f7f335be06f10675e1>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a9a65e43cdc103a1f769c3625b080c1d>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:a9a65e43cdc103a1f769c3625b080c1d"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:22f72a952683d19d554d47d3919c10f3>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-4>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00113-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-15>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00093-15"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:87f0fe251ba4940236c1e30de121922a>	<http://purl.org/dc/terms/title>	"Fatty amides"@en .
<http://bio2rdf.org/drugbank_resource:9a71495dd3f52eed3f338a39501d4bfa>	<http://purl.org/dc/terms/title>	"Aralkylamine"@en .
<http://bio2rdf.org/drugbank_resource:285048a510ce36e96744886cc83cc631>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:93c392ef94d70fc29c467d485b49f786> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-1>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00103-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fb96fa5c000dbd94c78671b5c79ff32b>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:fb96fa5c000dbd94c78671b5c79ff32b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-4>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:x-genatlas>	<http://bio2rdf.org/genatlas:CYP2D6> .
<http://bio2rdf.org/drugbank_resource:a9a58af69a8539d913c65b788eb5b178>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:a9a58af69a8539d913c65b788eb5b178"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-2>	<http://purl.org/dc/terms/title>	"Isoelectric Point: 9.38"@en .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"physiological process"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:x-genatlas>	<http://bio2rdf.org/genatlas:CYP3A5> .
<http://bio2rdf.org/drugbank_resource:e04ee332a67fe1dea4752f0a68c0a6ee>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:x-genatlas>	<http://bio2rdf.org/genatlas:CYP2C8> .
<http://bio2rdf.org/drugbank:BE0003533>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"physiological process"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:4fcc6e9455872b18c21b74aa6b82db13>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:4fcc6e9455872b18c21b74aa6b82db13"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/kegg_resource:bio2rdf.dataset.kegg.R3>	<http://www.w3.org/ns/dcat#distribution>	<http://download.bio2rdf.org/release/3/kegg/kegg-pathway.nq.gz> .
<http://bio2rdf.org/drugbank:DB00095>	<http://bio2rdf.org/drugbank_vocabulary:brand>	<http://bio2rdf.org/drugbank_vocabulary:64789d808f73ebe8eac3dbded4a95da0> .
<http://bio2rdf.org/drugbank_resource:DB00115_DB00446>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:DB00115_DB00446"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:22baeb726de652a99f0ad2fb61fac832>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:organism>	"Human"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e147a45842193f4b54cd46908fed6204>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2619a21616645ee9827c33c6e2f65268>	<http://www.w3.org/2000/01/rdf-schema#label>	"This compound belongs to the class of organic compounds known as d-alpha-amino acids. These are alpha amino acids which have the D-configuration of the alpha-carbon atom. [drugbank_resource:2619a21616645ee9827c33c6e2f65268]"@en .
<http://bio2rdf.org/drugbank_resource:225393798d1f4d7a00af1d777e454e22>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:76cc7a41e93863bcbab0bba32bc52311>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:12327177bfe077ccd10daa3d5ca9809c> .
<http://bio2rdf.org/drugbank_resource:df42fd14b400446e8cc7e69facd62cba>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:0e708564ecff800b67a0d210bc03042c>	<http://purl.org/dc/terms/title>	"half-life for drugbank:DB00091"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-3>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:76cc7a41e93863bcbab0bba32bc52311>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:76cc7a41e93863bcbab0bba32bc52311"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:220e1c2f3029a37a26fd263b95f90c89>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-1>	<http://purl.org/dc/terms/title>	"Melting Point: 60 \u00B0C from Luo, P., Protein Science 11:1218-1226 (2002)"@en .
<http://bio2rdf.org/drugbank_resource:dedcaba12fd68e71a4930ea18843aa61>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:dc4a561c55d386ce9aa0ac35fa50583b>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:dc4a561c55d386ce9aa0ac35fa50583b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-5>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00116-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:228bf0dff0e17c650e98e541c5291e94>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e02568426e5e3817cd6fcddc8dee4bee>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"physiological process"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:20aa32f603258f15ceef0ba521a5bd87>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:de11407327a5468776fbcbec28a97ca0>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-2>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:24189bc5fb16bfce4551ecdfb0196def>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:b88bccf74c38082763f5b2378ade9668> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB01268>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:DB00112_DB01268"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8eb135a8f519839c5f289226017b68a3>	<http://purl.org/dc/terms/description>	"18-20 days (in adults)"@en .
<http://bio2rdf.org/drugbank_resource:DB00115_DB01394>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-16>	<http://www.w3.org/2000/01/rdf-schema#label>	"Polarizability: 42.95 from ChemAxon [drugbank_resource:calculated-properties-DB00116-16]"@en .
<http://bio2rdf.org/drugbank_resource:1fc54dd8ec20644e59a52e0b31197dd9>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00115_DB00446>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-1>	<http://www.w3.org/2000/01/rdf-schema#label>	"Melting Point: 55 \u00B0C from Forastieri, H., Ingham, K.C. J. Biol. Chem. 257:7976-7981 (1982) [drugbank_resource:experimental-properties-DB00094-1]"@en .
<http://bio2rdf.org/drugbank:BE0000456>	<http://bio2rdf.org/drugbank_vocabulary:x-uniprot>	<http://bio2rdf.org/uniprot:Q96EY8> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"CYPIIC8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-12>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00114-12"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a2615bbb5710b9b992785e63c058b3db>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"480 ug/1.6mL"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00932>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:DB00109_DB00932"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Biotech>	<http://purl.org/dc/terms/title>	"Biotech"@en .
<http://bio2rdf.org/drugbank_resource:a8454a4c3a73e4a65b3965d9947cc4bd>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:76ef13d358eacf63a71abd72dcbb5fbf> .
<http://bio2rdf.org/drugbank_resource:dc4a561c55d386ce9aa0ac35fa50583b>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:85e4414ae6d2bc12695a4539100e286f>	<http://www.w3.org/2000/01/rdf-schema#label>	"mechanism-of-action for drugbank:DB00115 [drugbank_resource:85e4414ae6d2bc12695a4539100e286f]"@en .
<http://bio2rdf.org/drugbank_resource:75aa077303c09d80af404a7a6c6ac735>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"75aa077303c09d80af404a7a6c6ac735"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:1f87ebefeca8e494680a6a81334c6078>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f7f0a15346b2f02764550cb8d9f8ef30>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:773530fb248596d00289b12dba48a0cc>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:773530fb248596d00289b12dba48a0cc"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f2977936270a493873be5432bb760ef7>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-21>	<http://purl.org/dc/terms/title>	"H Bond Donor Count: 3 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:2a828069e3c5a4b098468f8a2091e89f>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:93c392ef94d70fc29c467d485b49f786> .
<http://bio2rdf.org/drugbank_resource:1c7495e7ba342d224b5028d72d73010d>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:fa632501828d57a2c1fda712393a3927> .
<http://bio2rdf.org/drugbank_resource:f38592452c305d31bbbb2909013724ac>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/drugbank_vocabulary:locus>	"7q21.1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:1cb959cb5d30e328a863a3d9f64c120a>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:db3cf7df3e4a56b21665da45352819bc>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f84c0f373fd98f4297607f206aadd302>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:4d9d641daef8c178a249f1266f1150e5>	<http://purl.org/dc/terms/description>	"Alpha-galactosidase A catalyzes the hydrolysis of globotriaosylceramide (GL-3) and other a-galactyl-terminated neutral glycosphingolipids, such as galabiosylceramide and blood group B substances to ceramide dihexoside and galactose."@en .
<http://bio2rdf.org/drugbank_resource:DB00115_DB01394>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:x-pfam>	<http://bio2rdf.org/pfam:PF00067> .
<http://bio2rdf.org/drugbank_resource:DB00115_DB00446>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:brand>	<http://bio2rdf.org/drugbank_vocabulary:6826daa495527ec54b81079e04e89d24> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-21>	<http://purl.org/dc/terms/title>	"pKa (strongest acidic): 3.69 from ChemAxon"@en .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:x-pfam>	<http://bio2rdf.org/pfam:PF00067> .
<http://bio2rdf.org/drugbank_resource:d56193a54171cd8858918adbb1b34e8c>	<http://purl.org/dc/terms/title>	"6-aminopurines"@en .
<http://bio2rdf.org/drugbank_resource:da9625c635b6c208626fef4666f9f883>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:8ad571235d010ca525f3733fd9b517fb>	<http://www.w3.org/2000/01/rdf-schema#label>	"Amevive [drugbank_vocabulary:8ad571235d010ca525f3733fd9b517fb]"@en .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"generation of precursor metabolites and energy"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-20>	<http://bio2rdf.org/drugbank_vocabulary:value>	"14.67"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:1c7495e7ba342d224b5028d72d73010d>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:da8dbfa1d167bdbfac5e83608be911ea>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f2540530a3858d9fa40e7bfd96e4c77d>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:x-pfam>	<http://bio2rdf.org/pfam:PF00067> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-3>	<http://bio2rdf.org/drugbank_vocabulary:value>	"-2.6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"generation of precursor metabolites and energy"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:1cb2d5b9df573a57849083d75e49a5fe>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"generation of precursor metabolites and energy"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:brand>	<http://bio2rdf.org/drugbank_vocabulary:3465ee54a79f5fd937ce86304a05d4e3> .
<http://bio2rdf.org/drugbank_vocabulary:8550beb9aaabcff323bdfeef04608bb8>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"8550beb9aaabcff323bdfeef04608bb8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-4>	<http://bio2rdf.org/drugbank_vocabulary:value>	"C3160H4848N898O881S12"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Conditionally-Essential-Amino-Acids>	<http://purl.org/dc/terms/title>	"Conditionally Essential Amino Acids"@en .
<http://bio2rdf.org/drugbank_resource:6215bb81f14ea29a233fa4efbf660bf9>	<http://purl.org/dc/terms/title>	"clearance for drugbank:DB00109"@en .
<http://bio2rdf.org/drugbank_resource:a78396bd0ab3d3f25852a0d4008cbdf4>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"a78396bd0ab3d3f25852a0d4008cbdf4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pdb:SAM>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"SAM"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:Citanest-Octapressin>	<http://bio2rdf.org/drugbank_vocabulary:ingredient>	<http://bio2rdf.org/drugbank_resource:Prilocaine> .
<http://bio2rdf.org/drugbank_resource:f5f75e6bf165e0a25b8c2fab60ccf2e0>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:1c54727b6a9a48b74b53723fbee43d80>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f30bb36d9cf1cde63e806eb49b64d341>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-22>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-22"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-3>	<http://bio2rdf.org/drugbank_vocabulary:value>	"8.61"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:328c87b1ad60e7356c52d11e15011e6f>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:328c87b1ad60e7356c52d11e15011e6f"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-2>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:c78f5087e52c969400b9d748ae4a9485> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-12>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-12"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:organism>	"Human"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fb96fa5c000dbd94c78671b5c79ff32b>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-22>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00116-22"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:64b9dc4a304f0bbee322be682a49f08b>	<http://www.w3.org/2000/01/rdf-schema#label>	"Organic phosphoric acid derivative [drugbank_resource:64b9dc4a304f0bbee322be682a49f08b]"@en .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:organism>	"Human"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Supplements>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:Supplements"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fba31fe582cac619f85335c144278e17>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:c51b5b3f72bf15f717f23f1fdda6fe44>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"c51b5b3f72bf15f717f23f1fdda6fe44"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:Citanest-Octapressin>	<http://bio2rdf.org/drugbank_vocabulary:ingredient>	<http://bio2rdf.org/drugbank_resource:Felypressin> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:organism>	"Human"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:b8238b8599e6fdc40599cf773d5fb991>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:b8238b8599e6fdc40599cf773d5fb991"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:55f06b8fc86fce71f0db4c1832cfa819>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"55f06b8fc86fce71f0db4c1832cfa819"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c3ea863492592dff31fb000b21cd1a19>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:fa632501828d57a2c1fda712393a3927> .
<http://bio2rdf.org/drugbank_resource:Citanest-Dental-Octapressin>	<http://bio2rdf.org/drugbank_vocabulary:ingredient>	<http://bio2rdf.org/drugbank_resource:Felypressin> .
<http://bio2rdf.org/drugbank_resource:19d3289105c9a843a041cb4f7a0883a1>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-5>	<http://purl.org/dc/terms/title>	"Molecular Formula: C845H1343N223O243S9"@en .
<http://bio2rdf.org/drugbank_resource:fc61d172cba7ae19145ff846ca1f0aef>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"EC 1.14.13.49"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"generation of precursor metabolites and energy"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:Citanest-Dental>	<http://bio2rdf.org/drugbank_vocabulary:ingredient>	<http://bio2rdf.org/drugbank_resource:Felypressin> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-16>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-16"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00094>	<http://bio2rdf.org/drugbank_vocabulary:brand>	<http://bio2rdf.org/drugbank_vocabulary:0f3c814d30566a7614f1fab32f4e0302> .
<http://bio2rdf.org/drugbank_resource:fa9ea24c47c4cc6ec20e42b245e43401>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Indication> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-3>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Weight: 4491.8760 [drugbank_resource:experimental-properties-DB00109-3]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-1>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3afc1cd15f9de2a07db0081098265ac4>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:3afc1cd15f9de2a07db0081098265ac4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-4>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:55f06b8fc86fce71f0db4c1832cfa819>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:55f06b8fc86fce71f0db4c1832cfa819"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:aa64bf1510edae009ba1d31553912173>	<http://www.w3.org/2000/01/rdf-schema#label>	"ProstaScint [drugbank_vocabulary:aa64bf1510edae009ba1d31553912173]"@en .
<http://bio2rdf.org/drugbank_resource:Citanest-Dental>	<http://bio2rdf.org/drugbank_vocabulary:ingredient>	<http://bio2rdf.org/drugbank_resource:Prilocaine> .
<http://bio2rdf.org/drugbank_resource:Citanest-Dental-Octapressin>	<http://bio2rdf.org/drugbank_vocabulary:ingredient>	<http://bio2rdf.org/drugbank_resource:Prilocaine> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-15>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00091-15"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:908621b9e3153f791dd6dbd4ef6d62a5>	<http://bio2rdf.org/drugbank_vocabulary:name>	"CEA-Scan"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-3>	<http://purl.org/dc/terms/title>	"logS: -3.2 from ALOGPS"@en .
<http://bio2rdf.org/drugbank_resource:195ccf935d3c9947bcc17b096fdca329>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:9d6d13e90c7dfeb0d8d2cac125c20125>	<http://purl.org/dc/terms/title>	"Glycosyl compounds"@en .
<http://bio2rdf.org/drugbank_resource:DB00103_DB01118>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:DB00103_DB01118"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"heme binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-5>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00116-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-6>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:c78f5087e52c969400b9d748ae4a9485> .
<http://bio2rdf.org/drugbank_resource:2df9c46833999f4cf9a8383d1003158e>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"2df9c46833999f4cf9a8383d1003158e"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:180176f4e85931ffb36c855eab8691da>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-7>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:c78f5087e52c969400b9d748ae4a9485> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:group>	<http://bio2rdf.org/drugbank_vocabulary:Nutraceutical> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-5>	<http://www.w3.org/2000/01/rdf-schema#label>	"logP: -4.2 from ChemAxon [drugbank_resource:calculated-properties-DB00116-5]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-1>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00109>	<http://bio2rdf.org/drugbank_vocabulary:affected-organism>	<http://bio2rdf.org/drugbank_vocabulary:122193da65e00a63d46700928a244018> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-8>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:c78f5087e52c969400b9d748ae4a9485> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:group>	<http://bio2rdf.org/drugbank_vocabulary:Nutraceutical> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-10>	<http://purl.org/dc/terms/title>	"SMILES: NC1=NC(=O)C2=C(NCC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2)N1 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:DB00099_DB00531>	<http://www.w3.org/2000/01/rdf-schema#label>	"DDI between Filgrastim and Cyclophosphamide - Filgrastim may enhance the adverse/toxic effect of Cyclophosphamide. Specifically, the risk of pulmonary toxicity may be enhanced. [drugbank_resource:DB00099_DB00531]"@en .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:group>	<http://bio2rdf.org/drugbank_vocabulary:Nutraceutical> .
<http://bio2rdf.org/drugbank_resource:fa8e5850916f505d7329bb36ce55c161>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:e9f580ccd34b70a11720b2f316225025>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:e9f580ccd34b70a11720b2f316225025"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:b8f9ca946fec2fca3eb84c3b8cf1ff12>	<http://www.w3.org/2000/01/rdf-schema#label>	"Benzoyl derivatives [drugbank_resource:b8f9ca946fec2fca3eb84c3b8cf1ff12]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-10>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00114-10"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:e1e572616d493b2affcc653e19cbcd21"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-21>	<http://purl.org/dc/terms/title>	"pKa (strongest basic): 9.41 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:fa9ea24c47c4cc6ec20e42b245e43401>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:group>	<http://bio2rdf.org/drugbank_vocabulary:Nutraceutical> .
<http://bio2rdf.org/drugbank:BE0000456>	<http://bio2rdf.org/drugbank_vocabulary:general-function>	"Involved in ATP binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-8>	<http://www.w3.org/2000/01/rdf-schema#label>	"Traditional IUPAC Name: 30-ethyl-14,17,23,32-tetrahydroxy-33-[(4E)-1-hydroxy-2-methylhex-4-en-1-yl]-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriaconta-13,16,22,31-tetraene-2,5,8,11,20,26,29-heptone from ChemAxon [drugbank_resource:calculated-properties-DB00091-8]"@en .
<http://bio2rdf.org/drugbank:BE0000456>	<http://bio2rdf.org/drugbank_vocabulary:x-hgnc>	<http://bio2rdf.org/hgnc:19331> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:name>	"Cytochrome P450 3A5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-19>	<http://www.w3.org/2000/01/rdf-schema#label>	"Refractivity: 38.06 from ChemAxon [drugbank_resource:calculated-properties-DB00117-19]"@en .
<http://bio2rdf.org/drugbank_resource:17055fe13e90f0599fe8f9fd1c90c871>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:22f72a952683d19d554d47d3919c10f3>	<http://purl.org/dc/terms/title>	"Organonitrogen compounds"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-27>	<http://purl.org/dc/terms/title>	"MDDR-Like Rule: 1 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00114-1>	<http://www.w3.org/2000/01/rdf-schema#label>	"Water Solubility: Appreciable [drugbank_resource:experimental-properties-DB00114-1]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-27>	<http://www.w3.org/2000/01/rdf-schema#label>	"MDDR-Like Rule: 1 from ChemAxon [drugbank_resource:calculated-properties-DB00118-27]"@en .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"P450-254C"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:17b27330dfdb2b245beadb493e911ddb>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fb96fa5c000dbd94c78671b5c79ff32b>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank:DB00106>	<http://purl.org/dc/terms/description>	"Synthetic decapeptide antagonist to gonadotropin releasing hormone (GnRH). It is marketed by Praecis Pharmaceuticals as Plenaxis. Praecis announced in June 2006 that it was voluntarily withdrawing the drug from the market."@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-4>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:c78f5087e52c969400b9d748ae4a9485> .
<http://bio2rdf.org/drugbank_resource:abc4b12d5153eba9af71c2c651bd4ff1>	<http://www.w3.org/2000/01/rdf-schema#label>	"absorption for drugbank:DB00097 [drugbank_resource:abc4b12d5153eba9af71c2c651bd4ff1]"@en .
<http://bio2rdf.org/drugbank_resource:ef0da8f521b780a50b08c455970978ac>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"ef0da8f521b780a50b08c455970978ac"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-25>	<http://www.w3.org/2000/01/rdf-schema#label>	"Rule of Five: 1 from ChemAxon [drugbank_resource:calculated-properties-DB00118-25]"@en .
<http://bio2rdf.org/drugbank:DB00091>	<http://www.w3.org/2000/01/rdf-schema#label>	"Cyclosporine [drugbank:DB00091]"@en .
<http://bio2rdf.org/drugbank_resource:2a828069e3c5a4b098468f8a2091e89f>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:bee4f78f9cba3b09abdc595ab87f170e> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"cellular metabolism"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fc61d172cba7ae19145ff846ca1f0aef>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_vocabulary:aa64bf1510edae009ba1d31553912173>	<http://bio2rdf.org/drugbank_vocabulary:company>	"Cytogen Corp."^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01232>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:DB00109_DB01232"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:specific-function>	"Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:organism>	"Human"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-23>	<http://purl.org/dc/terms/title>	"Number of Rings: 3 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:b77ba88d4df43eb6dd239cb83101c022>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:b77ba88d4df43eb6dd239cb83101c022"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-7>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00115-7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-25>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00093-25"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:x-uniprot>	<http://bio2rdf.org/uniprot:P48147> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-3>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00118-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-3>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:c78f5087e52c969400b9d748ae4a9485> .
<http://bio2rdf.org/drugbank:DB00095>	<http://purl.org/dc/terms/title>	"Efalizumab"@en .
<http://bio2rdf.org/drugbank_resource:1588f62bddb8c0b1cca8f11ce8e653b9>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00105>	<http://purl.org/dc/terms/description>	"Interferon alpha 2b (human leukocyte clone hif-sn 206 protein moiety reduced). A type I interferon consisting of 165 amino acid residues with arginine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent."@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-23>	<http://purl.org/dc/terms/title>	"H Bond Donor Count: 3 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-24>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00091-24"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fba31fe582cac619f85335c144278e17>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-18>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-18"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:051943c0db4f9d17f7dfc49f7bb4329a>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:051943c0db4f9d17f7dfc49f7bb4329a"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0000456>	<http://bio2rdf.org/drugbank_vocabulary:x-gi>	<http://bio2rdf.org/gi:26284726> .
<http://bio2rdf.org/drugbank_resource:7fc0069b68f72ba58fdad65bec3cc1df>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:7fc0069b68f72ba58fdad65bec3cc1df"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c7d119b1e6d46c382382c2c17e2801ac>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:dfe1ce914314329264e9646b2686f5ff> .
<http://bio2rdf.org/drugbank_resource:07769f07381a36b9cbc482dc6db9e40d>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:07769f07381a36b9cbc482dc6db9e40d"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:372918cb5733e55c6d5baa7bc6f4a30c>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:93c392ef94d70fc29c467d485b49f786> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-4>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00097-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fa8e5850916f505d7329bb36ce55c161>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-9>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-24>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00118-24"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:14e62611474f52c8e22248963b84f59b>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-13>	<http://bio2rdf.org/drugbank_vocabulary:value>	"InChI=1/C62H111N11O12/c1-25-27-28-40(15)52(75)51-56(79)65-43(26-2)58(81)67(18)33-48(74)68(19)44(29-34(3)4)55(78)66-49(38(11)12)61(84)69(20)45(30-35(5)6)54(77)63-41(16)53(76)64-42(17)57(80)70(21)46(31-36(7)8)59(82)71(22)47(32-37(9)10)60(83)72(23)50(39(13)14)62(85)73(51)24/h25,27,34-47,49-52,75H,26,28-33H2,1-24H3,(H,63,77)(H,64,76)(H,65,79)(H,66,78)/b27-25+"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-17>	<http://www.w3.org/2000/01/rdf-schema#label>	"Number of Rings: 8 from ChemAxon [drugbank_resource:calculated-properties-DB00115-17]"@en .
<http://bio2rdf.org/drugbank_resource:129ef94b8ca8b89a244a3cd1c5b2c72b>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"129ef94b8ca8b89a244a3cd1c5b2c72b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:13bf7e351282b3c815c4b958aedb585f>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:e78186eb12eeaebda8a530a67513beea>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:e78186eb12eeaebda8a530a67513beea"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-7>	<http://bio2rdf.org/drugbank_vocabulary:value>	"[(1R,2R,3S,4S,8S,9S,14S,18R,19R)-4,9,14-tris(2-carbamoylethyl)-3,8,19-tris(carbamoylmethyl)-18-(2-{[(2R)-2-({[(2R,3S,4R,5S)-5-(5,6-dimethyl-1,3-benzodiazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy(hydroxy)phosphoryl}oxy)propyl]carbamoyl}ethyl)-2,3,6,8,13,13,16,18-octamethyl-20,21,22,23-tetraazapentacyclo[15.2.1.1\u00B2,\u2075.1\u2077,\u00B9\u2070.1\u00B9\u00B2,\u00B9\u2075]tricosa-5(23),6,10(22),11,15(21),16-hexaen-20-yl]cobaltcarbonitrile"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f31c373ea0d5f6b6f514f58cf30652a6>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-12>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00117-12"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:29ad2163821ce9d547ef52b7bddcf404>	<http://purl.org/dc/terms/description>	"1.5-3.6 hrs"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-3>	<http://www.w3.org/2000/01/rdf-schema#label>	"Isoelectric Point: 8.26 [drugbank_resource:experimental-properties-DB00113-3]"@en .
<http://bio2rdf.org/drugbank:BE0003612>	<http://purl.org/dc/terms/title>	"Cytochrome P450 3A7"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-2>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00097-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f7f0a15346b2f02764550cb8d9f8ef30>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:f2a30f76a373192265e4b663c8339602>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Indication> .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"CYPIIIA7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:129ef94b8ca8b89a244a3cd1c5b2c72b>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3d51d314e6796004243d124d2c5f0793>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"100 mg"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f38592452c305d31bbbb2909013724ac>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-4>	<http://bio2rdf.org/drugbank_vocabulary:value>	"-5.3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f84c0f373fd98f4297607f206aadd302>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_vocabulary:Angiogenesis-Inhibitors>	<http://www.w3.org/2000/01/rdf-schema#label>	"Angiogenesis Inhibitors [drugbank_vocabulary:Angiogenesis-Inhibitors]"@en .
<http://bio2rdf.org/drugbank_resource:80aadabf31c519e42d80748f499c7689>	<http://www.w3.org/2000/01/rdf-schema#label>	"indication for drugbank:DB00110 [drugbank_resource:80aadabf31c519e42d80748f499c7689]"@en .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/drugbank_vocabulary:amino-acid-sequence>	">Cytochrome P450 3A4\nMALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMF\nDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISI\nAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYS\nMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICV\nFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSI\nIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVV\nNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFS\nKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLG\nGLLQPEKPVVLKVESRDGTVSGA"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:131ed90e7634d72c92f27daf9a85454a>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00677>	<http://www.w3.org/2000/01/rdf-schema#label>	"DDI between Enfuvirtide and Isoflurophate - Enfuvirtide may increase the serum concentration of Protease Inhibitors. Protease Inhibitors may increase the serum concentration of Enfuvirtide. [drugbank_resource:DB00109_DB00677]"@en .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00091"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3d51d314e6796004243d124d2c5f0793>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:3d51d314e6796004243d124d2c5f0793"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-10>	<http://purl.org/dc/terms/title>	"SMILES: C[S+](CC[C@H](N)C(O)=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=CN=C12 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-4>	<http://purl.org/dc/terms/title>	"Molecular Weight: 19271.0000"@en .
<http://bio2rdf.org/drugbank_resource:6621165671a52f286c0f04fbfcf81106>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:76ef13d358eacf63a71abd72dcbb5fbf> .
<http://bio2rdf.org/drugbank_resource:2d6f2db0443dc24ac01149b8df7afb05>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:b8bd6b6d11ddec6e6466cff8d0a20424> .
<http://bio2rdf.org/drugbank_resource:f2540530a3858d9fa40e7bfd96e4c77d>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-19>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00114-19"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f31c373ea0d5f6b6f514f58cf30652a6>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Mechanism-of-action> .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:specific-function>	"Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-21>	<http://purl.org/dc/terms/title>	"pKa (strongest basic): 10.18 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:f2977936270a493873be5432bb760ef7>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-1>	<http://purl.org/dc/terms/title>	"Melting Point: 62 \u00B0C from Flora, K. et al., Biophys J. 75:1084-1096 (1998)"@en .
<http://bio2rdf.org/drugbank_resource:f2a30f76a373192265e4b663c8339602>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-6>	<http://bio2rdf.org/drugbank_vocabulary:value>	"-3.1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:0f798f4d70ca79c6d20f50856c6d9d11>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:246c82890dc31bdd6e899b6c63a0f254>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:246c82890dc31bdd6e899b6c63a0f254"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:1059233feb371b14b03a21571fa19968>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-14>	<http://bio2rdf.org/drugbank_vocabulary:value>	"InChIKey=PMATZTZNYRCHOR-IMVLJIQENA-N"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:07769f07381a36b9cbc482dc6db9e40d>	<http://www.w3.org/2000/01/rdf-schema#label>	"Thia fatty acid [drugbank_resource:07769f07381a36b9cbc482dc6db9e40d]"@en .
<http://bio2rdf.org/drugbank_resource:f5f75e6bf165e0a25b8c2fab60ccf2e0>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/pubchem.compound:44176380>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"44176380"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:03746a740bf18cbf4beaae7cc5b7504f>	<http://purl.org/dc/terms/title>	"Pyrimidine"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-16>	<http://www.w3.org/2000/01/rdf-schema#label>	"Physiological Charge: 2 from ChemAxon [drugbank_resource:calculated-properties-DB00115-16]"@en .
<http://bio2rdf.org/drugbank_resource:f30bb36d9cf1cde63e806eb49b64d341>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB03880>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:DB00109_DB03880"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-30>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00117-30"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:7fc0069b68f72ba58fdad65bec3cc1df>	<http://purl.org/dc/terms/title>	".5 mg/mL Emulsion form with ophthalmic route"@en .
<http://bio2rdf.org/drugbank_resource:5eace972d6db7e2d3395f1ce1f56c40a>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"5eace972d6db7e2d3395f1ce1f56c40a"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00096>	<http://www.w3.org/2000/01/rdf-schema#label>	"Serum albumin [drugbank:DB00096]"@en .
<http://bio2rdf.org/drugbank_resource:0e708564ecff800b67a0d210bc03042c>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0000300>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"EC 2.5.1.16"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:70f28c5b4aa0741b1c2d0997a89319ea>	<http://purl.org/dc/terms/title>	"Pyrrolidines"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-9>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00114-9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:4fcc6e9455872b18c21b74aa6b82db13>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#value>	"Avoid salt substitutes containing potassium."^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:36cf3fe3b4f939b051085b627e517597>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:36cf3fe3b4f939b051085b627e517597"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:0e7611deb0124f99ac54f3684b112d25>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3f54718d1deb0dbafe47e6e45eda5914>	<http://www.w3.org/2000/01/rdf-schema#label>	"0.05 % Emulsion form with ophthalmic route [drugbank_resource:3f54718d1deb0dbafe47e6e45eda5914]"@en .
<http://bio2rdf.org/drugbank_resource:4f9f96147f2386295de420eed7aa9274>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-5>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00096-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00106>	<http://www.w3.org/2000/01/rdf-schema#label>	"Abarelix [drugbank:DB00106]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-5>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00111-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-27>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-27"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ffc8ae70d9900ffb750da168c0f58cc5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:3c77091e1ee2397a2767e73267a25af5>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"3c77091e1ee2397a2767e73267a25af5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB06290>	<http://purl.org/dc/terms/title>	"DDI between Enfuvirtide and Simeprevir - Enfuvirtide may increase the serum concentration of Protease Inhibitors. Protease Inhibitors may increase the serum concentration of Enfuvirtide."@en .
<http://bio2rdf.org/drugbank_vocabulary:Hematopoietic-Agents>	<http://www.w3.org/2000/01/rdf-schema#label>	"Hematopoietic Agents [drugbank_vocabulary:Hematopoietic-Agents]"@en .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"catalytic activity"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ffe7ffbc4b8e341c6b137f185bb434e0>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank:DB00095>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00095"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:4fcc6e9455872b18c21b74aa6b82db13>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-3>	<http://bio2rdf.org/drugbank_vocabulary:value>	"4491.88"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:30d0083606d3fa4b4b602b5d3ed0feda>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:93c392ef94d70fc29c467d485b49f786> .
<http://bio2rdf.org/drugbank_resource:fffcf97ccb1aeb21dae91caa501b8255>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-22>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00117-22"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:13bf7e351282b3c815c4b958aedb585f>	<http://purl.org/dc/terms/title>	"Oxolane"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-3>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00109-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Angiogenesis-Inducing-Agents>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"Angiogenesis-Inducing-Agents"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-6>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e6fc137e236497aea65dd3bb99d52e53>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"25 mg"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0000456>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/BE0000456> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB08879>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"cellular metabolism"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:8ad571235d010ca525f3733fd9b517fb>	<http://bio2rdf.org/drugbank_vocabulary:name>	"Amevive"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Anti-tocolytic-Agents>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:Anti-tocolytic-Agents"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-17>	<http://www.w3.org/2000/01/rdf-schema#label>	"Refractivity: 54.75 from ChemAxon [drugbank_resource:calculated-properties-DB00114-17]"@en .
<http://bio2rdf.org/drugbank_resource:22baeb726de652a99f0ad2fb61fac832>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"22baeb726de652a99f0ad2fb61fac832"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003533>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"cellular metabolism"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:986ea485795ab092b3199f449ca4056e>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:986ea485795ab092b3199f449ca4056e"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a9a65e43cdc103a1f769c3625b080c1d>	<http://purl.org/dc/terms/title>	"Secondary alcohol"@en .
<http://bio2rdf.org/drugbank_resource:4d9d641daef8c178a249f1266f1150e5>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:0e708564ecff800b67a0d210bc03042c>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:0e708564ecff800b67a0d210bc03042c"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:372918cb5733e55c6d5baa7bc6f4a30c>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:c5eeb0cb7807d3f1cec573ef5532f521> .
<http://bio2rdf.org/drugbank_resource:fdb0a3b06aac9bbd85eeda7b1daf8545>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank_resource:807b0e58e0eead4b875202221ebe0f53>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:807b0e58e0eead4b875202221ebe0f53"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fdb8e90f512977b9fb2141486454a079>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Clearance> .
<http://bio2rdf.org/drugbank_resource:fe2051219bbed1c3f26d756ec49dea95>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:1c7495e7ba342d224b5028d72d73010d>	<http://purl.org/dc/terms/title>	"35 mg Powder for solution form with intravenous route"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-2>	<http://purl.org/dc/terms/title>	"Hydrophobicity: -0.423"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-1>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c7d119b1e6d46c382382c2c17e2801ac>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:93c392ef94d70fc29c467d485b49f786> .
<http://bio2rdf.org/drugbank_resource:4dcb2d242a80267002194ce81be5670e>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-13>	<http://purl.org/dc/terms/title>	"InChIKey: InChIKey=MSTNYGQPCMXVAQ-KIYNQFGBSA-N from ChemAxon"@en .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"cellular metabolism"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-11>	<http://purl.org/dc/terms/title>	"Molecular Formula: C15H23N6O5S from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-14>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00116-14"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2ddeeca2fe9449969ab1519d768237c6>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:93c392ef94d70fc29c467d485b49f786> .
<http://bio2rdf.org/drugbank_resource:4d6d8a0bb0437361e22c5fbaf04819ea>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:0f3c814d30566a7614f1fab32f4e0302>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Name> .
<http://bio2rdf.org/drugbank_resource:a2615bbb5710b9b992785e63c058b3db>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:66a4f22d1577f66fd9737b00a8525f55> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB08879>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/pubchem.substance:46506428>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"46506428"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:x-genecards>	<http://bio2rdf.org/genecards:CYP3A5> .
<http://bio2rdf.org/drugbank_vocabulary:Vasoconstrictor-Agents>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"Vasoconstrictor-Agents"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-8>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00115-8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/drugbank_vocabulary:organism>	"Human"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3314d6a38b90d6a9ef0419bc7224913d>	<http://www.w3.org/2000/01/rdf-schema#label>	"Organic metal salt [drugbank_resource:3314d6a38b90d6a9ef0419bc7224913d]"@en .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:x-genecards>	<http://bio2rdf.org/genecards:CYP2D6> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-5>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00093>	<http://purl.org/dc/terms/title>	"Felypressin"@en .
<http://bio2rdf.org/drugbank_resource:74985c763ecb65fc6e794b1a003e061f>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"74985c763ecb65fc6e794b1a003e061f"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-4>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:6ac630c499c16fd6e1f2a125e397688a>	<http://www.w3.org/2000/01/rdf-schema#label>	"Aminobenzamide [drugbank_resource:6ac630c499c16fd6e1f2a125e397688a]"@en .
<http://bio2rdf.org/drugbank_resource:e52e95d4f4c438c7fbf93397e39c26e3>	<http://purl.org/dc/terms/description>	"Felypressin binds to the vasopressin receptor V1a. This causes contraction of the smooth muscle in the vascular bed, especially capillaries, small arterioles and venules."@en .
<http://bio2rdf.org/drugbank_vocabulary:0f3c814d30566a7614f1fab32f4e0302>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:a61e3adec088927f97197e2f1513790d>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:a61e3adec088927f97197e2f1513790d"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-13>	<http://purl.org/dc/terms/title>	"InChIKey: InChIKey=SEKGMJVHSBBHRD-WZHZPDAFSA-M from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-5>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00094-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fdb8e90f512977b9fb2141486454a079>	<http://purl.org/dc/terms/description>	"* 42 +/- 22 mL/hr"@en .
<http://bio2rdf.org/drugbank_vocabulary:3465ee54a79f5fd937ce86304a05d4e3>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00118-1>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fd9ee6482e9b1c5516cff7b904f27169>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:ba0f878619b43a5be9083f01d8ba77fd>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"ba0f878619b43a5be9083f01d8ba77fd"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a61e3adec088927f97197e2f1513790d>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:251aa2c7f843f73a59fa2779ab4a885a> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-1>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:908621b9e3153f791dd6dbd4ef6d62a5>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:908621b9e3153f791dd6dbd4ef6d62a5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00116-1>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-20>	<http://bio2rdf.org/drugbank_vocabulary:value>	"1.71"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-14>	<http://bio2rdf.org/drugbank_vocabulary:value>	"405.32"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank:DB00099>	<http://purl.org/dc/terms/description>	"Filgrastim is a recombinant, non-pegylated human granulocyte colony stimulating factor (G-CSF) analogue manufactured by recombinant DNA technology using a strain of E. coli. It is marketed as the brand name Neupogen by Amgen. Chemically, it consists of 175 amino acid residues. The protein has an amino acid sequence that is identical to the natural sequence predicted from human DNA sequence analysis, except for the addition of an N-terminal methionine necessary for expression in E coli. Tbo-filgrastim, which is marketed by Sicor Biotech and FDA approved on August 29, 2012, contains the same active ingredient as Neupogen and is biologically similar, but it is formulated to be short-acting. On March 6, 2015, the FDA approved the biosimilar Zarxio (filgrastim-sndz) and is indicated for use in the same conditions as Neupogen. Zarxio is marketed by Sandoz."@en .
<http://bio2rdf.org/drugbank_vocabulary:122193da65e00a63d46700928a244018>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-3>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-17>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-17"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-5>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Formula: C1105H1770N318O336S26 [drugbank_resource:experimental-properties-DB00097-5]"@en .
<http://bio2rdf.org/drugbank_resource:fe02b6034f5c4d73f73a58815355abf5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-16>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00091-16"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-2>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-4>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c7d119b1e6d46c382382c2c17e2801ac>	<http://purl.org/dc/terms/title>	"11.6 ug/.5mL Injection, solution form with intramuscular; subcutaneous route"@en .
<http://bio2rdf.org/drugbank_resource:fe02b6034f5c4d73f73a58815355abf5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00114-3>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:80aadabf31c519e42d80748f499c7689>	<http://purl.org/dc/terms/title>	"indication for drugbank:DB00110"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00114-2>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fe2051219bbed1c3f26d756ec49dea95>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:4aaab29fd43effbe133e376c024d5f06>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-14>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-14"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:246c82890dc31bdd6e899b6c63a0f254>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:246c82890dc31bdd6e899b6c63a0f254"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00115-2>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:96faa670b368b06113b9e58e3db1d86c>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:96faa670b368b06113b9e58e3db1d86c"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a02555c5c58332bf7ac5fef198a34814>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:a02555c5c58332bf7ac5fef198a34814"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00115-1>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00107_DB00834>	<http://www.w3.org/2000/01/rdf-schema#label>	"DDI between Oxytocin and Mifepristone - May enhance the QTc-prolonging effect of QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying). [drugbank_resource:DB00107_DB00834]"@en .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:x-genecards>	<http://bio2rdf.org/genecards:CYP3A7> .
<http://bio2rdf.org/drugbank_resource:fe2051219bbed1c3f26d756ec49dea95>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"fe2051219bbed1c3f26d756ec49dea95"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e4e539077bcedbc155e950cadab01679>	<http://www.w3.org/2000/01/rdf-schema#label>	"mechanism-of-action for drugbank:DB00109 [drugbank_resource:e4e539077bcedbc155e950cadab01679]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-4>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-8>	<http://bio2rdf.org/drugbank_vocabulary:value>	"1356.37"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:DB00115_DB01394>	<http://www.w3.org/2000/01/rdf-schema#label>	"DDI between Cyanocobalamin and Colchicine - May decrease the serum concentration of Cyanocobalamin. [drugbank_resource:DB00115_DB01394]"@en .
<http://bio2rdf.org/drugbank_resource:47d86c7cb8687c843b27225a6715c3c1>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ff5b4bb2ae4fdc7811f87fd38c8b8eda>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-3>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:4a0d48b5f8e157c4bbcb34092d4edaf3>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a39e93df12255155561f3d4acd297da8>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:76ef13d358eacf63a71abd72dcbb5fbf> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00114-1>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"physiological process"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a595cc1c66cf7314ca9d50542e429c85>	<http://purl.org/dc/terms/description>	"Abarelix binds to the gonadotropin releasing hormone receptor and acts as a potent inhibitor of gonadotropin secretion."@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-5>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:1c9905a95fe27572eaf4822554262551>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-3>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-16>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00091-16"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-2>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01601>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:DB00109_DB01601"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-2>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-7>	<http://bio2rdf.org/drugbank_vocabulary:value>	"-0.4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:eb2ea139d16c3216009f5eb2eceb62c8>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:eb2ea139d16c3216009f5eb2eceb62c8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00112>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:DB00112"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-1>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fd9ee6482e9b1c5516cff7b904f27169>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-4>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ff5b4bb2ae4fdc7811f87fd38c8b8eda>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Indication> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-3>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fdb0a3b06aac9bbd85eeda7b1daf8545>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-1>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00107_DB00917>	<http://purl.org/dc/terms/title>	"DDI between Oxytocin and Dinoprostone - May enhance the adverse/toxic effect of Oxytocin. Specifically,oxytocic effects may be enhanced."@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-1>	<http://www.w3.org/2000/01/rdf-schema#label>	"Melting Point: 61 \u00B0C (FAB fragment), 71 \u00B0C (whole mAb) from Vermeer, A.W.P. & Norde, W., Biophys. J. 78:394-404 (2000) [drugbank_resource:experimental-properties-DB00112-1]"@en .
<http://bio2rdf.org/drugbank_resource:fdb8e90f512977b9fb2141486454a079>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-5>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:0d54035b86f9a43f56ecd493c3a6fd59>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"0d54035b86f9a43f56ecd493c3a6fd59"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ffa1ac4af9ac617e01349d78fdc482f1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Indication> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-20>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-20"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:57ad8968da7ad0cb58cba7e058039db9>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:57ad8968da7ad0cb58cba7e058039db9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00110-1>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-4>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:585c665fefee46ff4931f369bfe6004a>	<http://purl.org/dc/terms/title>	"indication for drugbank:DB00092"@en .
<http://bio2rdf.org/drugbank_resource:451abb4a53a3d4bc5e17cc485a3899b3>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-22>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00093-22"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-2>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-7>	<http://www.w3.org/2000/01/rdf-schema#label>	"Traditional IUPAC Name: felypressin from ChemAxon [drugbank_resource:calculated-properties-DB00093-7]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-21>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00118-21"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:450004b6cb1a30c3690aa11d2cd941a2>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ba0f878619b43a5be9083f01d8ba77fd>	<http://www.w3.org/2000/01/rdf-schema#label>	"6-aminopurine [drugbank_resource:ba0f878619b43a5be9083f01d8ba77fd]"@en .
<http://bio2rdf.org/drugbank_resource:0d47651b62c008d202fcec19e0c3b7c7>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:0d47651b62c008d202fcec19e0c3b7c7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-1>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:1c9905a95fe27572eaf4822554262551>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a5a6248bbc8b4dd7520b62e64aa85462>	<http://purl.org/dc/terms/title>	"Imidolactam"@en .
<http://bio2rdf.org/drugbank_resource:433dda4a1117986cabe237dcf80bd242>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-1>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:684d8812e411c70454900dc745e593c8>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:684d8812e411c70454900dc745e593c8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:17b27330dfdb2b245beadb493e911ddb>	<http://www.w3.org/2000/01/rdf-schema#label>	"indication for drugbank:DB00114 [drugbank_resource:17b27330dfdb2b245beadb493e911ddb]"@en .
<http://bio2rdf.org/drugbank_resource:592de4a57c1d28519d666f4b36fa6b2b>	<http://www.w3.org/2000/01/rdf-schema#label>	"indication for drugbank:DB00100 [drugbank_resource:592de4a57c1d28519d666f4b36fa6b2b]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-3>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:43ebb1f4d3ddbd9ec70fcbba40c42a45>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-2>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ffa1ac4af9ac617e01349d78fdc482f1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-2>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2619a21616645ee9827c33c6e2f65268>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:2619a21616645ee9827c33c6e2f65268"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ffa1ac4af9ac617e01349d78fdc482f1>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"ffa1ac4af9ac617e01349d78fdc482f1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ffc8ae70d9900ffb750da168c0f58cc5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-1>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:42e21c05e96b3040136e54dfed4bf794>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:d46b970056d0a083cca1f813197ccf0c>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:d46b970056d0a083cca1f813197ccf0c"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ffe7ffbc4b8e341c6b137f185bb434e0>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-4>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2c7d5048f3ab623475c1e9c503997a85>	<http://purl.org/dc/terms/title>	"Benzimidazole"@en .
<http://bio2rdf.org/drugbank_resource:dedcaba12fd68e71a4930ea18843aa61>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"dedcaba12fd68e71a4930ea18843aa61"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:122193da65e00a63d46700928a244018>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Affected-organism> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-3>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fffcf97ccb1aeb21dae91caa501b8255>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-4>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00114-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:x-gi>	<http://bio2rdf.org/gi:558596> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-6>	<http://bio2rdf.org/drugbank_vocabulary:value>	"5.70e+00 g/l"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-5>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e6fc137e236497aea65dd3bb99d52e53>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:e6fc137e236497aea65dd3bb99d52e53"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-12>	<http://purl.org/dc/terms/title>	"SMILES: CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-4>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:81987a5783579e8eae4261b8d95226da>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:81987a5783579e8eae4261b8d95226da"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-6>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00118-6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00106-2>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3f34afd99cc9695ee26d778d111874cf>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:3f34afd99cc9695ee26d778d111874cf"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00106-1>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:405bc988f44cffeeb0d7149d00e5918b>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003533>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"catalytic activity"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:81ce8d1a0627bc88956132de1e1a93c2>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:81ce8d1a0627bc88956132de1e1a93c2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00114-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-1>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3f34afd99cc9695ee26d778d111874cf>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:3f34afd99cc9695ee26d778d111874cf"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:38b20638a91b63e0378b18fb8d8f4c38>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:38b20638a91b63e0378b18fb8d8f4c38"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3f54718d1deb0dbafe47e6e45eda5914>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Melting-Point> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00114-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Formula> .
<http://bio2rdf.org/drugbank_resource:408e99a507da89ecb16b006481be4f7d>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pubchem.substance:46509031>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00115-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-3>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:908621b9e3153f791dd6dbd4ef6d62a5>	<http://bio2rdf.org/drugbank_vocabulary:company>	"Immunomedics Inc"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Weight> .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"catalytic activity"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:451abb4a53a3d4bc5e17cc485a3899b3>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:bee4f78f9cba3b09abdc595ab87f170e> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Water-Solubility> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00115-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-2>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:cb386ea42baf8766a3e98e9d24d46516>	<http://www.w3.org/2000/01/rdf-schema#label>	"Organic transition metal salt [drugbank_resource:cb386ea42baf8766a3e98e9d24d46516]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-2>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00116-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00115-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Water-Solubility> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Hydrophobicity> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Formula> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Isoelectric-Point> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-4>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"catalytic activity"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-1>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Weight> .
<http://bio2rdf.org/drugbank_resource:3f34afd99cc9695ee26d778d111874cf>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-4>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:3eff294ae1a633c8845359753061fac9>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:5c103a2b0c3fce1acc1c2e135c6684bf>	<http://purl.org/dc/terms/title>	"1,2-diols"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-3>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-9>	<http://www.w3.org/2000/01/rdf-schema#label>	"logP: -3.6 from ChemAxon [drugbank_resource:calculated-properties-DB00117-9]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00114-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:LogP> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00115-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Melting-Point> .
<http://bio2rdf.org/drugbank_resource:3afc1cd15f9de2a07db0081098265ac4>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:fa632501828d57a2c1fda712393a3927> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-2>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-22>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00091-22"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-22>	<http://bio2rdf.org/drugbank_vocabulary:value>	"1.68"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:3c77091e1ee2397a2767e73267a25af5>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-1>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00114-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Water-Solubility> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:3d51d314e6796004243d124d2c5f0793>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-4>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-16>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-16"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Hydrophobicity> .
<http://bio2rdf.org/drugbank_resource:069ab916580192548ff172f164a424bf>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:069ab916580192548ff172f164a424bf"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00114-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Melting-Point> .
<http://bio2rdf.org/drugbank_resource:2ddeeca2fe9449969ab1519d768237c6>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:fa632501828d57a2c1fda712393a3927> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-3>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pubchem.substance:46507001>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3>	<http://www.w3.org/ns/dcat#distribution>	<http://download.bio2rdf.org/release/3/pharmgkb/drugs.nq.gz> .
<http://bio2rdf.org/pubchem.substance:46506428>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:e147a45842193f4b54cd46908fed6204>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:e147a45842193f4b54cd46908fed6204"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pubchem.compound:34756>	<http://purl.org/dc/terms/identifier>	"pubchem.compound:34756"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:003185d1d24af95f95de2d64dd76ed33>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"003185d1d24af95f95de2d64dd76ed33"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00116-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:LogP> .
<http://bio2rdf.org/drugbank_resource:3afc1cd15f9de2a07db0081098265ac4>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Melting-Point> .
<http://bio2rdf.org/drugbank_vocabulary:abd3e42d8c67111954c278994aa4591d>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:abd3e42d8c67111954c278994aa4591d"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:43ebb1f4d3ddbd9ec70fcbba40c42a45>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:43ebb1f4d3ddbd9ec70fcbba40c42a45"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Hydrophobicity> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:LogP> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:81ce8d1a0627bc88956132de1e1a93c2>	<http://purl.org/dc/terms/title>	"Carboxylic acid"@en .
<http://bio2rdf.org/drugbank_resource:fffcf97ccb1aeb21dae91caa501b8255>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:fffcf97ccb1aeb21dae91caa501b8255"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-9>	<http://bio2rdf.org/drugbank_vocabulary:value>	"445.171"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00114-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:a2d4a403a964b1f3a6d6fa73cb73921a>	<http://purl.org/dc/terms/description>	"Binds to the beta platelet-derived growth factor (PDGF) receptor, a tyrosine kinase receptor. PDGF is known to exist as a dimer, and activates its signaling pathway by a ligand induced receptor dimerization and autophosphorylation. PDGF receptors also contain many auto-phosphorylation sites, which serve to mediate binding of SH2 sites and subsequently signal corresponding pathways. There are five different isoforms of PDGF that activate through two different receptors (alpha and beta)."@en .
<http://bio2rdf.org/drugbank_resource:b15aa7d1fbce9f1563623833e416d8f7>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"b15aa7d1fbce9f1563623833e416d8f7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-18>	<http://www.w3.org/2000/01/rdf-schema#label>	"H Bond Acceptor Count: 10 from ChemAxon [drugbank_resource:calculated-properties-DB00118-18]"@en .
<http://bio2rdf.org/drugbank:DB00089>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pubchem.substance:46505280>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:Citanest-Dental-Octapressin>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:Citanest-Dental-Octapressin"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00088>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3732893325a7ecb9126a15736796f117>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:3732893325a7ecb9126a15736796f117"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00107_DB00834>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:DB00107_DB00834"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-10>	<http://www.w3.org/2000/01/rdf-schema#label>	"Monoisotopic Weight: 1201.841368071 from ChemAxon [drugbank_resource:calculated-properties-DB00091-10]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:LogS> .
<http://bio2rdf.org/pubchem.substance:46504756>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-23>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00117-23"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:55694a43ccf43a29349054f94c2ce2e7>	<http://purl.org/dc/terms/title>	"Monoalkyl phosphates"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Hydrophobicity> .
<http://bio2rdf.org/pubchem.compound:91443>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-11>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-11"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pubchem.compound:1051>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"1051"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a57533055c136af9a471684ba442d058>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:a57533055c136af9a471684ba442d058"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:904bc2c9127fa8f18e0965559eecc60c>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:904bc2c9127fa8f18e0965559eecc60c"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:30d0083606d3fa4b4b602b5d3ed0feda>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:fa632501828d57a2c1fda712393a3927> .
<http://bio2rdf.org/pubchem.compound:6274>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/bindingdb:7953>	<http://purl.org/dc/terms/identifier>	"bindingdb:7953"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-21>	<http://www.w3.org/2000/01/rdf-schema#label>	"H Bond Donor Count: 3 from ChemAxon [drugbank_resource:calculated-properties-DB00114-21]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-10>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-10"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:39094d4a5017cb7945c3ca22e421306d>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00095>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:38b20638a91b63e0378b18fb8d8f4c38>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00094>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3732893325a7ecb9126a15736796f117>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00097>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:372918cb5733e55c6d5baa7bc6f4a30c>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00096>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Hydrophobicity> .
<http://bio2rdf.org/drugbank_resource:376c6e6cad258f51a802ccce8c53ca4c>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00118-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00090>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:05261dbd457e9d2aa8254610c0f9df46>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"05261dbd457e9d2aa8254610c0f9df46"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3669e274097fc69149d3dbad3ba6b01c>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00106>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00106"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:9be1f0fbe27fc41feab5fa848add809b>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"9be1f0fbe27fc41feab5fa848add809b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00092>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Hydrophobicity> .
<http://bio2rdf.org/drugbank_resource:36cf3fe3b4f939b051085b627e517597>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pubchem.compound:44176380>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00116-1>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00116-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00106>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pdb:THL>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/pdb:THL"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:366d45e2564940d9162a27ad0e9e3571>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pubchem.compound:34756>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank:DB00105>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:cb386ea42baf8766a3e98e9d24d46516>	<http://purl.org/dc/terms/title>	"Organic transition metal salt"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Formula> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Isoelectric-Point> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-16>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00093-16"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-17>	<http://bio2rdf.org/drugbank_vocabulary:value>	"InChIKey=HNDVDQJCIGZPNO-YFKPBYRVSA-N"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00109>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:913e4e077c76fcc7c941f5fbedf4db30>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"913e4e077c76fcc7c941f5fbedf4db30"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Weight> .
<http://bio2rdf.org/drugbank_resource:3549163466db2fa5b979545848c2ef00>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00107>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00088>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00088"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00100>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:4dcb2d242a80267002194ce81be5670e>	<http://purl.org/dc/terms/title>	"manufacturer for drugbank:DB00109"@en .
<http://bio2rdf.org/drugbank_resource:17055fe13e90f0599fe8f9fd1c90c871>	<http://www.w3.org/2000/01/rdf-schema#label>	"mechanism-of-action for drugbank:DB00095 [drugbank_resource:17055fe13e90f0599fe8f9fd1c90c871]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-2>	<http://purl.org/dc/terms/title>	"Isoelectric Point: 7.41"@en .
<http://bio2rdf.org/drugbank_resource:451abb4a53a3d4bc5e17cc485a3899b3>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:93c392ef94d70fc29c467d485b49f786> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-25>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-25"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00099>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Formula> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Isoelectric-Point> .
<http://bio2rdf.org/drugbank_resource:17b27330dfdb2b245beadb493e911ddb>	<http://purl.org/dc/terms/title>	"indication for drugbank:DB00114"@en .
<http://bio2rdf.org/pubchem.compound:1051>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/pharmgkb_resource:bio2rdf.dataset.pharmgkb.R3> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00103>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2af3e19f02b1eb81db93222ed2b38a44>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:2af3e19f02b1eb81db93222ed2b38a44"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Weight> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00102>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-15>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00117-15"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2c808757b9d5f22f13a70bae1f9e7737>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"2c808757b9d5f22f13a70bae1f9e7737"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00106-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-23>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-23"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8c59273d79bb6ce81fe2a4c0596fa577>	<http://www.w3.org/2000/01/rdf-schema#label>	"Vinylogous amide [drugbank_resource:8c59273d79bb6ce81fe2a4c0596fa577]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00106-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:gene-sequence>	">1473 bp\nATGGATTCTCTTGTGGTCCTTGTGCTCTGTCTCTCATGTTTGCTTCTCCTTTCACTCTGG\nAGACAGAGCTCTGGGAGAGGAAAACTCCCTCCTGGCCCCACTCCTCTCCCAGTGATTGGA\nAATATCCTACAGATAGGTATTAAGGACATCAGCAAATCCTTAACCAATCTCTCAAAGGTC\nTATGGCCCTGTGTTCACTCTGTATTTTGGCCTGAAACCCATAGTGGTGCTGCATGGATAT\nGAAGCAGTGAAGGAAGCCCTGATTGATCTTGGAGAGGAGTTTTCTGGAAGAGGCATTTTC\nCCACTGGCTGAAAGAGCTAACAGAGGATTTGGAATTGTTTTCAGCAATGGAAAGAAATGG\nAAGGAGATCCGGCGTTTCTCCCTCATGACGCTGCGGAATTTTGGGATGGGGAAGAGGAGC\nATTGAGGACCGTGTTCAAGAGGAAGCCCGCTGCCTTGTGGAGGAGTTGAGAAAAACCAAG\nGCCTCACCCTGTGATCCCACTTTCATCCTGGGCTGTGCTCCCTGCAATGTGATCTGCTCC\nATTATTTTCCATAAACGTTTTGATTATAAAGATCAGCAATTTCTTAACTTAATGGAAAAG\nTTGAATGAAAACATCAAGATTTTGAGCAGCCCCTGGATCCAGATCTGCAATAATTTTTCT\nCCTATCATTGATTACTTCCCGGGAACTCACAACAAATTACTTAAAAACGTTGCTTTTATG\nAAAAGTTATATTTTGGAAAAAGTAAAAGAACACCAAGAATCAATGGACATGAACAACCCT\nCAGGACTTTATTGATTGCTTCCTGATGAAAATGGAGAAGGAAAAGCACAACCAACCATCT\nGAATTTACTATTGAAAGCTTGGAAAACACTGCAGTTGACTTGTTTGGAGCTGGGACAGAG\nACGACAAGCACAACCCTGAGATATGCTCTCCTTCTCCTGCTGAAGCACCCAGAGGTCACA\nGCTAAAGTCCAGGAAGAGATTGAACGTGTGATTGGCAGAAACCGGAGCCCCTGCATGCAA\nGACAGGAGCCACATGCCCTACACAGATGCTGTGGTGCACGAGGTCCAGAGATACATTGAC\nCTTCTCCCCACCAGCCTGCCCCATGCAGTGACCTGTGACATTAAATTCAGAAACTATCTC\nATTCCCAAGGGCACAACCATATTAATTTCCCTGACTTCTGTGCTACATGACAACAAAGAA\nTTTCCCAACCCAGAGATGTTTGACCCTCATCACTTTCTGGATGAAGGTGGCAATTTTAAG\nAAAAGTAAATACTTCATGCCTTTCTCAGCAGGAAAACGGATTTGTGTGGGAGAAGCCCTG\nGCCGGCATGGAGCTGTTTTTATTCCTGACCTCCATTTTACAGAACTTTAACCTGAAATCT\nCTGGTTGACCCAAAGAACCTTGACACCACTCCAGTTGTCAATGGATTTGCCTCTGTGCCG\nCCCTTCTACCAGCTGTGCTTCATTCCTGTCTGA"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3314d6a38b90d6a9ef0419bc7224913d>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:5b282e6fa4562e2752afccabea3c29c1>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"5b282e6fa4562e2752afccabea3c29c1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-9>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00118-9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Isoelectric-Point> .
<http://bio2rdf.org/drugbank_resource:451abb4a53a3d4bc5e17cc485a3899b3>	<http://purl.org/dc/terms/title>	"480 ug/.8mL Injection, solution form with subcutaneous route"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-2>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Melting-Point> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00111>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:4f9f96147f2386295de420eed7aa9274>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:4f9f96147f2386295de420eed7aa9274"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fba31fe582cac619f85335c144278e17>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:4880c0f12c06dd6d142e7a40b041bf1a> .
<http://bio2rdf.org/drugbank_resource:5b47883807d5fa7a5b0b5ce2dc6e7939>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:93c392ef94d70fc29c467d485b49f786> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00762>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:DB00112_DB00762"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00110>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00106-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Formula> .
<http://bio2rdf.org/drugbank_resource:328c87b1ad60e7356c52d11e15011e6f>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-4>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00113>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00106-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Weight> .
<http://bio2rdf.org/drugbank_resource:7aa53fec8bf96c3555379e2680167034>	<http://purl.org/dc/terms/title>	"half-life for drugbank:DB00100"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-14>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-14"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00112>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Formula> .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"(S)-limonene 6-monooxygenase"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:036d7e3cfbf77c5f19b4baba9ff7aed2>	<http://purl.org/dc/terms/title>	"Aryl-aldehydes"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Weight> .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/drugbank_vocabulary:organism>	"Human"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0000300>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/BE0000300> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-10>	<http://purl.org/dc/terms/title>	"SMILES: NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Formula> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Isoelectric-Point> .
<http://bio2rdf.org/drugbank_resource:31af673f5d82841086059243563cd4c6>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"(S)-limonene 6-monooxygenase"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00116"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Weight> .
<http://bio2rdf.org/drugbank_resource:3181b99b434a8db59d197070956de3d9>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:20aa32f603258f15ceef0ba521a5bd87>	<http://www.w3.org/2000/01/rdf-schema#label>	"mechanism-of-action for drugbank:DB00096 [drugbank_resource:20aa32f603258f15ceef0ba521a5bd87]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00110-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-21>	<http://bio2rdf.org/drugbank_vocabulary:value>	"3.58"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-3>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00092-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:d56193a54171cd8858918adbb1b34e8c>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"d56193a54171cd8858918adbb1b34e8c"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:x-hgnc>	<http://bio2rdf.org/hgnc:2640> .
<http://bio2rdf.org/drugbank:BE0003533>	<http://bio2rdf.org/drugbank_vocabulary:organism>	"Human"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:64789d808f73ebe8eac3dbded4a95da0>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-28>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00114-28"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Weight> .
<http://bio2rdf.org/drugbank_resource:1059233feb371b14b03a21571fa19968>	<http://purl.org/dc/terms/description>	"Binds selectively to cell-surface carcinoembryonic antigen (CEA) expressed on colorectal tumors."@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:organism>	"Human"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-25>	<http://www.w3.org/2000/01/rdf-schema#label>	"Number of Rings: 1 from ChemAxon [drugbank_resource:calculated-properties-DB00114-25]"@en .
<http://bio2rdf.org/drugbank:BE0000456>	<http://bio2rdf.org/drugbank_vocabulary:x-genatlas>	<http://bio2rdf.org/genatlas:MMAB> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Isoelectric-Point> .
<http://bio2rdf.org/drugbank_resource:3f54718d1deb0dbafe47e6e45eda5914>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:7237727df18936550876a7cb89a0aa86> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-5>	<http://bio2rdf.org/drugbank_vocabulary:value>	"C6332H9808N1678O1989S42"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-22>	<http://bio2rdf.org/drugbank_vocabulary:value>	"1.94"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:df42fd14b400446e8cc7e69facd62cba>	<http://purl.org/dc/terms/title>	"Dicarboxylic acid or derivatives"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"electron transport"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ffc8ae70d9900ffb750da168c0f58cc5>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-11>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00115-11"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Melting-Point> .
<http://bio2rdf.org/drugbank_resource:03746a740bf18cbf4beaae7cc5b7504f>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:03746a740bf18cbf4beaae7cc5b7504f"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ffa1ac4af9ac617e01349d78fdc482f1>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00095-1>	<http://www.w3.org/2000/01/rdf-schema#label>	"Melting Point: 61 \u00B0C (FAB fragment), 71 \u00B0C (whole mAb) from Vermeer, A.W.P. & Norde, W., Biophys. J. 78:394-404 (2000) [drugbank_resource:experimental-properties-DB00095-1]"@en .
<http://bio2rdf.org/drugbank_resource:30d0083606d3fa4b4b602b5d3ed0feda>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00110-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Melting-Point> .
<http://bio2rdf.org/drugbank_resource:14e62611474f52c8e22248963b84f59b>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"14e62611474f52c8e22248963b84f59b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-1>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fffcf97ccb1aeb21dae91caa501b8255>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:0f798f4d70ca79c6d20f50856c6d9d11>	<http://purl.org/dc/terms/title>	"Dialkyl phosphates"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Formula> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:ffe7ffbc4b8e341c6b137f185bb434e0>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:68664b41f20b902d0fcad004203c7cc8>	<http://purl.org/dc/terms/title>	"Hippuric acid"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00112-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Melting-Point> .
<http://bio2rdf.org/drugbank_resource:ff5b4bb2ae4fdc7811f87fd38c8b8eda>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-14>	<http://bio2rdf.org/drugbank_vocabulary:value>	"1.84"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00113-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Hydrophobicity> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Formula> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Isoelectric-Point> .
<http://bio2rdf.org/drugbank_resource:2ec24002f6e3cb0430a51468ee1d26da>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:6826daa495527ec54b81079e04e89d24>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00111-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Weight> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00109-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:2ddeeca2fe9449969ab1519d768237c6>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fe2051219bbed1c3f26d756ec49dea95>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2d76fb5dd0f39b41fe92dc87dd6a96d9>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-1>	<http://www.w3.org/2000/01/rdf-schema#label>	"Melting Point: 60 \u00B0C from Luo, P., Protein Science 11:1218-1226 (2002) [drugbank_resource:experimental-properties-DB00099-1]"@en .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"electron transport"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fe02b6034f5c4d73f73a58815355abf5>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-3>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00091-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:24189bc5fb16bfce4551ecdfb0196def>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"24189bc5fb16bfce4551ecdfb0196def"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003533>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"electron transport"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-24>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00116-24"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-21>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00115-21"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2df9c46833999f4cf9a8383d1003158e>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-16>	<http://www.w3.org/2000/01/rdf-schema#label>	"Polarizability: 103.93 from ChemAxon [drugbank_resource:calculated-properties-DB00093-16]"@en .
<http://bio2rdf.org/drugbank_resource:2c7d5048f3ab623475c1e9c503997a85>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:408e99a507da89ecb16b006481be4f7d>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"408e99a507da89ecb16b006481be4f7d"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-5>	<http://bio2rdf.org/drugbank_vocabulary:value>	"-5.3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:57ad8968da7ad0cb58cba7e058039db9>	<http://www.w3.org/2000/01/rdf-schema#label>	"Organotransition metal compounds [drugbank_resource:57ad8968da7ad0cb58cba7e058039db9]"@en .
<http://bio2rdf.org/drugbank_resource:2d6f2db0443dc24ac01149b8df7afb05>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-20>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-20"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fdb8e90f512977b9fb2141486454a079>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:be8afc258733f250df3262d94e93265b>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:be8afc258733f250df3262d94e93265b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2c808757b9d5f22f13a70bae1f9e7737>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fdb0a3b06aac9bbd85eeda7b1daf8545>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:go-process>	"electron transport"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00088>	<http://purl.org/dc/terms/title>	"Alglucerase"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-12>	<http://purl.org/dc/terms/title>	"InChI: InChI=1S/C62H90N13O14P.CN.Co/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;1-2;/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H15,63,64,65,66,67,68,69,71,72,73,74,77,78,79,80,81,82,83,85,86);;/q;;+1/p-1/t31-,34-,35-,36-,37+,41-,52-,53-,56-,57+,59-,60+,61+,62+;;/m1../s1 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-6>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00110_DB08879>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00110_DB08879"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fd9ee6482e9b1c5516cff7b904f27169>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Vasoconstrictor-Agents>	<http://www.w3.org/2000/01/rdf-schema#label>	"Vasoconstrictor Agents [drugbank_vocabulary:Vasoconstrictor-Agents]"@en .
<http://bio2rdf.org/drugbank_resource:fc61d172cba7ae19145ff846ca1f0aef>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f2977936270a493873be5432bb760ef7>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"1000 ug/mL"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8f7450a053d86ee89751c06a230561d0>	<http://www.w3.org/2000/01/rdf-schema#label>	"Phenylalkylamine [drugbank_resource:8f7450a053d86ee89751c06a230561d0]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-18>	<http://www.w3.org/2000/01/rdf-schema#label>	"Rotatable Bond Count: 15 from ChemAxon [drugbank_resource:calculated-properties-DB00091-18]"@en .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:x-gi>	<http://bio2rdf.org/gi:220149> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:x-gi>	<http://bio2rdf.org/gi:181346> .
<http://bio2rdf.org/drugbank_resource:b77ba88d4df43eb6dd239cb83101c022>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:b77ba88d4df43eb6dd239cb83101c022"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:x-hgnc>	<http://bio2rdf.org/hgnc:2622> .
<http://bio2rdf.org/drugbank_resource:ae52c40c7c1761e3027e159477756625>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"ae52c40c7c1761e3027e159477756625"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:x-gi>	<http://bio2rdf.org/gi:181350> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:x-hgnc>	<http://bio2rdf.org/hgnc:2638> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-10>	<http://www.w3.org/2000/01/rdf-schema#label>	"SMILES: NC1=NC(=O)C2=C(NCC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2)N1 from ChemAxon [drugbank_resource:calculated-properties-DB00116-10]"@en .
<http://bio2rdf.org/drugbank_resource:70f28c5b4aa0741b1c2d0997a89319ea>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:5888181b550399d2a84e1e4db3715340>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:5888181b550399d2a84e1e4db3715340"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"P450-HFLA"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:70d5905dbbb671a2bf66275527b38e09>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:aa64bf1510edae009ba1d31553912173>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"aa64bf1510edae009ba1d31553912173"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:x-hgnc>	<http://bio2rdf.org/hgnc:2625> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-22>	<http://www.w3.org/2000/01/rdf-schema#label>	"Physiological Charge: 2 from ChemAxon [drugbank_resource:calculated-properties-DB00093-22]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-30>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00117-30"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-3>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-3>	<http://bio2rdf.org/drugbank_vocabulary:value>	"5.2"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank:BE0003533>	<http://bio2rdf.org/drugbank_vocabulary:specific-function>	"Metabolizes several precarcinogens, drugs, and solvents to reactive metabolites. Inactivates a number of drugs and xenobiotics and also bioactivates many xenobiotic substrates to their hepatotoxic or carcinogenic forms"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:6f3fc4bb7965f22f3fc655ec5e1faab0>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:BE0003612"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fba31fe582cac619f85335c144278e17>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:14e62611474f52c8e22248963b84f59b>	<http://www.w3.org/2000/01/rdf-schema#label>	"manufacturer for drugbank:DB00112 [drugbank_resource:14e62611474f52c8e22248963b84f59b]"@en .
<http://bio2rdf.org/drugbank_resource:fb96fa5c000dbd94c78671b5c79ff32b>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-2>	<http://purl.org/dc/terms/title>	"logP: -0.96 from ALOGPS"@en .
<http://bio2rdf.org/drugbank_resource:6d66b6aba13ddd36f6f9c8c32bc1927d>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Dietary-Supplements>	<http://purl.org/dc/terms/title>	"Dietary Supplements"@en .
<http://bio2rdf.org/drugbank:DB00091>	<http://purl.org/dc/terms/description>	"A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. Cyclosporine is produced as a metabolite by the fungus species Cordyceps militaris. (From Martindale, The Extra Pharmacopoeia, 30th ed)."@en .
<http://bio2rdf.org/drugbank_resource:29ad2163821ce9d547ef52b7bddcf404>	<http://purl.org/dc/terms/title>	"half-life for drugbank:DB00090"@en .
<http://bio2rdf.org/drugbank_vocabulary:Enzyme-Inhibitors>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"Enzyme-Inhibitors"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fa9ea24c47c4cc6ec20e42b245e43401>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:585c665fefee46ff4931f369bfe6004a>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:585c665fefee46ff4931f369bfe6004a"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fa8e5850916f505d7329bb36ce55c161>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:x-genecards>	<http://bio2rdf.org/genecards:PREP> .
<http://bio2rdf.org/drugbank_vocabulary:Gonadotropins>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"Gonadotropins"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:55842b12e140e13ee25b3a59430d097e>	<http://purl.org/dc/terms/description>	"Bioavailability after IM administration is 63%."@en .
<http://bio2rdf.org/drugbank_resource:20aa32f603258f15ceef0ba521a5bd87>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:20aa32f603258f15ceef0ba521a5bd87"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:0e7611deb0124f99ac54f3684b112d25>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:0e7611deb0124f99ac54f3684b112d25"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:6d460a13d1af93268984ab262cef479d>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00111>	<http://purl.org/dc/terms/title>	"Daclizumab"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-27>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00093-27"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a8454a4c3a73e4a65b3965d9947cc4bd>	<http://purl.org/dc/terms/title>	"100 mg Powder for solution form with intramuscular route"@en .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00220>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00109_DB00220"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f84c0f373fd98f4297607f206aadd302>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:85745be17d6c5d398a5d3540508f1a44>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:85745be17d6c5d398a5d3540508f1a44"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Antifungal-Agents>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:Antifungal-Agents"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:81987a5783579e8eae4261b8d95226da>	<http://purl.org/dc/terms/description>	"Enfuvirtide is an antiretroviral drug used in combination therapy for the treatment of HIV-1/AIDS."@en .
<http://bio2rdf.org/drugbank_resource:6be4db795caa5a4f0e9b208f115d277b>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-12>	<http://purl.org/dc/terms/title>	"Molecular Formula: C62H111N11O12 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:195ccf935d3c9947bcc17b096fdca329>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:195ccf935d3c9947bcc17b096fdca329"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2d76fb5dd0f39b41fe92dc87dd6a96d9>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:2d76fb5dd0f39b41fe92dc87dd6a96d9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/chemspider:82572>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/chemspider/82572> .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/drugbank_vocabulary:cellular-location>	"Endoplasmic reticulum membrane"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/chemspider:6038>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/chemspider/6038> .
<http://bio2rdf.org/drugbank_resource:6ac630c499c16fd6e1f2a125e397688a>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003533>	<http://bio2rdf.org/drugbank_vocabulary:cellular-location>	"Endoplasmic reticulum membrane"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-17>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-17"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:43ebb1f4d3ddbd9ec70fcbba40c42a45>	<http://purl.org/dc/terms/title>	"Imidazolyl carboxylic acids and derivatives"@en .
<http://bio2rdf.org/drugbank_resource:f7f0a15346b2f02764550cb8d9f8ef30>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00103_DB00608>	<http://www.w3.org/2000/01/rdf-schema#label>	"DDI between Agalsidase beta and Chloroquine - May diminish the therapeutic effect of Agalsidase Beta. [drugbank_resource:DB00103_DB00608]"@en .
<http://bio2rdf.org/drugbank:DB00112>	<http://purl.org/dc/terms/identifier>	"drugbank:DB00112"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fc61d172cba7ae19145ff846ca1f0aef>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"fc61d172cba7ae19145ff846ca1f0aef"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00117-5>	<http://www.w3.org/2000/01/rdf-schema#label>	"pKa: 2.76 (at 0 \u00B0C) from KORTUM,G ET AL (1961) [drugbank_resource:experimental-properties-DB00117-5]"@en .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-8>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-4>	<http://www.w3.org/2000/01/rdf-schema#label>	"logS: -4.5 from ALOGPS [drugbank_resource:calculated-properties-DB00115-4]"@en .
<http://bio2rdf.org/drugbank_vocabulary:Anti-Testosterone-Agents>	<http://purl.org/dc/terms/title>	"Anti-Testosterone Agents"@en .
<http://bio2rdf.org/drugbank_resource:c0c3695e2cc0b1f8b2708aa4329a566e>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:c0c3695e2cc0b1f8b2708aa4329a566e"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-7>	<http://bio2rdf.org/drugbank_vocabulary:value>	"-2.1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/chemspider:4575342>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/chemspider/4575342> .
<http://bio2rdf.org/drugbank_resource:684d8812e411c70454900dc745e593c8>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:fa632501828d57a2c1fda712393a3927> .
<http://bio2rdf.org/drugbank_resource:a2615bbb5710b9b992785e63c058b3db>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:a2615bbb5710b9b992785e63c058b3db"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f5f75e6bf165e0a25b8c2fab60ccf2e0>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://www.w3.org/2000/01/rdf-schema#label>	"Cytochrome P450 3A5 [drugbank:BE0002362]"@en .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00503>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:DB00109_DB00503"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:67b3d3945732c5188334e7f955ca6288>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:47d86c7cb8687c843b27225a6715c3c1>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"47d86c7cb8687c843b27225a6715c3c1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-8>	<http://purl.org/dc/terms/title>	"Water Solubility: 6.20e+01 g/l from ALOGPS"@en .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:68664b41f20b902d0fcad004203c7cc8>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c987b0d07b89f29a364501bc29cfebc8>	<http://purl.org/dc/terms/title>	"Aminopyrimidines and derivatives"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-24>	<http://purl.org/dc/terms/title>	"pKa (strongest acidic): 1.85 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:684d8812e411c70454900dc745e593c8>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:85745be17d6c5d398a5d3540508f1a44>	<http://www.w3.org/2000/01/rdf-schema#label>	"Methylpyridine [drugbank_resource:85745be17d6c5d398a5d3540508f1a44]"@en .
<http://bio2rdf.org/drugbank_resource:893efa195cf56cf85e98a5c5f0867045>	<http://purl.org/dc/terms/title>	"clearance for drugbank:DB00112"@en .
<http://bio2rdf.org/chemspider:31983>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/chemspider/31983> .
<http://bio2rdf.org/drugbank_resource:f38592452c305d31bbbb2909013724ac>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002793>	<http://purl.org/dc/terms/title>	"Cytochrome P450 2C9"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-4>	<http://bio2rdf.org/drugbank_vocabulary:value>	"C2306H3594N610O694S26"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8f7450a053d86ee89751c06a230561d0>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"8f7450a053d86ee89751c06a230561d0"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Nutraceutical>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:Nutraceutical"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:6621165671a52f286c0f04fbfcf81106>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Angiogenesis-Inhibitors>	<http://purl.org/dc/terms/title>	"Angiogenesis Inhibitors"@en .
<http://bio2rdf.org/drugbank_resource:f31c373ea0d5f6b6f514f58cf30652a6>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:0f798f4d70ca79c6d20f50856c6d9d11>	<http://www.w3.org/2000/01/rdf-schema#label>	"Dialkyl phosphates [drugbank_resource:0f798f4d70ca79c6d20f50856c6d9d11]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-5>	<http://bio2rdf.org/drugbank_vocabulary:value>	"C2936H4624N786O889S41"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-18>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-18"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-2>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:5b47883807d5fa7a5b0b5ce2dc6e7939>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:fa632501828d57a2c1fda712393a3927> .
<http://bio2rdf.org/drugbank_resource:f2a30f76a373192265e4b663c8339602>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:6205a409adf418d0390045ac349b481a>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:6205a409adf418d0390045ac349b481a"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:773530fb248596d00289b12dba48a0cc>	<http://purl.org/dc/terms/title>	"Monocarboxylic acids and derivatives"@en .
<http://bio2rdf.org/drugbank_vocabulary:Conditionally-Essential-Amino-Acids>	<http://www.w3.org/2000/01/rdf-schema#label>	"Conditionally Essential Amino Acids [drugbank_vocabulary:Conditionally-Essential-Amino-Acids]"@en .
<http://bio2rdf.org/drugbank_resource:f30bb36d9cf1cde63e806eb49b64d341>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:6d66b6aba13ddd36f6f9c8c32bc1927d>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:6d66b6aba13ddd36f6f9c8c32bc1927d"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fd9ee6482e9b1c5516cff7b904f27169>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"fd9ee6482e9b1c5516cff7b904f27169"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-1>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00090-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:684d8812e411c70454900dc745e593c8>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"480 ug/.8mL"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-23>	<http://www.w3.org/2000/01/rdf-schema#label>	"Number of Rings: 3 from ChemAxon [drugbank_resource:calculated-properties-DB00116-23]"@en .
<http://bio2rdf.org/drugbank_resource:64b9dc4a304f0bbee322be682a49f08b>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"64b9dc4a304f0bbee322be682a49f08b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a8454a4c3a73e4a65b3965d9947cc4bd>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:a8454a4c3a73e4a65b3965d9947cc4bd"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:64b9dc4a304f0bbee322be682a49f08b>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f2540530a3858d9fa40e7bfd96e4c77d>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:78c0a8b73fca87dcc5402f26970c94a4>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"78c0a8b73fca87dcc5402f26970c94a4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f31c373ea0d5f6b6f514f58cf30652a6>	<http://purl.org/dc/terms/description>	"Inhibits T-lymphocyte activation and production by binding to the CD2 lymphocyte antigen."@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-9>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:f2977936270a493873be5432bb760ef7>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"ion binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00110-1>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00110-1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:627446b31de3941cb82db7d08189b597>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e9f580ccd34b70a11720b2f316225025>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:e9f580ccd34b70a11720b2f316225025"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB00398>	<http://purl.org/dc/terms/title>	"DDI between Bevacizumab and Sorafenib - Bevacizumab may enhance the adverse/toxic effect of SORAfenib. Specifically, the risk for hand-foot skin reaction may be increased."@en .
<http://bio2rdf.org/drugbank:BE0002793>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"ion binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e39dd3e5ddfc2038fa77efd8d6d5305d>	<http://purl.org/dc/terms/description>	"S-Adenosylmethionine is absorbed from the small intestine following oral intake. As absorption is affected by food, it is best to take on an empty stomach. Bioavailability is low following oral intake."@en .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/drugbank_vocabulary:x-genbank>	<http://bio2rdf.org/genbank:X74496> .
<http://bio2rdf.org/drugbank_resource:e4e539077bcedbc155e950cadab01679>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:a57533055c136af9a471684ba442d058>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:a57533055c136af9a471684ba442d058"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e52e95d4f4c438c7fbf93397e39c26e3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"ion binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2d6f2db0443dc24ac01149b8df7afb05>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:548bb431406ebb2d5ba9dd380ede692a> .
<http://bio2rdf.org/drugbank_resource:6215bb81f14ea29a233fa4efbf660bf9>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e147a45842193f4b54cd46908fed6204>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:6205a409adf418d0390045ac349b481a>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8bb9fceb6f80460936af862e9f7d1d94>	<http://www.w3.org/2000/01/rdf-schema#label>	"Pyridoxal [drugbank_resource:8bb9fceb6f80460936af862e9f7d1d94]"@en .
<http://bio2rdf.org/drugbank:BE0003533>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"ion binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pubchem.substance:46507001>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/pubchem.substance:46507001"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-17>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00118-17"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:6621165671a52f286c0f04fbfcf81106>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:bee4f78f9cba3b09abdc595ab87f170e> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-8>	<http://www.w3.org/2000/01/rdf-schema#label>	"Molecular Weight: 1356.3731 from ChemAxon [drugbank_resource:calculated-properties-DB00115-8]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-21>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-21"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e650b92d5679a4bc966570691fe2d7e4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:Enzyme-Inhibitors>	<http://purl.org/dc/terms/title>	"Enzyme Inhibitors"@en .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:general-function>	"Involved in monooxygenase activity"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-12>	<http://bio2rdf.org/drugbank_vocabulary:value>	"InChI=1/C46H65N13O11S2/c47-18-8-7-14-29(40(64)52-23-38(51)62)54-45(69)35-15-9-19-59(35)46(70)34-25-72-71-24-28(48)39(63)55-31(20-26-10-3-1-4-11-26)43(67)56-32(21-27-12-5-2-6-13-27)42(66)53-30(16-17-36(49)60)41(65)57-33(22-37(50)61)44(68)58-34/h1-6,10-13,28-35H,7-9,14-25,47-48H2,(H2,49,60)(H2,50,61)(H2,51,62)(H,52,64)(H,53,66)(H,54,69)(H,55,63)(H,56,67)(H,57,65)(H,58,68)/t28-,29-,30-,31-,32-,33-,34-,35-/s2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:de11407327a5468776fbcbec28a97ca0>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:e4e539077bcedbc155e950cadab01679>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Mechanism-of-action> .
<http://bio2rdf.org/drugbank_resource:DB00115_DB01394>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:DB00115_DB01394"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e52e95d4f4c438c7fbf93397e39c26e3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Mechanism-of-action> .
<http://bio2rdf.org/drugbank_resource:051943c0db4f9d17f7dfc49f7bb4329a>	<http://www.w3.org/2000/01/rdf-schema#label>	"Cyclic peptoid/peptide [drugbank_resource:051943c0db4f9d17f7dfc49f7bb4329a]"@en .
<http://bio2rdf.org/drugbank_resource:dedcaba12fd68e71a4930ea18843aa61>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:e340b19fed6c2eaebccc1a4c652c8eb5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-18>	<http://purl.org/dc/terms/title>	"Polar Surface Area (PSA): 92 from ChemAxon"@en .
<http://bio2rdf.org/drugbank:DB00107>	<http://purl.org/dc/terms/identifier>	"drugbank:DB00107"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:df42fd14b400446e8cc7e69facd62cba>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank:DB00106>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:DB00106"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:00199edd2aba5de431eaa55bda5406d7>	<http://www.w3.org/2000/01/rdf-schema#label>	"mechanism-of-action for drugbank:DB00105 [drugbank_resource:00199edd2aba5de431eaa55bda5406d7]"@en .
<http://bio2rdf.org/drugbank_resource:e39dd3e5ddfc2038fa77efd8d6d5305d>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-14>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00115-14"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-9>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00116-9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e04ee332a67fe1dea4752f0a68c0a6ee>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"CYPIIC17"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:5eace972d6db7e2d3395f1ce1f56c40a>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:e6be3ee899ac0f450592b2c5985631de>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:e6be3ee899ac0f450592b2c5985631de"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:06832c77d22e34a13e2de6990e7f3cf2>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:06832c77d22e34a13e2de6990e7f3cf2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e02568426e5e3817cd6fcddc8dee4bee>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://www.w3.org/2000/01/rdf-schema#label>	"Prolyl endopeptidase [drugbank:BE0002148]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-21>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-21"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:8abd75317f3f7b8f7d56e3fe7d6204bd>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:8abd75317f3f7b8f7d56e3fe7d6204bd"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e91ecbd8702c2bd53755e648fa5c9435>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:1c54727b6a9a48b74b53723fbee43d80>	<http://purl.org/dc/terms/title>	"mechanism-of-action for drugbank:DB00091"@en .
<http://bio2rdf.org/drugbank_resource:5d2074ef1500127ada3cef721a746c89>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-14>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00115-14"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-14>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00114-14"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/drugbank_vocabulary:gene-name>	"CYP2C19"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3d51d314e6796004243d124d2c5f0793>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"3d51d314e6796004243d124d2c5f0793"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-13>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00118-13"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:HIV-Fusion-Inhibitors>	<http://purl.org/dc/terms/identifier>	"drugbank_vocabulary:HIV-Fusion-Inhibitors"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:06832c77d22e34a13e2de6990e7f3cf2>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:06832c77d22e34a13e2de6990e7f3cf2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e9ee4548d6d10b87a4a259470fe32c97>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:5c103a2b0c3fce1acc1c2e135c6684bf>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e9f580ccd34b70a11720b2f316225025>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:592de4a57c1d28519d666f4b36fa6b2b>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:592de4a57c1d28519d666f4b36fa6b2b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:5ba52774f54e88019dd4d17f32a34f7b>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-5>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-5"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:eb2ea139d16c3216009f5eb2eceb62c8>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:eb2ea139d16c3216009f5eb2eceb62c8"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:787ef58546dc52c80027a1e3a2b925b9>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"300 \u00B5g"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:be8afc258733f250df3262d94e93265b>	<http://purl.org/dc/terms/title>	"Pyridoxals and derivatives"@en .
<http://bio2rdf.org/drugbank_resource:3afc1cd15f9de2a07db0081098265ac4>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:548bb431406ebb2d5ba9dd380ede692a> .
<http://bio2rdf.org/drugbank_resource:53e4e7c3f9db35ed7e24a59c1546788c>	<http://purl.org/dc/terms/title>	"Cobalamin"@en .
<http://bio2rdf.org/drugbank_resource:ea9490984599c557a86db10a8e93e890>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:5ac86da3649163846e9e9d65b58c49fc>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a9a58af69a8539d913c65b788eb5b178>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:a9a58af69a8539d913c65b788eb5b178"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:bbf3cb3443969f24e50666e131185bd8>	<http://www.w3.org/2000/01/rdf-schema#label>	"Benzene and substituted derivatives [drugbank_resource:bbf3cb3443969f24e50666e131185bd8]"@en .
<http://bio2rdf.org/drugbank_resource:e9ee4548d6d10b87a4a259470fe32c97>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Manufacturer> .
<http://bio2rdf.org/drugbank_resource:3d51d314e6796004243d124d2c5f0793>	<http://bio2rdf.org/drugbank_vocabulary:route>	<http://bio2rdf.org/drugbank_vocabulary:251aa2c7f843f73a59fa2779ab4a885a> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-14>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00093-14"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00092>	<http://www.w3.org/2000/01/rdf-schema#label>	"Alefacept [drugbank:DB00092]"@en .
<http://bio2rdf.org/drugbank_resource:e6fa8c632405b98301de119a72894c49>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:da9625c635b6c208626fef4666f9f883>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:e91ecbd8702c2bd53755e648fa5c9435>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Manufacturer> .
<http://bio2rdf.org/drugbank_resource:5b47883807d5fa7a5b0b5ce2dc6e7939>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e6fc137e236497aea65dd3bb99d52e53>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-24>	<http://purl.org/dc/terms/title>	"Physiological Charge: -2 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:5b282e6fa4562e2752afccabea3c29c1>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002148>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:684d8812e411c70454900dc745e593c8>	<http://bio2rdf.org/drugbank_vocabulary:form>	<http://bio2rdf.org/drugbank_vocabulary:93c392ef94d70fc29c467d485b49f786> .
<http://bio2rdf.org/drugbank_resource:db3cf7df3e4a56b21665da45352819bc>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-4>	<http://purl.org/dc/terms/title>	"Molecular Formula: C2532H3854N672O711S16"@en .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"heme binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:db3cf7df3e4a56b21665da45352819bc>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:db3cf7df3e4a56b21665da45352819bc"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00096>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00096"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:da8dbfa1d167bdbfac5e83608be911ea>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Half-life> .
<http://bio2rdf.org/drugbank_resource:c51b5b3f72bf15f717f23f1fdda6fe44>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:c51b5b3f72bf15f717f23f1fdda6fe44"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-28>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00091-28"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e8fbddfaa9a4fe87d9328de7cf8cd326>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:e8fbddfaa9a4fe87d9328de7cf8cd326>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/drugbank_vocabulary:specific-function>	"Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It performs a variety of oxidation reactions (e.g. caffeine 8-oxidation, omeprazole sulphoxidation, midazolam 1'-hydroxylation and midazolam 4- hydroxylation) of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. The enzyme also hydroxylates etoposide"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:b86c00de25382c6ce4d94dae5e4502db>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"b86c00de25382c6ce4d94dae5e4502db"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-4>	<http://purl.org/dc/terms/title>	"Molecular Formula: C43H66N12O12S2"@en .
<http://bio2rdf.org/drugbank_resource:dc4a561c55d386ce9aa0ac35fa50583b>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:Anti-Testosterone-Agents>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:Anti-Testosterone-Agents"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"heme binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:amino-acid-sequence>	">Cytochrome P450 3A7\nMDLIPNLAVETWLLLAVSLILLYLYGTRTHGLFKKLGIPGPTPLPFLGNALSFRKGYWTF\nDMECYKKYRKVWGIYDCQQPMLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKNAISI\nAEDEEWKRIRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKHVFGAYS\nMDVITSTSFGVSIDSLNNPQDPFVENTKKLLRFNPLDPFVLSIKVFPFLTPILEALNITV\nFPRKVISFLTKSVKQIKEGRLKETQKHRVDFLQLMIDSQNSKDSETHKALSDLELMAQSI\nIFIFAGYETTSSVLSFIIYELATHPDVQQKVQKEIDTVLPNKAPPTYDTVLQLEYLDMVV\nNETLRLFPVAMRLERVCKKDVEINGMFIPKGVVVMIPSYVLHHDPKYWREPEKFLPERFS\nKKNKDNIDPYIYTPFGSGPRNCIGMRFALVNMKLALVRVLQNFSFKPCKETQIPLKLRFG\nGLLLTEKPIVLKAESRDETVSGA"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:58cc96ec8bd0d25f62dde9d4e4a829dd>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:80e4560d8a88ff69231ec21ee09506be>	<http://purl.org/dc/terms/title>	"This compound belongs to the class of organic compounds known as cobalamin derivatives. These are organic compounds containing a corrin ring, a cobalt atom, an a nucleotide moiety. Cobalamin Derivatives are actually derived from vitamin B12."@en .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"heme binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-11>	<http://bio2rdf.org/drugbank_vocabulary:value>	"C19H23N7O6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-4>	<http://purl.org/dc/terms/title>	"Molecular Weight: 18.8 kDa"@en .
<http://bio2rdf.org/drugbank_resource:07c2684a57210d1f5bc920d112d11ecd>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:07c2684a57210d1f5bc920d112d11ecd"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:592de4a57c1d28519d666f4b36fa6b2b>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:81ce8d1a0627bc88956132de1e1a93c2>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:81ce8d1a0627bc88956132de1e1a93c2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"heme binding"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-9>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00093-9"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0000300>	<http://bio2rdf.org/drugbank_vocabulary:x-genbank>	<http://bio2rdf.org/genbank:M34338> .
<http://bio2rdf.org/drugbank_resource:Citanest-Octapressin>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"Citanest-Octapressin"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e6fc137e236497aea65dd3bb99d52e53>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Dosage> .
<http://bio2rdf.org/pubchem.compound:91443>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"pubchem.compound"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pubchem.compound:91443>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/pubchem.compound:91443"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:Small-molecule>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:cb386ea42baf8766a3e98e9d24d46516>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"cb386ea42baf8766a3e98e9d24d46516"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:5888181b550399d2a84e1e4db3715340>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pubchem.compound:6274>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"pubchem.compound"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00103-2>	<http://purl.org/dc/terms/title>	"Isoelectric Point: 5.17"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-22>	<http://purl.org/dc/terms/title>	"Physiological Charge: 2 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:ea9490984599c557a86db10a8e93e890>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:6d66b6aba13ddd36f6f9c8c32bc1927d>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:6d66b6aba13ddd36f6f9c8c32bc1927d"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:da8dbfa1d167bdbfac5e83608be911ea>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:57db98e1612a44845256ccbbbc457ff8>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:da9625c635b6c208626fef4666f9f883>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:e6fa8c632405b98301de119a72894c49>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:Xylonest-Octapressin>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"Xylonest-Octapressin"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:dc4a561c55d386ce9aa0ac35fa50583b>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Manufacturer> .
<http://bio2rdf.org/drugbank_resource:e39dd3e5ddfc2038fa77efd8d6d5305d>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Absorption> .
<http://bio2rdf.org/drugbank_resource:585c665fefee46ff4931f369bfe6004a>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e9f580ccd34b70a11720b2f316225025>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Clearance> .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/drugbank_vocabulary:theoretical-pi>	"9.59"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/pubchem.compound:44176380>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"pubchem.compound"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:574e7d1136f355daec35f6fd17ef29e5>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:55f06b8fc86fce71f0db4c1832cfa819>	<http://www.w3.org/2000/01/rdf-schema#label>	"absorption for drugbank:DB00109 [drugbank_resource:55f06b8fc86fce71f0db4c1832cfa819]"@en .
<http://bio2rdf.org/pubchem.compound:34756>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"pubchem.compound"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:db3cf7df3e4a56b21665da45352819bc>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:a61e3adec088927f97197e2f1513790d>	<http://www.w3.org/2000/01/rdf-schema#label>	"50 mg Capsule, liquid filled form with oral route [drugbank_resource:a61e3adec088927f97197e2f1513790d]"@en .
<http://bio2rdf.org/drugbank_vocabulary:e6be3ee899ac0f450592b2c5985631de>	<http://purl.org/dc/terms/title>	"Zenapax"@en .
<http://bio2rdf.org/drugbank_resource:285048a510ce36e96744886cc83cc631>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:285048a510ce36e96744886cc83cc631"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-24>	<http://www.w3.org/2000/01/rdf-schema#label>	"pKa (strongest acidic): 1.85 from ChemAxon [drugbank_resource:calculated-properties-DB00117-24]"@en .
<http://bio2rdf.org/bindingdb:50271301>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"50271301"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:57ad8968da7ad0cb58cba7e058039db9>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-25>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00116-25"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-13>	<http://www.w3.org/2000/01/rdf-schema#label>	"InChIKey: InChIKey=MSTNYGQPCMXVAQ-KIYNQFGBSA-N from ChemAxon [drugbank_resource:calculated-properties-DB00116-13]"@en .
<http://bio2rdf.org/drugbank_resource:c3ea863492592dff31fb000b21cd1a19>	<http://www.w3.org/2000/01/rdf-schema#label>	"0.58 mg Solution form with intravenous route [drugbank_resource:c3ea863492592dff31fb000b21cd1a19]"@en .
<http://bio2rdf.org/drugbank:BE0002638>	<http://bio2rdf.org/drugbank_vocabulary:go-function>	"monooxygenase activity"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e04ee332a67fe1dea4752f0a68c0a6ee>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/pdb:PLP>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/pdb:PLP"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00115_DB01394>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00115_DB01394"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-3>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00107-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e147a45842193f4b54cd46908fed6204>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:ffc8ae70d9900ffb750da168c0f58cc5>	<http://www.w3.org/2000/01/rdf-schema#label>	"Thia fatty acids [drugbank_resource:ffc8ae70d9900ffb750da168c0f58cc5]"@en .
<http://bio2rdf.org/drugbank_resource:a57533055c136af9a471684ba442d058>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"a57533055c136af9a471684ba442d058"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-3>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:c78f5087e52c969400b9d748ae4a9485> .
<http://bio2rdf.org/drugbank_resource:55842b12e140e13ee25b3a59430d097e>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-4>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:c78f5087e52c969400b9d748ae4a9485> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-26>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-26"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:55694a43ccf43a29349054f94c2ce2e7>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:78c0a8b73fca87dcc5402f26970c94a4>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:78c0a8b73fca87dcc5402f26970c94a4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/pubchem.compound:1051>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"pubchem.compound"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0003533>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"P450-J"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c28ad3ee91a708824325b58f26c403a5>	<http://purl.org/dc/terms/title>	"Pterins and derivatives"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-5>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:c78f5087e52c969400b9d748ae4a9485> .
<http://bio2rdf.org/drugbank_resource:0e7611deb0124f99ac54f3684b112d25>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:0e7611deb0124f99ac54f3684b112d25"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:ffe7ffbc4b8e341c6b137f185bb434e0>	<http://www.w3.org/2000/01/rdf-schema#label>	"Oxacyclic compounds [drugbank_resource:ffe7ffbc4b8e341c6b137f185bb434e0]"@en .
<http://bio2rdf.org/drugbank_vocabulary:HIV-Fusion-Inhibitors>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_vocabulary:HIV-Fusion-Inhibitors"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:55f06b8fc86fce71f0db4c1832cfa819>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a2d4a403a964b1f3a6d6fa73cb73921a>	<http://www.w3.org/2000/01/rdf-schema#label>	"mechanism-of-action for drugbank:DB00102 [drugbank_resource:a2d4a403a964b1f3a6d6fa73cb73921a]"@en .
<http://bio2rdf.org/pubchem.compound:6274>	<http://rdfs.org/ns/void#inDataset>	<http://bio2rdf.org/kegg_resource:bio2rdf.dataset.kegg.R3> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00220>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:DB00109_DB00220"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e650b92d5679a4bc966570691fe2d7e4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:ae0431719c906d80aa97a27025adc99f>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:ae0431719c906d80aa97a27025adc99f"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:53e4e7c3f9db35ed7e24a59c1546788c>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:de11407327a5468776fbcbec28a97ca0>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:e340b19fed6c2eaebccc1a4c652c8eb5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Half-life> .
<http://bio2rdf.org/drugbank_resource:762a7c535540c35c3ec0a9932635da58>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:762a7c535540c35c3ec0a9932635da58"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/chemspider:31983>	<http://purl.org/dc/terms/identifier>	"chemspider:31983"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a61e3adec088927f97197e2f1513790d>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:a61e3adec088927f97197e2f1513790d"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:dedcaba12fd68e71a4930ea18843aa61>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:57db98e1612a44845256ccbbbc457ff8>	<http://www.w3.org/2000/01/rdf-schema#label>	"half-life for drugbank:DB00107 [drugbank_resource:57db98e1612a44845256ccbbbc457ff8]"@en .
<http://bio2rdf.org/drugbank_resource:5295f08395d80bb2a78d48e62dbf8c19>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-26>	<http://www.w3.org/2000/01/rdf-schema#label>	"Bioavailability: 1 from ChemAxon [drugbank_resource:calculated-properties-DB00114-26]"@en .
<http://bio2rdf.org/drugbank_resource:df42fd14b400446e8cc7e69facd62cba>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:225393798d1f4d7a00af1d777e454e22>	<http://purl.org/dc/terms/title>	"N-acyl-alpha-amino acid"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-4>	<http://purl.org/dc/terms/title>	"Molecular Weight: 66472.2000"@en .
<http://bio2rdf.org/drugbank:BE0003536>	<http://bio2rdf.org/drugbank_vocabulary:amino-acid-sequence>	">Cytochrome P450 2C19\nMDPFVVLVLCLSCLLLLSIWRQSSGRGKLPPGPTPLPVIGNILQIDIKDVSKSLTNLSKI\nYGPVFTLYFGLERMVVLHGYEVVKEALIDLGEEFSGRGHFPLAERANRGFGIVFSNGKRW\nKEIRRFSLMTLRNFGMGKRSIEDRVQEEARCLVEELRKTKASPCDPTFILGCAPCNVICS\nIIFQKRFDYKDQQFLNLMEKLNENIRIVSTPWIQICNNFPTIIDYFPGTHNKLLKNLAFM\nESDILEKVKEHQESMDINNPRDFIDCFLIKMEKEKQNQQSEFTIENLVITAADLLGAGTE\nTTSTTLRYALLLLLKHPEVTAKVQEEIERVVGRNRSPCMQDRGHMPYTDAVVHEVQRYID\nLIPTSLPHAVTCDVKFRNYLIPKGTTILTSLTSVLHDNKEFPNPEMFDPRHFLDEGGNFK\nKSNYFMPFSAGKRICVGEGLARMELFLFLTFILQNFNLKSLIDPKDLDTTPVVNGFASVP\nPFYQLCFIPV"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:0f3c814d30566a7614f1fab32f4e0302>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00107>	<http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in>	<http://bio2rdf.org/drugbank_resource:DB00107_DB00917> .
<http://bio2rdf.org/drugbank:DB00107>	<http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in>	<http://bio2rdf.org/drugbank_resource:DB00107_DB00929> .
<http://bio2rdf.org/drugbank_resource:e147a45842193f4b54cd46908fed6204>	<http://purl.org/dc/terms/title>	"D-alpha-amino acid"@en .
<http://bio2rdf.org/drugbank_resource:53ca67aedcd10f1c9afc4de0f2138502>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_resource"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00107>	<http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in>	<http://bio2rdf.org/drugbank_resource:DB00107_DB00429> .
<http://bio2rdf.org/drugbank:DB00107>	<http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in>	<http://bio2rdf.org/drugbank_resource:DB00107_DB00834> .
<http://bio2rdf.org/drugbank_resource:e02568426e5e3817cd6fcddc8dee4bee>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-25>	<http://purl.org/dc/terms/title>	"Number of Rings: 1 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Formula> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Isoelectric-Point> .
<http://bio2rdf.org/drugbank_resource:5d2074ef1500127ada3cef721a746c89>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:5d2074ef1500127ada3cef721a746c89"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0000300>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:069ab916580192548ff172f164a424bf>	<http://purl.org/dc/terms/description>	"Absorbed from the small intestine via an active transport mechanism requiring the presence of sodium."@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Weight> .
<http://bio2rdf.org/drugbank_resource:fdb0a3b06aac9bbd85eeda7b1daf8545>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"25 mg"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:2c7d5048f3ab623475c1e9c503997a85>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:2c7d5048f3ab623475c1e9c503997a85"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:122193da65e00a63d46700928a244018>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00095-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:DB00115_DB00446>	<http://purl.org/dc/terms/title>	"DDI between Cyanocobalamin and Chloramphenicol - May diminish the therapeutic effect of Vitamin B12."@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Hydrophobicity> .
<http://bio2rdf.org/drugbank_resource:282d8423d2c45b369fa817ef1edbccd5>	<http://www.w3.org/2000/01/rdf-schema#label>	"Substituted aniline [drugbank_resource:282d8423d2c45b369fa817ef1edbccd5]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-3>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:ab9182be757cbb637b820f0951931ae2>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-2>	<http://bio2rdf.org/drugbank_vocabulary:source>	<http://bio2rdf.org/drugbank_resource:c78f5087e52c969400b9d748ae4a9485> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00107-4>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00107-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:abd3e42d8c67111954c278994aa4591d>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:9e10be5c3dafcd8441cdeb69f72cc3f4>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:9e10be5c3dafcd8441cdeb69f72cc3f4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Isoelectric-Point> .
<http://bio2rdf.org/drugbank_resource:57db98e1612a44845256ccbbbc457ff8>	<http://purl.org/dc/terms/description>	"1-6 min, this is decreased in late pregnancy and during lactation."@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Melting-Point> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-2>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00102-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:a2615bbb5710b9b992785e63c058b3db>	<http://www.w3.org/2000/01/rdf-schema#label>	"480 ug/1.6mL Injection, solution form with intravenous; subcutaneous route [drugbank_resource:a2615bbb5710b9b992785e63c058b3db]"@en .
<http://bio2rdf.org/drugbank:DB00103>	<http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in>	<http://bio2rdf.org/drugbank_resource:DB00103_DB00608> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-22>	<http://purl.org/dc/terms/title>	"Physiological Charge: -2 from ChemAxon"@en .
<http://bio2rdf.org/drugbank:DB00103>	<http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in>	<http://bio2rdf.org/drugbank_resource:DB00103_DB01118> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00093-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Melting-Point> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:5c103a2b0c3fce1acc1c2e135c6684bf>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:5c103a2b0c3fce1acc1c2e135c6684bf"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Melting-Point> .
<http://bio2rdf.org/drugbank:DB00117>	<http://www.w3.org/2000/01/rdf-schema#label>	"L-Histidine [drugbank:DB00117]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:efd9b57513efb0eb6e90f59807e0e8d9>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank:DB00099>	<http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in>	<http://bio2rdf.org/drugbank_resource:DB00099_DB01030> .
<http://bio2rdf.org/drugbank_resource:5888181b550399d2a84e1e4db3715340>	<http://www.w3.org/2000/01/rdf-schema#label>	"Imidazolyl carboxylic acid derivative [drugbank_resource:5888181b550399d2a84e1e4db3715340]"@en .
<http://bio2rdf.org/drugbank:DB00099>	<http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in>	<http://bio2rdf.org/drugbank_resource:DB00099_DB00290> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00095-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Melting-Point> .
<http://bio2rdf.org/drugbank_resource:7767fecbc1fcbba1764734e284afdd13>	<http://www.w3.org/2000/01/rdf-schema#label>	"clearance for drugbank:DB00097 [drugbank_resource:7767fecbc1fcbba1764734e284afdd13]"@en .
<http://bio2rdf.org/drugbank:DB00099>	<http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in>	<http://bio2rdf.org/drugbank_resource:DB00099_DB00531> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:ec0915fa5d5da881fd812adc490bcd65>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Absorption> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Formula> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Hydrophobicity> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Weight> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-9>	<http://www.w3.org/2000/01/rdf-schema#label>	"Monoisotopic Weight: 445.170981503 from ChemAxon [drugbank_resource:calculated-properties-DB00116-9]"@en .
<http://bio2rdf.org/drugbank_resource:b77ba88d4df43eb6dd239cb83101c022>	<http://www.w3.org/2000/01/rdf-schema#label>	"Pteridines and derivatives [drugbank_resource:b77ba88d4df43eb6dd239cb83101c022]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Isoelectric-Point> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-3>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:experimental-properties-DB00092-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Formula> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-13>	<http://www.w3.org/2000/01/rdf-schema#label>	"InChIKey: InChIKey=SFKQVVDKFKYTNA-YVGXZPIDNA-N from ChemAxon [drugbank_resource:calculated-properties-DB00093-13]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00093-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Weight> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:ffb414ea32db58bec7ec3339a42c9dee>	<http://www.w3.org/2000/01/rdf-schema#label>	"Profasi [drugbank_vocabulary:ffb414ea32db58bec7ec3339a42c9dee]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:0d47651b62c008d202fcec19e0c3b7c7>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:0d47651b62c008d202fcec19e0c3b7c7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00096>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:DB00096"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00091>	<http://purl.org/dc/terms/title>	"Cyclosporine"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-12>	<http://www.w3.org/2000/01/rdf-schema#label>	"InChI: InChI=1/C46H65N13O11S2/c47-18-8-7-14-29(40(64)52-23-38(51)62)54-45(69)35-15-9-19-59(35)46(70)34-25-72-71-24-28(48)39(63)55-31(20-26-10-3-1-4-11-26)43(67)56-32(21-27-12-5-2-6-13-27)42(66)53-30(16-17-36(49)60)41(65)57-33(22-37(50)61)44(68)58-34/h1-6,10-13,28-35H,7-9,14-25,47-48H2,(H2,49,60)(H2,50,61)(H2,51,62)(H,52,64)(H,53,66)(H,54,69)(H,55,63)(H,56,67)(H,57,65)(H,58,68)/t28-,29-,30-,31-,32-,33-,34-,35-/s2 from ChemAxon [drugbank_resource:calculated-properties-DB00093-12]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Weight> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-10>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00118-10"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:5ac86da3649163846e9e9d65b58c49fc>	<http://purl.org/dc/terms/title>	"Transition metal cyanide salts"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-15>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00115-15"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_vocabulary:aa64bf1510edae009ba1d31553912173>	<http://bio2rdf.org/bio2rdf_vocabulary:namespace>	"drugbank_vocabulary"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_vocabulary:ffb414ea32db58bec7ec3339a42c9dee>	<http://bio2rdf.org/drugbank_vocabulary:company>	"Serono S.A."^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-4>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00096-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB01264>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:DB00109_DB01264"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:3314d6a38b90d6a9ef0419bc7224913d>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"3314d6a38b90d6a9ef0419bc7224913d"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Isoelectric-Point> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00116-25>	<http://www.w3.org/2000/01/rdf-schema#label>	"Rule of Five: 0 from ChemAxon [drugbank_resource:calculated-properties-DB00116-25]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Melting-Point> .
<http://bio2rdf.org/drugbank_resource:2696048bf20ed0e2d578eb2938c6d8d3>	<http://purl.org/dc/terms/title>	"clearance for drugbank:DB00091"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00115-2>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00115-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/drugbank_vocabulary:name>	"Cytochrome P450 2D6"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Melting-Point> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-10>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00117-10"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0002363>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/BE0002363> .
<http://bio2rdf.org/drugbank_resource:c254aba7ca3db4f83cda45b27adb5b2b>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:c254aba7ca3db4f83cda45b27adb5b2b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2ec24002f6e3cb0430a51468ee1d26da>	<http://purl.org/dc/terms/title>	"Benzoic acid or derivatives"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0002887>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/BE0002887> .
<http://bio2rdf.org/drugbank_vocabulary:e328a6cf619c4105669d93dc30d36096>	<http://www.w3.org/2000/01/rdf-schema#label>	"Ceredase [drugbank_vocabulary:e328a6cf619c4105669d93dc30d36096]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Formula> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/BE0002362> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00115-2>	<http://purl.org/dc/terms/title>	"Melting Point: > 300 \u00B0C from PhysProp"@en .
<http://bio2rdf.org/drugbank_resource:ef0da8f521b780a50b08c455970978ac>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:b15aa7d1fbce9f1563623833e416d8f7>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:b15aa7d1fbce9f1563623833e416d8f7"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00109>	<http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in>	<http://bio2rdf.org/drugbank_resource:DB00109_DB00932> .
<http://bio2rdf.org/drugbank:DB00112>	<http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in>	<http://bio2rdf.org/drugbank_resource:DB00112_DB00398> .
<http://bio2rdf.org/drugbank:DB00112>	<http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in>	<http://bio2rdf.org/drugbank_resource:DB00112_DB00445> .
<http://bio2rdf.org/drugbank_resource:abc4b12d5153eba9af71c2c651bd4ff1>	<http://purl.org/dc/terms/description>	"The mean absolute bioavailability following a single subcutaneous injection to healthy female volunteers is about 40%."@en .
<http://bio2rdf.org/drugbank:DB00109>	<http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in>	<http://bio2rdf.org/drugbank_resource:DB00109_DB01072> .
<http://bio2rdf.org/drugbank:DB00109>	<http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in>	<http://bio2rdf.org/drugbank_resource:DB00109_DB00503> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Melting-Point> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-20>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00093-20"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:eb23978cb768321237553e12616e3b84>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:ad715d0a2b2bcdcad22b975675537588>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:ad715d0a2b2bcdcad22b975675537588"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00112>	<http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in>	<http://bio2rdf.org/drugbank_resource:DB00112_DB00363> .
<http://bio2rdf.org/drugbank:DB00109>	<http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in>	<http://bio2rdf.org/drugbank_resource:DB00109_DB00677> .
<http://bio2rdf.org/drugbank_vocabulary:64789d808f73ebe8eac3dbded4a95da0>	<http://bio2rdf.org/drugbank_vocabulary:company>	"Genentech Inc"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00091-2>	<http://www.w3.org/2000/01/rdf-schema#label>	"caco2 Permeability: -6.05 from ADME Research, USCD [drugbank_resource:experimental-properties-DB00091-2]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Formula> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Isoelectric-Point> .
<http://bio2rdf.org/drugbank:DB00109>	<http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in>	<http://bio2rdf.org/drugbank_resource:DB00109_DB00220> .
<http://bio2rdf.org/drugbank:DB00112>	<http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in>	<http://bio2rdf.org/drugbank_resource:DB00112_DB01177> .
<http://bio2rdf.org/drugbank_resource:684d8812e411c70454900dc745e593c8>	<http://purl.org/dc/terms/title>	"480 ug/.8mL Injection, solution form with intravenous route"@en .
<http://bio2rdf.org/drugbank:DB00112>	<http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in>	<http://bio2rdf.org/drugbank_resource:DB00112_DB01268> .
<http://bio2rdf.org/drugbank:DB00109>	<http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in>	<http://bio2rdf.org/drugbank_resource:DB00109_DB00224> .
<http://bio2rdf.org/drugbank:DB00112>	<http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in>	<http://bio2rdf.org/drugbank_resource:DB00112_DB00694> .
<http://bio2rdf.org/drugbank_vocabulary:705836a5549e0548d20a0ef04e009f28>	<http://purl.org/dc/terms/title>	"Syntocinon"@en .
<http://bio2rdf.org/drugbank:DB00112>	<http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in>	<http://bio2rdf.org/drugbank_resource:DB00112_DB00762> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:eb2ea139d16c3216009f5eb2eceb62c8>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Classification-Category> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Weight> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-21>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00115-21"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:bf1a15ece689c3f449c06ebc0a90dae3>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:bf1a15ece689c3f449c06ebc0a90dae3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Isoelectric-Point> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Formula> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB08879>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction> .
<http://bio2rdf.org/drugbank:DB00110>	<http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in>	<http://bio2rdf.org/drugbank_resource:DB00110_DB08879> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-5>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:3c77091e1ee2397a2767e73267a25af5>	<http://www.w3.org/2000/01/rdf-schema#label>	"Primary aromatic amines [drugbank_resource:3c77091e1ee2397a2767e73267a25af5]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Weight> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-13>	<http://purl.org/dc/terms/title>	"InChI: InChI=1/C62H111N11O12/c1-25-27-28-40(15)52(75)51-56(79)65-43(26-2)58(81)67(18)33-48(74)68(19)44(29-34(3)4)55(78)66-49(38(11)12)61(84)69(20)45(30-35(5)6)54(77)63-41(16)53(76)64-42(17)57(80)70(21)46(31-36(7)8)59(82)71(22)47(32-37(9)10)60(83)72(23)50(39(13)14)62(85)73(51)24/h25,27,34-47,49-52,75H,26,28-33H2,1-24H3,(H,63,77)(H,64,76)(H,65,79)(H,66,78)/b27-25+ from ChemAxon"@en .
<http://bio2rdf.org/drugbank_vocabulary:ab9182be757cbb637b820f0951931ae2>	<http://purl.org/dc/terms/title>	"Bedodeka"@en .
<http://bio2rdf.org/drugbank_resource:08f1295028a77909e61816add07f6343>	<http://www.w3.org/2000/01/rdf-schema#label>	"Pyrimidones [drugbank_resource:08f1295028a77909e61816add07f6343]"@en .
<http://bio2rdf.org/drugbank:DB00109>	<http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in>	<http://bio2rdf.org/drugbank_resource:DB00109_DB03880> .
<http://bio2rdf.org/drugbank_resource:20aa32f603258f15ceef0ba521a5bd87>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"20aa32f603258f15ceef0ba521a5bd87"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00109>	<http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in>	<http://bio2rdf.org/drugbank_resource:DB00109_DB06290> .
<http://bio2rdf.org/drugbank:DB00109>	<http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in>	<http://bio2rdf.org/drugbank_resource:DB00109_DB01319> .
<http://bio2rdf.org/drugbank_resource:Citanest-Octapressin>	<http://purl.org/dc/terms/title>	"Citanest Octapressin"@en .
<http://bio2rdf.org/drugbank:DB00109>	<http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in>	<http://bio2rdf.org/drugbank_resource:DB00109_DB01601> .
<http://bio2rdf.org/drugbank_resource:88491d7d06bc30fa9586740372808b10>	<http://purl.org/dc/terms/title>	"50 mg/.5mL Injection, solution form with intramuscular route"@en .
<http://bio2rdf.org/drugbank:DB00109>	<http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in>	<http://bio2rdf.org/drugbank_resource:DB00109_DB01232> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-2>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00118-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:DB00109_DB00677>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00109_DB00677"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00109>	<http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in>	<http://bio2rdf.org/drugbank_resource:DB00109_DB01264> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-19>	<http://www.w3.org/2000/01/rdf-schema#label>	"H Bond Acceptor Count: 16 from ChemAxon [drugbank_resource:calculated-properties-DB00091-19]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00091-21>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"calculated-properties-DB00091-21"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:84e1544b4af68672a960baf683724f87>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:84e1544b4af68672a960baf683724f87"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:synonym>	"HLp2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:19d3289105c9a843a041cb4f7a0883a1>	<http://www.w3.org/2000/01/rdf-schema#label>	"50 mg Powder for solution form with intramuscular route [drugbank_resource:19d3289105c9a843a041cb4f7a0883a1]"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-11>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-11"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00100-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Hydrophobicity> .
<http://bio2rdf.org/drugbank_vocabulary:Indicators-and-Reagents>	<http://purl.org/dc/terms/title>	"Indicators and Reagents"@en .
<http://bio2rdf.org/drugbank:DB00088>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank:DB00088"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:fa9ea24c47c4cc6ec20e42b245e43401>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:fa9ea24c47c4cc6ec20e42b245e43401"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:094779e1e90e423f19e46305ba872c9c>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:094779e1e90e423f19e46305ba872c9c"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:eda68d4a7955df0290c1f8b709e905ec>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:904bc2c9127fa8f18e0965559eecc60c>	<http://www.w3.org/2000/01/rdf-schema#label>	"25 mg Capsule, liquid filled form with oral route [drugbank_resource:904bc2c9127fa8f18e0965559eecc60c]"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00105-2>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00105-2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:39094d4a5017cb7945c3ca22e421306d>	<http://purl.org/dc/terms/title>	"Phosphoethanolamines"@en .
<http://bio2rdf.org/drugbank_resource:abc4b12d5153eba9af71c2c651bd4ff1>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:abc4b12d5153eba9af71c2c651bd4ff1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-1>	<http://purl.org/dc/terms/title>	"Hydrophobicity: -0.160"@en .
<http://bio2rdf.org/drugbank_resource:ef0da8f521b780a50b08c455970978ac>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:eb23978cb768321237553e12616e3b84>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:ffe7ffbc4b8e341c6b137f185bb434e0>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"ffe7ffbc4b8e341c6b137f185bb434e0"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Hydrophobicity> .
<http://bio2rdf.org/drugbank_resource:eda68d4a7955df0290c1f8b709e905ec>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Mechanism-of-action> .
<http://bio2rdf.org/drugbank_vocabulary:f6203f7c9646b21edf1fa81c5cdf94d1>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"f6203f7c9646b21edf1fa81c5cdf94d1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:85e4414ae6d2bc12695a4539100e286f>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:85e4414ae6d2bc12695a4539100e286f"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:eb2ea139d16c3216009f5eb2eceb62c8>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:c2dbd6b14df7875575496a70dff7a209>	<http://www.w3.org/2000/01/rdf-schema#label>	"Glycosyl compound [drugbank_resource:c2dbd6b14df7875575496a70dff7a209]"@en .
<http://bio2rdf.org/drugbank_resource:8399ac082eecc289dcd0ff6ce9ff3420>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:8399ac082eecc289dcd0ff6ce9ff3420"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-11>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00117-11"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:d56193a54171cd8858918adbb1b34e8c>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:d56193a54171cd8858918adbb1b34e8c"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:c254aba7ca3db4f83cda45b27adb5b2b>	<http://www.w3.org/2000/01/rdf-schema#label>	"Monosaccharide phosphates [drugbank_resource:c254aba7ca3db4f83cda45b27adb5b2b]"@en .
<http://bio2rdf.org/drugbank_resource:05261dbd457e9d2aa8254610c0f9df46>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:05261dbd457e9d2aa8254610c0f9df46"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:2af3e19f02b1eb81db93222ed2b38a44>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"2af3e19f02b1eb81db93222ed2b38a44"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:9ea94506ab138833cc18501d48712af4>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"9ea94506ab138833cc18501d48712af4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:986ea485795ab092b3199f449ca4056e>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:986ea485795ab092b3199f449ca4056e"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:e147a45842193f4b54cd46908fed6204>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:e147a45842193f4b54cd46908fed6204"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:DB00112_DB08879>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-13>	<http://purl.org/dc/terms/title>	"Molecular Formula: C8H10NO6P from ChemAxon"@en .
<http://bio2rdf.org/drugbank:BE0003612>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/BE0003612> .
<http://bio2rdf.org/drugbank_resource:ec0915fa5d5da881fd812adc490bcd65>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00097-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Hydrophobicity> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-13>	<http://www.w3.org/2000/01/rdf-schema#label>	"InChIKey: InChIKey=MEFKEPWMEQBLKI-AIRLBKTGSA-O from ChemAxon [drugbank_resource:calculated-properties-DB00118-13]"@en .
<http://bio2rdf.org/drugbank_resource:22baeb726de652a99f0ad2fb61fac832>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:22baeb726de652a99f0ad2fb61fac832"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:8399ac082eecc289dcd0ff6ce9ff3420> .
<http://bio2rdf.org/drugbank_resource:893efa195cf56cf85e98a5c5f0867045>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:893efa195cf56cf85e98a5c5f0867045"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00099-3>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:experimental-properties-DB00099-3"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:84e1544b4af68672a960baf683724f87> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-14>	<http://www.w3.org/2000/01/rdf-schema#label>	"Polar Surface Area (PSA): 182.63 from ChemAxon [drugbank_resource:calculated-properties-DB00118-14]"@en .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:8399ac082eecc289dcd0ff6ce9ff3420> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:85745be17d6c5d398a5d3540508f1a44> .
<http://bio2rdf.org/drugbank:DB00100>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"DB00100"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00089-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Hydrophobicity> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00102-3>	<http://purl.org/dc/terms/title>	"Molecular Weight: 12294.4000"@en .
<http://bio2rdf.org/drugbank_resource:fdb8e90f512977b9fb2141486454a079>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:fdb8e90f512977b9fb2141486454a079"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-19>	<http://purl.org/dc/terms/title>	"H Bond Donor Count: 12 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0002362>	<http://bio2rdf.org/drugbank_vocabulary:gene-sequence>	">1509 bp\nATGGACCTCATCCCAAATTTGGCGGTGGAAACCTGGCTTCTCCTGGCTGTCAGCCTGGTG\nCTCCTCTATCTATATGGGACCCGTACACATGGACTTTTTAAGAGACTGGGAATTCCAGGG\nCCCACACCTCTGCCTTTGTTGGGAAATGTTTTGTCCTATCGTCAGGGTCTCTGGAAATTT\nGACACAGAGTGCTATAAAAAGTATGGAAAAATGTGGGGAACGTATGAAGGTCAACTCCCT\nGTGCTGGCCATCACAGATCCCGACGTGATCAGAACAGTGCTAGTGAAAGAATGTTATTCT\nGTCTTCACAAATCGAAGGTCTTTAGGCCCAGTGGGATTTATGAAAAGTGCCATCTCTTTA\nGCTGAGGATGAAGAATGGAAGAGAATACGGTCATTGCTGTCTCCAACCTTCACCAGCGGA\nAAACTCAAGGAGATGTTCCCCATCATTGCCCAGTATGGAGATGTATTGGTGAGAAACTTG\nAGGCGGGAAGCAGAGAAAGGCAAGCCTGTCACCTTGAAAGACATCTTTGGGGCCTACAGC\nATGGATGTGATTACTGGCACATCATTTGGAGTGAACATCGACTCTCTCAACAATCCACAA\nGACCCCTTTGTGGAGAGCACTAAGAAGTTCCTAAAATTTGGTTTCTTAGATCCATTATTT\nCTCTCAATAATACTCTTTCCATTCCTTACCCCAGTTTTTGAAGCATTAAATGTCTCTCTG\nTTTCCAAAAGATACCATAAATTTTTTAAGTAAATCTGTAAACAGAATGAAGAAAAGTCGC\nCTCAACGACAAACAAAAGCACCGACTAGATTTCCTTCAGCTGATGATTGACTCCCAGAAT\nTCGAAAGAAACTGAGTCCCACAAAGCTCTGTCTGATCTGGAGCTCGCAGCCCAGTCAATA\nATCTTCATTTTTGCTGGCTATGAAACCACCAGCAGTGTTCTTTCCTTCACTTTATATGAA\nCTGGCCACTCACCCTGATGTCCAGCAGAAACTGCAAAAGGAGATTGATGCAGTTTTGCCC\nAATAAGGCACCACCTACCTATGATGCCGTGGTACAGATGGAGTACCTTGACATGGTGGTG\nAATGAAACACTCAGATTATTCCCAGTTGCTATTAGACTTGAGAGGACTTGCAAGAAAGAT\nGTTGAAATCAATGGGGTATTCATTCCCAAAGGGTCAATGGTGGTGATTCCAACTTATGCT\nCTTCACCATGACCCAAAGTACTGGACAGAGCCTGAGGAGTTCCGCCCTGAAAGGTTCAGT\nAAGAAGAAGGACAGCATAGATCCTTACATATACACACCCTTTGGAACTGGACCCAGAAAC\nTGCATTGGCATGAGGTTTGCTCTCATGAACATGAAACTTGCTCTAATCAGAGTCCTTCAG\nAACTTCTCCTTCAAACCTTGTAAAGAAACACAGATCCCCTTGAAATTAGACACGCAAGGA\nCTTCTTCAACCAGAAAAACCCATTGTTCTAAAGGTGGATTCAAGAGATGGAACCCTAAGT\nGGAGAATGA"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-9>	<http://www.w3.org/2000/01/rdf-schema#label>	"Monoisotopic Weight: 399.145063566 from ChemAxon [drugbank_resource:calculated-properties-DB00118-9]"@en .
<http://bio2rdf.org/drugbank_resource:efdc5ed439af008904afce03f4dd2ec8>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Mechanism-of-action> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-18>	<http://purl.org/dc/terms/identifier>	"drugbank_resource:calculated-properties-DB00114-18"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00096-4>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"experimental-properties-DB00096-4"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00110>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:88491d7d06bc30fa9586740372808b10> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:84c4d4608be206e204e18bc4fee8d4a9> .
<http://bio2rdf.org/drugbank:BE0000300>	<http://bio2rdf.org/drugbank_vocabulary:molecular-weight>	"33825.0"^^<http://www.w3.org/2001/XMLSchema#float> .
<http://bio2rdf.org/drugbank:DB00089>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/DB00089> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:14e62611474f52c8e22248963b84f59b>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:14e62611474f52c8e22248963b84f59b"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00089>	<http://bio2rdf.org/drugbank_vocabulary:indication>	<http://bio2rdf.org/drugbank_resource:9be1f0fbe27fc41feab5fa848add809b> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Weight> .
<http://bio2rdf.org/drugbank:DB00088>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/DB00088> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-3>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:BE0000300>	<http://bio2rdf.org/drugbank_vocabulary:amino-acid-sequence>	">Spermidine synthase\nMEPGPDGPAASGPAAIREGWFRETCSLWPGQALSLQVEQLLHHRRSRYQDILVFRSKTYG\nNVLVLDGVIQCTERDEFSYQEMIANLPLCSHPNPRKVLIIGGGDGGVLREVVKHPSVESV\nVQCEIDEDVIQVSKKFLPGMAIGYSSSKLTLHVGDGFEFMKQNQDAFDVIITDSSDPMGP\nAESLFKESYYQLMKTALKEDGVLCCQGECQWLHLDLIKEMRQFCQSLFPVVAYAYCTIPT\nYPSGQIGFMLCSKNPSTNFQEPVQPLTQQQVAQMQLKYYNSDVHRAAFVLPEFARKALND\nVS"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:9e10be5c3dafcd8441cdeb69f72cc3f4> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:87f0fe251ba4940236c1e30de121922a> .
<http://bio2rdf.org/drugbank_resource:a61e3adec088927f97197e2f1513790d>	<http://bio2rdf.org/drugbank_vocabulary:strength>	"50 mg"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:9d6d13e90c7dfeb0d8d2cac125c20125> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00091-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank:DB00117>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:8ae8b01597df174d257016596812aeab> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Isoelectric-Point> .
<http://bio2rdf.org/drugbank:DB00091>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:74985c763ecb65fc6e794b1a003e061f> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-15>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00115-15"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00091-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-25>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00118-25"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00115>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:8e7e8f5ff3cf3466586b956d7330151b> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00094-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Hydrophobicity> .
<http://bio2rdf.org/drugbank:DB00100>	<http://purl.org/dc/terms/title>	"Coagulation Factor IX"@en .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00114-20>	<http://purl.org/dc/terms/title>	"H Bond Acceptor Count: 6 from ChemAxon"@en .
<http://bio2rdf.org/drugbank_resource:05261dbd457e9d2aa8254610c0f9df46>	<http://purl.org/dc/terms/title>	"Aldehyde"@en .
<http://bio2rdf.org/drugbank_resource:efd9b57513efb0eb6e90f59807e0e8d9>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00117-27>	<http://purl.org/dc/terms/title>	"Number of Rings: 1 from ChemAxon"@en .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:mixture>	<http://bio2rdf.org/drugbank_resource:Citanest-Dental> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-14>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-14"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00116>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:8c59273d79bb6ce81fe2a4c0596fa577> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:mixture>	<http://bio2rdf.org/drugbank_resource:Citanest-Dental-Octapressin> .
<http://bio2rdf.org/drugbank_resource:calculated-properties-DB00093-11>	<http://bio2rdf.org/drugbank_vocabulary:value>	"C46H65N13O11S2"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00097>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/DB00097> .
<http://bio2rdf.org/drugbank_resource:efdc5ed439af008904afce03f4dd2ec8>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Resource> .
<http://bio2rdf.org/drugbank_resource:01c6a15f6a299a85cd866fc4092d0dce>	<http://bio2rdf.org/bio2rdf_vocabulary:identifier>	"01c6a15f6a299a85cd866fc4092d0dce"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00090-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Isoelectric-Point> .
<http://bio2rdf.org/drugbank_resource:abc4b12d5153eba9af71c2c651bd4ff1>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/drugbank_resource:abc4b12d5153eba9af71c2c651bd4ff1"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00089-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Melting-Point> .
<http://bio2rdf.org/drugbank:DB00097>	<http://bio2rdf.org/drugbank_vocabulary:clearance>	<http://bio2rdf.org/drugbank_resource:7767fecbc1fcbba1764734e284afdd13> .
<http://bio2rdf.org/drugbank:DB00099>	<http://bio2rdf.org/drugbank_vocabulary:dosage>	<http://bio2rdf.org/drugbank_resource:8750c04d33b8546006e83e736eb80647> .
<http://bio2rdf.org/drugbank:DB00093>	<http://bio2rdf.org/drugbank_vocabulary:mixture>	<http://bio2rdf.org/drugbank_resource:Citanest-Octapressin> .
<http://bio2rdf.org/drugbank:DB00096>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/DB00096> .
<http://bio2rdf.org/drugbank:DB00114>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:8bb9fceb6f80460936af862e9f7d1d94> .
<http://bio2rdf.org/drugbank_resource:experimental-properties-DB00088-4>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://bio2rdf.org/drugbank_vocabulary:Molecular-Formula> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:97f751c9423321c8864c0243afcff111> .
<http://bio2rdf.org/pdb:HIS>	<http://bio2rdf.org/bio2rdf_vocabulary:uri>	"http://bio2rdf.org/pdb:HIS"^^<http://www.w3.org/2001/XMLSchema#string> .
<http://bio2rdf.org/drugbank:DB00094>	<http://bio2rdf.org/bio2rdf_vocabulary:x-identifiers.org>	<http://identifiers.org/drugbank/DB00094> .
<http://bio2rdf.org/drugbank:DB00118>	<http://bio2rdf.org/drugbank_vocabulary:drug-classification-category>	<http://bio2rdf.org/drugbank_resource:96b90ed2d49ca40e5c82fd787db32b84> .